TW568897B - Aminobutanoic acid derivatives - Google Patents
Aminobutanoic acid derivatives Download PDFInfo
- Publication number
- TW568897B TW568897B TW087116686A TW87116686A TW568897B TW 568897 B TW568897 B TW 568897B TW 087116686 A TW087116686 A TW 087116686A TW 87116686 A TW87116686 A TW 87116686A TW 568897 B TW568897 B TW 568897B
- Authority
- TW
- Taiwan
- Prior art keywords
- amino
- hydroxy
- pentamidine
- methyl
- ethoxymethoxy
- Prior art date
Links
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical class CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 14
- 201000010099 disease Diseases 0.000 claims abstract description 13
- 210000004027 cell Anatomy 0.000 claims abstract description 8
- 230000008595 infiltration Effects 0.000 claims abstract description 6
- 238000001764 infiltration Methods 0.000 claims abstract description 6
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 5
- 210000000265 leukocyte Anatomy 0.000 claims abstract description 5
- 206010003210 Arteriosclerosis Diseases 0.000 claims abstract description 4
- 208000028006 Corneal injury Diseases 0.000 claims abstract description 4
- 206010014561 Emphysema Diseases 0.000 claims abstract description 4
- 208000001132 Osteoporosis Diseases 0.000 claims abstract description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 claims abstract description 4
- 201000011510 cancer Diseases 0.000 claims abstract description 4
- 208000019425 cirrhosis of liver Diseases 0.000 claims abstract description 4
- 201000006334 interstitial nephritis Diseases 0.000 claims abstract description 4
- 201000006417 multiple sclerosis Diseases 0.000 claims abstract description 4
- 201000008482 osteoarthritis Diseases 0.000 claims abstract description 4
- 208000028169 periodontal disease Diseases 0.000 claims abstract description 4
- 208000023275 Autoimmune disease Diseases 0.000 claims abstract description 3
- 208000006386 Bone Resorption Diseases 0.000 claims abstract description 3
- 230000033115 angiogenesis Effects 0.000 claims abstract description 3
- 230000024279 bone resorption Effects 0.000 claims abstract description 3
- 230000001575 pathological effect Effects 0.000 claims abstract description 3
- 150000003839 salts Chemical class 0.000 claims abstract 11
- -1 methylthio, phenylthio Chemical group 0.000 claims description 595
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 531
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 512
- 229960004448 pentamidine Drugs 0.000 claims description 415
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 claims description 409
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 354
- 150000001875 compounds Chemical class 0.000 claims description 320
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 169
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 149
- 125000000217 alkyl group Chemical group 0.000 claims description 115
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 111
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 84
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 68
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 68
- 150000001412 amines Chemical class 0.000 claims description 66
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 59
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 53
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 44
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 43
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 claims description 38
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 33
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 28
- 239000011159 matrix material Substances 0.000 claims description 26
- 125000003545 alkoxy group Chemical group 0.000 claims description 22
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 22
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 claims description 22
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 22
- KXHZWUUTWSKONE-UHFFFAOYSA-N 4-[4-(4-carbamimidoylphenoxy)butoxy]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCOC1=CC=C(C(N)=N)C=C1 KXHZWUUTWSKONE-UHFFFAOYSA-N 0.000 claims description 21
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 21
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 21
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims description 20
- 229940005605 valeric acid Drugs 0.000 claims description 19
- 125000003277 amino group Chemical group 0.000 claims description 16
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 15
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 15
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 15
- 101150032584 oxy-4 gene Proteins 0.000 claims description 15
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 15
- 125000005843 halogen group Chemical group 0.000 claims description 14
- 231100000252 nontoxic Toxicity 0.000 claims description 14
- 230000003000 nontoxic effect Effects 0.000 claims description 14
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 13
- 230000033228 biological regulation Effects 0.000 claims description 12
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 12
- 229920002554 vinyl polymer Polymers 0.000 claims description 12
- 101150041968 CDC13 gene Proteins 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 claims description 11
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 11
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 11
- 230000002401 inhibitory effect Effects 0.000 claims description 11
- 125000003342 alkenyl group Chemical group 0.000 claims description 10
- 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 10
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 9
- 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 8
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 7
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 claims description 6
- SNJVRMMSSZDTHE-UHFFFAOYSA-N 4-[(4-butoxybenzoyl)amino]butanoic acid Chemical compound CCCCOC1=CC=C(C(=O)NCCCC(O)=O)C=C1 SNJVRMMSSZDTHE-UHFFFAOYSA-N 0.000 claims description 6
- 239000007789 gas Substances 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052737 gold Inorganic materials 0.000 claims description 6
- 239000010931 gold Substances 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 6
- 150000007857 hydrazones Chemical class 0.000 claims description 6
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 6
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 239000000443 aerosol Substances 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 230000005764 inhibitory process Effects 0.000 claims description 5
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 4
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 4
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 4
- 229940100684 pentylamine Drugs 0.000 claims description 4
- LEWNRJZXHMWQCY-JTQLQIEISA-N (2S)-2-[(4-chlorobenzoyl)amino]pentanoic acid Chemical compound CCC[C@H](NC(=O)c1ccc(Cl)cc1)C(O)=O LEWNRJZXHMWQCY-JTQLQIEISA-N 0.000 claims description 3
- MTDIVDWUWBGJQV-OAHLLOKOSA-N (2r)-4-[[4-(1-benzofuran-2-yl)benzoyl]amino]-2-hydroxybutanoic acid Chemical compound C1=CC(C(=O)NCC[C@@H](O)C(O)=O)=CC=C1C1=CC2=CC=CC=C2O1 MTDIVDWUWBGJQV-OAHLLOKOSA-N 0.000 claims description 3
- VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical compound C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 claims description 3
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 3
- 201000009273 Endometriosis Diseases 0.000 claims description 3
- 150000001335 aliphatic alkanes Chemical group 0.000 claims description 3
- 125000005605 benzo group Chemical group 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 230000001394 metastastic effect Effects 0.000 claims description 3
- 206010061289 metastatic neoplasm Diseases 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 238000004088 simulation Methods 0.000 claims description 3
- KSVCWNSINNTMMG-PKTZIBPZSA-N (2R,4S)-4-[[4-(1-benzofuran-2-yl)benzoyl]amino]-2-benzyl-5-hydroxypentanoic acid Chemical compound C([C@H](C[C@@H](CO)NC(=O)C=1C=CC(=CC=1)C=1OC2=CC=CC=C2C=1)C(O)=O)C1=CC=CC=C1 KSVCWNSINNTMMG-PKTZIBPZSA-N 0.000 claims description 2
- AOWUTXPABBYCCR-AAEUAGOBSA-N (2s,4s)-5-(ethoxymethoxy)-2-methyl-4-[(4-nitrobenzoyl)amino]pentanoic acid Chemical compound CCOCOC[C@H](C[C@H](C)C(O)=O)NC(=O)C1=CC=C([N+]([O-])=O)C=C1 AOWUTXPABBYCCR-AAEUAGOBSA-N 0.000 claims description 2
- XLHUBROMZOAQMV-UHFFFAOYSA-N 1,4-benzosemiquinone Chemical group [O]C1=CC=C(O)C=C1 XLHUBROMZOAQMV-UHFFFAOYSA-N 0.000 claims description 2
- JQQFXAKTNZWSCK-UHFFFAOYSA-N 4-[[4-(4-methoxyphenyl)benzoyl]amino]butanoic acid Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C(=O)NCCCC(O)=O)C=C1 JQQFXAKTNZWSCK-UHFFFAOYSA-N 0.000 claims description 2
- XDIJWFAFDHMHCI-UHFFFAOYSA-N 4-[[5-[2-(4-chlorophenyl)ethenyl]furan-2-carbonyl]amino]butanoic acid Chemical compound O1C(C(=O)NCCCC(=O)O)=CC=C1C=CC1=CC=C(Cl)C=C1 XDIJWFAFDHMHCI-UHFFFAOYSA-N 0.000 claims description 2
- ITBKBOAOORYAQP-LPHOPBHVSA-N COC[C@](C(=O)O)(C[C@@H](COCCOC)NC(=O)C1=CC=C(C=C1)C#N)OC Chemical compound COC[C@](C(=O)O)(C[C@@H](COCCOC)NC(=O)C1=CC=C(C=C1)C#N)OC ITBKBOAOORYAQP-LPHOPBHVSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- LMVCYSFYDRCQTG-UHFFFAOYSA-N ONCC(CCNC(=O)C1=CC=C(C=C1)C)CO Chemical compound ONCC(CCNC(=O)C1=CC=C(C=C1)C)CO LMVCYSFYDRCQTG-UHFFFAOYSA-N 0.000 claims description 2
- 229910000831 Steel Inorganic materials 0.000 claims description 2
- 150000001336 alkenes Chemical class 0.000 claims description 2
- 150000001555 benzenes Chemical group 0.000 claims description 2
- 125000006268 biphenyl-3-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C(*)=C([H])C([H])=C1[H] 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000004871 hexylcarbonyl group Chemical group C(CCCCC)C(=O)* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 2
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 claims description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
- 239000010959 steel Substances 0.000 claims description 2
- 230000002792 vascular Effects 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims 8
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 6
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 claims 6
- 102000000424 Matrix Metalloproteinase 2 Human genes 0.000 claims 5
- 125000002541 furyl group Chemical group 0.000 claims 5
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 5
- 125000001041 indolyl group Chemical group 0.000 claims 5
- 125000001624 naphthyl group Chemical group 0.000 claims 5
- 230000000144 pharmacologic effect Effects 0.000 claims 5
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 4
- 125000005030 pyridylthio group Chemical group N1=C(C=CC=C1)S* 0.000 claims 4
- 125000000168 pyrrolyl group Chemical group 0.000 claims 4
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 3
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- WQADWIOXOXRPLN-UHFFFAOYSA-N 1,3-dithiane Chemical compound C1CSCSC1 WQADWIOXOXRPLN-UHFFFAOYSA-N 0.000 claims 2
- WYGBUQIDRCASOD-UHFFFAOYSA-N 4-[(3-butoxybenzoyl)amino]butanoic acid Chemical compound CCCCOC1=CC=CC(C(=O)NCCCC(O)=O)=C1 WYGBUQIDRCASOD-UHFFFAOYSA-N 0.000 claims 2
- AKFYZTIXPURZLB-XYPYZODXSA-N ONCCCCNC(=O)[C@@H]1CC[C@H](CC1)C Chemical compound ONCCCCNC(=O)[C@@H]1CC[C@H](CC1)C AKFYZTIXPURZLB-XYPYZODXSA-N 0.000 claims 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 2
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 2
- YVZACCLFRNQBNO-UHFFFAOYSA-N pentylhydrazine Chemical compound CCCCCNN YVZACCLFRNQBNO-UHFFFAOYSA-N 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 claims 2
- OZHIYEINSCNALY-SCSAIBSYSA-N (1r)-1-aminobutan-1-ol Chemical compound CCC[C@H](N)O OZHIYEINSCNALY-SCSAIBSYSA-N 0.000 claims 1
- YZQLBWPSRQBTSB-QFBILLFUSA-N (2R,4S)-4-[(4-bromobenzoyl)amino]-5-(ethoxymethoxy)-2-(2-methoxyethoxy)-2-methylpentanoic acid Chemical compound COCCO[C@@](C)(C(O)=O)C[C@@H](COCOCC)NC(=O)C1=CC=C(Br)C=C1 YZQLBWPSRQBTSB-QFBILLFUSA-N 0.000 claims 1
- WJVAPCGKNWQKRT-SVBPBHIXSA-N (2S)-2-[(2S)-2-[[4-(1-benzofuran-2-yl)benzoyl]amino]-3-(methoxymethoxy)propyl]-5-phenylpent-4-enoic acid Chemical compound C([C@@H](C[C@@H](COCOC)NC(=O)C=1C=CC(=CC=1)C=1OC2=CC=CC=C2C=1)C(O)=O)C=CC1=CC=CC=C1 WJVAPCGKNWQKRT-SVBPBHIXSA-N 0.000 claims 1
- LSOPEVBOCBBEIM-JTQLQIEISA-N (2S)-2-[(4-nitrobenzoyl)amino]pentanoic acid Chemical compound [N+](=O)([O-])C1=CC=C(C=C1)C(=O)N[C@H](C(=O)O)CCC LSOPEVBOCBBEIM-JTQLQIEISA-N 0.000 claims 1
- RCOQTMUIDIUDHT-HIFRSBDPSA-N (2r,4s)-4-[(4-chlorobenzoyl)amino]-5-(ethoxymethoxy)-2-(methoxymethyl)pentanoic acid Chemical compound CCOCOC[C@H](C[C@H](COC)C(O)=O)NC(=O)C1=CC=C(Cl)C=C1 RCOQTMUIDIUDHT-HIFRSBDPSA-N 0.000 claims 1
- BMCZOJUFYCQVHB-KGLIPLIRSA-N (2r,4s)-5-(ethoxymethoxy)-2-(methoxymethyl)-4-[(4-nitrobenzoyl)amino]pentanoic acid Chemical compound CCOCOC[C@H](C[C@H](COC)C(O)=O)NC(=O)C1=CC=C([N+]([O-])=O)C=C1 BMCZOJUFYCQVHB-KGLIPLIRSA-N 0.000 claims 1
- IFIQBZOKETZOTD-HOCLYGCPSA-N (2s)-2-[(2s)-2-[(4-bromobenzoyl)amino]-3-(ethoxymethoxy)propyl]pent-4-ynoic acid Chemical compound CCOCOC[C@H](C[C@H](CC#C)C(O)=O)NC(=O)C1=CC=C(Br)C=C1 IFIQBZOKETZOTD-HOCLYGCPSA-N 0.000 claims 1
- HUQULORRAXZRNC-SFHVURJKSA-N (2s)-4-[[4-(1-benzofuran-2-yl)benzoyl]amino]-2-(methoxymethoxymethyl)butanoic acid Chemical compound C1=CC(C(=O)NCC[C@@H](COCOC)C(O)=O)=CC=C1C1=CC2=CC=CC=C2O1 HUQULORRAXZRNC-SFHVURJKSA-N 0.000 claims 1
- TZSDYAVAYAZPQH-WFASDCNBSA-N (2s,4s)-4-[(4-bromobenzoyl)-methylamino]-5-(ethoxymethoxy)-2-methylpentanoic acid Chemical compound CCOCOC[C@H](C[C@H](C)C(O)=O)N(C)C(=O)C1=CC=C(Br)C=C1 TZSDYAVAYAZPQH-WFASDCNBSA-N 0.000 claims 1
- MBSNEAPDUDUNHP-FZMZJTMJSA-N (2s,4s)-4-[(4-chlorobenzoyl)amino]-5-(ethoxymethoxy)-2-methylpentanoic acid Chemical compound CCOCOC[C@H](C[C@H](C)C(O)=O)NC(=O)C1=CC=C(Cl)C=C1 MBSNEAPDUDUNHP-FZMZJTMJSA-N 0.000 claims 1
- UQDRKANLBMLQHD-KXBFYZLASA-N (2s,4s)-4-[[4-(1-benzofuran-2-yl)benzoyl]amino]-5-(methoxymethoxy)-2-methylpentanoic acid Chemical compound C1=CC(C(=O)N[C@@H](C[C@H](C)C(O)=O)COCOC)=CC=C1C1=CC2=CC=CC=C2O1 UQDRKANLBMLQHD-KXBFYZLASA-N 0.000 claims 1
- KRHXPUPKJRXVDS-KKSFZXQISA-N (2s,4s)-4-[[4-(4-cyanophenyl)benzoyl]amino]-5-(ethoxymethoxy)-2-methylpentanoic acid Chemical compound C1=CC(C(=O)N[C@@H](C[C@H](C)C(O)=O)COCOCC)=CC=C1C1=CC=C(C#N)C=C1 KRHXPUPKJRXVDS-KKSFZXQISA-N 0.000 claims 1
- ABQKREZHCULJFH-WFASDCNBSA-N (2s,4s)-5-(ethoxymethoxy)-2-methyl-4-[methyl-(4-nitrobenzoyl)amino]pentanoic acid Chemical compound CCOCOC[C@H](C[C@H](C)C(O)=O)N(C)C(=O)C1=CC=C([N+]([O-])=O)C=C1 ABQKREZHCULJFH-WFASDCNBSA-N 0.000 claims 1
- GRSLSWDTWDWEMK-FUKCDUGKSA-N (4S)-2-(ethoxymethoxy)-4-[(4-phenoxybenzoyl)amino]pentanoic acid Chemical compound C(C)OCOC(C(=O)O)C[C@H](C)NC(=O)C1=CC=C(C=C1)OC1=CC=CC=C1 GRSLSWDTWDWEMK-FUKCDUGKSA-N 0.000 claims 1
- XEXIGSVPWSHGAC-KRWDZBQOSA-N (4s)-4-[[4-(4-chlorophenyl)benzoyl]amino]-5-methoxypentanoic acid Chemical compound C1=CC(C(=O)N[C@@H](CCC(O)=O)COC)=CC=C1C1=CC=C(Cl)C=C1 XEXIGSVPWSHGAC-KRWDZBQOSA-N 0.000 claims 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 1
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 claims 1
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 claims 1
- JZCXXLRGQVHYQJ-UHFFFAOYSA-N 2-(2-aminocyclohexyl)acetic acid Chemical compound NC1CCCCC1CC(O)=O JZCXXLRGQVHYQJ-UHFFFAOYSA-N 0.000 claims 1
- XGBZVGSRSFOIOL-UHFFFAOYSA-N 2-[[4-(1-benzofuran-2-yl)benzoyl]amino]butanoic acid Chemical compound CCC(C(=O)O)NC(=O)C1=CC=C(C=C1)C2=CC3=CC=CC=C3O2 XGBZVGSRSFOIOL-UHFFFAOYSA-N 0.000 claims 1
- TUCRZHGAIRVWTI-UHFFFAOYSA-N 2-bromothiophene Chemical compound BrC1=CC=CS1 TUCRZHGAIRVWTI-UHFFFAOYSA-N 0.000 claims 1
- HXMZLDUBSSPQIB-UHFFFAOYSA-N 2-phenyl-1-benzofuran Chemical compound O1C2=CC=CC=C2C=C1C1=CC=CC=C1 HXMZLDUBSSPQIB-UHFFFAOYSA-N 0.000 claims 1
- BRRPLPVWTLNZGF-UHFFFAOYSA-N 2-phenylcyclopenta[b]pyran Chemical compound C1(=CC=CC=C1)C=1OC=2C(C=CC2)=CC1 BRRPLPVWTLNZGF-UHFFFAOYSA-N 0.000 claims 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 claims 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- QOPYEEXBYYASHI-UHFFFAOYSA-N 4-(1-benzofuran-2-carbonylamino)butanoic acid Chemical compound C1=CC=C2OC(C(=O)NCCCC(=O)O)=CC2=C1 QOPYEEXBYYASHI-UHFFFAOYSA-N 0.000 claims 1
- RHDQZLDUFXDAHE-QHCPKHFHSA-N 4-(1-benzofuran-2-yl)-n-[(2s)-4-(hydroxyamino)-4-oxo-2-(phenylmethoxymethoxy)butyl]benzamide Chemical compound O([C@H](CNC(=O)C=1C=CC(=CC=1)C=1OC2=CC=CC=C2C=1)CC(=O)NO)COCC1=CC=CC=C1 RHDQZLDUFXDAHE-QHCPKHFHSA-N 0.000 claims 1
- UTQRCQWZKSAJPS-UHFFFAOYSA-N 4-[(4-butylbenzoyl)amino]butanoic acid Chemical compound CCCCC1=CC=C(C(=O)NCCCC(O)=O)C=C1 UTQRCQWZKSAJPS-UHFFFAOYSA-N 0.000 claims 1
- XMZXRSDFZJFYMR-UHFFFAOYSA-N 4-[(4-chlorobenzoyl)amino]-2-[2-(n-methylanilino)-2-oxoethoxy]butanoic acid Chemical compound C=1C=CC=CC=1N(C)C(=O)COC(C(O)=O)CCNC(=O)C1=CC=C(Cl)C=C1 XMZXRSDFZJFYMR-UHFFFAOYSA-N 0.000 claims 1
- KAOJECJXESECIB-UHFFFAOYSA-N 4-[(4-cyclohexylbenzoyl)amino]butanoic acid Chemical compound C1=CC(C(=O)NCCCC(=O)O)=CC=C1C1CCCCC1 KAOJECJXESECIB-UHFFFAOYSA-N 0.000 claims 1
- PKBDEULZMLFZJS-UHFFFAOYSA-N 4-[(4-methylbenzoyl)amino]-2-(phenylmethoxymethyl)butanoic acid Chemical compound C1=CC(C)=CC=C1C(=O)NCCC(C(O)=O)COCC1=CC=CC=C1 PKBDEULZMLFZJS-UHFFFAOYSA-N 0.000 claims 1
- ROOXOEPLHGAHAX-UHFFFAOYSA-N 4-[(4-methylbenzoyl)amino]butanoic acid Chemical compound CC1=CC=C(C(=O)NCCCC(O)=O)C=C1 ROOXOEPLHGAHAX-UHFFFAOYSA-N 0.000 claims 1
- IKBWVKRRZCKMSK-UHFFFAOYSA-N 4-[[4-(1-benzofuran-2-yl)benzoyl]amino]butanoic acid Chemical compound C1=CC(C(=O)NCCCC(=O)O)=CC=C1C1=CC2=CC=CC=C2O1 IKBWVKRRZCKMSK-UHFFFAOYSA-N 0.000 claims 1
- DZYZNDVMQPHTRH-UHFFFAOYSA-N 4-[[4-(3-methoxyprop-1-ynyl)benzoyl]amino]butanoic acid Chemical compound COCC#CC1=CC=C(C(=O)NCCCC(O)=O)C=C1 DZYZNDVMQPHTRH-UHFFFAOYSA-N 0.000 claims 1
- AVFHDEJVUJPZGG-UHFFFAOYSA-N 4-[[4-(4-chlorophenyl)benzoyl]amino]butanoic acid Chemical compound C1=CC(C(=O)NCCCC(=O)O)=CC=C1C1=CC=C(Cl)C=C1 AVFHDEJVUJPZGG-UHFFFAOYSA-N 0.000 claims 1
- FQEBJXMRSOXOBQ-UHFFFAOYSA-N 4-[[4-(4-propylphenyl)benzoyl]amino]butanoic acid Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)NCCCC(O)=O)C=C1 FQEBJXMRSOXOBQ-UHFFFAOYSA-N 0.000 claims 1
- NYGUVTLBWZLSQU-UHFFFAOYSA-N 4-[[4-[(4-bromophenyl)sulfamoyl]benzoyl]amino]butanoic acid Chemical compound C1=CC(C(=O)NCCCC(=O)O)=CC=C1S(=O)(=O)NC1=CC=C(Br)C=C1 NYGUVTLBWZLSQU-UHFFFAOYSA-N 0.000 claims 1
- QYGBHAMRBRWBHM-UHFFFAOYSA-N 4-[[4-[2-(4-imidazol-1-ylphenyl)ethynyl]benzoyl]amino]butanoic acid Chemical compound C1=CC(C(=O)NCCCC(=O)O)=CC=C1C#CC1=CC=C(N2C=NC=C2)C=C1 QYGBHAMRBRWBHM-UHFFFAOYSA-N 0.000 claims 1
- JSPREZGCQVTMGY-UHFFFAOYSA-N 4-[[4-[2-(4-methylphenyl)ethynyl]benzoyl]amino]butanoic acid Chemical compound C1=CC(C)=CC=C1C#CC1=CC=C(C(=O)NCCCC(O)=O)C=C1 JSPREZGCQVTMGY-UHFFFAOYSA-N 0.000 claims 1
- DWFLRDUPBZTCKD-UHFFFAOYSA-N C(=O)=C(C(=O)O)CCNC(=O)C1=CC=C(C=C1)C=1OC2=C(C1)C=CC=C2 Chemical compound C(=O)=C(C(=O)O)CCNC(=O)C1=CC=C(C=C1)C=1OC2=C(C1)C=CC=C2 DWFLRDUPBZTCKD-UHFFFAOYSA-N 0.000 claims 1
- BBPVTCAOJOFTAW-UHFFFAOYSA-N C(CCCC)C1=C(C=2CC3=CC=CC=C3C2C=C1)N Chemical compound C(CCCC)C1=C(C=2CC3=CC=CC=C3C2C=C1)N BBPVTCAOJOFTAW-UHFFFAOYSA-N 0.000 claims 1
- VSQDVMXCJSPYJF-UHFFFAOYSA-N C1CCC(CC1)C2=CC=C(C=C2)C(=O)NCCCCNO Chemical compound C1CCC(CC1)C2=CC=C(C=C2)C(=O)NCCCCNO VSQDVMXCJSPYJF-UHFFFAOYSA-N 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- OWQVNQZIWAQREM-HAQNSBGRSA-N CCC[C@H]1CC[C@H](C(=O)NCCCC(O)=O)CC1 Chemical compound CCC[C@H]1CC[C@H](C(=O)NCCCC(O)=O)CC1 OWQVNQZIWAQREM-HAQNSBGRSA-N 0.000 claims 1
- APWFSXSDSJRVAO-MGCOHNPYSA-N C[C@H]1CC[C@H](C(=O)NCCCC(O)=O)CC1 Chemical compound C[C@H]1CC[C@H](C(=O)NCCCC(O)=O)CC1 APWFSXSDSJRVAO-MGCOHNPYSA-N 0.000 claims 1
- 101100166166 Drosophila melanogaster cas gene Proteins 0.000 claims 1
- 102000005741 Metalloproteases Human genes 0.000 claims 1
- 108010006035 Metalloproteases Proteins 0.000 claims 1
- 101100518501 Mus musculus Spp1 gene Proteins 0.000 claims 1
- LFHSVFPSHHJEQU-UHFFFAOYSA-N N-cyclopentyl-4-(3-methoxyprop-1-ynyl)benzamide Chemical compound COCC#CC1=CC=C(C=C1)C(=O)NC1CCCC1 LFHSVFPSHHJEQU-UHFFFAOYSA-N 0.000 claims 1
- 229910002651 NO3 Inorganic materials 0.000 claims 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 1
- YCAOQHDESRPREY-INIZCTEOSA-N O(C1=CC=CC=C1)C1=CC=C(C=C1)C(=O)N[C@H](C(=O)O)CCC Chemical compound O(C1=CC=CC=C1)C1=CC=C(C=C1)C(=O)N[C@H](C(=O)O)CCC YCAOQHDESRPREY-INIZCTEOSA-N 0.000 claims 1
- LGFWDVOPLOFHPB-AWEZNQCLSA-N OC[C@@H](C(=O)O)CCNC(=O)C1=CC=C(C=C1)C#CCOC Chemical compound OC[C@@H](C(=O)O)CCNC(=O)C1=CC=C(C=C1)C#CCOC LGFWDVOPLOFHPB-AWEZNQCLSA-N 0.000 claims 1
- MHQINTRBVVQWKO-INIZCTEOSA-N OC[C@@H](C(=O)O)CCNC(=O)C1=CC=C(C=C1)C=1OC2=C(C1)C=CC=C2 Chemical compound OC[C@@H](C(=O)O)CCNC(=O)C1=CC=C(C=C1)C=1OC2=C(C1)C=CC=C2 MHQINTRBVVQWKO-INIZCTEOSA-N 0.000 claims 1
- UMILEDQTDLJXNW-UHFFFAOYSA-N ONCC(CCNC(=O)C1=CC=C(C=C1)C)COCC1=CC=CC=C1 Chemical compound ONCC(CCNC(=O)C1=CC=C(C=C1)C)COCC1=CC=CC=C1 UMILEDQTDLJXNW-UHFFFAOYSA-N 0.000 claims 1
- IOLHFBZGNDFBDO-UHFFFAOYSA-N ONCC(CCNC(=O)C1=CC=C(C=C1)OC1=CC=CC=C1)CC(C)C Chemical compound ONCC(CCNC(=O)C1=CC=C(C=C1)OC1=CC=CC=C1)CC(C)C IOLHFBZGNDFBDO-UHFFFAOYSA-N 0.000 claims 1
- NWTMGNPKVIJBGX-UHFFFAOYSA-N ONCCCCNC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)Cl Chemical compound ONCCCCNC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)Cl NWTMGNPKVIJBGX-UHFFFAOYSA-N 0.000 claims 1
- UPANBTODVFQCEX-UHFFFAOYSA-N ONCCCCNC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)O Chemical compound ONCCCCNC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)O UPANBTODVFQCEX-UHFFFAOYSA-N 0.000 claims 1
- KJECSXQGFZSUPL-UHFFFAOYSA-N ONCCCCNC(=O)C1=CC=C(C=C1)OCCCC Chemical compound ONCCCCNC(=O)C1=CC=C(C=C1)OCCCC KJECSXQGFZSUPL-UHFFFAOYSA-N 0.000 claims 1
- UYUPGBUHJWPLDR-UHFFFAOYSA-N ONCCCCNC(=O)C=1NC2=CC=C(C=C2C1)OCC1=CC=CC=C1 Chemical compound ONCCCCNC(=O)C=1NC2=CC=C(C=C2C1)OCC1=CC=CC=C1 UYUPGBUHJWPLDR-UHFFFAOYSA-N 0.000 claims 1
- XFZQPLDTAIISNB-UHFFFAOYSA-N ONCCCCNC(=O)C=1OC(=CC1)C=CC1=CC=C(C=C1)Cl Chemical compound ONCCCCNC(=O)C=1OC(=CC1)C=CC1=CC=C(C=C1)Cl XFZQPLDTAIISNB-UHFFFAOYSA-N 0.000 claims 1
- ASSHYBMOOKIOCH-KRWDZBQOSA-N ONCCC[C@H](NC(=O)C1=CC=C(C=C1)C=1OC2=C(C1)C=CC=C2)CO Chemical compound ONCCC[C@H](NC(=O)C1=CC=C(C=C1)C=1OC2=C(C1)C=CC=C2)CO ASSHYBMOOKIOCH-KRWDZBQOSA-N 0.000 claims 1
- 102100036163 Phosphatidylinositol N-acetylglucosaminyltransferase subunit C Human genes 0.000 claims 1
- 101710109732 Phosphatidylinositol N-acetylglucosaminyltransferase subunit C Proteins 0.000 claims 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000003368 amide group Chemical group 0.000 claims 1
- 208000007474 aortic aneurysm Diseases 0.000 claims 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims 1
- 125000006364 carbonyl oxy methylene group Chemical group [H]C([H])([*:2])OC([*:1])=O 0.000 claims 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical group ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims 1
- 239000009937 cyclo 3 Substances 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 125000004494 ethyl ester group Chemical group 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 claims 1
- 229960001915 hexamidine Drugs 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 150000004702 methyl esters Chemical class 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methylcyclopentane Chemical compound CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- XMLFTCHRMYUXFV-WCQYABFASA-N n-[(1r,2s)-2-[2-(hydroxyamino)-2-oxoethyl]cyclohexyl]-4-nitrobenzamide Chemical compound ONC(=O)C[C@@H]1CCCC[C@H]1NC(=O)C1=CC=C([N+]([O-])=O)C=C1 XMLFTCHRMYUXFV-WCQYABFASA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229950010879 phenamine Drugs 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 125000002653 sulfanylmethyl group Chemical group [H]SC([H])([H])[*] 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 229930192474 thiophene Natural products 0.000 claims 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract description 6
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000035755 proliferation Effects 0.000 abstract description 2
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 208000004145 Endometritis Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 586
- 238000011049 filling Methods 0.000 description 185
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 184
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 184
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 133
- 238000000034 method Methods 0.000 description 83
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 81
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 64
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 63
- 230000002079 cooperative effect Effects 0.000 description 60
- 230000000704 physical effect Effects 0.000 description 56
- 239000000243 solution Substances 0.000 description 54
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 52
- 239000000460 chlorine Substances 0.000 description 45
- 239000011541 reaction mixture Substances 0.000 description 44
- 230000000875 corresponding effect Effects 0.000 description 40
- 238000010511 deprotection reaction Methods 0.000 description 38
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 30
- 239000000203 mixture Substances 0.000 description 28
- 239000007864 aqueous solution Substances 0.000 description 24
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 21
- 239000002585 base Substances 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 21
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 19
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 238000003379 elimination reaction Methods 0.000 description 17
- 230000002441 reversible effect Effects 0.000 description 17
- 230000008030 elimination Effects 0.000 description 15
- 230000002378 acidificating effect Effects 0.000 description 14
- 229920006395 saturated elastomer Polymers 0.000 description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 13
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 11
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 10
- 235000017491 Bambusa tulda Nutrition 0.000 description 10
- 241001330002 Bambuseae Species 0.000 description 10
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 10
- 125000002947 alkylene group Chemical group 0.000 description 10
- 239000011425 bamboo Substances 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 10
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
- 125000000623 heterocyclic group Chemical group 0.000 description 9
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 8
- 238000007792 addition Methods 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 125000002837 carbocyclic group Chemical group 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- UUIQMZJEGPQKFD-UHFFFAOYSA-N n-butyric acid methyl ester Natural products CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 7
- 238000012856 packing Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical group [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 238000006297 dehydration reaction Methods 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical group NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 125000005245 nitryl group Chemical group [N+](=O)([O-])* 0.000 description 6
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 6
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- ORXQCFXGVWJQOV-BYPYZUCNSA-N (2s)-4-amino-2-methoxycarbonylbutanoic acid Chemical compound COC(=O)[C@H](C(O)=O)CCN ORXQCFXGVWJQOV-BYPYZUCNSA-N 0.000 description 5
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 5
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 5
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 5
- PWLNAUNEAKQYLH-UHFFFAOYSA-N butyric acid octyl ester Natural products CCCCCCCCOC(=O)CCC PWLNAUNEAKQYLH-UHFFFAOYSA-N 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 230000003301 hydrolyzing effect Effects 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 125000002950 monocyclic group Chemical group 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 125000004430 oxygen atom Chemical group O* 0.000 description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 4
- ORXQCFXGVWJQOV-SCSAIBSYSA-N COC(=O)[C@H](CCN)C(=O)O Chemical compound COC(=O)[C@H](CCN)C(=O)O ORXQCFXGVWJQOV-SCSAIBSYSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 102000010750 Metalloproteins Human genes 0.000 description 4
- 108010063312 Metalloproteins Proteins 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- 229920001131 Pulp (paper) Polymers 0.000 description 4
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 4
- 150000001409 amidines Chemical class 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 125000002619 bicyclic group Chemical group 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 238000009434 installation Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- LRANPJDWHYRCER-UHFFFAOYSA-N 1,2-diazepine Chemical compound N1C=CC=CC=N1 LRANPJDWHYRCER-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 3
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 229960002424 collagenase Drugs 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 3
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 3
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 125000004055 thiomethyl group Chemical group [H]SC([H])([H])* 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- RXBYRTSOWREATF-UHFFFAOYSA-N 1,2,3,4-tetrahydroacridine Chemical compound C1=CC=C2C=C(CCCC3)C3=NC2=C1 RXBYRTSOWREATF-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 2
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 2
- MDNGXAFGRWQHNZ-UHFFFAOYSA-N 2,3,3a,4,5,6,7,7a-octahydro-1h-benzimidazole Chemical compound C1CCCC2NCNC21 MDNGXAFGRWQHNZ-UHFFFAOYSA-N 0.000 description 2
- PZJFUNZDCRKXPZ-UHFFFAOYSA-N 2,5-dihydro-1h-tetrazole Chemical compound C1NNN=N1 PZJFUNZDCRKXPZ-UHFFFAOYSA-N 0.000 description 2
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 108010026132 Gelatinases Proteins 0.000 description 2
- 102000013382 Gelatinases Human genes 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 229930194542 Keto Natural products 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- 241000577218 Phenes Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical compound CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 102100030416 Stromelysin-1 Human genes 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 229940122618 Trypsin inhibitor Drugs 0.000 description 2
- 101710162629 Trypsin inhibitor Proteins 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 2
- 229910001863 barium hydroxide Inorganic materials 0.000 description 2
- MXMZCLLIUQEKSN-UHFFFAOYSA-N benzimidazoline Chemical compound C1=CC=C2NCNC2=C1 MXMZCLLIUQEKSN-UHFFFAOYSA-N 0.000 description 2
- 229940049706 benzodiazepine Drugs 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- PVEOYINWKBTPIZ-UHFFFAOYSA-N but-3-enoic acid Chemical compound OC(=O)CC=C PVEOYINWKBTPIZ-UHFFFAOYSA-N 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- RWRIWBAIICGTTQ-UHFFFAOYSA-N difluoromethane Chemical compound FCF RWRIWBAIICGTTQ-UHFFFAOYSA-N 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
- 125000005935 hexyloxycarbonyl group Chemical group 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 239000003701 inert diluent Substances 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229910052762 osmium Inorganic materials 0.000 description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 2
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 239000002753 trypsin inhibitor Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- QHGUHUZRVLNOLK-JTQLQIEISA-N (2S)-2-[(4-bromobenzoyl)amino]pentanoic acid Chemical compound CCC[C@H](NC(=O)c1ccc(Br)cc1)C(O)=O QHGUHUZRVLNOLK-JTQLQIEISA-N 0.000 description 1
- XLBVNMSMFQMKEY-SCSAIBSYSA-N (2r)-2-(methylamino)pentanedioic acid Chemical compound CN[C@@H](C(O)=O)CCC(O)=O XLBVNMSMFQMKEY-SCSAIBSYSA-N 0.000 description 1
- FQJHEJPSXOJCMX-CTNGQTDRSA-N (2r,4s)-4-[(4-bromobenzoyl)amino]-5-(ethoxymethoxy)-2-(phenylmethoxymethyl)pentanoic acid Chemical compound C([C@@H](C[C@@H](COCOCC)NC(=O)C=1C=CC(Br)=CC=1)C(O)=O)OCC1=CC=CC=C1 FQJHEJPSXOJCMX-CTNGQTDRSA-N 0.000 description 1
- ZHXQWCRPLHNVDA-GJZGRUSLSA-N (2s)-2-[(2s)-3-(ethoxymethoxy)-2-[(4-nitrobenzoyl)amino]propyl]pent-4-ynoic acid Chemical compound CCOCOC[C@H](C[C@H](CC#C)C(O)=O)NC(=O)C1=CC=C([N+]([O-])=O)C=C1 ZHXQWCRPLHNVDA-GJZGRUSLSA-N 0.000 description 1
- QFHKDIJBGZXUQP-DEOSSOPVSA-N (2s)-4-[[4-(1-benzofuran-2-yl)benzoyl]amino]-2-(phenylmethoxymethoxy)butanoic acid Chemical compound O([C@@H](CCNC(=O)C=1C=CC(=CC=1)C=1OC2=CC=CC=C2C=1)C(=O)O)COCC1=CC=CC=C1 QFHKDIJBGZXUQP-DEOSSOPVSA-N 0.000 description 1
- IVUOMFWNDGNLBJ-VKHMYHEASA-N (2s)-4-amino-2-hydroxybutanoic acid Chemical compound NCC[C@H](O)C(O)=O IVUOMFWNDGNLBJ-VKHMYHEASA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- LGSNPDZPLAPNLI-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a,6b,7,8,9,9a,9b,10,11,12,12a,12b,12c-icosahydroperylene Chemical group C12C3CCCC2CCCC1C1CCCC2C1C3CCC2 LGSNPDZPLAPNLI-UHFFFAOYSA-N 0.000 description 1
- HQDYNFWTFJFEPR-UHFFFAOYSA-N 1,2,3,3a-tetrahydropyrene Chemical compound C1=C2CCCC(C=C3)C2=C2C3=CC=CC2=C1 HQDYNFWTFJFEPR-UHFFFAOYSA-N 0.000 description 1
- IXTPCSZJZAKJTO-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7,8,8a,9,9a,10,10a-tetradecahydroacridine Chemical compound N1C2CCCCC2CC2C1CCCC2 IXTPCSZJZAKJTO-UHFFFAOYSA-N 0.000 description 1
- PIHAUZGWAXLKCA-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7,8,8a-decahydro-1,8-naphthyridine Chemical compound N1CCCC2CCCNC21 PIHAUZGWAXLKCA-UHFFFAOYSA-N 0.000 description 1
- ZCZVGQCBSJLDDS-UHFFFAOYSA-N 1,2,3,4-tetrahydro-1,8-naphthyridine Chemical compound C1=CC=C2CCCNC2=N1 ZCZVGQCBSJLDDS-UHFFFAOYSA-N 0.000 description 1
- LWHXMYTXHFOYHA-UHFFFAOYSA-N 1,2,3,4-tetrahydrophosphinoline Chemical compound C1=CC=C2CCCPC2=C1 LWHXMYTXHFOYHA-UHFFFAOYSA-N 0.000 description 1
- OTPDWCMLUKMQNO-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine Chemical compound C1NCC=CN1 OTPDWCMLUKMQNO-UHFFFAOYSA-N 0.000 description 1
- HGQBCKVFVUCIML-UHFFFAOYSA-N 1,3,3a,4,5,6,7,7a-octahydro-2-benzofuran Chemical compound C1CCCC2COCC21 HGQBCKVFVUCIML-UHFFFAOYSA-N 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- WBBXZFBNIWQJQG-UHFFFAOYSA-N 1-O-butyl 3-O-methyl 2-[2-(phenylmethoxycarbonylamino)ethyl]propanedioate Chemical compound COC(C(CCNC(=O)OCC1=CC=CC=C1)C(=O)OCCCC)=O WBBXZFBNIWQJQG-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- DQFQCHIDRBIESA-UHFFFAOYSA-N 1-benzazepine Chemical compound N1C=CC=CC2=CC=CC=C12 DQFQCHIDRBIESA-UHFFFAOYSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- TVZDWYYXHAIMCR-BKNSPTOHSA-N 158584-09-9 Chemical compound C([C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCNC(N)=N)NC(=O)CC=1C=2C=CC(OC)=CC=2OC(=O)C=1)C(C)C)CCC)C(N)=O)CCCNC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O TVZDWYYXHAIMCR-BKNSPTOHSA-N 0.000 description 1
- NITMACBPVVUGOJ-UHFFFAOYSA-N 2,2,2-trifluoroethanimidamide Chemical compound NC(=N)C(F)(F)F NITMACBPVVUGOJ-UHFFFAOYSA-N 0.000 description 1
- DNZWAKVIOXCEHH-UHFFFAOYSA-N 2,3,3a,4,5,6,7,7a-octahydro-1-benzofuran Chemical compound C1CCCC2OCCC21 DNZWAKVIOXCEHH-UHFFFAOYSA-N 0.000 description 1
- LVJPACZOEKXFAY-UHFFFAOYSA-N 2,3,3a,4,5,6,7,7a-octahydro-1h-indazole Chemical compound C1CCCC2CNNC21 LVJPACZOEKXFAY-UHFFFAOYSA-N 0.000 description 1
- SBVSDAFTZIVQEI-UHFFFAOYSA-N 2,3,4,4a,4b,5,6,7,8,8a,9,9a-dodecahydro-1h-carbazole Chemical compound C1CCCC2C3CCCCC3NC21 SBVSDAFTZIVQEI-UHFFFAOYSA-N 0.000 description 1
- NGQQUXXTDZADNX-UHFFFAOYSA-N 2,3,4,5-tetrachlorofuran Chemical compound ClC=1OC(Cl)=C(Cl)C=1Cl NGQQUXXTDZADNX-UHFFFAOYSA-N 0.000 description 1
- SCEIUGQQBYRBPP-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-azepine Chemical compound C1CCC=CNC1 SCEIUGQQBYRBPP-UHFFFAOYSA-N 0.000 description 1
- YYVKQFQZKSLYFN-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-diazepine Chemical compound C1CNNC=CC1 YYVKQFQZKSLYFN-UHFFFAOYSA-N 0.000 description 1
- XKLNOVWDVMWTOB-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1h-carbazole Chemical compound N1C2=CC=CC=C2C2=C1CCCC2 XKLNOVWDVMWTOB-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- QDKGOMZIPXGDDJ-UHFFFAOYSA-N 2,3-dihydro-1h-indazole Chemical compound C1=CC=C2CNNC2=C1 QDKGOMZIPXGDDJ-UHFFFAOYSA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N 2,5-dimethylfuran Chemical compound CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
- ZECQLHQEHJJSAN-UHFFFAOYSA-N 2,9-dihydro-1h-carbazole Chemical compound N1C2=CC=CC=C2C2=C1CCC=C2 ZECQLHQEHJJSAN-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- RQLSGOSPWXLLQA-UHFFFAOYSA-N 2-[(4-methylbenzoyl)amino]butanoic acid Chemical compound CCC(C(O)=O)NC(=O)C1=CC=C(C)C=C1 RQLSGOSPWXLLQA-UHFFFAOYSA-N 0.000 description 1
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- VKUYLANQOAKALN-UHFFFAOYSA-N 2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C(CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N 2-aminopentanoic acid Chemical compound CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- UXGVMFHEKMGWMA-UHFFFAOYSA-N 2-benzofuran Chemical compound C1=CC=CC2=COC=C21 UXGVMFHEKMGWMA-UHFFFAOYSA-N 0.000 description 1
- MLRBNIXMTWSDJU-UHFFFAOYSA-N 2-benzylfuran Chemical compound C=1C=CC=CC=1CC1=CC=CO1 MLRBNIXMTWSDJU-UHFFFAOYSA-N 0.000 description 1
- AJYLWDRNNNHBEV-UHFFFAOYSA-N 2-hydrazinylbutanoic acid Chemical class CCC(NN)C(O)=O AJYLWDRNNNHBEV-UHFFFAOYSA-N 0.000 description 1
- QKPVEISEHYYHRH-UHFFFAOYSA-N 2-methoxyacetonitrile Chemical compound COCC#N QKPVEISEHYYHRH-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- UKYIWGPUGDLWFB-UHFFFAOYSA-N 2-propyl-1-benzofuran Chemical compound C1=CC=C2OC(CCC)=CC2=C1 UKYIWGPUGDLWFB-UHFFFAOYSA-N 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- ZJSQZQMVXKZAGW-UHFFFAOYSA-N 2H-benzotriazol-4-ol hydrate Chemical compound O.OC1=CC=CC2=C1N=NN2 ZJSQZQMVXKZAGW-UHFFFAOYSA-N 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
- WGTASENVNYJZBK-UHFFFAOYSA-N 3,4,5-trimethoxyamphetamine Chemical compound COC1=CC(CC(C)N)=CC(OC)=C1OC WGTASENVNYJZBK-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- HCUUTQMXIXCAFA-UHFFFAOYSA-N 3-O-benzyl 1-O-butyl 2-(2-aminoethyl)propanedioate Chemical compound C(C1=CC=CC=C1)OC(C(CCN)C(=O)OCCCC)=O HCUUTQMXIXCAFA-UHFFFAOYSA-N 0.000 description 1
- YACFFSVYSPMSGS-UHFFFAOYSA-N 3-methoxyprop-1-yne Chemical compound COCC#C YACFFSVYSPMSGS-UHFFFAOYSA-N 0.000 description 1
- WLYUMBPDHPMKHM-UHFFFAOYSA-N 3a,4,5,6,7,7a-hexahydro-3h-2-benzofuran-1-one Chemical compound C1CCCC2C(=O)OCC21 WLYUMBPDHPMKHM-UHFFFAOYSA-N 0.000 description 1
- NYXOOUJNXJFBDU-UHFFFAOYSA-N 4-(1-benzofuran-2-yl)-N-[5-(hydroxyamino)pentyl]benzamide Chemical compound C1=CC(C(=O)NCCCCCNO)=CC=C1C1=CC2=CC=CC=C2O1 NYXOOUJNXJFBDU-UHFFFAOYSA-N 0.000 description 1
- GHSYTTUDMYEMCB-DEOSSOPVSA-N 4-(1-benzofuran-2-yl)-n-[(3s)-4-(hydroxyamino)-4-oxo-3-(phenylmethoxymethoxy)butyl]benzamide Chemical compound O([C@@H](CCNC(=O)C=1C=CC(=CC=1)C=1OC2=CC=CC=C2C=1)C(=O)NO)COCC1=CC=CC=C1 GHSYTTUDMYEMCB-DEOSSOPVSA-N 0.000 description 1
- VSNNTVMTUYOYTB-UHFFFAOYSA-N 4-(1-benzofuran-2-yl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC2=CC=CC=C2O1 VSNNTVMTUYOYTB-UHFFFAOYSA-N 0.000 description 1
- VCYGPJCGMPXMDG-UHFFFAOYSA-N 4-(1-benzofuran-2-yl)benzoyl chloride Chemical compound C1=CC(C(=O)Cl)=CC=C1C1=CC2=CC=CC=C2O1 VCYGPJCGMPXMDG-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- XQVKLMRIZCRVPO-UHFFFAOYSA-N 4-[(2-arsonophenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C12=CC=C(S(O)(=O)=O)C=C2C=C(S(O)(=O)=O)C(O)=C1N=NC1=CC=CC=C1[As](O)(O)=O XQVKLMRIZCRVPO-UHFFFAOYSA-N 0.000 description 1
- SGPPLQUOBJVMJN-UHFFFAOYSA-N 4-[(4-chlorobenzoyl)amino]-2-(phenylmethoxymethoxy)butanoic acid Chemical compound C=1C=CC=CC=1COCOC(C(=O)O)CCNC(=O)C1=CC=C(Cl)C=C1 SGPPLQUOBJVMJN-UHFFFAOYSA-N 0.000 description 1
- JHQJKVFYSDWZJX-UHFFFAOYSA-N 4-[(4-phenoxybenzoyl)amino]butanoic acid Chemical compound C1=CC(C(=O)NCCCC(=O)O)=CC=C1OC1=CC=CC=C1 JHQJKVFYSDWZJX-UHFFFAOYSA-N 0.000 description 1
- BHNLYOXFSPDOSN-UHFFFAOYSA-N 4-[(4-pyrrol-1-ylbenzoyl)amino]butanoic acid Chemical compound C1=CC(C(=O)NCCCC(=O)O)=CC=C1N1C=CC=C1 BHNLYOXFSPDOSN-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-n-(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 description 1
- WTFUTSCZYYCBAY-SXBRIOAWSA-N 6-[(E)-C-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-N-hydroxycarbonimidoyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C/C(=N/O)/C1=CC2=C(NC(O2)=O)C=C1 WTFUTSCZYYCBAY-SXBRIOAWSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WJRFOSBCACMRMM-UHFFFAOYSA-N 9H-fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1.C1=CC=C2CC3=CC=CC=C3C2=C1 WJRFOSBCACMRMM-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 102100036013 Antigen-presenting glycoprotein CD1d Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- PYPBSOVTDXVXNF-KRWDZBQOSA-N C(C1=CC=CC=C1)NC(=O)[C@@H](C(=O)O)CCNC(=O)C1=CC=C(C=C1)C Chemical compound C(C1=CC=CC=C1)NC(=O)[C@@H](C(=O)O)CCNC(=O)C1=CC=C(C=C1)C PYPBSOVTDXVXNF-KRWDZBQOSA-N 0.000 description 1
- NEULNOMQCRVFOQ-UHFFFAOYSA-J C([O-])([O-])=O.[Re+4].C([O-])([O-])=O Chemical compound C([O-])([O-])=O.[Re+4].C([O-])([O-])=O NEULNOMQCRVFOQ-UHFFFAOYSA-J 0.000 description 1
- AXEOTDBULDKESH-UHFFFAOYSA-K C1(=CC=CC=C1)S(=O)(=O)[O-].[Eu+3].C1(=CC=CC=C1)S(=O)(=O)[O-].C1(=CC=CC=C1)S(=O)(=O)[O-] Chemical compound C1(=CC=CC=C1)S(=O)(=O)[O-].[Eu+3].C1(=CC=CC=C1)S(=O)(=O)[O-].C1(=CC=CC=C1)S(=O)(=O)[O-] AXEOTDBULDKESH-UHFFFAOYSA-K 0.000 description 1
- LSTYEJWVJIPJFT-UHFFFAOYSA-N C1=CC(=CC=C1C2=COC(=C2)C(=O)NCCCCNO)Cl Chemical compound C1=CC(=CC=C1C2=COC(=C2)C(=O)NCCCCNO)Cl LSTYEJWVJIPJFT-UHFFFAOYSA-N 0.000 description 1
- PYKQOCONAOZOEF-UHFFFAOYSA-N C1=CC=C2C3=CC=CC=C3C=CC2=C1.C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1.C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 PYKQOCONAOZOEF-UHFFFAOYSA-N 0.000 description 1
- UFRLIVTWHNNQQJ-UHFFFAOYSA-N C1CN(CCC1C2=CC=CC=C2)C3=CC=C(C=C3)C(=O)NCCCCNO Chemical compound C1CN(CCC1C2=CC=CC=C2)C3=CC=C(C=C3)C(=O)NCCCCNO UFRLIVTWHNNQQJ-UHFFFAOYSA-N 0.000 description 1
- WJFHFIWGVKZSQN-KRWDZBQOSA-N CC1=CC=C(C=C1)C(=O)NCC[C@@](CCCCO)(C(=O)N)C(=O)O Chemical compound CC1=CC=C(C=C1)C(=O)NCC[C@@](CCCCO)(C(=O)N)C(=O)O WJFHFIWGVKZSQN-KRWDZBQOSA-N 0.000 description 1
- JVMUOBVVJLMBFH-UHFFFAOYSA-N CCCCOC1=CC=CC(=C1)C(=O)NCCCCNO Chemical compound CCCCOC1=CC=CC(=C1)C(=O)NCCCCNO JVMUOBVVJLMBFH-UHFFFAOYSA-N 0.000 description 1
- GHCVDAJWXCXGEN-UHFFFAOYSA-N CN(C)NC1CCCC1 Chemical compound CN(C)NC1CCCC1 GHCVDAJWXCXGEN-UHFFFAOYSA-N 0.000 description 1
- IHYUMGWXWCKXHT-AWEZNQCLSA-N COC(=O)[C@@H](CCNC(=O)C1=CC=C(C=C1)C#CCCO)C(=O)O Chemical compound COC(=O)[C@@H](CCNC(=O)C1=CC=C(C=C1)C#CCCO)C(=O)O IHYUMGWXWCKXHT-AWEZNQCLSA-N 0.000 description 1
- 101100037762 Caenorhabditis elegans rnh-2 gene Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 241000508725 Elymus repens Species 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000789014 Hexaplex Species 0.000 description 1
- 101000716121 Homo sapiens Antigen-presenting glycoprotein CD1d Proteins 0.000 description 1
- 101000897407 Homo sapiens T-cell surface glycoprotein CD1e, membrane-associated Proteins 0.000 description 1
- JGFBQFKZKSSODQ-UHFFFAOYSA-N Isothiocyanatocyclopropane Chemical compound S=C=NC1CC1 JGFBQFKZKSSODQ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229940124761 MMP inhibitor Drugs 0.000 description 1
- 108010016160 Matrix Metalloproteinase 3 Proteins 0.000 description 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 229930182474 N-glycoside Natural products 0.000 description 1
- 108010042992 NFF 3 Proteins 0.000 description 1
- 241000270276 Natrix Species 0.000 description 1
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
- 102100030411 Neutrophil collagenase Human genes 0.000 description 1
- 101710118230 Neutrophil collagenase Proteins 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 241000245301 Nymphoides Species 0.000 description 1
- FWSMOHRVWAHCHW-UHFFFAOYSA-B P(=O)([O-])([O-])[O-].[Os+4].P(=O)([O-])([O-])[O-].P(=O)([O-])([O-])[O-].P(=O)([O-])([O-])[O-].[Os+4].[Os+4] Chemical compound P(=O)([O-])([O-])[O-].[Os+4].P(=O)([O-])([O-])[O-].P(=O)([O-])([O-])[O-].P(=O)([O-])([O-])[O-].[Os+4].[Os+4] FWSMOHRVWAHCHW-UHFFFAOYSA-B 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229910002666 PdCl2 Inorganic materials 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Natural products NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 101710108790 Stromelysin-1 Proteins 0.000 description 1
- 102100028848 Stromelysin-2 Human genes 0.000 description 1
- 101710108792 Stromelysin-2 Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 102100021989 T-cell surface glycoprotein CD1e, membrane-associated Human genes 0.000 description 1
- 108700012920 TNF Proteins 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- 241000679125 Thoron Species 0.000 description 1
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- QROGIFZRVHSFLM-QHHAFSJGSA-N [(e)-prop-1-enyl]benzene Chemical group C\C=C\C1=CC=CC=C1 QROGIFZRVHSFLM-QHHAFSJGSA-N 0.000 description 1
- OKCLPEQDGYAKFO-UHFFFAOYSA-K [Eu+3].CC1=CC=C(S([O-])(=O)=O)C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 Chemical compound [Eu+3].CC1=CC=C(S([O-])(=O)=O)C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 OKCLPEQDGYAKFO-UHFFFAOYSA-K 0.000 description 1
- GLYFHNJCKRZZCI-SPSNFJOYSA-H [Eu+3].[Eu+3].[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O Chemical compound [Eu+3].[Eu+3].[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O GLYFHNJCKRZZCI-SPSNFJOYSA-H 0.000 description 1
- YEFJHNZIYIHXJQ-UHFFFAOYSA-N [Os+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O Chemical compound [Os+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O YEFJHNZIYIHXJQ-UHFFFAOYSA-N 0.000 description 1
- ITBPIKUGMIZTJR-UHFFFAOYSA-N [bis(hydroxymethyl)amino]methanol Chemical compound OCN(CO)CO ITBPIKUGMIZTJR-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- NPWVNMLBQVMTOF-UHFFFAOYSA-N acetic acid;carbonochloridic acid Chemical compound CC(O)=O.OC(Cl)=O NPWVNMLBQVMTOF-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- RXSUFCOOZSGWSW-UHFFFAOYSA-M acetyloxy-(4-aminophenyl)mercury Chemical compound CC(=O)O[Hg]C1=CC=C(N)C=C1 RXSUFCOOZSGWSW-UHFFFAOYSA-M 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- HHFJXGNFTBSDLF-UHFFFAOYSA-N aminomethylcarbamic acid Chemical compound NCNC(O)=O HHFJXGNFTBSDLF-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical group N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- YADDYKXZVNQFBH-UHFFFAOYSA-N argon;hydrobromide Chemical compound [Ar].Br YADDYKXZVNQFBH-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- HIMJYPIKSSLZDZ-UHFFFAOYSA-N benzoic acid;europium Chemical compound [Eu].OC(=O)C1=CC=CC=C1 HIMJYPIKSSLZDZ-UHFFFAOYSA-N 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- NHOWLEZFTHYCTP-UHFFFAOYSA-N benzylhydrazine Chemical compound NNCC1=CC=CC=C1 NHOWLEZFTHYCTP-UHFFFAOYSA-N 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- MZJUGRUTVANEDW-UHFFFAOYSA-N bromine fluoride Chemical group BrF MZJUGRUTVANEDW-UHFFFAOYSA-N 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- LFMHGJILZFLGJJ-UHFFFAOYSA-N butanoic acid chloromethane Chemical compound CCl.C(CCC)(=O)O LFMHGJILZFLGJJ-UHFFFAOYSA-N 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- MQOHJJURSQZEFF-UHFFFAOYSA-N butyl(silyl)silane Chemical compound CCCC[SiH2][SiH3] MQOHJJURSQZEFF-UHFFFAOYSA-N 0.000 description 1
- MXOSTENCGSDMRE-UHFFFAOYSA-N butyl-chloro-dimethylsilane Chemical compound CCCC[Si](C)(C)Cl MXOSTENCGSDMRE-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 150000001723 carbon free-radicals Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- JYHBPKNOVQWAPT-UHFFFAOYSA-N chloroform;formic acid Chemical compound OC=O.ClC(Cl)Cl JYHBPKNOVQWAPT-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- LADPCMZCENPFGV-UHFFFAOYSA-N chloromethoxymethylbenzene Chemical compound ClCOCC1=CC=CC=C1 LADPCMZCENPFGV-UHFFFAOYSA-N 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000006640 cycloheptyl carbonyl group Chemical group 0.000 description 1
- DELUNUNQVWNZKQ-UHFFFAOYSA-N cyclohexa-2,4-dien-1-ylidenemethanone Chemical compound O=C=C1CC=CC=C1 DELUNUNQVWNZKQ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 125000002576 diazepinyl group Chemical class N1N=C(C=CC=C1)* 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- ZYMCGHKVJXMQRR-UHFFFAOYSA-N dimethylarsenic Chemical compound C[As]C ZYMCGHKVJXMQRR-UHFFFAOYSA-N 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- CJYQQUPRURWLOW-YDLUHMIOSA-M dmsc Chemical compound [Na+].OP(=O)=O.OP(=O)=O.OP(=O)=O.[O-]P(=O)=O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O CJYQQUPRURWLOW-YDLUHMIOSA-M 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- MAFQLJCYFMKEJJ-UHFFFAOYSA-N ethyl 4-aminobutanoate Chemical compound CCOC(=O)CCCN MAFQLJCYFMKEJJ-UHFFFAOYSA-N 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- ZAXRBBFYXGCLBB-UHFFFAOYSA-N europium 1H-indole Chemical compound [Eu].N1C=CC2=CC=CC=C12 ZAXRBBFYXGCLBB-UHFFFAOYSA-N 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- SULCVUWEGVSCPF-UHFFFAOYSA-L europium(2+);carbonate Chemical compound [Eu+2].[O-]C([O-])=O SULCVUWEGVSCPF-UHFFFAOYSA-L 0.000 description 1
- WAXMHAWXXPUEFZ-UHFFFAOYSA-K europium(3+) methanesulfonate Chemical compound CS(=O)(=O)[O-].CS(=O)(=O)[O-].CS(=O)(=O)[O-].[Eu+3] WAXMHAWXXPUEFZ-UHFFFAOYSA-K 0.000 description 1
- STCBLHRJWCCQSC-UHFFFAOYSA-K europium(3+);2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Eu+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O STCBLHRJWCCQSC-UHFFFAOYSA-K 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002341 glycosylamines Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229910021505 gold(III) hydroxide Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000000569 greater omentum Anatomy 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 208000009326 ileitis Diseases 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- NDDAHWYSQHTHNT-UHFFFAOYSA-N indapamide Chemical compound CC1CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 NDDAHWYSQHTHNT-UHFFFAOYSA-N 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical group OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- FUJCRWPEOMXPAD-UHFFFAOYSA-N lithium oxide Chemical compound [Li+].[Li+].[O-2] FUJCRWPEOMXPAD-UHFFFAOYSA-N 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- FBBDOOHMGLLEGJ-UHFFFAOYSA-N methane;hydrochloride Chemical compound C.Cl FBBDOOHMGLLEGJ-UHFFFAOYSA-N 0.000 description 1
- PKAUVIXBZJUYRV-UHFFFAOYSA-N methane;hydroiodide Chemical compound C.I PKAUVIXBZJUYRV-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- RUZLIIJDZBWWSA-INIZCTEOSA-N methyl 2-[[(1s)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoate Chemical group COC(=O)C1=CC=CC=C1N[C@@H](C)C1=CC(C)=CN2C(=O)C=C(N3CCOCC3)N=C12 RUZLIIJDZBWWSA-INIZCTEOSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 150000008278 pentosamines Chemical class 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- SFLGSKRGOWRGBR-UHFFFAOYSA-N phthalane Chemical compound C1=CC=C2COCC2=C1 SFLGSKRGOWRGBR-UHFFFAOYSA-N 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010029690 procollagenase Proteins 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000004353 pyrazol-1-yl group Chemical group [H]C1=NN(*)C([H])=C1[H] 0.000 description 1
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical compound C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 description 1
- DDWJFSYHYPDQEL-UHFFFAOYSA-N pyrimidine;1h-pyrrole Chemical compound C=1C=CNC=1.C1=CN=CN=C1 DDWJFSYHYPDQEL-UHFFFAOYSA-N 0.000 description 1
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical group [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
- RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical group CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- NNBZCPXTIHJBJL-UHFFFAOYSA-N trans-decahydronaphthalene Natural products C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical class C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 1
- 229960003986 tuaminoheptane Drugs 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/83—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/34—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/08—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/42—Y being a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
- C07D333/44—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
568897 A7 B7 五、發明説明(1 ) 枋《镅城 (讀先閱讀背面之注意事項再楨寫本頁) 本發明係有闞胺基丁酸衍生物、其製造方法、及含有 該衍生物做為有效成分之藥劑者。 更詳细而言,係有« —般式(I)所示之胺基丁酸衍生 物,該衍生物之非毒性塩,其製造方法以及含有上述化合 物之藥劑者:
坊術赀暑 基質金屬蛋白 _ (natrix lettalloprotease) (M 下簡 稱為MMP)為一種在其活性中心含有鋅(Μ下籣稱Zn + 2)中之 性金雇蛋白酶,在生理狀況下藉由分解膠原、毘布戚酸、 蛋白多_、纖維網蛋白、獐性蛋白、明膠等,而具有對闞 節組嫌、骨組孅、接合組孅等之成長及組嫌改建之作用。 MMP迄今已鑑定出10種Μ上其一鈒结構相異之分子類型。 具艘而言,可列舉如間質性膠原酶(ΜΜΡ-1)、白血球膠原 卿(ΜΜΡ-8)、明膠酶Α(ΜΜΡ-2)、明膠_Β(ΜΜΡ-9)、基質溶 素1(ΜΜΡ-3)、基質溶素2(ΜΜΡ-10)、基質溶素(ΜΜΡ-7)、金 羼彈性蛋白酶(ΜΜΡ-12)等)。 已知以上各酵素之共同性質如下: (U於活性中心含有Ζη + 2,鈣離子(Ca + 2>為酵素活性所必 需、 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X 297公釐) 310112 568897 A7 B7 五、發明説明(2 ) (2) M滑在_形態分泌,而在细胞外被活性化、 (3) 於胺基酸序列具有相當高之相同性、 (4) 具有存在於生體內之各種细胞外基質成分分解能、 (5) 因共同之抑制劑之組孅金羼蛋白酶抑制劑(TIMP),其 活性抑制等。 MMP之抑制劑一般認為可用於預防及/或治療因MMP之 分泌及活性異常亢進所導致之種種疾病。例如,可列舉如 風濕性闞節炎、骨醑節炎、病態的骨吸收、骨質疏鬆症、 牙周病、間質性腎炎、動脈硬化、肺氣腫、肝硬化、角膜 損傷、癌细胞之轉移浸獮或镨殖之疾病、自艚免疫疾病( 局部性迴腸炎、風濕性紫斑病、白血球系细胞之血管滲出 或浸引起之疾病、血管新生、多發性硬化症、大動脈痗、 子宮内膜症等。 部 十 消 A 卬 f (讀先閱讀背面之注意事項再填寫本頁) 已知數種對基質金屬蛋白_具抑制作用之化合物。其 中已知膠原被切斷點附近之基質(Gly-Ili-Ala-Gly或Gly-Len-AU-Gly)與膠原_之親和性甚高。對該基質之切斷部 位帶有鋅親和性基,且經化學改質之類似基質類基質金羼 蛋白酶抑制劑已有許多研究[參照Inhibitors of iiatrix ®e11a 1 1oproteinases (Μ ΜP fS) , Nigel RA Beeley,
Philip RJ Ansell, Andreu, JP Docherty等 Curr. 0 p i n . T h e r . Patents. ,i_, 7-16(1994) , Current Drugs, Ltd ISSN 0962 -2594 ]。但是,上逑之基質類似物抑制劑為一 種胜肱類似物因此可預知應會產生種種藺鼸。為此,亦有 許多企圖將上逑抑制劑非胜肽化之報告。 本紙iR尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) 2 310112 568897
(W)
A7 Β7 五、發明説明(3 ) 例如,ΕΡ757037號說明書之實施例中t揭示一種式( W)所示之磺醯基胺基衍生物,具有抑制基質金羼蛋白酶之 作用。 HOOC^^N" Η EP7 5798 4號說明書之實施例中,揭示式(X)所示之異 羥肪酸衍生物具有抑制基質金屬強白_之作用: (X) W097 2 3459號說明軎之實梅例中,掲示式(Υ)所示之芳 香族酮-酸衍生物具有抑制基質金屬蛋白_之作用: (讀先閱讀背面之注意事項再瑣寫本頁) 部 屮 •λ 消 f; Λ 卬
(Y) W09718188號說明書之實施例中,擷示(Z)所示之異羥 310112 本紙張尺度適;1]中國國家標準(CNS ) A4規格(210X297公釐) 3 4568897 A7 B7 五、發明説明 肪酸具有抑制基質金雇蛋白酶及TNFa分泌之作用
(Z) 搿明撝示 本發明人等為尋爲對基質金屬蛋白例如明膠酶、 基霣溶素或膠原酶等具有抑制作用之化合物,銳意進行研 究結果發現7-胺基酸之羧酸胺基衍生物,即一般式(I)所 示之新穎胺基丁酸衍生物可達成目的。 本發明係有» : 1) 一般式(I)所示之胺基丁酸衍生物、或其非骞性塩·: R2 R3R6 R7 Ο Υ人9 (ι) (讀先閱讀背面之注意事項再填寫本ιίο 部 屮 •火 ]! JT π 竹 卬 ί: [式中,R1示-COOR10、-CONHOR10、-CONHHHR10 > - (CH2) n SR50或-Y-P0(0R5i)2、 R1G〒U)氫原子、(ii)Cl〜8烷基、(iii)苯基、(iv)苯基 或Cl〜8烷氧基所取代之Cl〜8烷基、或(V)笨基、苄基或 C1〜8烷基所取代之氧基羰基、η示0〜3之鳌數、 R5C^(i)氫原子、(ii)Cl〜8烷基、(iii卜C0R52(基中, 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X 297公釐) 4 310112 568897 A7 B7 、u -:1,? 、,丨. 中 消 合 卬 五、發明説明 羥基、(ix)苄氧基、(x)-NRi01R102(R101及R102各自分別 示氫原子或C1〜8烷基)、(xi)-COOR1Q3(R1G3示氫原子或 C1〜8烷基)、(xii)三氟甲基、(xiii)三氟甲基氧基、( xiv)苯基、(xv)Cl〜8烷基或被C1〜8烷氧基取代之苯基、 (xvi)苯基氧基、(xvii)苯基磺醢基、(xviii)苯基或被硝 釀基取代之C1〜8烷基、(xix)雑環或(XX)酮基、(xxi)被 -CONR1G4R105基取代之C1〜8烷氧基(基中,各 自分別示氫原子、C1〜8烷基或苯基)所取代。 R1 1示(i)氫原子, (i i ) C1〜8烷基、 (i i i ) C y c 1 基、 (i v)-C0R 1 8基、 (v)邐自-OR15、 -SR15、 -NR16R17、 -COR18、胍基或 Cycl之基所取代之Cl〜8烷基、 R15示氫原子、Cl〜8烷基、Cycl或被Cycl或Cl〜8烷氧基 所取代之C1〜8烷基、 R 16示氩原子或C1〜8烷基、 R17示氫原子、C1〜8烷基或-C0R19(基中,R19示C1〜8烷 基、Cycl或Cycl所取代之C1〜8烷基)、 R18示羥基、C1〜8烷基、C1〜8烷氧基或- NR2〇R2i(基中, 1?20及1^21各自分別示氫原子、C1〜8烷基、Cycl或Cycl所 取代之C1〜8烷基、 R12示氫原子、C1〜8烷基、Cycl或Cycl所取代之C1〜8烷 基、 (讀先閱讀背面之注意事項再填寫本頁} 本紙张尺度適州中國國家摞準(CNS ) A4規格(210X 297公釐) 6 310112 568897 NR27R28或-C0R29之基所取代 A7 五、發明説明(7 ) R13示氫原子、C1〜8烷基、Cycl、Cycl所取代之C1〜8烷 基或-COR22(基中,R22示C1〜8烷基、Cycl或Cycl所取代 之C1〜8烷基)、 R14示羥基、C1〜8烷基、C1〜8烷氧基、Cycl、Cycl所取 代之Cl〜8烷基或-NR23R24(基中,R23及R24各自分別示( i)氫原子、(ii>Cl〜8焼基、(iii)Cycl或(iv)Cycl或翔基 所取代之C1〜8烷基), (1)R8示 1) 氫原子、 2) C1〜8烷基、 3) C1〜8烷氧基羰基、 4) 由邐自-OR26、-SR26 之Cl〜8烷基或 (1ί先閱讀背面之注意事項再瑣寫本頁)
(2)R8示一/A \(r2% 基或 一Μ - (R25 \基時, R9示 1) C1〜8烷基、 2) Cl〜8烷氧基、 3) Cyc2所取代之C1〜8烷氧基 本紙队尺度通州中國國家標準(CNS ) A4規格(210X 297公釐) 310112 4 568897 A7 B7 五、發明説明 4)選白-0R26、-SR26、«HR27R28 , - C0R29或 Cyc2 之基 所取代之Cl〜8烷基,或 5) 示 ~0"
(R25)P 基 ··') I, 屮 十 r'j
消 fc A 基中,Cyc2示碳環或雜環、該碳環或雜環亦可被1儸或1個 Μ上之(i)Cl〜8烷基、(ii)Cl〜8烷氧基、(iii)硝基、( 胍基、(v)脒基、(vi)鹵原子、(vii)硝釀基、(viii) 羥基、(ix)苄氧基、(x)-NR201R202(R2G1及R202各自分別 示氫原子或C1〜8烷基)、(xi)-C00R2Q3(R2G3示氫原子或 C1〜8烷基)、(xii)三氟甲基、(xiii)三氟甲基氧基、( xiv)苯基、(xv)被C1〜8烷基或C1〜8烷氧基取代之笨基、 (xvi)笨基氧基、(xvii)笨基磺釀基、(xviii)被苯基或硝 醜基取代之C1〜8烧基、(xix)嫌環或(XX)釀基、(xxi) -C0NR2t)4R2G5基所取代之Cl〜8烷氧基(基中,R2G4及R2GS 各自分別示氫原子、Cl〜8烷基或笨基)所取代。 R26示氳原子、C1〜8烷基、Cyc2或Cyc2取代之C1〜8烷基 R27示.氫原子、C1〜8烷基、Cyc2或Cyc2所取代之C1〜8烷 基、 R28示氫原子、C1〜8烷基、Cyc2、Cyc2所取代之C1〜8烷 基或-COR30(R30示C1〜8烷基、Cyc2或Cyc2取代之C1〜8烷 基、 (讀先閲讀背面之注意事項再瑣寫本頁} 本紙张尺度逃州中國國家標準(CNS ) Λ4規格(210X297公釐) 310112 568897 A7 B7 五、發明説明(9 ) R29示羥基、C1〜8烷基、Cyc2、Cyc2取代之C1〜8烷基或 -NR31R32(R31或R32各自分別示氫原子、C1〜8烷基、Cyc2 或Cyc2取代之Cl〜8烷基、
消 f A 〇 示碳環、或雜環 R25示-E-G 、 E示 1) 單鐽、 2) -COHR33- > 3) -NR33C0… 4) -C0_0-、 5) -0-C0-、 6) HR33-C0-NR34、 7) -CO-CH2… 8卜CO… 9) -O-CO-HR33- 10) -NR33-C0-0-、 1 1 ) -0-C0-0-、 12) -CS-NR33… 13) -NR33-CS… 14) -CS-0- ' 15) -0-CS-、 16) -NR33-CS-R34-、 (麴先閱讀背面之注意事項再楨寫本頁) 本紙張尺度通州中國國家標準(CNS ) A4規格(210X297公釐) 9 310112 10568897 A7 B7 、Λ 'Λ\ 部 屮
I
消f. AA 五、發明説明 17) -CS-CH2- > 18) -CS- 19) US-NR33-、 20) -NR33-CS-0… 21) +CS-0-、 22) -CH2-CH2-、 23) -HC = CH-、 24) -C匿 O、 25) -SO2-NR33-、 26) -NR33-S〇2-、 27) -SO2-CH2- > WL 28) -CH2-S〇2-、 基中,R33及R34各自分別示氫原子、Cl〜8烷基、Cyc3或 Cyc3取代之Cl〜8烷基,Cyc3示碳環或雑環、該碳環或雑 環亦可被1個或1個Μ上之U)C1〜8烷基、(ii)Cl〜8烷氧 基、(iii)硝基、(iv)腿基、(v)將基、(vi)鹵原子、(vii )硝醸基、(viii)羥基、(ix)苄氧基、(x)-NR301R302( R3G1及R302各自分別示氫原子或ci-〜8烷基)、(xi) -COOR303(R303示氫原子或Cl〜8烷基)、(xii)三氟甲基、 (xiii)三氟甲基氧基、(xiv)苯基、(xv)Cl〜8烧基或C1〜 8烷氧基取代之笨基、(xvi)笨基氧基、(xvii)笨基磺_基 、(xviii)笨基或硝醢基取代之C1〜8烷基、(xix)雜環或( XX)酮基、(xxi)-C0NR3C)4R3G5基取代之C1〜8烷氧基(基中 ,R3〇4及R3G5各自分別示氫原子、C1〜8烷基或苯基)所取 (謂先閱讀背面之注意事項再楨寫本頁)
、1T 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X297公釐) 10 310112 568897 A7 B7 五、發明説明f1 ) 代0 G示 1) 氫原子、 2) C1〜8燒基、 3) Cyc4、 4) -〇R35、 6) 鹵原子、 7) 硝基、 8) 硝醢基、 9) -HR36R37、 10) -COR38 - 11) 由遵自 Cyc4、-or35、-SR35、齒原子、-NR36R37或- C0R38之基所取代之Cl〜8烷基, 基中,Cyc4示碳瓌或雑環、該碳環或雜環亦可被1儸或1個 、P ?;; 屮 中 ik ii j j 消 f 合 ii 卬 f (邡先閱讀背面之注意事項再楨寫本頁) Μ上之(i)Cl〜8烷基、(ii)Cl〜8烷氧基、(iii)硝基、( iv)胍基、(v)脒基、(νί)鹵原子、(vii)硝醢基、(viiU 羥基、(ix)苄氧基、(X)-NR4〇lR4〇2(R401SR402各自分別 示氫原子或C1〜8烷基)、(xi)-C00R4G3(R4〇3示氫原子或 C1〜8烷基)、(Xii)三氟甲基、(xiii)三氟甲基氧基、( xiv)苯基、(XV)C1〜8烷基或C1〜8烷氧基取代之苯基、( xvi)苯基氧基、(xvii)苯基磺醵基、(xviii)苯基或硝醢 基取代之C1〜8烷基、(xix)雑環或(XX)鹬基、(xxi) -COHR4〇4R40S基取代之C1〜8焼氧基(基中,[{404及1{405各 自分別示氩原子、C1〜8烷基或苯基)所取代。 >紙張尺度適;^卜國'^家標率((:阳)/\4規格(210/ 297公釐) Π — ΤΠΓΓΓ2一~ 568897 A7 B7 五、發明説明(1 2 ) R35示氫原子、C1〜8烷基、C1〜8烷基氧基、Cyc4或Cyc4 所取代之之Cl〜8烷基、 R36示氩原子、C1〜8烷基、Cyc4或Cyc4所取代之C1〜8烷 基、 R37示氫原子、C1〜8燒基、Cyc4、Cyc4所取代之C1〜8燒 基或- COR39(R39示C1〜8烷基、Cyc4或Cyc4取代之C1〜8燒 基)、 R38示氫原子、C1〜8烷基、Cyc4、Cyc4取代之C1〜8烷 基、-NR40R41(R40及R41各自分別示氫原子、C1〜8烷基、 Cyc4或Cyc4取代之C1〜8烷基),或與-E-G共同形成C1〜4 亞烷基, P示1〜5之整數, Μ示C1〜8伸烷基, J示單鐽、氣原子、碲原子或- NR42-(R42示氩原子或C1〜 8烷基), =為單鐽,或當R2、R3、R4、R5、R6、R7之中非結合在同 一碳原子之兩個相鄰基為氫時,代表脫離之雙鍵,(但是, 當R3基與R4基共同形成C1〜8伸烷基、R5基與R6基共同形 成C1〜8伸烷基、R3基與R6基共同形成C1〜8伸烷基時則不 代表雙鍵)], 2) —般式(I)所示之胺基丁酸衍生物及其非骞性塩之製造 方法,Μ及 3) 含有一般式(I)所示之胺基丁酸衍生物及其非毒性塩做 為有效成分之藥劑。 (謂先閱讀背面之注意事項再楨寫本頁) -. 、1Τ 本紙張尺度通州中國國家標準(CNS ) Λ4規格(210X297公釐) 12 310112 568897 A7 五、發明説明(1 3 ) 發明之詳细說明 (讀先閱讀背面之注意事項再楨寫本頁) 本發明中除非特別指示外係包括所有異構物。例如, 烷基、烷氧基及伸烷基中之直鐽基及枝鍵基。伸烯基中之 雙鍵包括E、Z及EZ之混合物。又,有枝鐽烷基、烷氧基及 伸烷基存在而有不對稱碳原子時所產生之異構物亦包括在 內0 本發明中C1〜8烷基為甲基、乙基、丙基、丁基、戊 基、丁基、庚基、辛基及該等基之異構物。 C1〜8烷氧基為甲氧基、乙氧基、丙氧基、丁氧基、 戊氧基、己氧基、庚氧基、辛氧基及該等基之異構物。 笨基取代之C1〜8烷基為被一個苯基所取代之甲基、 乙基、丙基、丁基、戊基、己基、庚基、辛基及該等基之 異構物。 C1〜8烷氧基取代之C1〜8烷基為甲氧基、乙氧基、丙 氧基、丁氧基、戊氧基、己氧基、庚氧基、辛氧基及被1 個該等異構物基取代之甲基、乙基、丙基、丁基、戊基、 己基、庚基、辛基、辛基及該等基之異構物。 钟 硝醢基取代之Cl〜8烷基為被1個硝醢基取代之甲基、 、 | 乙基、丙基、丁基、戊基、己基、庚基、辛基及該等基之 •火 II 異構物。 苯基取代之氧基羰基為苯氧基羰基。 苄基取代之氧基羰基為苄氧基羰基。 C1〜8烷基取代之氧基羰基為甲氧基羰基、乙氧基羰 基、丙氧基羰基、丁氧基羰基、戊氧基羰基、己氧基羰基 本紙張尺度適州中國國家標率(CNS ) A4規格(210X297公釐) 13 310112 568897 A7 B7 五、 發明説明 (14 ) Λ 庚 氧 基 羧 基 辛 氧 基 羰基 及 該 等 基 之異構 物 〇 C2 8鐽烯基為乙烯基 、丙烯基 、丁烯基 、戊烯基、 己 烯 基 \ 庚 烯 基 辛 烯 基、 丁 二 烯 基 、戊二 烯 基、 己二烯 基 庚 二 烯 基 Λ 辛 二 烯 基、 己 三 烯 基 、庚三 烯 基、 辛三烯 基 及 該 等 基 之 烯 構 物 〇 C1 8伸烷基為伸甲基, 、伸乙基 、伸丙基 、伸丁基、 伸 戊 基 伸 己 基 Λ 伸 庚 基、 伸 辛 基 及 該等基 之 異構 物0 C2 8伸烷基為伸乙基、 k伸丙基· 、伸丁基· 、伸戊基、 伸 己 基 \ 伸 庚 基 伸 辛 基Μ 及 該 等 基 之異構 物 0 鹵 原 子 為 氛 溴 \ 氟、 碘 原 子 〇 C1 8烷氧羰基為甲氧基羰基、 乙氧基羰基、丙氧基 羰 基 、 丁 氧 基 羰 基 戊 氧基 羰 基 己 氧基羰 基 、庚 氧基羰 基 > 辛 氧 基 羰 基 及 該 等 基之 異 構 物 〇 C1 4亞烷基為甲烷基、 >亞乙烷基、亞丙烷基、 •亞丁 烷 基 及 該 等 基 之 異 構 物 〇 碳 環 意 諝 C3 15之 單瓌 二 m 三環式 碳 環。 此等環 可 列 舉 如 $ 環 丙 烷 Ν 環 丁烷 、 瓌 戊 烷 、環己 烧 、環 庚烷、 環 戊 烯 N 環 己 烯 環 戊 一 4eJ& % 環 己 二 烯、苯 戊搭 烯、茚 7)' 部 中 ,1 萘 > 甘 菊 環 笏 Λ 菲 、憩 \ 苊 烯 伸聯苯 基 、全 氫戊搭 •火 烯 全 氫 茚 全 氫 萘 全氫 甘 菊 環 全氫芴 \ 全餛 菲、全 1 1 氫 憩 全 氫 m 烯 Λ 全 氫 伸聯 笨 基 Λ 金 鋼烷基 環 等。 消 f A m 環 示 含 卜 - 4個 氮 原子 1〜2個 氧原子 及 /或1 〜2傾 卬 碗 原 子 之 5〜18員單環、 >二環或三環式雜環。 含1〜 4偭氮 ί] 原 子 N 1产 - 2個 氧 原 子 及 /或1 2個磙原子之5 18貝 單環、 本紙張尺度適州中國國家標率(CNS ) Λ4規格(210X297公釐) 14 310112 (謂先閲讀背面之注意事項再填寫本頁) /15568897 A7 B7 五、發明説明( 二環或三環式雜環包括含1〜4個氮原子、1〜2個氧原子及 /或1〜2個磙原子之單環、二環或三環式雜芳基或其部分 或全部飽和者。 上述含1〜4個氮原子,1〜4個氮原子,1〜2個氧原子 及/或1〜2個硫原子之5〜18員之單環、二環或三環式雜環 芳基可列舉如,吡咯、眯唑、三唑、四唑、吡唑、吡啶、 吡肼、喃啶、噠_、吖庚因、二吖庚因、呋喃、吡喃、HI 庚英、吗吖庚英、睡吩、《茚(《喃)、成庚英、11琴唑、異 n琴唑、《唑、異《唑、β等二唑、n|畊、鸣二_、吖庚因 、B等二吖庚因、睡二唑、睡畊、《二姘、《吖庚因、α二 吖庚因、吲睬、異吲睐、苯并呋喃、異苯并呋喃、苯并《 吩、異笨《吩、吲唑、Df啉、異時啉、酞畊、萘啶、α| Β辱 啉、Df唑咐、噌咐、苯并垮唑、笨并B*唑、苯并嘧唑、咔 唑、吖啶環等。 "Λ 一'十 十 •火 ii -1 消 合 卬 (讀先閱讀背面之注意事項再楨寫本頁) 上述1〜4锢氮原子,1〜2個氧原子及/或1〜2個硫原 子之5〜18員之單環或環式雜環,局部或全部飽和者可列 舉如,吡咯啉、吡咯啶、咪唑啉、眯唑啶、三唑啉、三唑 啶、四唑啉、四唑啶、吡唑啉、Bft唑啶、哌啶、哌肼、四 氫吡啶、四氫嘧啶、四氫喊畊、二氫呋喃、四氯呋喃、二 氫吡喃、四氫吡喃、二氣《吩、四氫1«吩、二氫《茚(二 氫《喃)、四氫《茚(四氫躔喃)、二氲垮唑、四氫垮唑、 二氫異垮唑、四氫異鸣唑、二氫異鸣唑、四氫異垮唑、二 氫《唑、四氫[«唑、二氫異α唑、四氳異《唑、嗎啉、碗 代嗎啉、吲睬啭、異吲睬啉、二氫笨并呋喃、全氫苯并呋 本紙張尺度適州中國國家標準(CNS ) Λ4規格(210X297公釐) 15 310112 568897 A7 B7 五、發明説明(1 6 ) (謂先閱讀背面之注意事項再填寫本頁) 喃、二氫異苯并呋喃、全氫異苯并呋喃、二氫苯并α吩、 全氫苯并《吩、二氫異苯并《吩、全氫異苯并α吩、二氫 吲唑、全氫吲唑、二氫〇f啉、四氫咐、全氫睹啉、二氫 異睹啉、四氫異〇t啉、全氪異時咐、二氫酞畊、四氫酞胼 、全氫酞_、二氱萘啶、四氫萘啶、全氫萘啶、二氫等 啉、四氫〇1 啉、全氫啉、二氫時唑啉、四氫睹唑咐 、全氫睹唑啉、二氫噌啉、四氫嗜啉、全氫噌啉、二氫苯 并鸣唑、全氫苯并垮唑、二氫苯并β唑、全氫笨并α唑、 二氫苯并眯唑、全氫笨并咪唑、苯并垮庚英、苯并鸣二吖 庚因、笨并I*吖庚因、苯并β:二吖庚因、苯并吖庚因、苯 并二吖庚因、吲睐垮二吖庚因、吲睬四氫鸣二吖庚因、吲 睬《吖庚因、吲睬四氪《二吖庚因、吲睬吲吖庚因、吲睬 四氫吖庚因、吲睬二吖庚因、吲睬四氫二吖庚因、苯并鸣 二唑、笨并a二唑、苯并三唑、樟腦、眯《唑、二氫咔唑 、四氫咔唑、全氫咔唑、二氩吖啶、四氫吖啶、全氫吖啶 、二氧雑戊環、二鸣烷、二硫雑戊環、二α烷、二鸣畊、 二睡畊環等。 [塩] 本發明中所述塩類係包括所有非毒性塩。例如,可列 舉如一般之塩、酸加成塩、水合物塩等。 一般式(I)所示之本發明化合物,可依週知方法轉變 成相對應之塩類。塩類Μ無毒性、水溶性者為佳。適當之 塩可列舉如鐮金屬(納、鉀等)塩、鹼土金屬(鈣、鎂等)塩 、銨塩、藥學上容許之有機胺(四甲基銨、三乙胺、甲胺 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X 297公釐) 16 310112 568897 A7 B7 17 五、發明説明 基、二甲胺基、環戊胺、苄胺、苯乙胺、礮啶、單乙酵胺 、二乙酵胺、三(羥甲基)胺、離胺酸、精胺酸、N-甲基-D-麩胺酸等)塩。 一般式(I)所示本發明化合物,可藕一般週知方法轉 變為相對應之酸加成塩。酸加成塩Μ無毒性且具有水溶性 者為佳。適當的酸加成塩可例舉如塩酸,氩溴酸塩,磙酸 塩,磷酸塩,硝酸塩等無櫬酸塩,或乙酸塩,三氟乙酸塩 ,乳酸塩,滴石酸塩,草酸塩,富馬酸塩,馬來酸塩,檸 樺酸塩,苯甲酸塩,甲磺酸塩,乙磺酸塩,苯磺酸塩,甲 苯磺酸塩,羥乙磺酸塩,葡萄醛酸塩,葡糖酸塩等有機酸 塩類。 又,一般式(I)所示之本發明化合物及其塩類,可藉 一般週知方法轉變為其水合物。 一般式(I)所示之本發明化合物中較佳者可列舉.如下 列一般式(Ι-A)所示之化合物: (謂先閱讀背面之注意事項再蛾寫本頁) 、ο π 部 十 -火 I j J 消 f 合
(Ι-Α) (式中,所有符號之意義均同上述) 一般式(Ι-Β) 本紙张尺度適州中國國家標準(CNS ) Α4規格(210X 297公釐) 17 3101 1Ζ 568897 A7 B7 五、發明説明 /18 人 R4 R5 L _ R2 R3 R6 R7 (1-B)
(式中,所有符號之意義均同上述), 一般式(I - C ) R7 〇
(I-C)
W (讀先閱讀背面之注意事項再瑣寫本頁) 裂 、,) 7r' 部 十 •火 j j .Λ 消 f A j ί; (式中,所有符號之意義均同上述) 一般式(I-D)
0-D) 本紙張尺度適州屮國國家標率(CNS ) A4規格(210X297公釐) 18 310112 568897 A7 B7 五、發明説明(19 ) (式中,所有符號之意義均同上述), 一般式(I-E)
V3RkR7I (式中,所有符號之意義均同上述) 一般式(I-F) (I-E) (謂先閱讀背面之注意事項再楨寫本頁) R1 R4 R5
0-F) 訂
、u 中 •火 ii. -T 消 合· A (式中,所有符號之意義均同上述) 一般式(I-G) R2 R3R6 R7 〇ϋχτ (l-G) (式中,所有符號之意義均同上述 一般式(I-H) 本紙張尺度速州中國國家標準(CNS ) Λ4規格(210X 297公釐) 19 310112 568897 A7 B7 /2 0 五、發明説明(R1 乂人 r9 R4 R5
(«-Η) (式中,所有符號之意義均同上述) 一般式(I-J)
(I-J) (讀先閱讀背面之注意事項再填寫本頁)
、1T
Cl (式中,所有符號之意義均同上述), 一般式(I-K) ,抑 、,> Ϊ.. -、屮 十 .火 巧. \ ^ .1 消 卬 ί:
(式中,所有符號之意義均同上述) 一般式(I - L ) 本紙張尺度適州中國國家標率(CNS ) Λ4規格(210X 297公釐)
CI 20 (I-K) 310112 /21568897 A7 B7 五、發明説明
0-L) (式中,所有符號之意義均同上述), 一般式(I-M)
(I-M)
本纸张尺度適州中國國家標率(CNS ) A4規格(210X 297公釐) 21 310 112 (讀先閱讀背面之注意事項再楨寫本頁) 訂 .4 568897 A7 B7 五、發明説明( 22 R1 R2 R3R6 R7 〇¥人, (!-〇) (式中,所有符號之意義均同上述), 一般式(I-P) R1 (I-P) (謂先閲讀背面之注意事項再¾寫本頁) (i-Q) 屮 •火 a ·;/ί f- A ϋ 卬 f: G1 (式中,G1示甲基、鹵原子、硝基、硝醢基,其他符號之 意義均同前述), 一般式(I - Q ) R4 Rs Re ^v^Gi (式中,所有符號之意義均同上述)。 更佳者可列舉如Μ下之表1至表105中所逑之化合物或 其非毒性塩以及實_例中所逑之化合物等。又下列各表中 ,phth示酞醢亞胺基,ph示苯基,Μ0Μ示甲氧基甲基, Ε0Μ示乙氧基甲基,MEM示(2 -甲氧基乙氧基)甲基,Β0Μ示 苄氧基甲基。 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 22 310112 568897
經濟部中央標準局員工消費合作社印製
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth .(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph .(CH2)5-CH3 H H 10 -(CH2)4-〇H -(CH2)5-CH3 H H 11 Η -(ch2)4-〇h H H 12 Η H •(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 23 310112 568897
經濟部中央標準局員工消費合作社印製
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η , •(CH2)2-Phth H 5 Η Η H ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth •(ch2)5-ch3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(CH2)4-〇H -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H •(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 24 310112 568897
經濟部中央標準局員工消費合作社印製
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η 'Ϋ -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 -(CH2)4-Ph _(ch2)5-ch3 H H 10 -(ch2)4-〇h -(CH2)5-CH3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 25 310112 568897 Λ7 B? 五、發明説明(26 ) 表 4 R2 R6 0
(I-A-4) 經濟部中央標準局員工消費合作社印製
R1=CH2SH 編號 R2 R4 R6 R8 1 Η Η H H 2 •(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η 'ί -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -coch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H •(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) 裝. 線- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 26 310112 568897 Λ7 B7 五、發明説明(27 表5 R2 R6 〇 R1
N
(I-A-5) 經濟部中央標準局員工消費合作社印製
R1=P〇(〇H)2 编號. R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η 可 (CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -coch3 7 •(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 -(CH2)4-Ph -(ch2)5_ch3 H H 10 -(CH2)4_〇H -(ch2)5-ch3 H H 11 Η -(CH2)4-OH H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 27 310112 568897
經濟部中央標準局員工消費合作社印製
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η ^ -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 •(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth •(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-〇H -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 •(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 28 310112 568897 Λ7 B7 五、發明説明(29 )
經濟部中央標準局員工消費合作社印製
R1=C〇NH〇H 編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η ^ -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)rPhth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項寫本頁) 裝-
、1T 線 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇Χ 297公釐) 29 310112 η 568897 Λ 7 Β7 五、發明説明(30 )
經濟部中央標準局員工消費合作社印製 煽號 R2 R4 R6 R9 1 Η Η Η Η 2 -(CH2)2-Phth Η Η Η 3 Η -(CH2)rPhth Η Η 4 Η Η ^ -(CH2)2-Phth Η 5 Η Η Η -CH3 6 Η Η Η -〇ch3 7 -(CH2)2-Phth -(ΟΗ2)5-〇Η3 Η Η 8 Η -(CH2)2-Phth -(ch2)5-ch3 Η 9 -(CH2)4-Ph -(CH2)5-CH3 Η Η 10 -(ch2)4-〇h -(ch2)5-ch3 Η Η 11 Η -(ch2)4-oh Η Η 12 Η Η -(CH2)4-〇H Η 13 -(CH2)4-NH2 Η Η Η 14 Η -(CH2)4-NH2 Η Η (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 30 310112 31、568897 A7 B7 五、發明説明( 表 9
本紙張尺度適中國國家標準(CNS ) A4規格(210X297公釐)
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η、 -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -och3 7 -(CH2)2-Phth .(CH2)5.CH3 H H 8 Η -(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(ch2)4-〇h -(CH2)5-CH3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H 31 310112 568897 A7
7 B 五、發明説明(3 2) 表1 0
(I-B-5)
R1=PO(OH; 編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)rPhth H H 4 Η Η ^ -(CH2)rPhth H 5 Η Η H -ch3 6 Η Η H -och3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η •(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(CH2)4-OH -(CH2)5-CH3 H H 11 Η •(ch2)4-oh H H 12 Η H -(CH2)4-〇H H 13 .(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (讀先閱讀背面之注意事項再楨寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 32 310112 568897 A7 B7 五 發明説明(3 3) 表1 1
CN 經米部中决«.導XJh 5消费合竹ii印來
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η, (CH2)rPhth H 5 Η Η H -ch3 6 Η Η H -COCH3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-〇H -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η (ch2)4-nh2 H H (讀先閱讀背面之注意事項再填寫本頁) 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 33 310112 34、568897 A7 B7 五、發明説明( 表1 2
N八N (IC-2)
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η , -(CH2)2-Phth H 5 Η Η H _ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 3ΤΌ112 568897 A7 B7 五、發明説明(35) 表1 3
N八N (IC-3)
煸號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η , -(CH2)rPhth H 5 Η Η H -ch3 6 Η Η H -COCH3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η、 -(CH2)2-Phth •(ch2)5-ch3 H 9 .(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 35 310112 568897 A7 B7 五 發明説明(3 6) 表1 4
(KM)
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η , -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth •(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(CH2)5-CH3 H H 11 Η •(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 (ch2)4-nh2 H H H 14 Η .(CH2)4-NH2 H H (請先閱讀背面之注意事項再瑣寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 36 310112 568897 A7 B7 五、發明説明(3 7) 表1 5
(I心 5 )
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η , -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -COCH3 7 -(CH2)2-Phth .(CH2)5-CH3 H H 8 Η -(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(CH2)4-OH H H 12 Η H -(CH2)4-OH H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 37 310112 568897 A7 B7 五、發明説明(3 8) 表1 6 R2 R6 〇
N (I-D-1)
W
R1=C〇0· · 編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η, -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 •(CH2)4-OH -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再楨寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 38 310112 568897 A7 B7 五、發明説明(3 9) 表1 7 R2 R6 〇
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η , -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 •(CH2)2-Phth _(CH2)5.CH3 H H 8 Η •(CH2)rPhth (CH2)5-CH3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(ch2)4-〇h -(CH2)5_CH3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 39 310112 568897 A7 B7 五、發明説明(4 0) 表1 8
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η •(CH2)2-Phth H H 4 Η Η , -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 •(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-OH H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 40 310112 568897 A7 B7
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η ^ -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -och3 7 _(CH2)2_Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(CH2)5_CH3 H H 11 Η -(ch2)4-oh H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再楨寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 568897 A7 B7 五、發明説明(4 2) 表2 0
經浐部中决«.率而h τ_消贽合竹^印¥
鏞號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η •(CH2)rPhth H H 4 Η Η , -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(CH2)5_CH3 H 9 -(CH2)4-Ph .(CH2)5-CH3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再镇寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 42 310112 568897 五、發明説明(43 ) A7 B7表2 1
£rcl (I-E-1) 部 中 A il .T 消 合 竹 才i 印 製
R1=C〇〇H 編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η •(CH2)2-Phth H H 4 Η Η -(CH2)rPhth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-OH H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閲讀背面之注意事項再楨寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 43 310112 568897 A7
7 B 五、發明説明(44) 表22
R1=C〇NH〇H 編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η ' H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph .(CH2)5-CH3 H H 10 -(ch2)4-〇h -(CH2)5-CH3 H H 11 Η -(CH2)4-OH H H 12 Η H -(ch2)4-〇h H 13 •(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (讀先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 44 310112 568897 五、發明説明(45) A7 B7 表2 3
j〇rcl (I-E-3 ) 部 中 决 a 率 \\ 消 合 作 卬 t
R1=CONHNH2 編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)rPhth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth •(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 •(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-〇H H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再镇寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 45 310112 568897 A7
7 B 五、發明説明(4 6) 表2 4 R2 R6 9
L〇XJCI (_
r1=ch2sh 鏞號 R2 R4 R6 R8 1 Η Η H H 2 •(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)rPhth H 5 Η Η H -CH3 6 Η Η H -COCH3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-OH H 13 -(CH2)4-NH2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 46 310112 568897 A7 B7 表2 5
CI 五、發明説明(47) (I-E-5) 煸號 R2 R4 R6 R8 1 Η Η Η Η 2 -(CH2)2-Phth Η Η Η 3 Η -(CH2)2-Phth Η Η 4 Η Η -(CH2)2-Phth Η 5 Η Η Η -CH3 6 Η Η Η -c〇ch3 7 -(CH2)2-Phth (ch2)5-ch3 Η Η 8 Η -(CH2)2-Phth (ch2)5-ch3 Η 9 -(CH2)4-Ph -(ΟΗ2)5"〇Η3 Η Η 10 -(ch2)4-〇h .(ch2)5-ch3 Η Η 11 Η -(ch2)4-〇h Η Η 12 Η Η •(ch2)4-〇h Η 13 •(ch2)4-nh2 Η Η Η 14 Η -(CH2)4-NH2 Η Η (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 47 310112 568897 A7 B7 表2 6 五、發明説明(4 8)
0OCI (I-F-1) :¾¾‘部中呔«.卑而m t,消贽合竹;^印$
編號 R2 R4 R6 R9 1 Η Η H H 2 •(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η 'j -(CH2)2-Phth H 5 Η Η H -CH3 6 Η Η H -OCH3 7 -(CH2)2-Phth .(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-〇H -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 48 310112 568897 Α7 Β7 表2 7 五、發明説明(49)
(I-F-2) 經浐部中次«.^-XJh τ_消贽合作拍卬緊
緘號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η •(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 •(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 49 310112 568897 Α7 Β7 五、發明説明(50) 表2 8
Χτα (I-F-3)
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η •(CH2)2-Phth H H 4 Η Η 'ί -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 50 310112 568897 A7 B7 五、發明説明(51) 表2 9
〇^rc, (I-F-4) 經潢部中次«.卑h T,消贽合竹私印f
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)rPhth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(CH2)5_CH3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(CH2)4-OH -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再镇寫本頁)
、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 51 310112 ? 568897 A7 B7 五、發明説明(5 2: 表3 0
〇Xrcl (I-F-5) 經浐部中呔«.率而消贽合竹ii卬來
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-〇H -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再瑣寫本頁) -裝·
、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 52 310112 >y 568897 A7 B7 五、發明説明(5 3) 表3 1
(I-G-1) 麫浐部中呔«.卑而h T,消贽合竹私印來
R1=C〇〇H 編號 R2 R4 R6 R8 1 Η Η H H 2 •(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 •(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η •(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (讀先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 53 310112 568897 A7 B7 五、發明説明(54) 表3 2
(I-G-2) 部 中 jk 乂;j _丁 消 贽 合 竹 才i 卬 t
R1=C〇NHOH 编號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(CH2)5_CH3 H 9 -(CH2)4-Ph -(CH2)5_CH3 H H 10 -(CH2)4-〇H -(ch2)5-ch3 H H 11 Η -(CH2)4-〇H H H 12 Η H -(CH2)4-〇H H 13 -(ch2)4-nh2 H H H 14 Η •(ch2)4-nh2 H H (讀先閱讀背面之注意事項再镇寫本頁)
、1T 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 54 310112 568897 A7 B7 五、發明説明(5 5: 表3 3
(I-G-3) 經浐部中次«.^-^h 3消费合作私印來
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -COCH3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-OH -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 •(ch2)4_nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 55 310112 568897 A7 B7 表3 4 五、發明説明(56)
(I-G-4)
r1=ch2sh 編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η ^ H -ch3 6 Η Η H -COCH3 7 -(CH2)rPhth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h •(ch2)5-ch3 H H 11 Η -(CH2)4-OH H H 12 Η H -(CH2)4-OH H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 56 310112 568897 A7 B7
經浐部中呔«.^-XJh 消贽合竹ii印¥
r1=p〇(oh)2 鏞號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)rPhth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) :裝.
、1T 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 57 310112 568897 A7 B7 五、發明説明(5 8: 表3 6 R2 R6
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(CH2)5-CH3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-OH H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4_nh2 H H (請先閱讀背面之注意事項再填寫本頁) :裝· 、-口 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 58 310112 568897 A7 B7 五、發明説明(59) 表3 7
(I-H-2)
編號 R2 R4 R6 R9 1 Η Η H H 2 •(CH2)2-Phth Η H H 3 Η -(CH2)rPhth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 •(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(CH2)5-CH3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η (ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 59 310112 568897 A7 B7 五 發明説明(60) 表3 8 經浐部中呔«.^f^m h消贽合作
本紙張尺度適/fl中國國家標準(CNS ) A4規格(2丨0X297公釐) 60 310112 (讀先閱讀背面之注意事項再填寫本頁) 568897 A7 B7 表3 9 五、發明説明(61) 經浐部中次«.^-XJh τ-消贽合作私印來
(請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 6 1 310112 568897 A7 B7 五、發明説明(62 表4 0
(I-H-5)
煽號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η •(CH2)2-Phth H H 4 Η Η 'ί -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -och3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5,ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閲讀背面之注意事項再填寫本頁) 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 62 310112 568897 A7 B7 五、發明説明(63) 表4 1
(I-H)
CI 編號· R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)rPhth H 5 Η Η H •CH3 6 Η Η H -COCH3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) •裝·
、1T 11 本紙張尺度適ffl中國國家標準(CNS ) Α4規格(210X297公釐) 63 310112 568897 A7 B7 五、發明説明(6 4) 表4 2
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η •(CH2)rPhth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth •(ch2)5-ch3 H H 8 Η -(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(CH2)4-OH -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 64 310112 568897 A7 B7 五、發明説明(65 表4 3
CI 锔醮 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)rPhth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 .(CH2)4-Ph •(ch2)5-ch3 H H 10 -(CH2)4-〇H -(ch2)5-ch3 H H 11 Η -(CH2)4-OH H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) •裝·
、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 65 310112 568897 A7 B7 五 、發明説明(6 6) R2 r1=ch2sh 表4 4
經浐部中^«.^-^h 消贽合竹私印來
編號 R2 R4 R6 R8 1 Η Η H H 2 •(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η (CH2)rPhth H 5 Η Η H -ch3 6 Η Η H -COCH3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-〇H -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-〇H H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) •裝· 、11
本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 66 310112 568897 A7 B7 五、發明説明(67) 表4 5 R2 R6 〇
CI 鎇號 R2 R4 R6 R8 1 ·'>.> ·:-Η Η H H 2 -(CH2)2-Phth Η H H 3 Η •(CH2)rPhth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(CH2)4-OH -(CH2)5-CH3 H H 11 Η -(CH2)4-OH H H 12 Η H -(CH2)4-OH H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) -裝.
、1T
本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 67 310112 568897 A7 B7 五、發明説明(6 8) 表4 6
(I-K-1)
CI 縮號 R2 R4 R6 R9 1 Η Η H H 2 •(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η . -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 •(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth .(CH2)5.CH3 H 9 •(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-oh H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η .(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 68 310112 568897 A7 B7 五、發明説明(69) 表4 7
(I-K-2) 經浐部中次«.卑XJh 消贽合作.^卬來
CI 編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η , -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h .(CH2)5-CH3 H H 11 Η -(ch2)4-〇h H H 12 Η H •(CH2)4-OH H 13 •(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 69 310112 70 568897 Α7 Β7 五、發明説明( 表4 8
(I-K-3)
煽虢 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2_Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η . -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 •(CH2)rPhth -(CH2)5-CH3 H H 8 Η •(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(CH2)4.〇H H H 12 Η H -(CH2)4-OH H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 3 1 υ I 1 z 568897 A7 B7 表4 9 五、發明説明(71)
本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 71 310112
編號 R2 · _ · R4 R6 R9 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η , -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -och3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(ch2)4-〇h •(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-OH H 13 . -(CH2)4-NH2 H H H 14 Η -(CH2)4-NH2 H H 568897 A7 B7 五、發明説明(72 表5 0
(I-K-5) 好沪部中呔i'?.卑而h 5消贽合竹私印¥
:編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η •(CH2)rPhth H H 4 Η Η , - (CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -och3 7 -(CH2)rPhth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth .(CH2)5-CH3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(CH2)4-〇H H H 12 Η H -(ch2)4-〇h H 13 _(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再瑣寫本頁) 本紙張尺度適ffl中國國家標準(CNS ) A4規格(210X297公釐) 7 2 310112 568897 A7 B7 五、發明説明(7 3) R2 R1
6 R
(M-Ι)
R1=C〇〇H 編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)rPhth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth (ch2)5-ch3 H H 8 Η -(CH2)rPhth -(CH2)5,CH3 H 9 .(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-OH •(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再楨寫本頁) 本紙張尺度適中國國家標準(CNS ) A4規格(210X297公釐) 73 310112 568897 A7 B7
經浐部中·λ«·率而h T,消贽合竹ii印掣
編號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)rPhth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η .(CH2)2-Phth H 5 Η 'ί Η H -ch3 6 Η Η H -coch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(CH2)4-OH H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η •(ch2)4-nh2 H H (請先閱讀背面之注意事項再镇寫本頁) 4 本紙張尺度適/fl中國國家標準(CNS ) A4規格(210X297公釐) 310112 568897 A7 B7 五 發明説明(7 5) 表5 3
(1心3) 經浐部中λ«·擎/01'只消贽合作ii卬y
编號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η •(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(ch2)4-〇h -(CH2)5-CH3 H H 11 Η -(CH2)4-OH H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適州中國國家標準(CNS ) A4規格(21 OX 297公釐) 75 310112 568897 A7 B7 五、發明説明(76) 表5 4
(I-L-4) 經浐部中呔«.^-而^ τ_消贽合竹私印欠
鏞號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η •(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth •(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(CH2)4-OH H H 12 Η H -(CH2)4-OH H 13 -(CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H (請先閱讀背面之注意事項再镇寫本頁) 本紙張尺度適Λ中國國家標準(CNS ) Α4規格(210X 297公釐) 76 310112 568897 A7 B7 五、發明説明(77: 表5 5
(I-L-5)
鏞號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -COCH3 7 -(CH2)rPhth -(ch2)5-ch3 H H 8 Η -(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(CH2)5-CH3 H H 11 Η •(ch2)4-oh H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η •(ch2)4-nh2 H H (請先閱讀背.面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 77 310112 568897 A7 B7
煽號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 •(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(CH2)5-CH3 H 9 •(CH2)4-Ph -(CH2)5-CH3 H H 10 •(ΟΗ2)4·〇Η -(CH2)5-CH3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-OH H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適州中國國家標準(〇~5)厶4規格(210'乂297公釐) 78 310112 568897 A7 B7 表5 7 五、發明説明(79) :¾¾‘部中决«.^-XJh T,消贽合作私印¥ R2 R6 〇
(請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 79 310112 568897 A7 B7 表5 8 五、發明説明(80)
(請先閱讀背面之注意事項再填寫本頁) -裝·
、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 80 310112 568897 A7 B7 表5 9 五、發明説明(8 1)
(請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 81 310112 568897 A7 B7 五、發明説明(82) 表6 0
煽賊 R2 % ·: R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)rPhth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H _ch3 6 Η Η H -och3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η •(CH2)2-Phth -(CH2)5_CH3 H 9 -(CH2)4-Ph -(CH2)5-CH3 H H 10 -(CH2)4-〇H -(CH2)5-CH3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(ch2)4-nh2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再镇寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 82 310112 568897 A7 B7 表6 1 五、發明説明(8 3)
(讀先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 83 310112 568897 A7 B7 五 明 説明發 2 6 表
1R
Η 〇 Η Ν 〇 c II ip
(I-N-2) 〇ch3
鏞號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)rPhth H H 4 Η Η •(CH2)rPhth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 .(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-〇H -(CH2)5-CH3 H H 11 Η -(CH2)4-〇H H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(CH2)4-NH2 H H - (請先閱讀背面之注意事項再镇寫本頁)
本紙張尺度適用中國國家標準(匸奶)八4規格(210'/ 297公釐) 84 310112 568897 A7 B7 五、發明説明(8 5) 表6 3
och3 (I-N-3) :¾浐部中呔^.^-XJh 消贽合作衫印繁
編號 R2 R4 R6 R8 1 Η H H 2 -(CH2)2-Phth Η H H 3 Η •(CH2)rPhth H H 4 Η Η -(CH2)rPhth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth -(ch2)5,ch3 H H 8 Η •(CH2)2-Phth .(CH2)5-CH3 H 9 •(CH2)4-Ph -(CH2)5_CH3 H H 10 -(ch2)4-〇h •(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-〇H H 13 -(CH2)4-NH2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁)
、1T 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 85 310112 568897 A7 B7 表6 4 五、發明説明(86) 經沪部中呔«.^fXJm 5消贽合竹私印?^
(請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適ffl中國國家標準(CNS)A4規格( 210X297公釐) 86 310112 568897 A7 B7 五、發明説明(87) 表6 5
部 中 JT 4、 竹 才士 印 t
R1=P〇(OH)2 煽號 R2 R4 R6 R8 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -c〇ch3 7 -(CH2)2-Phth .(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph .(CH2)5-CH3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(CH2)4-OH H 13 -(ch2)4-nh2 H H H 14 Η -(ch2)4-nh2 H H (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 87 310112 568897 A7 B7 五、發明説明(88) 表6 6 R2 R6 〇
(1-0-1)
och3 編號 R2 R4 R6 R9 1 Η Η H H 2 •(CH2)rPhth Η H H 3 Η -(CH2)rPhth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(ch2)4-〇h -(CH2)5-CH3 H H 11 Η -(ch2)4-oh H H 12 Η H -(CH2)4-OH H 13 -(CH2)4-NH2 H H H 14 Η -(CH2)4-NH2 H H (謂先閱讀背面之注意事項再填寫本頁) 裝·
、1T 線 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 88 310112 568897 經Μ部中呔if.準而B 消於合竹ii印-fi
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η *(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(ch2)5-ch3 H H 8 Η -(CH2)2-Phth -(CH2)5~CH3 H 9 -(CH2)4-Ph -(ch2)5_ch3 H H 10 -(CH2)4-OH -(CH2}5-CH3 H H 11 Η -(CH2)4-OH H H 12 Η H •(CH2)4-OH H 13 -{CH2)4-NH2 H H H 14 Η -(ch2)4-nh2 H H 本紙張尺度適用t國國家標隼(CNS ) A4規格(210X297公釐) 568897 A7 B7
編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)rPhth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -och3 7 -(CH2)2-Phth (CH2)rCH3 H H 8 Η -(CH2)2-Phth -(ch2)5_ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-〇H -(ch2)5-ch3 H H 11 Η -(CH2)4*〇H H H 12 Η H -{CH2)rOH H 13 -(CH2)rNH2 H H H 14 Η -(ch2)4-nh2 H H 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐〉 90 310112 568897 A7 五、發明説明(9 1) 表6 9
(1-0-4) 經 Τ;Γ·.部中JAi?lf^n〈 T,消贽合竹如卬4,]未
〇CH3 編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -och3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)2-Phth -(ch2)5-ch3 H 9 -(CH2)4-Ph -(ch2)5-ch3 H H 10 -(CH2)4-OH •(CH2)5_CH3 H H 11 Η -(CH2)4-OH .H H 12 Η H -(CH2)4-OH H 13 -{CH2)4-NH2 H H H 14 Η -(CH2)4-NH2 H H
("1閱讀背而之注意事項""ft?本頁J 本紙張尺度適用中國國家標準(CNS ) A4規格(2iOX 297公釐) 91 310112 568897 A7 B7 五、發明説明(9 2: 表7 0
(1-0-5) 經浐部中次i?.^-^h 消贽合竹ii印$
〇CH3 編號 R2 R4 R6 R9 1 Η Η H H 2 -(CH2)2-Phth Η H H 3 Η -(CH2)2-Phth H H 4 Η Η -(CH2)2-Phth H 5 Η Η H -ch3 6 Η Η H -〇ch3 7 -(CH2)2-Phth -(CH2)5-CH3 H H 8 Η -(CH2)rPhth -(ch2)5-ch3 H 9 -(CH2)4-Ph .(CH2)5-CH3 H H 10 -(ch2)4-〇h -(ch2)5-ch3 H H 11 Η -(ch2)4-〇h H H 12 Η H -(ch2)4-〇h H 13 -(CH2)4-NH2 H H H 14 Η -(CH2)4-NH2 H H (請先閱讀背面之注意事項再填寫本頁) 丁 、-口
本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 92 310112 568897 A7 B7 五、發明説明(93) 表7 1 R2 R6 0 R4 R8
R1=C〇〇H
經浐部中呔«.^-XJh T,消贽合竹私卬?水 编號 R2' R4 R6 R8 1 -ch3 H •ch2-〇-e〇m H 2 2-丙烯基 H -ch2-o-eom H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -ch2-o-eom H 5 EOM H -ch2-o-eom H 6 MEM H -ch2-o-eom H 7 BOM H -ch2-o-eom H 8 -ch3 H -ch2-o-e〇m -ch3 9 2-丙烯基 H -ch2-〇-eom -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -ch2-o-e〇m -ch3 12 EOM H -ch2-o-e〇m -ch3 13 MEM H -ch2-〇-e〇m -ch3 14 BOM H -ch2-〇-e〇m -ch3 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 93 310112 568897 A7 B7 五、發明説明(94) 表7 2 R2 R6
(I-P1-2) R1=C〇NH〇H 編號 R2 R4 R6 R8 1 -ch3 H -ch2-o-eom H 2 2-丙烯基 H -ch2-〇-e〇m H 3 2-丙炔基 H -ch2-o-eom H 4 MOM H -ch2-〇-e〇m H 5 EOM H -ch2-〇-e〇m H 6 MEM H -ch2-o-e〇m H 7 BOM H -ch2-〇-e〇m H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-o-eom -ch3 10 2-丙炔基 H •ch2-〇-e〇m -ch3 11 MOM H -ch2-〇-e〇m -ch3 12 EOM H -ch2-〇-e〇m -ch3 13 MEM H -ch2-o-eom -ch3 14 BOM H -ch2-〇-e〇m -ch3 (請先閱讀背面之注意事項再楨寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 94 310112 568897 A7
7 B 五、發明説明(95) R2 r1=c〇nhnh2 3M7
經浐部中-^^.^-XJh T,消贽合竹私卬¥ 编號 R2 R4 R6 R8 1 -ch3 H -ch2-〇-e〇m H 2 2-丙烯基 H -ch2-〇-e〇m H 3 2-丙炔基 H -CH2-O-EOM H 4 MOM H -ch2-〇-e〇m H 5 EOM H -ch2-o-e〇m H 6 MEM H -ch2-o-eom H 7 BOM H •ch2-o-eom H 8 -ch3 H -CH2-O-EOM -ch3 9 2-丙烯基 H -CH2-O-EOM -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -CH2-0-EOM -ch3 12 EOM H -CHr〇-EOM -ch3 13 MEM H -CH2-0-EOM -ch3 14 BOM H -ch2-〇-e〇m -ch3 (讀先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 95 310112 568897 R2 R6 0 R1
N R8
A7 B7 五、發明説明(96 ) 表7 4 (I-P1-4)
CI (請先閱讀背面之注意事項再填寫本頁)
r1=ch2sh 編號 R2 R4 R6 R8 1 -CH3 H -CH2-O-EOM H 2 2-丙烯基 H -CH2-O-EOM H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -CH2-O-EOM H 5 E〇M H -CH2-O-EOM H 6 MEM H -ch2-〇-e〇m H 7 BOM H -ch2-〇-e〇m H 8 -ch3 H -CH2-O-EOM -ch3 9 2-丙烯基 H -CH2-O-EOM -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -CH2-O-EOM -ch3 12 EOM H -CH2-O-EOM -ch3 13 MEM H -CH2-O-EOM _ch3 14 BOM H •ch2-〇-e〇m -ch3 本紙張尺度適/1]中國國家標準(CNS ) A4規格(210X297公釐) 9 6 310112 568897 A7 B7 五 發明説明(9 7) 表7 5
(I-P1-5) R1=PO(〇H)2 編號 R2 R4 R6 R8 1 -ch3 H -ch2-o-eom H 2 2-丙烯基 H -ch2-〇-e〇m H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -ch2-〇-e〇m H 5 EOM H -ch2-o-eom H 6 MEM H -CH2"0~E0M H 7 BOM H -ch2-o-e〇m H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-〇-e〇m -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -ch2-〇-e〇m -CH3 12 EOM H -ch2-〇-eom -ch3 13 MEM H -ch2-o-eom -ch3 14 BOM H -ch2-〇-e〇m -ch3 (讀先閱讀背面之注意事項再镇寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 97 310112 568897 A7 B7 五、發明説明(98) 表7 6 R2 R6 Ο
(I-P2-1) Br 輕浐部中央«.^-x;h 3消贽合作ii印y 編號 R2、 R4 R6 R8 1 -ch3 H -ch2-o-eom H 2 2-丙烯基 H -ch2-o-e〇m H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -ch2-o-eom H 5 EOM H -ch2-o-e〇m H 6 MEM H -ch2-o-e〇m H 7 BOM H -ch2-〇-e〇m H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-〇-e〇m -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -ch2-o-eom -ch3 12 EOM H -CH2-0-EOM _ch3 13 MEM H -ch2-〇-e〇m -ch3 14 BOM H -CH2-0-EOM -CH3 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(_ Μ規格(2似靖 310112 568897 A7 B7 五、發明説明(9 9) 表7 7 R2 R6
(I-P2-2)
R1=CONH〇H 編號 R2、 R4 R6 R8 1 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基; ϊ 2-丙炔基> MOM EOM MEM BOM -CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H
-CH2-O-EOM -CH2-0-E〇M -CH2*0*E0M •ch2-〇-e〇m -ch2-o-eom -CHyO-EOM -CHr〇-EOM -CH2-0-EOM -CH2-0-EOM -CH2-0-EOM -CH2-0-EOM -ch2-〇-e〇m -CH2-0-EOM -CH2-0-EOM H H H H H H H -CH3 -ch3 -ch3 -ch3 ch3 -ch3 -ch3 (讀先閱讀背面之注意事項再楨寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 99 310112 568897 A7 B7 五、發明説明-(10)0 表7 8 R1 R2 R6 Ο
N
(I-P2-3
Br 經浹部中决«.率XJh 5消贽合作it印y R1=CONHNH, 煽號 .Y •乂. R2 R4 R6 R8 1 -ch3 H -ch2-〇-eom H 2 2-丙烯基, H -ch2-〇-e〇m H 3 2-丙炔基_; H -ch2-o-eom H 4 MOM H -ch2-〇_eom H 5 EOM H -ch2-〇-e〇m H 6 MEM H •ch2-〇-e〇m H 7 BOM H -ch2-〇-e〇m H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-〇-e〇m -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H •ch2-o-e〇m -ch3 12 EOM H •ch2-o-eom -ch3 13 MEM H -ch2-〇-e〇m -ch3 14 BOM H _CHr〇-E〇M -ch3 (請先閱讀背面之注意事項再填寫本頁) 裝· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 100 310112 568897 A7 B7 五、發明説明(loi 表7 9 R2 R6 Ο R1’ \ F R1=CH2SH i4 、N’ XX. (I-P2-4) 編號 R2 R4 R6 R8 1 ch3 H -ch2-o-e〇m H 2 2_丙嫌基 H -ch2-〇-e〇m H 3 2-丙炔基 H -ch2-o-eom H 4 MOM H -ch2-o-e〇m H 5 EOM H -ch2-〇-e〇m H 6 MEM H -ch2-〇-eom H 7 BOM H -CH2-0-EOM H 8 -ch3 H -ch2-〇-e〇m •ch3 9 2-丙烯基 H -CH2-0-EOM -CH3 10 2-丙炔基 H -CH2-0-EOM -ch3 11 MOM H -CH2-0-EOM -ch3 12 EOM H -CH2-0-EOM -ch3 13 MEM H -CH2-0-EOM -ch3 14 BOM H -ch2-〇-e〇m _ch3 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準( CNS ) A4規格(210X297公釐) 101 310112 568897 A7 B7 五、發明説明(10> 表8 0 R2 R6
(I-P2-5) r1=po(〇h)2 編號 R2 R4 R6 R8 1 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM -CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H
-CH2-0-E0M -CHrO-EOM -CH2-0-E〇M -ch2-o-e〇m -ch2-o-eom -ch2-o-e〇m •CHrO-EOM -CH2-〇-E〇M •ch2-o-e〇m -ch2-o-eom -ch2-o-eom -ch2-o-eom -ch2-o-eom -CH2"OeEOM H H H H H H H -CH3 -ch3 -ch3 -ch3 -ch3 -ch3 -ch3 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 102 310112 568897 A7 B7 五、發明説明(10》 表8 1
(I-P3-1)
R1=COOH 編號 R2 R4 R6 R8 經浐部中^«.^-^m t,消贽合竹拉印f 1 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM -CH3 2-丙稀基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H
-CH2-0-E0M •ch2-o-e〇m -CHyO-EOM -ch2-〇-e〇m -CHr〇-EOM -CH2-〇-E〇M -CH2"0-E0M -CHyO-EOM -CH2~0~E0M -ch2-〇-e〇m -ch2-o-eom -ch2-o-e〇m -CHrO-E〇M -CH2-0-E〇M H H H H H H H -CH3 -ch3 -ch3 -ch3 -ch3 -ch3 -ch3 (讀先閱讀背面之注意事項再t寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 103 310112 568897 A7 B7 五、發明説明(l〇)l 表8 2 (請先閱讀背面之注意事項再镇寫本頁)
R2 R6 0
R1=CONHOH 锔號 ‘ V V.,· R2 Μ R6 R8 1 -ch3 H -CHr〇-EOM H 2 2-丙烯基/ H -ch2-o-e〇m H 3 2-丙炔基『 H -ch2-〇-e〇m H 4 MOM H -ch2-〇-eom H 5 EOM H -ch2-o-e〇m H 6 MEM H -ch2-〇-e〇m H 7 BOM H -ch2-o-e〇m H 8 -ch3 H -CHr〇-EOM -ch3 9 2-丙烯基 H -CHrO-EOM -ch3 10 2-丙炔基 H -CHr〇-EOM -ch3 11 MOM H -ch2-o-e〇m -ch3 12 EOM H -ch2-o-e〇m -ch3 13 MEM H -ch2-o-eom -ch3 14 BOM H -ch2-o-e〇m -ch3 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 104 310112 568897 A7 B7 五、發明説明(1〇h 表8 3 R2 R6
(I-P3-3) R1=CONHNH; 編號 R2 R4 R6 R8 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM -CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H -CH2-0-E0M -ch2-〇-e〇m •ch2-〇-e〇m -ch2-〇-e〇m -ch2-〇-e〇m -ch2-〇-e〇m -ch2-〇-e〇m -ch2-o-e〇m -CH2*0~E0M -ch2-o-eom -ch2-o-e〇m -CH2-0-EOM -CH2-0-EOM -ch2-o-eom H H H H H H H -CH3 -ch3 -ch3 -ch3 -ch3 -ch3 •ch3 (讀先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 105 310112 568897 A7 B7 五、發明説明(1 〇▲ 表8 4 R2 R6 0
R1^ v 、N R4
(I-P3-4 ) NO; 經沪部中次«.^fXJh.t.消贽合竹ii印?^ R1=CH2SH 鏞號 、>.·二-R2 R4 R6 R8 1 -ch3 H -ch2-o-eom H 2 2-丙烯基 H -CHr〇-EOM H 3 2-丙炔基 H -CH2-〇-EOM H 4 MOM H -ch2-〇-e〇m H 5 EOM H -CH2-O-EOM H 6 MEM H -ch2-〇-e〇m H 7 BOM H -CH2-O-EOM H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-o-eom -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -CH2-O-EOM -ch3 12 EOM H -CH2-O-EOM -ch3 13 MEM H -ch2-o-eom -ch3 14 BOM H -ch2-o-eom -ch3 (請先閱讀背面之注意事項再填寫本頁) :裝·
、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 106 310112 568897 R2 R1
:¾¾—部中呔«.準x;m T,消贽合竹私卬f A7 B7 五、發明説明(107) 表8 5 R6 〇 (Ι-Ρ3-5) R8 ^ΝΟ, (讀先閱讀背面之注意事項再填寫本頁)
R1=PO(〇H)2 編號 V V ” R2 R4 R6 R8 1 -CH3 H -CHr〇-EOM H 2 2-丙烯基 H -ch2-〇-e〇m H 3 2-丙炔基 H -CH2-O-EOM H 4 MOM H -CH2-O-EOM H 5 EOM H -CH2-O-EOM H 6 MEM H •ch2-〇-e〇m H 7 BOM H -CH2-O-EOM H 8 •ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -CH2-O-EOM -ch3 10 2-丙炔基 H -CH2-O-EOM -ch3 11 MOM H -ch2-o-eom -ch3 12 EOM H -CH2-O-EOM -ch3 13 MEM H -CH2-O-EOM -ch3 14 BOM H -CH2-O-EOM -ch3 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 107 310112 568897 A7 B7 五、發明説明(108) 表8 6 R2 R6 Ο R1
N
(I-P4-1)
CN R1=COOH 編號 Ά. R2 R4 R6 R8 1 -ch3 H -ch2-o-e〇m H 2 2-丙烯基 H •ch2-〇-e〇m H 3 2-丙炔基 H •ch2-〇-e〇m H 4 MOM H -ch2-〇-e〇m H 5 EOM H -ch2-o-eom H 6 MEM H -ch2-o-e〇m H 7 BOM H -ch2-o-eom H 8 -ch3 H -ch2-〇-e〇m •ch3 9 2-丙烯基 H -CHr〇-E〇M _ch3 10 2-丙炔基 H -CHr〇-E〇M -ch3 11 MOM H -CH2-O-EOM -ch3 12 EOM H -CH2-O-EOM -CH3 13 MEM H -CH2-O-EOM -ch3 14 BOM H •ch2-o-e〇m -ch3 (請先閱讀背面之注意事項再填寫本頁) ·_裝· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 108 310112 568897 A7 B7 五、發明説明(109) 表8 7 R2 R6 Ο R1
N R8
(I-P4-2)
CN 經浐部中λ«.^·而T,消贽合作私卬象 R1=CONH〇H 煽號 Ά.. R2 R4 R6 R8 1 -ch3 H -ch2-〇-e〇m H 2 2-丙輝基 H -ch2-o-eom H 3 2-丙炔基 H -ch2-o-e〇m H 4 MOM H -ch2-〇-e〇m H 5 EOM H -ch2-o-e〇m H 6 MEM H -ch2-o-e〇m H 7 BOM H -ch2-o-eom H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-o-eom -ch3 10 2-丙炔基 H -CH2-0-EOM -ch3 11 MOM H •ch2-o-e〇m -ch3 12 EOM H -CH2-0-EOM -ch3 13 MEM H -CH2-0-EOM -ch3 14 BOM H -CH2-0-EOM •ch3 (請先閱讀背面之注意事項再楨寫本頁)
、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 109 310112 568897 A7 B7 五 發明説明(110) 表8 8 R2 R6
(I-P4-3) R1=CONHNH5 編號 R2 R4 R6 R8 經沪部中-A«.^-x;h 5消ft合竹私印y 1 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM -CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H -CH2-0-E0M •ch2-〇-e〇m •ch2-〇-e〇m -ch2-〇-e〇m -ch2-o-eom -CHrO-EOM -CH2-〇-EOM •ch2-o-e〇m ch2-o-e〇m ·οη2·〇·ε〇μ ch2-o-e〇m •CHr〇-EOM •CH2-〇-E〇M -ch2-〇-e〇m H H H H H H H -CH3 -ch3 -ch3 -ch3 -ch3 -ch3 -ch3 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 110 310112 568897 A7 B7 五、發明説明(111) 表8 9 R2 R6 0 R1
N R8
(I-P4-4)
CN 經浐部中决«.^fXJn〈_T.消贽合作拉卬顰 R1=CH〇SH 編號 R2 ' R4 R6 R8 1 -ch3 H -CHr〇-EOM H 2 2-丙烯基 H -ch2-〇-e〇m H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -ch2-〇-eom H 5 EOM H •ch2-〇-e〇m H 6 MEM H -ch2-o-eom H 7 BOM H -ch2-o-eom H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙稀基 H -ch2-o-e〇m -ch3 10 2-丙炔基 H -ch2-o-eom -ch3 11 MOM H -CH2-0-EOM -ch3 12 EOM H -ch2-〇-e〇m -ch3 13 MEM H -ch2-o-e〇m -ch3 14 BOM H -ch2-o-eom ,ch3 (請先閲讀背面之注意事項再镇寫本頁) .¾.
、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 111 310112 568897 A7 B7 五、發明説明(112) 表9 0
(I-P4-5) r1=po(〇h)2 编號 R2 R4 R6 R8 1 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM _CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H -CH2-0-E〇M -ch2-〇-e〇m -ch2-〇-eom -ch2-〇-e〇m -ch2-〇-e〇m -ch2-o-eom -ch2-o-eom -ch2-〇-eom -ch2-〇-e〇m -ch2-o-e〇m •ch2-o-e〇m -ch2-〇-e〇m -ch2-〇-e〇m -ch2-〇-e〇m H H H H H H H -CH3 -ch3 -ch3 -ch3 -ch3 -ch3 •ch3 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 112 310112 568897 A7 B7 五、發明説明(113) R2 R1
(請先閱讀背面之注意事項再填寫本頁) 表9 1 R6 〇 W.,, 經浐部中^«.卑^以1,消贽合竹^印象
R1=COOH 編號 R2 R4 R6 R8 1 -CH3 H -ch2-〇-e〇m H 2 2-丙烯基 H -CHr〇-E〇M H 3 2-丙炔基 H •ch2-〇-e〇m H 4 MOM H -ch2-〇-e〇m H 5 EOM H -CHr〇-EOM H 6 MEM H •ch2-〇-e〇m H 7 BOM H -CHr〇-E〇M H 8 -ch3 H -CHrO-E〇M -ch3 9 2-丙烯基 H -ch2-〇-e〇m •ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -ch2-o-eom -ch3 12 EOM H -ch2-o-eom -ch3 13 MEM H -ch2-〇-e〇m -ch3 14 BOM H -CHrO-E〇M ch3 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 113 310112 568897 A7 B7 五、發明説明(114 ) 表9 2
R1=CONH〇H 编號 R2 R4 R6 R8 1 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM -CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H •CH2-〇-E〇M -ch2-〇-e〇m -ch2-〇-e〇m -ch2-〇-e〇m -ch2-〇-eom -ch2-〇-e〇m -ch2-〇-e〇m •CHr〇-EOM -CH2-0-E0M -ch2-〇-e〇m -ch2-〇-eom -ch2-〇-e〇m -ch2-〇-e〇m -ch2-o-e〇m H H H H H H H -CH3 -ch3 -ch3 -ch3 _ch3 -ch3 -ch3 (¾先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 114 310112 568897 A7 B7 五、發明説明i 1 5 ) 表9 3
(I-Q-3) R1=CONHNH; 編號 R2 R4 R6 R8 1 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM -CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H -CH2-0-E0M -ch2-〇-e〇m -CHrO-E〇M -CH2-〇-E〇M -ch2-〇-eom -ch2-o-eom -ch2-〇-eom -ch2-〇-e〇m -ch2-〇-e〇m -ch2-o-eom -ch2-〇-e〇m -ch2-o-eom -ch2-〇-e〇m -ch2-o-eom H H H H H H H -CH3 -ch3 -ch3 -ch3 -ch3 -ch3 -ch3 (讀先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 115 310112 568897 A7 B7 五、發明説明€ 1 6 表9 4 R2 R6 0
N
(I-Q-4) r1=ch2sh 煽號 R2 R4 R6 R8 1 -ch3 H -ch2-〇-e〇m H 2 2-丙烯基 H -CHg-O-EOM H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H •ch2-o-e〇m H 5 EOM H -ch2-o-eom H 6 MEM H -ch2-〇-e〇m H 7 BOM H -ch2-o-eom H 8 •ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-o-e〇m -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -ch2-o-eom -ch3 12 EOM H -CH2-0-EOM -ch3 13 MEM H •ch2-〇-e〇m ch3 14 BOM H -ch2-o-eom -ch3 (讀先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 116 310112 568897 A7 B7 五、發明説明t 17 ) 表9 5 R2 R6 0
R1=P〇(〇H)2 編號 R2 R4 R6 R8 1 -ch3 H -ch2-〇-e〇m H 2 2-丙烯基 H -ch2-〇-eom H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -ch2-〇-e〇m H 5 EOM H -ch2-〇-eom H 6 MEM H -ch2-〇-e〇m H 7 BOM H -ch2-〇-e〇m H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-〇-e〇m -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -ch2-〇-eom -ch3 12 EOM H -ch2-o-e〇m -ch3 13 MEM H -ch2-〇-e〇m -ch3 14 BOM H -ch2-o-eom -ch3 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 117 310112 568897 A7 B7 五、發明説明ί 1 8
表9 6
〇
Η ο 〇 C II 1R 經浐部中央«.^-XJh τ_消費合作社卬f 編號 R2 R4 R6 R8 1 -ch3 H -ch2-o-eom H 2 2-丙烯基 H -CHg^O^EOM H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -CHr〇-EOM H 5 EOM H -ch2-o-e〇m H 6 MEM H •ch2-o-e〇m H 7 BOM H -ch2-〇-e〇m H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-〇-e〇m -ch3 10 2-丙炔基 H -CHr〇-E〇M -ch3 11 MOM H -ch2-〇-e〇m -ch3 12 EOM H -ch2-〇-eom -ch3 13 MEM H -ch2-o-e〇m -ch3 14 BOM H -ch2-〇-e〇m -ch3 (請先閱讀背面之注意事項再填寫本頁) ,裝· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 118 310112 568897 A7 B7 五、發明説明(119) 表9 7 R1 R2 R6 0
N
〇X) (I-R-2 ) 經浐部中次«.率XJh T,消贽合竹私印掣 R1=C〇NH〇H 編號 R2 R4 R6 R8 1 -ch3 H -ch2-〇-eom H 2 2-丙烯基 H -ch2-〇-e〇m H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -ch2-o-eom H 5 EOM H -ch2-〇-e〇m H 6 MEM H -ch2-o-eom H 7 BOM H -ch2-o-eom H 8 -ch3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-o-e〇m -CH3 10 2-丙块基 H -ch2-o-eom -ch3 11 MOM H -ch2-〇-eom -CH3 12 EOM H -ch2-〇-e〇m -ch3 13 MEM H -ch2-o-e〇m -ch3 14 BOM H -ch2-o-eom -ch3 (讀先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 119 310112 568897 A7 B7 五 务明説明(120) 表9 8
〇X) (I-R-3) 編號 R2 R4 R6 R8 經浐部中呔«.^-x;h T,消贽合作社印欠 1 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM -CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H -CH2-〇-E〇M -ch2-〇-e〇m -CH2"0-E0M -ch2-〇-e〇m •ch2-〇-e〇m -ch2-〇-e〇m -ch2-o-e〇m -CH2-0-EOM -CH2-0-EOM -CH2-0-EOM -ch2-〇-e〇m -CH2-0-EOM -CH2-0-EOM •ch2-〇-e〇m H H H H H H H -ch3 -ch3 -ch3 -ch3 -ch3 -ch3 ch3 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 120 310112 568897 A7 B7 五 發明説明(121 ) 表9 9
(I-R-4) r1=ch2sh 編號 R2 R4 R6 R8 1 2 3 4 5 6 7 8 9 10 11 12 13 14
-CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM -CH3 2-丙烯基 2-丙炔基 MOM EOM MEM BOM
H H H H H H H H H H H H H H
-CH2-0-E0M -ch2-o-eom -ch2-〇-e〇m -CHr〇-EOM -CH2-0-E〇M -ch2-〇-e〇m •ch2-o-e〇m -ch2-〇-e〇m -CH2~0~E0M -CH2-0-E0M -ch2-〇-e〇m -CH2-0-EOM -CH2-0-EOM -CHrO-E〇M H H H H H H H -CH3 -ch3 -ch3 -ch3 -ch3 -ch3 -ch3 (讀先閲讀背面之注意事項再頊寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 121 310112 568897 A7 B7 五、發明説明(122) 表1 0 0 R2 R6 〇 R1
N
(I-R-5) 經浐部中央«.卒而h_T.消贽合作ii卬來 R1=P〇(〇H)2 編號 R2 R4 R6 R8 1 -ch3 H -CH2-O-EOM H 2 2-丙烯基 H -ch2-〇-e〇m H 3 2-丙炔基 H -CH2-O-EOM H 4 MOM H -ch2-o-eom H 5 EOM H •ch2-o-e〇m H 6 MEM H -CH2-O-EOM H 7 BOM H -CH2-O-EOM H 8 -CH3 2-丙烯基 H -CHr〇-EOM -ch3 9 H -ch2-〇-e〇m •CH3 10 2-丙炔基 H -ch2-〇-eom -ch3 11 MOM H -CHrO-EOM -ch3 12 EOM H -ch2-〇-e〇m -CH3 13 MEM H -ch2-〇-e〇m -ch3 14 BOM H -ch2-〇-e〇m -ch3 (請先閱讀背面之注意事項再填寫本頁) ,裝·
、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 122 310112 568897 A7 B7 五、發明説明丨23 ) 表1 0 1 R2 R6 Ο
經浐部中夾«.^-而巧T,消贽合作私印f 縐號 V . R2 R4 R6 R8 1 -ch3 H -ch2-〇-e〇m H 2 2-丙烯基 H -CHg-O-EOM H 3 2-丙炔基 H -CHr〇-E〇M H 4 MOM H -ch2-〇-e〇m H 5 EOM H •ch2-〇-e〇m H 6 MEM H -ch2-〇-e〇m H 7 BOM H -ch2-〇-e〇m H 8 -CH3 H -ch2-〇-eom -ch3 9 2-丙烯基 H -ch2-〇-e〇m -ch3 10 2-丙炔基 H -CHr〇-EOM -ch3 11 MOM H -CH2~0~E0M -ch3 12 EOM H -ch2-〇-e〇m ch3 13 MEM H -CHr〇-EOM -ch3 14 BOM H -CH2-O-EOM -ch3 (讀先閲讀背面之注意事項再瑣寫本頁) 4 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 123 310112 568897 A7 B7 五、發明説明4 24 ) 表1 0 2 R2 R6 0
(I-S-2) CN 編號 R2 R4 R6 R8 1 •ch3 H -ch2-o-eom H 2 2-丙烯基 H •CHr〇-EOM H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -ch2-o-eom H 5 EOM H -ch2-〇-e〇m H 6 MEM H -CHyO-EOM H 7 BOM H -ch2-〇-eom H 8 -ch3 H CHg-O-EOM -ch3 9 2-丙烯基 H -CH2-〇-E〇M -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -ch2-o-eom -ch3 12 EOM H -ch2-o-eom -ch3 13 MEM H -CH2-0~E0M -ch3 14 BOM H -CH2*0-E0M -ch3 (請先閱讀背面之注意事項再楨寫本頁) ,裝_ 本紙張尺度適/fl中國國家標準(CNS ) A4規格(210X297公釐) 124 310112 568897 A7 B7 五、發明説明《25 ) 表1 0 3 R2 R6 0
(I-S-3) CN 編號 R2 R4 R6 R8 1 -ch3 H -ch2-〇-eom H 2 2-丙烯基 H -CHg-O-EOM H 3 丙炔基 H -ch2-〇-e〇m H 4 MOM H -ch2-〇-e〇m H 5 EOM H -ch2-〇-e〇m H 6 MEM H -ch2-〇-e〇m H 7 BOM H -ch2-〇-e〇m H 8 -ch3 H -ch2-〇-e〇m • -ch3 9 2-丙烯基 H -ch2-〇-e〇m ch3 10 2-丙炔基 H -ch2-o-eom -ch3 11 MOM H -ch2-o-eom -ch3 12 EOM H -ch2-〇-e〇m CH3 13 MEM H -ch2-o-e〇m -ch3 14 BOM H -ch2-o-e〇m -ch3 (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 125 310112 568897
7 B 五、發明説明(126 ) 表1 0 4 R2 R6 〇
經沪部中灰i'?.^-x;M 5消贽合作私印來 鏞號, R2 R4 R6 R8 1 -ch3 H -ch2-o-e〇m H 2 2-丙烯基 H -ch2-〇-e〇m H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -CH2-O-EOM H 5 EOM H -ch2-〇-e〇m H 6 MEM H -ch2-o-eom H 7 BOM H -ch2-o-e〇m H 8 -ch3 H -CH2-0"E0M -ch3 9 2-丙烯基 H -ch2-〇-e〇m -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -ch2-〇-e〇m -ch3 12 EOM H -ch2-〇-e〇m -ch3 13 MEM H •CHr〇-EOM •ch3 14 .BOM H -ch2-〇-e〇m ch3 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 126 310112 568897 A7 B7 五、發明説明(127 ) 表1 0 5 R2 R6 0
:1各5) CN 編號 R2 R4 R6 R8 1 -ch3 H -CHr〇-EOM H 2 2-丙烯基 H -CHr〇-EOM H 3 2-丙炔基 H -ch2-〇-e〇m H 4 MOM H -ch2-〇-eom H 5 EOM H -ch2-〇-e〇m H 6 MEM H -ch2-o-eom H 7 BOM H -ch2-〇-e〇m H 8 -CH3 H -ch2-〇-e〇m -ch3 9 2-丙烯基 H -ch2-〇-eom -ch3 10 2-丙炔基 H -ch2-〇-e〇m -ch3 11 MOM H -CH2-0-EOM ch3 12 EOM H -CHrO-EOM -ch3 13 MEM H -ch2-o-e〇m _ch3 14 BOM H -ch2-〇-e〇m -ch3 (請先閱讀背面之注意事項再楨寫本頁) L裝·
、1T 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ι27 3 1 0 1 1 2 568897
R9 A7 —一 ΒΊ 五、發明説明ί28 ) 太掰明化合物之Μ诰方法 一般式(I)所示之本發明化合物,可依下逑方法或實 施例中所逑之方法製造。 [1] 一般式(I)所示之本發明化合物中,R1為-C00R1Q 之化合物,亦即一般式(卜所示之化合物,可依下列(a) 〜(c)之方法製造: (M) (式中,所有符號之意義如同上述)。 U)將 R1 基中-COOR10 基不為-COOH 基,且 R2、R3、R4 、R5、R6、R7、R8及R9基中之任一基不為-COOH基或含該 基之基,亦不為羥基或含該基之基或胺基或含該基^基的 化合物,亦即一般式(I-la)所示之化合物: (誚先閱讀背面之注意事項再楨寫本s ) 部 R10-1a〇 R2-1a R3-1aR6-1aR7.1a 〇 R9-1a (1-1 a) ο R4»1aRS-1
R 6-1a f A 卬 (式中,Rio-“示Cl〜8烷基、苯基、苯基或Cl〜8烷 氧基取代之Cl〜8烷基,或笨基、苄基或Cl〜8烧基取代之 1¾¾¾¾ 基,R 2 ~ 1 a > R 3 - 1 a λ R 4 - 1 a % R δ - 1 a N R6 一 la、 R 7 * 1 ® 、R9-1b 之意義分別如同 R2、R3、R4、R5、R6、 本紙张尺度適州中國國家標準(CNS ) Λ4規格(210X297公釐) 1 〇 ft 568897 A7 B7 五、發明説明(l29) R7、R8、R9所述)與一般式(ΙΠ所示之化合物 p2-1a p3-1a Q6-1a〇7-1a R10-1a〇
NH (") R8-1a (式中,所有符號之意義如同前逑)及一般式(III)所 示之化合物: H0 0") (讀先閲讀背面之注意事項再填寫本頁) R9m1s )r‘ -,11; il 消 A η 卬 (式中,所有符號之意義如同前逑)進行醢胺化反應而 可製得。 一般式(II)所示化合物與一般式(III)所示化合物之 釀胺化反應為通知者,例如 (1) 使用釀基鹵之方法。 (2) 使用醢酐之方法。 (3) 使用縮合劑等方法。 此等方法之具體說明如下:(1)使用醢基鹵之方法, 例如,使羧酸於惰性有機溶劑(氯仿、二氯甲烷、二乙醚 、四氫呋喃等)中或無溶劑之存在下,與醢基鹵(草釀氯、 亞磙釀氯等)於-201C〜回流溫度下進行反應,再將所得之 醣基鹵於三級胺(吡啶、三乙胺、二甲基苯胺、二甲胺基 吡啶等)之存在下,於胺及惰性有機溶劑(氯仿、二氣甲焼 、二乙醚、四氫呋喃等),中於0〜40C下進行反應。 本紙张尺度適州中國國家標準(CNS ) Λ4規格(210X 297公釐) 129 310112 568897 A7 B7 五、發明説明(! 30) (讀先閱讀背面之注意事項再楨寫本頁} (2) 使用混合酸酐之方法,例如,使羧酸於惰性有櫬 溶劑(氯仿、二氯甲烷、二乙醚、四氫呋喃等)中或無溶劑 之存在下,於三級胺(吡啶、三乙胺、二甲基笨胺、二甲 胺基吡啶等)之存在下,與酸衍生物(氯甲酸乙酶、氯甲酸 異丁 _等)於〇〜401下反應,再將所得之混合酸酐於惰性 有機溶劑(氯仿、二氯甲烷、二乙醚、四氫呋喃等)中,與 胺於0〜40¾下進行反應。 (3) 使用縮合劑之方法,例如,使羧酸與胺在有機溶 劑(氯仿、二氛甲烷、二甲基甲醢胺、二乙醚、四氫呋喃 等)中,或無溶劑下,於有或無三級胺(吡啶、三乙胺、二 甲基苯胺、二甲胺基吡啶等)之存在下,使用縮合劑(1,3-二環己基碳化二亞胺(DCC)、1-乙基-3-[3-(二甲胺基)丙 基]碳化二亞胺(EDC)、1,1’-羰基二眯唑(CDI)、2 -氱-1-甲基吡啶錄磧等),Μ及使用或不使用1-羥基苯并三唑( HOBt),於0〜40 t!下進行反應。 上述(1)、(2)及(3)之任一種反應,最好於惰性氣體( 氨、氮等)中,於無水條件下進行。 (b)將 R1 基中-COOR10 基不為-C00H 基,且 R2、R3、R4 、R5、R6、R7、R8及R9基中至少有一基為-C00H基或含該 基之基,為羥基或含該基之基或胺基或含該基之基的化合 物,亦即一般式(I-lb)所示之化合物: 本紙张尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 130 310112 568897 A7 B7 五、發明説明(131:
p9-1b (M b)
(式中,R2_ 7-lb、 |j8-lb、 ‘ R6、 R7、 R8 N b、 R3-lb、 JJ 4 - 1 b N j{ 5 - 1 b Λ JJ 6 - 1 b N 9_lb所示之意義分別與R2、R3、R4、R5 9 相同。但是 R 2 - 1 、R 3 - 1 、R 4 - 1 b、 R5-lh>、R6-lb、R7-lt>、R8,lb、R9-ll> 基中至少有一個基 為-COOH基、羥基或胺基或含該等基之基,其他符號之意 義如同前述),可將上述一般式(I-la)中-C00H基、羥基、 胺基或含此等基之基分別加Μ保護之化合物,亦即一般式 (I-lal)所示之化合物: R1〇e1a〇
R 9-1 a1 (1-1 a1) (讀先閱讀背面之注意事項再填寫本頁} ^ λί, 十 -火)i _τ 消 (式中,R2-lal、 R 3 - 1 a 1 N R 3 - 1 a 1 N R 4 - 1 a 1 、R5 裤 lal、R6-lal、R7-1B1、R8-lal、R9-lel 之意義分 別與R2、R3、R4、R5、R6、R7、R8、R9所示者相同。但是 U 2 - 1 a 1 N R3-lal、 jj 4 - 1 a 1 Λ JJ 5 - 1 a 1 ^ g 6 - 1 a 1 N R7-lal、RUd基中至少有一傾基為被保護之-C00H基(例如,甲基、乙基、第三丁基及苄基等所保護者) 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) 131 310112 568897 A7 B7 五、發明説明(132) (讀先閲讀背面之注意事項再填寫本頁) ,被保護之羥基(例如,甲氧甲基、四氫吡喃基、第三丁 基二甲基甲矽烷基、乙釀基、苄基等所保護者)或被保護 之胺基(例如,苄氧基羰基、第三丁氧基羰基、三氟乙釀 基等)或含上述基之基,其他符號之意義如同前述)藉鐮加 水分解,於酸性條件下脫保護反應,甲矽烷基之脫保護反 應或加氫分解等脫保護反應而製得。 藉鹼加水分解之脫保護反應為通知者,例如,於有機 溶劑(甲酵、四氫呋喃、二垮烷等)中,使用鐮金羼之氫氧 化物(氫氧化納、氫氧化鉀、氫氧化鋰等),_ 土類金靨之 氫氧化物(氫氧化鋇、氫氧化鈣等)或碳酸塩(碳酸納、碳 酸鉀等或其水溶液或者該等物之混合物於〇〜40¾之溫度 下進行之。 酸條件下之脫保護反應亦為週知者,例如於有機溶銷 (二氣甲烷、氯仿、二鸣烷、乙酸乙酗、甲氧基苯等)中, 於有櫬酸(乙酸、三氟乙酸、甲烷磺酸、磺化三甲基甲矽 烷等)或無機酸(塩酸、硫酸等)或者該等物之混合物(溴化 氫乙酸等)中,於0〜1001C之潘度下進行之。 甲矽烷基之脫保護反應為週知者,例如於能與水混合 之有櫬溶麵(四氫呋喃、乙請等)中,使用氟化四丁基銨於 0〜40之溫度下進行之。 賴加氯分解之脫保護反應為通知者,例如於惰性溶麵 [醚系(例如,四氫呋喃、二垮烷、二甲氧乙烷、二乙黼等 )、酵条(例如,甲酵、乙酵等)、苯系(例如,苯、甲苯等 )、酮系(例如,丙酮、甲基乙基酮等)、腈系(例如乙請等 本紙張尺度適州中國國家標準((:奶)八4規格(210父297公釐) 132 310112 568897 A7 B7 五、發明説明(13 3) )、醢胺系(例如,二甲基甲醢胺等)、水、乙酸乙_、乙 酸或其中2種Μ上之混合溶劑等]中,於氫化催化劑(例如, 鈀-碳、鈀黑、鈀、氫氧化鈀、二氧化鉑、鑠、阮來鎳等) 之存在下,於有或無無機酸(例如,塩酸、硫酸、次亞氯 酸、編酸、四氟確酸等)或有機酸(例如,乙酸、對甲苯磺 酸、草酸、三氟乙酸、甲酸等)之存在下,於常壓或加壓 下之氫氣中或甲酸銨之存在下,於0〜200¾之溫度下進行 之。使用酸時,亦可採用其塩類。 (c)R1基中之-C00R1G基示-C00H基之化合物,亦即一 般式(I-lc)所示之化合物: (讀先閱讀背面之注意事項再填寫本頁) R2 R3 R6 R7 9 (Me) 〇 R4 R5 (式中,所有符號之意義如同前述),係Μ上述一般式 I-la)製得之化合物,亦即將一般式(I-lab)所示之化合 物
R9 (Mab) (式中,所有符號之意義如同前述)藉進行鐮加水分解 本紙张尺度通州中®國家標準(CNS ) Λ4規格(210X 297公釐) 133 310112 568897
R
R9 A7 Β7 五、發明説明U 34) 、酸性條件下之脫保護反應或加氫分解之脫保護反應即可 製得。 該鐮性條件下之加水分解、酸條件下之脫保護反應、 加氫分解之脫保護反應均為週知者,可依上逑方法進行。 [2]—般式(U所示本發明化合物之中, R1為-CONHOR10或-CONHNHR10所示之化合物,亦即一 般式(I - 2 )所示之化合物: (1-2) (式中,示-COHHNHR1'其他符虢之意義如同前 逑),可依Μ下(a)及(b)之方法製造之。
(a)R1示-CONHOR10或-CONHNHR10,且 R2 、 R3、 R4 、 R 、R6、R7、R8及R9基中之任一基不為-C00H基或含該基之 基化合物,亦即一般式(I-2a)所示之化合物: (讀先閱讀背面之注意事項再楨寫本頁) π -、,ι: .1 消 f A η 卬 p^2-2a r3-2si r6-2si r7-23 13
R 1-2 R4-2aR5-2a ^8,23 (l-2a) (式中,R2— 本紙张尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 134 310112 568897 部 中 \\ j >/) fr
R9·23 0 A7 B7 五、發明説明(! 3 5) R7-2a> R8-2a, R9-2a^giJ||R2, R3、 R4、 R5 N R6、 R7、 R8、R9 所示意義相周。但是,R2_2a、R3_2a、R4_2a、 R5-2e、 R6-2a、 R7-2a、 R8-2a、 基中之任一基不為 -COOH基或含有該等基之基,其他符號之意義如同前述), 係將以上述一般式(1-1)所製得之化合物中R1基示C0H基, 且R2、R3、R4、R5、R6、R7、R8及R9基中之任一基不為 -(:0011基或含該基之化合物,亦即一般式(卜1(1) (1-1 d) (式中,所有符虢之意義如同前逑)所示之化合物與一 般式(I V ) H2N-0R 10 (IV) (式中,1?1()之意義如同前述)或一般式(V) H2H-NHR 10 (V) (式中,R1G2意義如同前述)所示之化合物進行醢胺 化反應,必要時繼鑛進行鹼條件下之加水分解及/或酸條 件下之脫保護反應及/或加氫分解之脫保護反應即可製得 Ο 該醢胺化反應,鐮條件下之加水分解、酸條件下之脫 保護反應,加氫分解之脫保護為通知者,可依上述方法進 行之。 ~ (讀先閲讀背面之注意事項再填寫本頁) 本紙张尺度適W中國國家標準(CNS ) A4規格(210X297公釐) 135 310112 568897 A7 B7 五、發明説明(136) (b)R1 示-CONHOR10或-CONHHHR10,且 R2、R3、R4、R5 、R6、R7、R8及R9基中至少有1個基為-COOH基或含有該基 之化合物,亦即一般式(I-2b) p2-2b p3-2b p6-2bp7-2b 〇
9-2b R4.2bp5.2b 8.2b (l-2b) (謂先閱讀背面之注意事項再楨寫本頁) R1-2-
本紙张尺度通州中國國家標準(CNS ) A4規格(2丨OX 297公釐) 136 310112 568897 A7 B7 五、發明説明(137) R5、R6、R7、R8、R9所示之意義相同。但是R2_2a1、 R3-2al、R 3 - 2 a 1 Λ R4 -2al、 R5-2al、R6-2al、R7_2al、 、R9-2al基中至少有一個基為被保護之-C〇〇H基(例 如,被甲基、乙基、第三丁基及苄基等所保護者)或含該 等基之基,其他符號之意義如同前述),進行鐮加水分解 、酸性條件下之脫保護反應或加氬分解之脫保讅反應即可 製得。 該鐮性條件下之加水分解、酸性條件下之脫保護反應 ,加氫分解之脫保護反應為週知者,可依上述方法進行之 〇 [3]—般式(I)所示之本發明化合物中, R1為- (CH2)nSR5〇之化合物,亦即一般式(卜3)所示之 化合物: (讀先閱讀背面之注意事項再楨寫本頁) R1·3
(式中,R1—3示- (CH2)nSR50,其他符號之意義如同前 述),依下列(a)及(b)之方法製造之。 (a)R1 示-(CH2)nSR50 之化合物,且 R2、R3、R4、R5、 R6、R7、R8及R9基中任一基均不為- COOH基或含該基之基 的化合物,亦即一般式(I-3a)所示之化合物: 本紙張尺度適州中國國家標準(cns )八4規格(210X297公釐) 1 37 3 1 0 1 1 2 568897 A7 B7 五、發明説明 ,138 p2-3a p3-3a p6-3ap^7-3a 〇
R 1-3 分人 R4-3aR5-3a ^8<Ja
R 9-3a (l_3a) (式中,R 2 - 3 a N R3 一 3a、 jj 4 - 3 a N J{ 5 - 3 a N jj 6 - 3 a > R7-3a、 R8-3a N R9 一3a之意義分別與 R2、 R3、 R4 Λ R5、 R6 、R7、 R8、 R9所示者相同。但是,R2_3·、 R3~3a、 、R5 一3a、 R6-3a N R7 -3a λ R8-3a Λ R9 - 3 a基中之任一基均 不為-COOH基或含該基之基,其他符號之意義如同前逑), 係由一般式(VI)所示之化合物: R4-3>R5.23a ^8.33 R2 3\ Rj-3a R6-3aR7-35 X-(CH2)n" (VI) (讀先閱讀背面之注意事項再瑣寫本頁) 部 屮 ik 消 f: 印 f (式中,X示鹵原子,其他符號之意義如同前述)與一 般式(VII)所示之化合物: R501SK (VII) (式中,R501 示 Cl 〜8 烷基、-COR52、-SR531 (基中, 示Cl〜8烷基或苯基))進行反應而製得。 又,R50為氫原子或-SH之化合物時,Μ上所得之化合 物可繼績進行脫保護反應而製得。 上述反懕為遇知之反應,例如,可於有櫬溶劑(丙酮 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X 297公釐) 138 310112 568897 A7 B7 五、發明説明(139) 、四氫呋喃等)中藉回流加熱而進行之。 又繼績進行之脫保護反應亦為週知者,例如,於有機 溶劑(甲酵、四氫呋喃、二垮烷等)中,使用鹹金臑之氫氧 化物(氫氧化納、氫氧化鉀、氫氧化鋰等)、鐮土類金屬之 氫氧化物(氫氧化鋇、氫氧化鈣)或碳酸塩(碳酸納、碳酸 鉀等)或其水溶液或上述之混合物於〇〜40C之溫度下進行 之0 (b)R1示-(CH2)nSR50,且 R2、 R3、 R4、 R5、 R6、 R7、 R8及R9基中至少有一個基為-COOH基或含該基之基,亦即 一般式(I-3b)所示之化合物: (讀先閱讀背面之注意事項再硪寫本頁) 中 式
與 別 分 義 意 之
6 R 是 但 ο 同 相 者 示 所 b b 基 之 基 該 含 或 Η ο ο C 辱 為 基 個 有述 少前 至同 , 如 中義 基意 3b之 9-號 R符 b 他 ? 其 含式 中般 a)一 7 即 (I亦 式 , 般物 一 合 述化 上之 將護 係保 被 別 分 : 基物 之 合 基化 該之 含示 或所 基1) 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) 139 310112 140、568897 A7 B7 五、發明説明 R2 3aJ R^3a1 R6-3a1R7-3a1 〇
R4.3afR5-3a1 ^3^ (讀先閱讀背面之注意事項再埴寫本lic) R1"3' \R9_3a1 〇-3a1) (式中,R2 - 3al、 R3-3al、 g 3 - 3 a 1 Λ |{ 4 - 3 a 1 N J{ 5 - 3 a 1 、R6-3al、R7-3al、R8-3al、R9-3al 之意義分別與 R2、R3 、R4、R5、R6、R7、R8、R9 所示之者相同。但是,R2-3al Λ R3-3al、 g 3 - 3 a 1 N g 4 - 3 a 1 Λ 5 - 3 a 1 > g 6 - 3 a 1 % 7 - 3 a 1 、R8-3al、R9-3alS中至少有一個基為被保護之-C〇〇H基( 例如,被甲基、乙基、第三丁基及苄基等所保護者)或含 上述基之基,其他符號之意義如同前述),進行鐮加水分 解、酸性條件下之脫保護反應或加氫分解之脫保護反應而 製得。 該鐮性條件下之加水分解、酸性條件下之脫保護反應 ,加氫分解之脫保護反應為«知者,可依上述方法進行之 [4] 一般式(I)所示本發明化合物中,R1為-Υ-Ρ0( 0R^)2之化合物,亦即一般式(卜4)所示之化合物: π t: A 卬
R
r9 (Μ) 本紙張尺度適W中國國家標準(CNS ) A4規格(210X 297公釐) 140 310112 568897 A7 B7 五、發明説明(141) (式中,R1—4示- Y- P0(0R5i)2,其他符號之意義如同 前述),可依下列(a)〜(¢0之方法製造之。 (a)R1示- YhPiHORHht基中,Y1示-0-,其他符號之 意義如同上述),且R2、R3、R4、R5、R6、R7、R8及R9基 中之任一基均不為-COOH基或含該基之化合物時,亦即一 般式(I-4a)所示之化合物: Ο (R510)2-P-Y1 p2-4a p3-4a p6-4ap7-4a 〇 人 R4-4aR5-4a
R 9-4a 0-4a) (讀先閱讀背面之注意事項再填寫本頁) 3-4 '4-4 5-4 (式中,R2_4a, R7-4e、 R8-4a , R9-4a之意義分別與 R2、 R3、 R4、 R5、 R6 、R7、 R8、 R9所示者相同。但是,R2-4a、 R3-4&、 R4-4· 、R5-4a、R6-4a、R7-4a、R8-4a、R9-4a基中之任一/基均 不為-COOH基或含該基者,其他符號之意義如同前述),可 將一般式(VIII)所示之化合物: 部 屮 ik il .1 消 合 卬 f p2-4a p3-4a p6-4ap7-4a 〇
9-4a R4-4aR5-4a (VIII) (式中,所有符號之意義如同前逑)與一般式(IX)所示 之化合物: 本紙张尺度適州中國國家標準(€奶)八4規格(210'/ 297公釐) 141 310112 568897 A7 B7 五、發明説明(142) 0 (R511〇)2-p-x (IX) (式中,R511示Cl〜8烷基,苯基等公知之磷酸之保護 基,其他符號之意義如同前述)進行反應,在磷酸被保護 之情況下,繼鱭進行脫保護反應而製得。 上述反應為週知者,例如,可於有機溶劑(吡啶等)中 ,於0〜40 t:下進行反應。 又,磷酸保護基之脫保護反應為週知者,例如,於有 櫬溶劑(吡啶等)中,使用乙酸鋅於0〜40 t下進行反應。 (b)R1^ - Y 1-P0 (OR5 1 ) 2 ,且 R2、R3、R4、R5、R6、R7 、R8及R9基中至少有一個基為-C00H基或含該基之化合物, 亦即一般式(I-4b)所示之化合物: (謂先閲讀背面之注意事項再填寫本頁) b 中 式 ollp - R51
b
Μ» -4
4 R b 與 別 分 義 意 之
6 R 是 但 0 同 相 者 示 所 9 有述被 少前別 至同分 , 如基 中義之 基意基 4b之該 9 號含 4 符或 I 他Is „ 其丨 基 之 基4a 該卜 Η 0 00一 -C述 為上 基將 個可 b b 中 - 8 ο ο I /V 式 般 一 亦 物 合 化 之 護 保 物 合 化 之 示 所 本紙张尺度適州中國國家標準(CNS ) Λ4規格(210X297公釐) 142 310112 14568897 A7 B7 五、發明説明(
o II p2-4a1 p3-4a1 p6-4a1 p7-4a1
(R51〇)2-P—Y1^ 、R9-4a1 R4^a1 R5-4a1 (式中,R2*4a 1 > R3-4al、 R3-4a 1 N R 4 - 4 et 1 、 R5 R6-4al、R7-4al、R8-4al、R9-4al 之意義分別與 R2 R4、R5、R6、R7、R8、R9 所示者相同。但是,R2-4, 、R8_4b1、R9-4al基中至少有一傾基為被保護之-c〇〇[^( 例如,被甲基、乙基、第三丁基及苄基等)或含該基之基, 其他符號之意義如同前逑),進行鐮加水分解、酸性條件 下之脫保護反應或加氫分解之脫保護反應而製造之。 該鐮性條件下之加水分解、酸性條件下之脫保護反應 ,藉加氫分解之脫保護反應為週知者,可依上逑方法進行 (c)R1 示- Y2-P〇(〇RSi>2 (基中,γ2示單鍵或-CH2 其 (謂先閱讀背面之注意事項再楨寫本頁)
^ί'τ/Γ,'-r屮-^打 7/η负/V” M .^CT 他符號之意義如同上述),且R2、R3、R4、R5、R6、R7、 R8及Re基中之任一基均不為-COOH基或含該基之化合物時 亦即一般式(I-4c)所示之化合物: o p2-4c p3-4c p6-4c p7-4c C ^ (RS10)2—P_Y2
R9-4c R4-4cR5-4c ^8.4〇 (l-4c) ~本紙張尺度適;1]中國國家標準(CNS ) A4規格(210X 297公釐) 143 310112 568897 A7 B7 五、發明説明(1 4 4) (式中,R2-4c、R 3 - 4 c Λ R4-4o、R5-4c n R6-4c、 R7-4c、 R8~4o, R9_4c之意義分別與 R2、 R3、 R4、 R5、 R6 是4C 但8-R ο r 同 0 相T 者R7 示 、 所40 均 基 1 任 之 中 基 OC式 -C般 為一 不將 述 前 同 如 義 意 之 號 符 他 其 者 基 該 含 或 基 可 物 合 化 之 示 所
g (讀先閱讀背面之注意事項再填寫本頁) (式中,所有符號之意義如同前述)與一般式(XI)或( X I I)所示之化合物: (R5110)3P (XI) (R5"0)2P0K (XII) (式中,所有符號之意義如同前述)進行反應,在磷酸 被保護之情況下,繼績進行脫保護反應而製得。 上述反應為週知者,例如,可於有櫬溶劑(四氫呋喃 、二甲基甲釀胺等)中,於0〜120t!下進行反應。 又,磷酸基之脫保護反應為週知者,可依上述方法進 行反應。 (d)Ri示-Y2_P〇(0R51)2,且 R2 、 R3、 R4 、 R5 , R6 N R7 、R8及R9基中至少有一個基為-COOH基或含該基之化合物, 亦即一般式(I-4d)所示之化合物: 本紙張尺度通/1]中國國家標準(CNS ) A4規格(210X297公釐) Γ3Τ 310112 568897 A7 B7 五、發明説明(145)
p2*4d p3-4d p6-4dp7-4d (rs1o)2 一贮 人 RW (l-4d) p4-4dR5-4d p8^d ψ , R2-4d % R3-4d N R4-4d , R5-4d , R6-4d , R7-4d、 R8-4d , R9-4d之意義分別與 R2、 R3、 R4 Λ R5、 R6 、R7、 R8、 R9所示者相同。但是,R2-4d、 R3-4d、 R4-4d 、R5-4d、 R6-4d、 R7-4d、 R8-4d、 R9-4d基中,至少有一 個基為-COOH或含該基之基,其他符虢之意義如同前述), 可將上逑一般式(I-4c)中-C00H基或含該基之基分別被 保護之化合物,亦即一般式(I-4cl)所示之化合物:
9-4c1
R (讀先閱讀背面之注意事項再楨朽本頁) (式中,R2_4 部中•火 消 f卬 R3-4cl、 R3-4cl、 g 4 - 4 c 1 Λ 5 - 4 R8-4el、R9-4el之意義分別與R2、 R8、R9所示者相同。但是,R2_4ci 、3 - 4 c 1 N g 3 - 4 c 1 Λ 4 - 4 ο 1 N 5 - 4 c 1 > 6 - 4 ο 1 Λ 7 - 4 c 1 、R8-4c^、R9_4ci基中至少有一個基為被保護之-C〇〇H基( 例如,被甲基、乙基、第三丁基及苄基等)或含該基之基, 其他符號之意義如同前逑),進行鐮加水分解、酸性條件 6-4 7-4 3 本紙张尺度適州中國國家標準(CNS ) Λ4規格(210X 297公釐) 145 310112 568897 九: 部 十 •火 ii. 消 Λ 卬 A7 B7 五、發明説明(146) 下之脫保護反應或加氫分解之脫保護反應而製造之。 該_性條件下之加水分解、酸性條件下之脫保護反應 或加氫分解之脫保護反應為遇知者,可依上逑方法進行之 〇 本發明中之脫保護反應係業者可容易瞭解之一般脫保 護反應,例如鐮加水分解,酸性條件下之脫保護反應,加 氫分解之脫保護反應,靈活運用上逑反應即可容易地製得 本發明之目的化合物。 由於業者可容易地瞭解,於羧基保護基所舉之例為甲 基、乙基、第三丁基及苄基,其他容易且可選擇性脫離之 基亦可,並無特殊限制。例如使用T.W. Greene, Protectire Groups in Organic Syntheses , Vi ley,
Nev York, 1991所記載者。 羥基之保護基可列舉如甲氧基甲基、四氫吡喃基、第 三丁基二由矽烷基、乙醢基、苄基,但其他容易且可遘擇 性脫離之基亦可,並無特別限定。例如使用T.W. Green, Pwtectire Groups in Organic synthesis, Wiley, New York , 1991所記載者。 胺基之保護基可列舉如苄氧羰基、第三丁氧羰基、三 氟乙醢基,但其他容易且可選擇性脫離之基亦可,並無特 別限定。例如使用 T.W· Green, Pwtectire Groups in Organic synthesis, Wiley, Hew York, 1991所記載者。 一般式(II)、一般式(III)、一般式(IV)、一般式(V) 、 一般式(VI)、一般式(VII)、一般式(VIII)、一般式( (讀先閲讀背面之注意事項再填寫本頁) 本紙張尺度適中國國家標準(CNS ) Λ4規格(210X 297公釐) 146 310112 568897 A7 —一 B7 五、發明説明(147) IX)、一般式(X)、一般式(XI)或一般式(XII)所示之化合 物,本身即為熟知者,或依通知方法即可容易製得。 本說明中各反應中,反應生成物可賴一般精製方法, 例如,常壓下或減壓下之蒸餾、使用矽膠或矽酸鎂之高效 液體層析法、薄層析法、或管柱曆析法或洙滌、再結晶等 方法精製之。可於每個反應後進行精製,亦可於數個反應 終了後再行精製。 太搿明化合物之蓊理活袢 從以下之實驗可證明一般式(I)所示之本發明化合物 對基質金屬蛋白睛具有抑制活性。 (1)明膠酶A抑制活性 審酴方法 將10nM之對-胺基苯基汞乙酸醣(APMA)(5/i 1)添加至 由入類正常皮嫌缴維幼细胞(HNDF)精製而得之原明膠酶A( 5/il)之分析用鍰衡液(40(/1)中,於371C下預先保溫1小 時,使酵素活性化。 *0 1 ? 屮 中 消 f. A A 卬 (讀先閱讀背面之注意事項再瑣寫本頁) 將合成基質(M0CAc-Pro-Leu-Gly-A2pr(Dnp)-Ala-Arg-NH2)(130iul;最終濃度13.5/iM)與添加各種濃度被 驗化合物之溶液或不添加驗化合物之溶液(20u 1)於37” 下預先保溫5分鐘。於其中添加Μ上所調製之活性化酵素( 50/il /孔),37t:下保溫15分鐘,開始酵素反應。酵素活 性K每分鐘螢光強度[325ηη(Εχ)/393ηιη(Ε»)]之增加量表 示之。抑制活性Μ相對於未添加試驗化合物時之酵素活性 之抑制率(涔)表示之。例如,實施例71之化合物,其 本紙張尺度適州中國國家標準(CNS ) Λ4規格(210X297公釐) ΓΪΤ ΤΤ 0112 _7/Γ;部屮呔打π消f合卬f 568897 A7 B7 五、發明説明(148) ICso 值為 0·5ηΜ。 (2 )膠原_抑制活性 奮驗方法 於人類正常皮虜纖維幼细胞(HNDF)所製得之原膠原酶 (5以1)之分析用緩衝溶液(105/il)中,添加liag/ml之胰蛋 白_(45/il), 37¾下預先保溫1分鐘,使酵素活性化。於 該溶液中添加Smg/ial之大豆胰蛋白_抑制劑(soybean trypsin inhibitorMSBTI; 50// 1)使胰蛋白_ 鈍化。將合 成基質(Ac-Pr〇-Leu-Gly-[2-蕷基-4-甲基-戊醯基]-Leu-Gly-0Et)(105w 1;最終湄度1.33»M)與添加各種濃度被驗 化合物之溶液(20w 1)或不添加被驗化合物之溶液(20// 1) 於26t!下預先保溫5分鐘。於其中添加K上所調製之活性 化酵素(75//1/管,50^/1),261C下保溫10分鐘。於此10 分鐘内測定324πιβ之吸光度,共測定40點,W其中之30點 做為Vaax之測定值。 (3)基質溶素抑制活性 奮蹌方法 將人類之基質溶素(Yagai社)9艚積與10mH之對胺基苯 基汞乙酸酯(APMA)l顦積混合,371C下活化20小時。於分 析用缓衡溶液(50mM Tris-HCl, IOmM CaCl2, 0.05知 Brij 35, 0.02 涔 NaN3(pH7.5))150/il 中,添加 10/il 溶有 被驗化合物之二甲基亞碾Μ及l〇w之l〇mM合作基質NFF-3( Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys (DHPD-NH2, Nva:正纈胺酸,胜肽研究所)之二甲基亞礙溶液以 本紙張尺度適W中1蜀國家標準(CNS ) Λ4規格(210X 297公釐) 148 310112 (讀先閲讀背面之注意事項再填寫本頁) 衣· •火 消 f: /·々 568897 Α7 Β7 五、發明説明(149) 水調成0.5aiM者,再添加30/il緩衝溶液並於37υ保溫10分 鐘後,添加50/il上述活性化基質溶素之溶液Κ開始醮素 反應。酵素活性以每分鐘螢光強度[325nni(Ex)/393(Eii)] 之增加量表示。抑制活性Μ相對於不添加試驗化合物時之 酵素活性之抑制率表示之。例如,實施例71之化合物,其 ICs〇 值為 26ηΜ。 [毒性] 本發明化合物之毒性非常低,因而判斷在翳藥上使用 極為安全。 [缠用之»蕖品] [對包括人類在内之動物,特別是人類的基質金臈蛋 白酶例如明膠酶、基質溶素或膠原酶等具有抑制作用,可 用於預防及/或治療風濕性翡節炎、骨闞節炎、病骨之吸 收、骨質疏鬆症、牙周病、間質性腎炎、動脈硬化、肺氣 腫、肝硬化、角膜損傷、癌细胞之轉移浸潤或增殖之疾病 、自體免疫疾病(回腸末鳙炎(clone)、風濕性紫斑病( schoniein disease)、白血球系細胞之血管壤出或浸满引 起之疾病、血管新生、多發性硬化症、大動脈癯、子宮膜 症等。 一般式(I)所示之本發明化合物,其非骞性塩、酸加 成塩、或其水合物用於上述目的時,一般係Μ全身性或局 部,經口或非經口之方式給藥。 投藥量因年龄、體重、症狀、治療效果、投綦方法、 處理時間而異,通常成人每人每次給與lBg至lOOOng之範 (讀先閱讀背面之注意事項再填寫本頁)
、1T 本紙張尺度適州中國國家標準(CNS ) Μ規格(210X 297公釐) 149 310112 568897 A7 B7 15 0、 五、發明説明 圍,每日1次至數次經口投蕖,或亦可每人每次給與lug至 內 脈 靜 為 好 較 藥 投 藥 投 內 脈 靜 績 藥持 給內 口園 經範 非之 次時 數小 至24 次至 1時 曰 、 每Μ , 曰 圍每 範或 之, 較 可 亦 時 要 必 動 變 而 〇 件圍 條範 各上 依過 可超 量可 藥或 投 , 之少 逑董 上蕖 但投 述 上 成射 組注 體用 固可 用時 可蕖 藥投 投口 口 經 經非 , 及 時以 蕖物 投成 物組 合他。 化其等 明及劑 發物坐 本成、 組劑 體用 膠 爾 九 、 劑 錠 括 包 〇 物 囊 成 膠 組 軟 體 及 固 囊 之 。膠 用等硬 蕖劑包 投粒劑 口顆囊 經、膠 劑 散 、 、 0 物劑 囊 fcK kf 液夕 至丙矽 Μ 鈣。羥 K 與羥偏 _ 酸劑、加 質、 、釋酵溶素膜 物耱酮稀二 肋維薄 性萄烷性乙等嫌之 活葡咯惰素酸基質 之 、吡 有維 胺丙物 上酵烯含嫌冬羥性 Μ 糖乙可、天、溶 種露聚亦劑或膠腸 一甘、法滑酸明或 或、粉常滴胺、性 種耱澱依等麩糖溶 一 乳、物 _ 、白爾 由如素成酸莆用等 係例維組脂定可酯 物 ,纖。硬安亦酸 成劑晶成如等時酞 組釋结而例耱要素 體稀微合、乳必維 固性、混劑、劑纖 類惰素鎂加劑九基 此種維酸添壞或甲 一 纖鋁之崩劑基 少基酸外等錠丙 收 吸 被 可 類 膠 明 括 包 亦 者 再 ο 上Μ 曆 二 覆 包 可 〇 亦囊 或膠 , 之 覆質 包物 之含 { 用中劑 使物釋 可成稀 許組性 上體惰 劑液之 蕖類用 有此般 含 〇 一 可等於 ,0 溶 物醮質 成、物 組劑性 體漿活 液糖之 之、上 用劑Μ 蕖液種 投溶一 口 、 或 經劑種 濁一 乳有 本紙張尺度適/彳]中國國家標準(CNS ) Α4規格(210X 297公釐) 150 310112 (讀先閱讀背面之注意事項再填寫本頁) 568897 A7 B7 五、發明説明(151) 例如,精製水、乙醇)中。該組成物除惰性稀釋劑之外亦 可含有濕酒劑,懸濁劑類之補助劑、甘味劑、風味劑、芳 香劑及防腐劑。 (讀先閱讀背面之注意事項再填寫本頁) 經口投藥之其他組成物,可含一種或一種以上之活性 物質,Μ習知方法所配製之噴露劑亦包括在內。該組成物 除惰性稀釋劑外亦可含有亞磙酸氫納等安定劑與可賦與等 張性之緩衝劑,例如含氯化納、擰樺酸鈉或擰樣酸等之等 張繭。噴露劑之製造方法例如詳載於美國專利第2,868, 691號公報W及同專利第3,095,355號公報中。 本發明之非經口投蕖用注射劑,可包含無菌之水性或 非水性之溶液劑、懸濁劑、乳濁劑等。水性之溶液劑、懸 濁劑,可包含例如注射用蒸餾水Μ及生理食塩水。非水溶 性之溶液劑、懸濁劑,例如可包含丙二酵、聚乙二醇,橄 攬油等植物性油,乙酵等酵類,聚山梨糖酵酐80(商禰登 記)。該組成物尚可包含防腐劑,乳化劑,分散劑,安定 化劑(例如乳糖),肋溶劑(例如麩胺酸,天冬胺酸)等輛肋 劑。上述可經由细菌留滯用滤器加Μ過濾,配合殺菌劑, 或使用輻射光照射等使之無菌化。又亦可製造無菌之固體 | 組成物,例如凍結乾燥物,在使用前Μ無菌化或無菌之注 -火 ?f 射用蒸餾水或其他溶劑溶解使用。 ^ 非經口投藥之其他組成物,可為含有一種或一種Μ上 消 | 之活性物質,依一般方法所配方之外溶液劑,軟膏,塗布 # 劑,直腸內投蘗用之栓劑以及陰道內投藥用之塞劑。 奮淪本發明^蕞住形戆 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 151 310112 568897 A7 B7 五、發明説明(1S2) Μ下將Μ參考例及實施例詳逑本發明,但不因此而限 制本發明。 Μ管柱層析法進行分離時及TLC中括弧內所示之溶劑 表示所用之溶離溶銷及展開溶劑,比例表示體積比。 NMR時括弧內所示溶劑表示测定時所用之溶劑。 參者例1 2-(二羥基»)苯并呋喃
Β(ΟΗ)2 含苯并呋喃(128克)之四氫呋喃(540毫升)溶液中,在 乾冰-甲酵浴冷却下,滴加1.6N正丁基鋰之己烷溶液(750 奄升)。反應混合物在01攪拌30分鐘後,在乾冰-甲酵浴 冷却下,滴加碥酸三異丙酿(275奄升)。反應混合物在01C 搅拌1小時。反應混合物經濃縮,於殘留物中添加1Ν塩酸 水溶液,Μ乙酸乙釀萃取。萃取物以水、飽和氯化納洗淨 ,Μ無水硫酸鎂脫水,濃縮。所得结晶以己烷洗淨、乾燥 ,得到具下列物性之檷化合物(1 5 7克)。 部 中 •火 i -1 消 A ^'ί 卬 (謂先閱讀背面之注意事項再瑣寫本頁) TLC: Rf: 0.28(正己烷:乙酸乙酯=1:1)。 參者例2 4-(苯并呋喃-2-基)笨甲酸乙酯 本紙張尺度適州中國國家標率(CNS ) A4規格(210X297公釐) 152 310112 568897 A7 B7 五、發明説明 15 3、 〇 C2H50
於含4-碘苯甲酸乙醮(5克)之二甲基甲釀胺(10奄升) 溶液中,添加參考例1製造之化合物(2.64克)及二氯雙(三 笨膦)鈀(II)[PdCl2(PPh3)2](0.635克)及三乙胺(10毫升) 。反應混合物在80 t:撹拌6小時。於反應混合物添加1N塩 酸,Μ乙酸乙酯萃取。萃取液Μ飽和氣化納水溶液洗淨, Μ無水硫酸納脫水並濃縮。所得结晶Μ己烷/乙継洗淨, 乾烷,得下列物性之檷題化合物(3.6克)。 TLC: Rf: 0.61(正己烷:乙酸乙 _=9:1)。 罃者俐3 4-(苯并呋喃-2-基)笨甲酸 (詞先閱讀背面之注意事項再填寫本頁) 衣·
、1T 、 部 '1,. •火 Ο
消 f: 合 ii 含參考例2製造之化合物(3.4克)之二鸣烷(15毫升)溶 液中,在室溫下添加1N氫氧化納水溶液(15. 3奄升)。反應 混合物於室溫搅拌9小時。反應混合物中添加1H塩酸水溶 本紙張尺度適州中國國家標準(CNS ) Λ4規格( 210X 297公釐) 153 310112 568897 A7 B7 五、發明説明(154) (讀先閱讀背面之注意事項再楨寫本頁) 液至呈酸性,K乙酸乙酯:四氫呋喃(2:1)萃取。萃取物 Μ飽和氯化納水溶液洗淨,Μ無水硫酸納脫水並濃縮。所 得结晶以乙酸乙_ /乙醚洗淨,乾煉,得具下列物性之摞 題化合物(2 · 1克)。 參者例4 4-(苯并呋喃-2-基)苯甲醃氯
參考例3製造之化合物(13.4克)與亞硫醢氯(80毫升) 之混合物在801C攪拌6小時。反應混合物冷却至室溫並濃 縮。所得殘留物以己烷/乙醚洗淨,得具下列物性之標題 化合物(1 2 · 7克)。 HHRiCDCla): d 8.19(2H,d,J=8.8Hz), 7.98(2H,d,J= 8.8Hz),7.68-7.61(lH,m),7.59-7.53(lH,m),7.42-7.23 (3H,m) 〇
本紙張尺度適川中國國家標準(CNS ) A4規格(210X297公釐) 154 310112 568897 A7 B7 五、發明説明(155) 含4-胺基丁酸乙簾(0·5克)之二氛甲烷(20毫升)溶液 中添加三乙胺(1毫升)。在0Ρ下於混合物中添加含參考例 4製造之化合物(0·72克)之二氯甲烷(10奄升)溶液。反應 混合物在室溫攪拌30分鐘。反應混合物中添加1Ν塩酸水溶 液,Μ乙酸乙豳萃取。萃取液Μ飽和氯化納水溶液洗淨, Μ無水硫酸納脫水並濃縮。所得殘留物Κ乙酸乙酯/乙醚 洗淨並乾燥,得具下列物性之檷題化合物(0.7 32克)。 TLC: Rf: 0.38(正己烷:乙酸乙酯=1:1)。 奮)fe例2 4-(H-(4 -苯并呋喃-2-基)苯羰基)胺基)丁酸 (讀先閱讀背面之注意事項再楨寫本頁) 裝. Ο
、1T 含實施例1製造之化合物(670*克)之四氫呋喃(5毫升 )溶液中,添加1H氫氧化納水溶液(4.4毫升)。反應混合物 於室溫攢拌3小時。反應混合物中添加1H塩酸水溶液至呈 酸性,Μ乙酸乙» /四氫呋喃萃取。萃取液K飽和氯化納 水溶液洗淨,Κ無水硫酸納脫水並濃縮,得具下列物性之 標題化合物(0.617克)。 TLC: Rf: 0.40(氯仿:甲酵:乙酸=100:10:1); 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 155 310112 568897
A B 五、發明説明(156) NMR (CD3CD) :δ 8.58 (1Η, t, J=5.6HzX 8.01 (2¾ d, J=8.8Hz), 7.96 (2H, d, J=8.8Hz), 7.71-7.63 (2H, m), 7.57 (1HT d, J=0.8Hz), 7.39-7.23 (2H, m), 3.32-3.25 (2H, m),2·29 (2H,t, J=7.6Hz),1.84-1.70 (2H, m)。 奮淪锎2 (1 )〜2 (24) 使用對應之酸鹵化物替代參考例4製造之化合物,依 實施例實施例2所示相同方法操作,得下列化合物。 v m m 2d) 4-(Ν·(4-甲基苯羰基)胺基)丁酸 (麴先閱讀背面之注意事項再填寫本頁)
TLC: Rf: 0.50(氯仿:甲酵:乙酸=18:2:1); NMR (CD3OD) : δ 12.10 (1Η, brs), 8.30 (1H, t, J=5.5Hz), 7.76 (2H, d, J=8.0Hz), 7.28 (2H,d,J=8.0Hz),3.30 (2H,m),2.30 (2H,t J=7.2Hz),1·75 (2H,m)。 奮淪例2 (2) (N-(4-丁氧基苯羰基)胺基)丁酸
TLC: Rf: 0.48(氯仿:甲酵:乙酸=18:2:1); NMR (d6-DMS〇) : S 12.03 (1H, brs), 8.29 (1H, t, J=5.5Hz), 7.78 (2H, d, J=8.8Hz), 6.95 (2H, dt J=8.8Hz), 3.99 (2H, ζ J=6.4Hz), 3.30-3.14 (2H, m), 2.24 (2H, ζ J=7.6Hz), 1.79-1.62 (4H, m), 1.51-1.32 (2H, m), 0.91 (3H, ζ J=7.4Hz)〇 310112 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X297公釐) 15 6 568897 A7 B7 五、發明説明(157) 奮淪例2 ( 4-(N-(4-丁氧基苯羰基)胺基)丁酸 0 TU: Rf: 0.58(氯仿:甲酵:乙酸=18:2:1); NMR (dg-DMSO) : S 12.04 (1H, brs), 8.42 (1H, t, J=5.4Hz), 7.41-7.28 (3H, m), 7.07-7.00 (1H, m), 3.99 (2H? ζ J=6.4Hz), 3.24 (2H, m), 2.25 (2H, ζ J=7.3Hz), 1.80-1.64 (4H, m), 1.42 (2H, m), 0.92 (3H, t, J=7.3Hz)〇 V m m 2(A) 甲基苯基)乙炔基)呋喃-2-基鑛基]胺 基]丁酸 (許先閱讀背面之注意事項再楨寫本頁)
TLC: Rf: 0.54(氯仿:甲酵:乙酸=18:2:1); NMR (dg-DMSO) *. S 12.07 (1H, brs), 8.51 (1H, t, J=6.0Hz), 7.44 (2H, d, J=8.1Hz), 7.25 (2H, d, J=8.1Hz), 7.12 (1H, dt J=3.7Hz), 6.94 (1H, d, J=3.7Hz), 3·26·3·23 (2H,m), 2·33 (3H,s),2.23 (2H,d,J=7.5Hz),1.79-1.63 (2H,m)。 奮_例2 ( 5 ) 4-(N-(4-(吡咯-1-基)苯羰基)胺基)丁酸 本紙张尺度適州中國國家標準(CNS ) A4規格(2丨0X297公釐) 157 TO 11 2 158568897 A7 B7 Ο 五、發明説明( Ο Η〇Υ— TLC: Rf: 0·59(氯仿:甲酵:乙酸=18:2:1); NMR (d6-DMS〇) : δ 12.04(1H, brs), 7.94 (2H, d, J=8.8Hz), 7.66 (2H, d? J=8.8Hz), 7.47-7.44 (2H, m), 6.31-6.28 (2H, m), 3.32-3.25 (2H, m), 2.29 (2H? t, J=7.3Hz),1.77 (2H, m)。 奮嫵俐2 (fi) 4-(N-(反-4-甲基環己基羰基)胺基)丁酸 (翱先閱讀背面之注意事項再填寫本頁)
TLC: Rf: 0.55(氛仿·•甲酵:乙酸=18:2:1);. NMR (dg-DMSO) : δ 12.01 (1H, brs), 7.67 (1H, t, J=6.0Hz), 3.02 (2H, m), 2.19 (2H, t, J=7.5Hz), 2.06-1.91 (1H, m)? 1.74-1.52 (6H, m), 1.46-1.18 (4H, m), 0.98-0.76 (4H, m)〇
本紙張尺度適/1]中國國家標準(CNS ) Λ4規格(210X 297公釐) 310112 568897 A7 B7 五、發明説明(Μ) TLC: Rf: 0.45(氯仿:甲酵:乙酸=18:2:1); NMR (dg-DMSO) : δ 12.03 (1Η, brs), 8.54 (1H, tt J=5.3Hz), 7.85 (2H, d, J=8.2Hz), 7.52 (2H, d, J=8.2Hz), 4.34 (2H, s), 3.35 (3H, s), 3.34-3.22 (2H, m), 2.28 (2H,ζ J=7.0Hz), 1·76 (2H,m)。 窗淪锎2 (8) 4-(H-(4-丁基苯羰基)胺基)丁酸
TLC: Rf: 0.54(氣仿·•甲酵:乙酸=18:2:1); NMR (CD3OD) : S 12.03 (1H, brs), 8.37 (1H, t, J=5.5Hz), 7.75 (2H, d, J=8.2Hz), 7.25 (2H, d, J=8.2Hz), 3.33-3.22 (2H, m), 2.62 (2H, t, J=7.5Hz), 2.27 (2H, t, J=7,4Hz), 1.83-1.67 (2H, m), 1.65-1.48 (2H, m), 1.40-1.22 (2H, m), 0.90.(3H, ζ J=7.1Hz)〇 奮淪例2 (9) 4-(H-(苯并呋喃-2-基羰基)胺基)丁酸
0 !; -、屮 屮
H 消 f: 合 Μ 卬 (讀先閱讀背面之注意事項再楨寫本頁) TLC: Rf: 0·32(氯仿:甲酵:乙酸=100:10:1); 本紙张尺度適州中國國家標率(CNS ) Α4規格(210Χ297公釐) 159 310112 568897 δ7 A / Β7_____ ------------------- -------------------------一’ 五、發明説明(16<>) NMR (d6-DMS0) 8.73 (1H, ζ J=5.4Hz), 7.78-7.73 (1H, m), 7.66-7.61 (1H, m), 7.51 (1H, d, J=0.8Hz), 7.49-7.41 (1H, m), 7.36-7.28 (1H, m), 3.28 (2H, m), 2.27 (2H,ζ J=7.4Hz),1.83-1.68 (2H,m)。 y淪你1 2 (10丄 4-(H-[4-(2-(4-氯笨基)乙嫌基)苯_基]胺基]丁酸
TLC: Rf: 0.28(氯仿:甲酵=10:1); NMR (d6-DMS〇) : δ 8.48 (1Η, t, J=5.6Hz), 7.85 (2H, d, J=8.4Hz), 7.67 (2H, d, J=8.4Hz), 7.65 (2H, d, J=8.8Hz), 7.44 (2H, d, J=8.8Hz), 7.40 (1H, d, J=16.4Hz), 7.30 (1H, d, J=16.4Hz), 3.27 (2H, m), 2.27 (2H, ζ J=7.4Hz), 1.82-1.68 (2H, m)〇 奮撫例2 (1 1 ) 4-(N-[4-(2-(4-(眯唑-1-基)苯基)乙炔基)笨羰基]胺 基]丁酸 (銷先閱讀背面之注意事項再硝寫本頁) 訂
本紙張尺度通州中國國家標準(CNS ) A4規格(210X 297公釐) 160 310112 568897 A7 B7 五、發明説明Ο61} TLC: Rf: 0.29(氣仿:甲酵:乙酸=100:10:1); NMR (d6-DMS〇) : S 8.65 (1H, t, J=5.4Hz), 8.36 (1H, brs), 7.90 (2H, d, J=8.4Hz)? 7.84 (1H, brs), 7.77 (2H, d, J=9.2Hz), 7.71 (2H, d, J=9.2Hz), 7.65 (2H, d, J=8.4Hz), 7·13 (1H, brs),3·28 (2H,m),2.31 (2H, U=7.2Hz),1.82-1.68 (2H,m)。 v m m 2(12) 4-(H-(反-4-丙基環己基羰基)胺基]丁酸
TLC: Rf: 0.65(氯仿:甲酵:乙酸=18:2:1); NMR (de-DMSO) : δ 12.00 (1Η, s), 7.74-7.61 (1H, t, J=6.0Hz), 3.02 (2H, m), 2.19 (2H, t, J=7.2Hz), 2.1M.92 (1H, m), 1.784.53 (6H, m), 1.43-1.08 (7H, m), 0.95-0.89 (5H, m)〇 V m m 2 (12) 4-[N-[4-(2-(4-甲基笨基)乙炔基)苯羰基)胺基]丁酸 (許先閲讀背面之注意事項再镇寫本頁) 、.ΐ 部 中 •火 ]< J Λ, ^ii 卬
0
TLC: Rf: 0.57(氛仿:甲酵:乙酸=18:2:1); 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 161 310112 568897 A7 B7_________ -------—------------------------------------- "* 一 * 五、發明说明() NMR (CD3①):ί 12.05 (1Η, s), 8.57 (1H, t, J=5.5Hz), 7.88 (2H, d, J=8.3Hz), 7.61 (2H,d,J=8.3Hz),7.47 (2H,d,J=8.3Hz),7·25 (2H,d,J:8.3Hz), 3.34-3.24 (2H, m), 2.35 (3H, s), 2.29 (2H, t, J=7.2Hz), L77 (2H, m)〇 g W8 例 2 (1 4 ) 4-[1[4-((4-溴苯基)胺磺醢基>苯羰基]胺基]丁酸 Ο
TLC: Rf: 0.45(氯仿:甲酵:乙酸=18:2:1); NMR (d6-DMS0) : δ 12.03 (1H, brs), 10.53 (1H, brs), 8.68-8.62 (1H, m), 7.95 (2H, d, J=8.6Hz), 7.81 (2H, d, J=8.6Hz), 7.42 (2H, d, J=9.0Hz), 7.05 (2H, d, J=9.0Hz), 3.33-3.21 (2H, m), 2.27 (2H, t, J=7.3Hz), 1.74 (2H, m)〇 謇廉例2 (Ί
(讀先閲讀背面之注意事項再填寫本頁)
4_[N-[4-環己基笨羰基)胺基]丁酸 HO TLC: Rf: 〇·33(氯仿:甲酵=9:1); 本紙張尺度適川中國國家標準(CNS ) Μ規格(21〇><297公楚) 162 310112 568897 A7 B7______ 五、發明说明(1 ) NMR (d6-DMS0) :δ 12.04 (1Η, s), 8.45-8.27 (1H, m), 7.75 (2H, d, J=8.4Hz), 7.28 (2H, d, J=8.4Hz), 3.34-3.21 (2H, m), 2.64-2.44 (1H, m), 2.26 (2H, t, J=7.3Hz), 1·85-1·61 (7H,m),1.56-1.19 (5H, m)。 V m m 2 (\&) 4-[H-[4-(4-丙基苯基)苯羰基]胺基]丁酸 Ο
(翱先閱讀背面之注意事項再楨寫本頁) HO. Ο T L C : R f : 0 · 3 2 (氯仿:甲酵=9 : 1); NMR (d^-DMSO) :δ 12.05 (1Η, s), 8.56-8.44 (1H, m), 7.93 (2H, d, J=8.4Hz), 7.73 (2HT d? J=8.4Hz), 7.64 (2H, d, J=8.4Hz), 7.30 (2H, d, J=8.4Hz), 3.40-3.25 (2H, m), 2.61 (2H, t, J=7.4Hz), 2.29 (2Ht ζ J=7.3Hz), 1.86-1.54 (4H, m), 0.92 (3H, t, J=7.4Hz)〇 IT施例2 M 7) 4-[H-[4-(4-羥苯基)苯羰基]胺基]丁酸 HO' Ο Ο
OH TLC: Rf : 〇·17(氯仿:甲酵=9:1); 本紙張尺度適州中國國家標準(CNS ) Λ4規格(21 OX 297公釐 ) 163 310112 164、568897 A7 B7 五、發明说明 NMR (dg-DMSO) :δ 12·05 (1Η,s),9·62 (1Η,s),8.53-8.42 (1Η, m),7·89 (2Η, d, J=8.5Hz), 7.66 (2H, d, J=8.2Hz)r 7.56 (2H, d, J=8.5Hz), 6.87 (2H? d, J=8.2Hz), 3.36-3.26 (2H, m), 2.29 (2H, t, J=7.2Hz), 1.77 (2H, m)〇 奮淪俐2 (1 8丄 4-[H-[4-(4-氯笨基)呋喃-2_基羰基]胺基]丁酸
TLC: Rf: 0.24(氯仿:甲醇= 9:1)5 NM R (d6-DMSO) : 12.07 (1H, s), 8.62-8.51 (1H, m), 7.94 (2H, d, J=8.4Hz), 7.54 (2H, d, J=8.4HzX 7.17-7.11 (2H, m), 3.33-3.22 (2H, m), 2.29 (2H, ζ J=7.2Hz), 1.77 (2H,m)〇 宭濂锎2 (1 9) 4-[N-[4-(4-庚基笨基)苯羰基]胺基]丁酸
(誚先閱讀背面之注意事項再填寫本頁) 部 屮 lk i?. 消 f: 卬 Ο
TLC: Rf: 0.65(氛仿:甲酵:乙酸=18:2:1); NMR (dg-DMSO) :δ 12.04 (1Η, s), 8.55-8.45 (1H, m), 7.93 (2H, d, J=8.4Hz), 7.73 (2H, d, J=8.4Hz)? 7.63 (2H, d, J=8.4Hz), 7.29 (2H, dt J=8.4Hz), 3.37-3.23 (2H, m)t 2.62 (2H, t, J=7.5Hz), 2.29 (2H, t, J=7.1Hz), 1.78 (2H, m), 1.68-1.48 (2H, m), 1.39-L15 (8H, m), 0.86 (3H, t, J=6.6Hz)〇 本紙張尺度適/1]中國國家標準(CNS ) A4規格(210X297公釐) 164 310112 568897 A7 B7 五、發明説明(1 ) 奮旛例2 (201 4-[N-[4-(4-甲氧苯基)苯羰基]胺基]丁酸 Ο
OCH3 TLC: Rf: 0.11 (氯仿:甲酵=9:1); NMR (d6-DMS0) :δ 12.05 (1Η, s), 8.55-8.45 (1H, m)T 7.91 (2H, d, J=8.4Hz), 7.71 (2H, d, J=8.4Hz), 7.68 (2H, d, J=8.9Hz), 7.05 (2H, d, J=8.9Hz), 3.81 (3H, s), 3·35-3·22 (2H, m),2.29 (2H,U J=7.3Hz), 1.76 (2H,m)〇 奮淪例2 (21 ) 4-[N-[4-(4-氯苯基)苯羰基]胺基]丁酸 0
(1^先閱讀背面之注意事項再頊寫本頁) ηού Ο H. d— ^ ,,κ MW Αρ λμ 令 TLC : Rf : NMR (d6-DMS〇) :δ 12.07 (1H, s), 8.59-8.50 (1H, m), 7.95 (2H, d, J=8.4Hz), 7.81- 7.71 (4H, m), 7.54 (2H, d, J=8.8Hz), 3.33-3.24 (2H, m), 2.29 (2H, t, J=7.3Hz), 1.82- 1.71 (2H,m)。 n m m 2 (22) 4-[H-[5_苯甲氧基吲睬-2-基羰基)胺基]丁酸 本紙張尺度適W中國國家標準((^^)六4規格(210父297公釐) 165 310112 568897 A7 B7 五、發明说明(166)
TLC: Rf: 〇.13(氛仿·•甲酵=9:1); NMR (dg-DMSO) :δ 11.39 (1Η,s),8·42 (1Η,t J=5.6Hz),7.50-7.20 (6Η,m), 7.15 (1H, d, J=2.2Hz), 6.99 (1H, d, J=1.8Hz), 6.89 (1H, dd, J=8.6, 2.2Hz), 5.07 (2H, s), 3·27 (2H, m),2·27 (2H,t J=7.4Hz),1.73 (2H,m)。 V m m 2 (23I_ 4-[N-[5-(2-(4-氯苯基)乙烯基)呋喃-2-基羰基]胺基 ]丁酸 (許先閱讀背面之注意事項再瑣寫本頁)
部 中 -失 H 消 fl /v η 卬 ί: TLC: Rf: 0.52(氣仿:甲酵·•乙酸••水=100:10:1:1) t NMR (dg-DMSO) : δ 12.06 (1Η, brs), 8.43 (1H, t, J=5.8Hz), 7.59 (2H? d, J=8.8Hz), 7.42 (2H, d, J=8.8Hz), 7.26 (1H, dt J=16.6Hz)? 7.14 (1H, d, J=16.6Hz), 7.09 (1H? d, J=3.2Hz), 6.63 (1HT d, J=3.2Hz)T 3.25 (2H, m)? 2.26 (2H, ζ J=7.2Hz)? 1·73(2Η,m)〇 奮_例2 ( 2 4丄 張尺度適Λ中國國家標準(CNS ) A4規格(210x297公釐) 166 310112 568897 A7 B7 五、發明説明(167) 一 4-[N-[4-(苯氧基)苯羰基]胺基]丁酸 TLC:Rf:〇.47i 毎 、 ”(辑仿••甲酵:乙酸••水=100:10:1:1) NMR (d6-DMS〇) :$ 8 41 nu 0 1 (1H,t J=5.4Hz),7·85 (2H,d,J=8.4Hz),7.42 (2H, 、J=8.0Hz),7·18 (1H, •2Hz),6·97,7·08 (4H,m),3·24 (2H,m),2·25 (2H,t J=7.4Hz), 1.72 (2H, m)〇 奮餱俐2 M il 二甲基甲基)氧基-4_(n (4苯并呋 喃-2-基)笨換基)胺基)丁醮胺 (麴先閲讀背面之注意事項再镇寫本頁) CH30 八 〇
.N Ο
於含實_例2製诰^ 化合物(0·55克)之二甲基甲醢胺( 1 〇奄升)溶液中,在冰a# 冷却下,添加^(卜甲氧基,卜二 甲基甲基氧基)胺 (<>·455克)、卜羥基苯并三唑•水合物( 〇·391克)、卜乙基 35 二甲胺基丙基)甲醢胺塩酸塩( 0·489克),於室溫擭换 3小時。反應混合物中添加水,以 乙酸乙酯萃取。宰取油 ________ 鉋和碳酸氫納水溶液、飽和氣化 本紙张尺度適十囤國家標準(CNS ------- 167 310112 168568897 、,ΐ /Γ: 部 屮 消 t: 卬 5’: A7 B7 五、發明説明(’ 納洗淨,K無水臃酸納脫水後濃縮,得具下列物性之檷題 化合物(0.230克)。 TLC: Rf: 0.13(氛仿:甲酵=10:1); 窗_俐4 N-羥基-4-(H-(4-(苯并呋喃-2-基)苯羰基)胺基)丁釀 胺 Ο
HO
含實施例3製造之化合物(0.230克)之甲酵(1〇毫升)溶 液中,添加1N塩酸水溶液(100毫升)。反應混合物於室溫 攪拌10分鐘。反應混合物經濃縮,所得殘留物Μ乙醚洗淨 ,得具下列物性之標題化合物(0.218克)。 TLC: Rf: 0.22(氯仿:甲酵·•乙酸=1〇〇:1〇··1); NMR (dg-DMSO) : δ 10.39 (1Η, brs), 8.59 (1H, t, J=5.8Hz), 8.01 (2H, d, J=9.0Hz), 7.96 (2H, d, J=9.0Hz), 7.67 (2H, m), 7.57 (1H, d, J=0.5Hz), 7.39-7.23 (2H,m), 3.27 (2H,q,J=5.8Hz), 2.03 (2H,t J=7.6Hz), 1.76 (2H, m)。 實 jfe 例 4 (1 )〜A f 使用實施例2(1)〜2(24)製造之化合物或對應之化合 物替代實施例2製造之化合物,依實施例實施例2所示 之相同方法操作所得之化合物,再依實施例34實施例4所 示之相同方法操作,得下列化合物。 奮撤例4 (η (詞先閱讀背面之注意事項再楨寫本頁) 本紙張尺度通瓜中丨f國家標準(CNS ) Α4規格(210X 297公釐) 168 310112 568897 A7 B7 五、發明说明I ) Η-羥基-4-(Ν-(4-甲基苯羰基)胺基)丁醢胺
TLC: Rf: 0.23(氣仿··甲醇=10:1); NMR (d6-DMS〇) : δ 10.39 (1Η, s), 8.70 (1H, s), 8.40 (1H, t, J=5.2Hz), 7.74 (2H, d, J=8.1Hz), 7.25 (2H, d, J=8.1Hz), 3.24 (2H, td, J=6.6, 5.2Hz)? 2.35 (3H, s), 2.02 (2H,t J=7.7Hz),1.74 (2H,m)。 窗淪锎4 (2) N-羥基- 4-(N-(4-丁氧基苯羰基)胺基)丁醣胺 (許先閱讀背面之注意事項再填寫本頁)
TLC: Rf: 0.29(氯仿:甲酵:乙酸=18:2:1); NMR(d6-DMS〇): S 10.39 (1H, s), 8.70 (1H, brs), 8.32 (1H, ζ J=5.8Hz), 7.80 (2H, d, J=9.0Hz), 6.96 (2H, d, J=9.0Hz), 4.01 (2H, t, J=6.4Hz), 3.35-3.15 (2H, m), 2.01 (2H, t, J=7.3Hz), L81-1.64 (4H, m), 1.44 (2H, m), 0.94 (3H, ζ J=7.4Hz)〇 奮撫例4 ( 3 ) N-羥基-4-(N-(3-丁氧基苯羰基)胺基)丁醸胺
iV' 169 度適w中國國家標率(CNS ) A4規格(210X297公釐) 568897 A7 五、發明説明(1 7 〇) TLC: Rf: 0.31(氣仿:甲酵:乙酸=18:2:1); NMR (d6-DMS0) : δ 10.39 (1H, s), 8.45 (1H, t, J=5.2Hz), 7.43-7.29 (3H, m)t 7.19-7.01 (1H, m), 4.01 (2H, t, J=6.3Hz), 3.30-3.18 (2H, m), 2.02 (2H, ζ J=7.5Hz), L83-1.64 (4H, m), 1.49 (2H,m),0·95 (3H,ς J=7.3Hz)。 窗施例4 ( 4 ) N-羥基-4-[N-[4-((4-甲基苯基)乙炔基)咲喃 基]胺基]丁醣胺
HCT Ο 基羰
(誚先閲讀背面之注意事項再楨寫本頁)
、1T 部 屮 •Λ il h .1 消 fr Λ 卬 ¥ 0 TLC: Rf: 〇·32(氯仿:甲酵:乙酸=18:2:1); NMR (dg-DMSO) : δ 10.40 (1Η, brs), 10.22 (1H, s), 8.56 (1H, t, J=5.7Hz), 7.47 (2H, d, J=8.3Hz), 7.28 (2H, d, J=8.3Hz), 7.16 (1H, d, J=3.6Hz), 6.96 (1H, d, J=3.6Hz), 3.28-3.14 (2H, m), 2.36 (3H, s), 2.00 (2H, t, J=7.5Hz), 1.83-1.64 (2H, m)〇 啻施例4 N -羥基-4-(N_(4-(吡咯-1-基)笨羰基)胺基)丁醢胺 Ο
HCT Ο TLC: Rf: 〇·31(氣仿:甲酵:乙酸=18:2:1); 本紙張尺度適;( CNS ) Α4規格(210χ 297公楚) f7〇 --3 10112 568897 A7 B7 171、 五、發明説明 NMR(d6-DMS0): 5 10.40 (1H, s), 9.00-8.24 (1H, brs), 8.52 (lHt t, J=5.6Hz), 7.94 (2H, d, J=8.5Hz), 7.68 (2H, d, J=8.5Hz), 7.50-7.44 (2H, m), 6.34-6.29 (2H, m), 3.38-3.31 (2H,m),2·04 (2H,t J=7.5Hz), 1.76 (2H,m)〇 奮)fe例4 (6丄 N-羥基(反-4-甲基環己基羰基)胺基)丁醮胺 Ο
HCT 0 •«^0. (許先閱讀背面之注意事項再頊寫本頁) TLC: Rf: 0·29(氣仿:甲酵:乙酸=18:2:1); NMR (d6-DMS〇) : $ 1〇 37 (1H, s), 10.20 (1H, s), 7.69 (1H, ζ J=5.3Hz), 3.07-2.92 (2Η, m), 2.31-1.88 (3H, m), 1.74-L52 (6H, m), 1.46-1.18 (3H, m)y 0.98-0.76 (2H, m), 0.85 (3H, d, J=6.6Hz)〇 V m Μ A(7) 甲氧基-1-丙炔基)苯羰基)胺基) 丁醢胺
OCH3 TLC : Rf : 32(氡仿:甲酵·•乙酸=18:2 :1) 本紙張尺度適中國國家標準 (210 X 297公釐) 171 <172568897 A7 B7 五、發明说明 NMR (d6-DMS0) : δ 10.39 (1H,s),8·57 (1H,t J=5.5Hz),7·85 (2H,d, J=8.6Hz), 7.53 (2H, d, J=8.6Hz), 4.35 (2H, s), 3.35 (3H, s), 3.25 (2H, dt, J=5.5, 7.2Hz), 2.02 (2H, t, J=7.2Hz), 1.74 (2H, quint, J=7.2Hz)〇 富_例4 ( 羥基- 4-(N-(4-丁基苯羰基)胺基)丁釀胺
TLC: Rf: 0.37(氯仿··甲酵:乙酸=18:2:1); NMR (d6-DMS〇) : $ 10.40 (1H, brs), 10.20 (1H, s), 8.41 (1H, t, J=5.4Hz), 7.76 (2H, d, J=8.0Hz), 7.25 (2H, d, J=8.0Hz), 3.23 (2H, J=5.4Hz, J=7.0Hz), 2.62 (2H, t, J=8.2Hz), 2.02 (2H, ζ J=7.0Hz), 1.83-1.66 (2H, m), 1.64-1.48 (2H, m), 1.30 (2H, m), 0.90 (3H? t, J=7.2Hz)〇 窗淪例4 (9) N-羥基- 4-(N-(笨并呋喃-2-基羰基)胺基)丁醢胺 (1i先閱讀背面之注意事項再楨寫本頁) Μ ^ ,1 w, -.11 ? -、,p'I,
I f A 印f:
TLC: Rf: 0.16(氯仿:甲醇··乙酸=1〇〇:1〇:1); NMR (dg-DMSO) : δ 10.38 (1Η, brs), 9.30-8.10 (1H, br), 8.75 (1H, t, J=6.2Hz), 7.76 (1H, m), 7.64 (1H, m), 7.51 (1H, d, J=0.6Hz), 7.45 (1H, dt, J=1.6, 7.0Hz), 7.32 (1H, dt, J=1.07 7.6Hz), 3.25 (2H, q, J=6.2Hz), 2.01 (2H, t, J=7.0Hz), 1.74 (2H, .m)〇 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) 172 310112 17568897 A7 B7 〇
五、發明説明 啻嫵例4 (1 0) 羥基-4-[N-[4-(2-(4-氯苯基)乙烯基)苯羰基]胺基 ]丁醯胺
CI TLC: Rf: 0·17(氯仿:甲酵:乙酸=100:10:1); NMR (d6-DMS〇) : δ 10.39 (1Η, brs), 8.50 (1H, t, J=5.8Hz), 7.86 (2H, d, J=8.4Hz), 7.67 (2H, d, J=8.4Hz), 7.65 (2H, d, J=8.4Hz), 7.44 (2H, d, J=8.4Hz), 7.39 (1H, d, J=16.2Hz), 7.30 (1H, d, J=16.2Hz), 3.25 (2H, m), 2.02 (2H, t, J=7.6Hz), 1.74 (2H,m)。 窗淪例4 m ) N-羥基-4-[N-[4-((4-咪唑-1-基)苯基)乙炔基)笨羰 基]胺基]丁醢胺 (讀先閱讀背面之注意事項再瑣寫本頁) > ,1 部 i’ k il )1 .1 消 1' 么、 竹
〇
TLC: Rf: 0.14(氯仿:甲酵:乙酸=100:10:1); 本紙張尺度適州中國國家標準(CNS ) A4規格(210X 297公釐) 173 310112 17568897 Α7 Β7 五、發明説明 NMR—(d6_DMSO) · s 10.43 (ih, brs)? 9 71 (1H? s)> 8 67 (1H^ ζ j=5.6Hz), 8.33(1H,brs),7.95-7.82 (8H,m),7·67 (2H,d,J=8 4Hz),3·25 (2H,m),2.02 (2H, t, J=7.4Hz),1.74 (2H,m)。 v m m a ^^2) N-經基-4-(N·(反-4•丙基苯羰基)胺基)丁釀胺
HO ,Ν. Ο 1¾. (讀先閱讀背面之注意事項再填寫本買) TLC: Rf: 〇·34(氡仿:甲酵:乙酸=18:2:1); NMR (d6-DMSO) j 10·35 (1H,s),7 67 (1H, t, J=5 3Ηζ),2·99 (2Η,⑻, 2·39-1·88 (3Η,m),L78-1.61 細,m),L45-1.07 (7Η,m),0.95-0.76 (5Η,m)。 審淪例4 (1 N -羥基- 4- [N-[4-((4 -甲基苯基)乙炔基)苯羰基]胺基 ]丁醢胺
TLC: Rf: 0·38(氯仿:甲酵:乙酸=18:2:1); 本紙张尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 174 310112 568897 A 7 B7_____ __________-—---.....-———....... 五、發明说明(ύδ NMR (d6-DMS〇) : $ 10.39 (1H,s),8·62-8·53 (1H,t,J=5.3Hz),7·89 (2H,d, J=8.6Hz), 7.61 (2H, d, J=8.6Hz), 7.47 (2H, d, J=8.0Hz), 7.25 (2H, d, J=8.0Hz), 3.27 (2H,m),2·35 (3H,s),2.03 (2H,ζ J=6.8Hz),1.76 (2H,m)。 n m m a(ia± H-羥基-4-[N-[4-((4-溴苯基)胺磺藤基)苯鑛基]胺基 ]丁醢胺
0
Br TLC: Rf: 0.16(氯仿:甲酵:乙酸=18:2:1); NMR (d6-DMS〇) : δ 10.55 (1Η, s),10.38 (1Η,brs),8·67 (1Η,m),7·96 (2Η, d, J=8.4Hz), 7.82 (2H, d, J=8.4Hz), 7.43 (2H? d, J=9.0Hz), 7.06 (2H, d, J=9.0Hz), 3.32-3.16 (2H,m),2·01 (2H, t J=7.4Hz),1·82-1·66 (2H,m)。 g m m 4(15) N-羥基-4-[N-(4-環己基苯羰基)胺基]丁醣胺 Η
〇
(麴先閱讀背面之注意事項再填寫本頁) 部 中 •火
H ::? 而 竹 TLC: Rf: 〇·40(氯仿:甲酵:乙酸=18:2:1); 本紙张尺度適州中國國家標準(CNS ) Α4規格(210X297公釐) 175 310112 568897 A7 —一一 B7 五、發明説明(17$ (¾先閱讀背面之注意事項再填寫本頁) NMR (d6-DMS〇) :δ 10.39 (1Η,s),8·43-8·36 (1Η,m),7·76 (2Η,d,J=8.4Hz), 7.34 (2H, d, J=8.4Hz), 3.30-3.13 (2H, m), 2.63-2.54 (1H, m), 2.01 (2H, t, J=7.6Hz), 1·86-1·65 (6H,m),1.48-1.24 (6H, m)。 奮撫例4 (1 fi) N-羥基- 4-[H-[4-(4-丁基苯基)苯羰基]胺基)丁醢胺
TLC: Rf: 0.40(氯仿:甲酵:乙酸=18:2:1); NMR (d6-DMS〇) : δ 10.40 (1Η, s), 8.70 (1H, brs), 8.57-8.49 (1H, m), 7.93 (2H, d, J=8.5Hz), 7.74 (2H, d, J=8.5Hz), 7.64 (2H, d, J=8.5Hz), 7.31 (2H, d, J=8.5Hz), 3.31-3.20 (2H, m), 2.61 (2H, t, J=7.4Hz), 2.04 (2H, ζ J=7.2Hz), 1.76 (2H, m), 1.62 (2H, m), 0.92 (3H, t, J=7.4Hz)〇
本紙張尺度適Jfl中國國家標準(CNS ) A4規格(21 OX 297公釐) .1 7 6---------- ----------------------HO 112 177、568897 A7 B7 五、發明説明 TLC: Rf: 0.23(氛仿:甲酵··乙酸=18:2:1); NMR (d6-DMS〇) : δ 10.40 (1Η, s),9·80-9·45 (1Η,brs),8.53-8.44 (1Η,m), — -----^一 -,—- (麴先閱讀背面之注意事項再楨寫本頁) 7.89 (2H, d, J=8.5Hz), 7.67 (2H, d? J=8.5Hz), 7.56 (2H, d, J=8.8Hz), 6.87 (2H, d, J=8.8Hz), 3.31-3.20 (2H, m), 2.03 (2H, t, J=7.4Hz), 1.83-1.68 (2H, m)〇 當嫵例4 (18) N-羥基-4-[N-[4-(4-氯苯基)呋喃-2-基羰基]胺基]丁 醢胺
HCT TLC: Rf: 0.38(氛仿:甲酵:乙酸=18:2:1); _________ ..........….* '' NMR (d6-DMS〇) :δ 10.40 (1Η, s), 8.64-8.51 (1H, m), 7.95 (2H, d, J=8.4Hz), 7.54 (2H, d, J=8.4Hz), 7.16-7.11 (2H, m), 3.31-3.18 (2HT m), 2.08-1.95 (2H, m), 1.76 (2H,m)。 奮嘸例4 f 1 Q) N-羥基-4-[N-[4-(4-庚基笨基)苯羰基]胺基]丁醸胺
Ο
本紙张尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 177 310112 17568897 A7 B7 五、發明説明 TLC: Rf: 〇·34(氯仿:甲酵:乙酸=18:2:1); NMR. (d6-DMS0) : δ 10.40 (1Η,brs),8.57-8.50 (1Η,m),7·93 (2Η,d, J=8.4Hz),7·74 (2H,d,J=8.4Hz),7.64 (2H,d,J=8.4Hz),7.30 (2H,d,J=8.4Hz), 3.32-3.22 (2H, m), 2.62 (2H, t, J=7.7Hz), 2.04 (2H, ζ J=7.3Hz), 1.76 (2H, m), L69-1.52 (2H,m),1.38-U7 (8H,m),0·86 (3H,ζ J=6.6Hz)。 奮_例4 (20) N-羥基-4-[N-[4-(4-甲氧基苯基)苯羰基]胺基]丁醢 胺
Ο
OCH3 (詞先閱讀背面之注意事項再蛾寫本頁) 部 十 •λ il 消 f 卬 y. TLC: Rf : 0·26(氯仿:甲酵=9:1); NMR (dg-DMSO) :δ 10.40 (1Η, s), 8.57-8.47 (1H, m), 7.91 (2H? d, J=8.5Hz), 7.71 (2H, d, J=8.5Hz), 7.68 (2H, d, J=8.8Hz), 7.05 (2H, d? J=8.8Hz), 3.81 (3H, s), 3.26 (2H,m), 2.03 (2H, U=7.5Hz), 1.83-1.69 (2H,m)。 啻淪例4 (21 ) H-羥基-4-[N-[4-(4-氯苯基)苯羰基]胺基]丁醢胺 Η
本紙張尺度適中國國家標準(CNS ) A4規格(210X297公釐) 178 310112 568897 A7 B7 五、發明説明(171 TLC: Rf: 0·34(氯仿 甲酵:乙酸=18:2:1); NMR (d6-DMS0) :δ 10·41 (1Η,s), 8·62-8·52 (1Η,m),7·95 (2Η,d,J=8‘4Hz), 7.82- 7.72 (4H, m), 7.55 (2H, d, J=8.4Hz), 3.35-3.20 (2H, m), 2.04 (2H, ζ J=7.5Hz), 1.83- 1.69 (2H, m)〇 奮淪例4 (22) H-羥基-4-[N-(5-苄氧基吲睐-2-基羰基)胺基]丁醢胺
〇_b (請先閱讀背面之注意事項再填寫本頁) 部 屮 ik il 而 | ^ -1 >/ί Μ TLC: Rf: 0·26(氯仿:甲酵:乙酸••水=100:10:1:1) I NMR (d6-DMS〇) : δ 11.38 (1H? brs), 10.38 (1H, brs), 8.70 (1H, brs), 8.43 (1H, t, J=5.8Hz), 7.28-7.48 (6H? m), 7.16 (1H, d, J=2.2Hz), 6.99 (1H, d7.J=1.4Hz), 6.89 (1H, dd, J=8.7Hz? 2.4Hz)? 5.07 (2H, s), 3.25 (2H, m)7 2.02 (2H, ζ J=6.8Hz), 1.70-1.81 (2H, m)。 窗)fe 例 4 ( 2 3) N-羥基- 4-[N-[5-(2-(4-氛苯基)乙烯基)呋喃-2-基羰 基]胺基]丁醢胺
紙张尺度適州中國國家標率(CNS ) A4規格(210X297公釐) 17 9 310112 18'568897 A7 B7 五、發明説明 TLC: Rf: 0·27(氯仿:甲醇:乙酸:水=1〇〇:1〇:1:1 NMR (dg-DMSO) . δ 10.38 (1Η, brs), 8.71 (1H, brs), 8.46 (1H, t, J=5.8Hz), 7.60 (2H, d, J=8.8Hz), 7.43 (2H, d, J=8.8Hz), 7.23 (1H, d, J=16,6Hz), 7.15 (1H, d, J=16.6Hz), 7.09 (1H, d, J=3.4Hz), 6.63 (1H, d, J=3.4Hz), 3.22 (2H, m), 2.00 (2H, t, J=7.4Hz), 1.73 (2H,m)。 奮撫俐4 (24) N-經基-4-[N-[4-(苯氧基)苯羰基]胺基]丁醢胺
TLC: Rf: 0·25(氯仿:甲酵·•乙酸:水=100:10:1:1) NMR (dg-DMSO) : δ 1036 (1Η, brs), 8.69 (1H, brs), 8.41 (1H, ζ J=5.6Hz), 7.85 (2H, d, J=8.8Hz), 7.41 (2H, t, J=7.4Hz), 7.19 (1H, t, J=7.4Hz), 6.97-7.09 (4H, m),3·22 (2H,m), 1.99 (2H,ζ J=7.6Hz),1·71 (2H,m)。 奮)fe 例 4 (2 ‘λ /Γ, 部 屮 il
(銷先閱讀背面之注意事項再填寫本lic) N-羥基-5-[N-[4-(苯并呋喃-2-基)苯羰基]胺基]戊釀 胺
HO
本紙張尺度適W中國國家標準(CNS ) A4規格(210X 297公釐) 180 310112 568897 A7 B7 18 lx 五、發明説明 TLC: Rf: 0·26 (氯仿:甲酵=l〇:1); NMR (d6-DMS0) : S 10.36 (1H, s), 8.67 (1H, br.s), 8.57 (1H, t, J=5.6Hz), 8.01 (2H, d, J=8.8Hz), 7.96 (2H, d, J=8.8Hz), 7.71-7.63 (2H, m), 7.57 (1H, br.s), 7.39-7.23 (2H,m),3.30-3.23 (2H, m),2.02-1.94 (2H, m),1.60-1.44 (4H, m)。 謇施例4 (26) H-羥基-6-[N-[4-(苯并呋喃-2-基)苯羰基]胺基]己醣 胺
HO
(麴先閱讀背面之注意事項再楨寫本頁} 、,ΐ /?· 部 屮 •λ .τ 消 f: Aii 卬 f: TLC: Rf: 0.28(氛仿:甲酵=10:1); NMR (d6-DMS〇) : δ Τ〇337Γη's), 8.80-8.50 (1H, br.s), 8.54 (1H, t, J=5.6Hz), 8.01 (2H, d, J=8.8Hz), 7.95 (2H, d, J=8.8H), 7.71-7.62 (2H, m), 7.56 (1H, s), 7.39- 7.23 (2H, m), 3.30-3.21 (2H, m), 1.95 (2H, ζ J=7.2Hz), 1.59-1.46 (4H, m), 1.36- L20 (2H, m)。 奮)fe 例 4 (27) N-羥基-4-[N-[[(4’-胺甲醢基甲氧基苯-4-基]羰 基]胺基]丁醢胺
0
Y 0 nh2 本紙張尺度適中國國家標準(CNS ) Α4規格(210X297公釐) 1ΧΓ 568897 A7 B7 五、發明说明(18$ TLC: Rf: 0·22(氯仿:甲醇:乙酸:水=50:10:1:1〉; NMR (d6-DMS0) : δ 10.37(1H, brs), 8.70(1H, brs)? 8.49(1H, t, J=5.4Hz), (讀先閱讀背面之注意事項再頊寫本頁) 7.89(2H, d, J=8.8Hz), 7.70(2H, d, J=8.2Hz), 7.67(2H, d, J=8.2Hz), 7.54(1H, brs), 7.39(1H, brs), 7.04(2H, d, J=8.8Hz), 4.46(2H, s), 3.20-3.31(2H, m), 2.01(2H, t, J=7.2Hz),1·66-1·80(2Η,m)。 當淪俐4 (28) N-羥基- 4-[N-[4-(4-苯基哌啶-1-基)苯羰基]胺基]丁 釀胺
TLC: Rf: 0.32(氛仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.39 (1H, s), 8.69 (1H, s), 8.20 (1H, t, J=5.8Hz), 7.73 (2H, d, J=8.6Hz), 7.40-7.12 (5H? m), 6.98 (2H, d, J=8.6Hz), 4.06-3.90 (2H, m), 3·30-3·16 (2H, m),2.96_2.60 (3H, m), 2.00 (2H,t,J=7.6Hz), 1.95-1.59 (6H, m)。 窗牖例4 (2(n N-羥基-4-[N-[4-[3-(4-氯苯氧基)-1-丙炔基]苯羰基 ]胺基]丁醢胺 本紙張尺度適ffl中國國家標準(CNS ) A4規格(210X 297公釐) TJ2 310112 568897 A7 B7 五、發明说明()
0 TLC: Rf: 0.26(氯仿:甲醇=8:1); NMR (d6-DMS〇) : δ 10.38 (1Η, s), 8.71 (1H, s), 8.57 (1H, t, J=5.4Hz), 7.85 (2H, d, J=8.4Hz), 7.53 (2H, d, J=8.4Hz), 7.38 (2H? d, J=9.2Hz), 7.08 (2H? d, J=9.2Hz),5.08 (2H,s),3.40-3.15 (2H, m,與 DMSO中H20 重疊),2·02 (2H, ζ J=7.2Hz),1·74 (2H,m)。 謇淪例4 ( 3 0丄 H-經基-4-[H-[4-(3-笨氧基**1-丙炔基)苯羧基]胺基] 丁酿胺
(麴先閱讀背面之注意事項再填寫本頁) TLC: Rf: 0·38(氯仿··甲醇=9:1); NMR (d6-DMSO) :5 10.38 (lH,s),8.70 (lH,s),8.57(lH,t,J=5.4Hz),7.85 (2H,d,J=8.3Hz), 7·52 (2H, d,J=8.3Hz), 7.34 (2H,dd,J=7.0 及 8.6Hz), 7.10-6.90 (3H, m), 5.06 (2H, s), 3.25 (2H, du J=5.4 and 7.2Hz)? 2.02 (2H, t, J=7.2Hz), 1.74 (2H, m)〇 本紙張尺度適W中國國家標準(CNS ) A4規格(210X297公釐) 183 310112 568897 A7 _ B7 五、發明説明(184) 實施例4 (31) N-羥基- 4-[N-[4-(4-甲氧基苯氧基)笨羰基]胺基]丁 醯胺
TLC: Rf: 0·40(氯仿:甲酵:乙酸:水=50:10:1:1); NMR (d6-DMS〇) : δ 10.37 (1Η, brs), 8.70 (1H, brs), 8.40 (1H, ζ J=5,5Hz), 7.82 (2H, d, J=9.1Hz), 7.06-6.91 (6H, m), 3.79 (3H, s), 3.21 (2H, m), 1.96 (2H, m), 1·72 (2H,m)〇 窗濂俐4 ( 3 2 ) N-羥基-4-[N-[4-(4-羥基苯氧基)苯羰基)]胺基]丁醢 (謂先閱讀背面之注意事項再硪寫本頁)
TLC: Rf: 〇·25(氯仿••甲醇:乙酸:水=50:10:1); NMR (d6-DMS〇) : δ 8.37 (1Η, t, J=5.5Hz)? 7.81 (2H, d, J=8.8Hz), 6.92 (2H, d, J=9.1Hz), 6.90 (2H, d, J=8.8Hz), 6.80 (2H, d, J=9.1Hz), 3.21 (2H, m), 1.99 (2H, m),1·71 (2H, m)〇 奮_俐4 ( 3 3 ) 本紙张尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 184 31011 2 568897 A7 B7 18 五、發明説明 N-羥基-4-[N-[4-(4-苯氧基哌啶 丁醯胺 基)苯羰基]胺基] H0 0 0
TLC: Rf: 〇·31(氡仿··甲酵=9:1); NMR (d6-DMS〇) : δ 10.38 (1H, s), 8.69 (1H, s), 8.19 (1H, t, J=5.2Hz), 7.73 (2H, d, J=8.8Hz), 7.28 (2H, dd, J=8.8, 7.4Hz), 7.02-6.87 (5H, m), 4.68-4.52 (1H, m), 3.73-3.56 (2H,m),3·32-3·10 (4H, m),2.11-1.92 (4H,m), 1.82-L50 (4H,m)。 奮_例4 (:U ) N -經基-4-[N-[4-(4_苯基-12 5 6_四氫吡啶-卜基) 笨羰基]胺基]丁醮胺
HO •S, Ο (讀先閱讀背面之注意事項再填寫本頁) 朽. 部 中 -λ il 導 )i j 消 f: 竹 卬 f
TLC· Rf· 〇·42(氡仿:甲酵:乙酸:水=50:10:1:1); 本紙张尺度適中國國家標準( ( 210X297 公釐) 18 5 310TT2 568897 A7 18 B7 五、發明説明NMR (d6-DMSO) : 5 ι〇·38 及 9·78 (共]H,均爲㈣,9 〇2 及 8 69 (共 m, 均爲brs),8·20 (1H,t,J=5.5Hz),7·75 (2H,d, ;Γ=9·1Ηζ),7·48 (2H, m), 7·36 (2H,m), 7.26 (1H, m), 6.98 (2H, d, J=9.1Hz), 6.29 (1H, brs), 3.94 (2H, m), 3.58 (2H, m), 3.20 (2H,m),2·62 (2H,m), 1.99 (2H,m), 1·71 (2H, m)。 窖)fe俐4 U ΡΠ 經基-4-[N-U-(卜庚炔基)苯羰基]胺基]丁 醢胺
(誚先閱讀背面之注意事項再填寫本頁) 部 屮 .火 il 而 t: 合 卬 TLC: Rf: 〇·24(氣仿:甲酵= ι〇:ι); NMR (dg-DMSO) : d 10.37 (1H, s), 8.52 (1H, t, J=5.6Hz), 7.80 (2H, d, J=8.4Hz), 7.44 (2H, d, J=8.4Hz), 3.23 (2H, br.q, J=5.8Hz), 2.43 (2H, t, J=6:6Hz), 2.00 (2H, t, J=7.4Hz), 1.79-1.65 (2H, m), 1.62-1.48 (2H, m), L44-1.22 (4H, m), 0.88 (3H, t, j=6.6Hz)〇 窨_例4 ( 3 6 )N-羥基-4-[N-[4M4-苄氧基苯羰基)胺基]丁醢胺
HO
TLC: Rf: 0·11(氯仿:甲醇··乙酸:水=100 :10:1:1) 本紙張尺度適州中國國家標準(CNS ) A4規格( 210X 297公釐) 186 310112 568897 A7 B7 五、發明説明 18 NMR (de-DMSO) : δ 10.36及 9.78(共 1Η,各為 br), 8·99 及 8.68(共 1H,各為 br), 8·31(1Η,πι),7.80(2H,d,J = 8·8Ηζ), 7·45-7·3(5Η,ηι),7.05(2H,d,J = 8.8Hz), 5·15( 2H,s), 3·21(2Η,ιη),1·99(2Η,υ = 7·4Ηζ), 1·72(2Η·ιη) Ο 奮)fe例5 4-(Ν-甲基-Ν-(4-(苯并呋喃-2-基)苯基羰基)胺基)丁 酸乙酯
〇C2H5(^iXX 0
(誚先閱讀背面之注意事項再楨寫本頁) h 部 屮 •λ i?. 消 Λii 卬 含實施例1製造之化合物(0.1克)之二甲基甲醸胺(3毫 升)溶液中,添加碘化甲烷(〇·35奄升)。在0C下於混合物 中添加60涔氫化納(13奄克),反應混合物在室溫攪拌1小 時。反應混合物中添加1Ν塩酸水溶液,Μ乙酸乙酯萃取。 萃取液Μ飽和氯化納溶液洗淨,經無水硫酸納脫水後湄縮 ,得具下列物性之標題化合物(113毫克)。 TLC: Rf 0.33(正己烷:乙酸乙酷=1:1)。 實:施Μ 4 -(Ν-甲基-N-U-苯并呋喃-2-基)苯羰基)胺基)丁酸 本紙張尺度適州中國國家標率(CNS ) Α4規格(210X 297公釐) 187 310112 568897 A7 ___ ___ B7 五、發明説明(181
〇 H0 以實施例5製造之化合物替代實施例1製造之化合物, 依實施例2之相同方法操作,得具下列物性之標題化合物 〇 TLC: Rf 0·51(氯仿:甲酵=9:1); NMR (CD3〇D) : 5 7.98 (2H, d, J=8.4Hz), 7.66-7.59 (1H, m), 7.57-7.46 (3H, m), 7.37-7.19 (3H, m), 3.62 ^ 3.40 (2H, ζ J=7.5Hz), 3.10 ^3.03 (3H, s), 2.45 及 2·20 (2H, U=7.5Hz),2·10-1·75 (2H,m)。 審餱例7 N-羥基-4-(N -甲基-N-(4-(苯并呋喃-2-基)苯羰基)胺 基)丁醯胺
(讀先閱讀背面之注意事項再填寫本頁} H〇\ 0 使用實施例6製造之化合物替代實施例2製造之化合物 ,依實施例34實施例4之方法相同操作,得具下列物性之 標題化合物。 TLC: Rf 0.31(氯仿:甲酵=9:1); NMR (CD3CO) : δ 7.99 (2Η, d, J=8.4Hz), 7.66-7.59 (1H, m), 7.58-7.45 (3H, m), 7.37-7.20 (3H, m), 3.70-3.54 ^ 3.42-3.30 (2H, m), 3.16-2.95 (3H, m), 2.30-1.80 (4H,m)。 彳州中國國家摞率(CNS ) Λ4規格(210X297公瘦) 188 310112 18568897 Α7 Β7 五、發明説明 奮)fe例8 4M卜(4-(苯并呋喃-2-基)苯羰基)胺基)-2(S)-羥基 丁酸甲酯
0H 〇 ch3〇
使用4-胺基- 2(s)-羥基丁酸甲_ (依EP393441所述方 法製造)替代4 -胺基丁酸乙酯,依實施例1所示方法相同操 作,得具下列物性之檷題化合物。 TLC: Rf 〇·ΐι(正己烷:乙酸乙酯=1:1); NMR (d6-DMS〇) : δ 8.58 (1Η, ζ J=6.0Hz), 8.01 (2Η, d, J=8.8Hz), 7.96 (2H, d, J=8.8Hz)? 7.71-7.63 (2H, m), 7.57 (1H, brs)7 7.39-7.24 (2H, m), 4.19-4.10 (1H, m),3.62 (3H,s),3.38 (2H, q,J=6.0Hz),2.06-1.68 (2H,m)。
奮_俐Q 4-(N- (4-(苯并呋喃 丁酸 基)苯羰基)胺基)-2(S)_羥基 (許先閱讀背面之注意事項再硝寫本S ) 、,> 部 '1丨 •λ IT. OH 〇
消 合 Μ 卬 ¥ 使用實施例8製造之化合物替代實施例1製造之化合物 ,依實施例2之方法相同操作,得具下列物性之檷的化合 物0 本紙张尺度適W中國國家標準(CNS ) A4規格(210X297公釐) 310112 19«568897 A7 B7 五、發明説明 TLC: Rf 0.10(氯仿:甲酵··乙酸=100:10:1); NMR (d6-DMS0) : ί 8.49 (1Η, t, J=5.6Hz), 7.92 (2H, d, J=8.8Hz), 7,87 (2H, d, J=8.8Hz), 7.62-7.53 (2H, m), 7.48 (1H, d, J=0.6Hz), 7.30-7.14 (2H, m)* 3.95 (1H, dd,J=4.4, 8.4Hz),3.29 (2H, m),1.98-1.58 (2H,m)。 奮)fe例9 Π ) 4-(N-(4-(苯并呋喃-2-基)苯羰基)胺基)-2(R)_羥基 丁酸
Ο
(讀先閱讀背面之注意事項再楨寫本頁)
部 中 •火 a -1 消 IV A 使用4-胺基-2(R)-羥基丁酸甲_替代4-胺基-2(S卜經 基丁酸甲酯,依實施例84實施例9所示方法相同操作,得 具下列物性之標題化合物。 TLC: Rf 0.10(氣仿:甲酵:乙酸=100:10:1); NMR (d6-DMS〇) : 〇 8.49 (1H, ζ J=5.6Hz), 7.92 (2H, d, J=8.8Hz), 7.87 (2H, d, J=8.8Hz), 7.62-7.53 (2H, m), 7.48 (1H, d;J=0.6Hz), 7.30-7.14 (2H, m), 3.95 (1H, dd,J=4.4, 8·4Ηζ), 3·29 (2H,m),1·98-1·58 (2H,m)。 奮_俐1 0 4- (Η- (4-(苯并呋喃 甲氧基丁酸甲_ 基)苯羰基)胺基>-2(S)-苄氧 本紙張尺度適W中國國家標準(CNS ) A4規格(210X297公釐) 190 310112 19568897 A7 B7 五、發明參L明 cr cr 〇 ch3〇
(讀先閱讀背面之注意事項再硪寫本頁) 含實施例8製造之化合物(〇·2克)之二氱甲烷(1奄升) 溶液中添加二異丙基乙胺(2毫升)。於混合物中添加苄氧 基甲基氛(0·79毫升)。反應混合物於501C搅拌30分鐘。反 應混合物中添加1Ν塩酸水溶液,Μ乙酸乙酯萃取。萃取液 以水、飽和氯化納水溶液洗淨,Κ無水硫酸納乾煉後澹縮 。殘留物Κ矽膠管柱曆析(正己烷:乙酸乙酿=3:2)純化, 得具下列物性之檷題化合物(0.176克)。 TLC: Rf 0.47(正己烷:乙酸乙酯=1:1)。 管餱例1 1 4-(N-(4-(苯并呋喃-2-基)苯羰基)胺基)-2(S)-苄氧 基甲氧基丁酸 本紙張尺度適州中國國家標率(CNS ) Α4規格(210X297公釐) 191 310112 568897 A7 19 五、發明说明 0一 Ο- 〇
使用實施例10製造之化合物替代實施例1製造之化合 物,依實施例2所示之方法相同操作,得具下列物性之標 題化合物。 TLC: Rf 0.45(氯仿:甲酵:乙酸= 1 00:20:1 ); NMR (dg-DMSO) : δ 8.61 (1Η, t, J=5.4Hz), 8.01 (2H, d, J=8.8Hz), 7.95 (2H, d, J=8.8Hz), 7.709-7.63 (2H, m), 7.57 (1H, brs), 4.80 (1H, d, J=8.8Hz), 4.79 (1H, d, J=8.8Hz), 4.64 (1H, d, J=11.8Hz), 4.54 (1H, d? J=11.8Hz), 4.13 (1H, dd, J=4.2, 8.2Hz), 3.52-3.28 (2H, m), 2.12-L82 (2H, m)〇 富_例 11(1)〜11(3) 使用對應之胺化合物及醢氯化物,依實施例84實施 例104實施例11之方法相同操作,得下列化合物.。 奮_例1 Ί (1) 4-(N-(4-(苯并呋喃-2-基)苯羰基)胺基- 2(R)-苄氧甲 氧基丁酸 (讀先閱讀背面之注意事項再楨寫本頁) 、'> 'Λ\ 部 '1,
I ί/ί A 卬 y. 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 192 310112 19568897 A7 B7 0 〇
五、發明説明
CT
CT H0 TLC: Rf 0.45(氯仿:甲酵:乙酸=1〇〇:20:1 NMR (d6-DMS〇) : δ 8.61 (1Η, ζ J=5.4Hz), 8.01 (2Η, d, J=8.8Hz), 7.95 (2H, d, J=8.8Hz)? 7.709-7.63 (2H, m), 7.57 (1H, brs), 4.80 (1H, d, J=8.8Hz), 4.79 (1H, d, J=8.8Hz), 4.64 (1H? d, J=11.8Hz), 4.54 (1H, d, J=11.8Hz), 4.13 (1H, dd, J=4.2, 8.2Hz), 3.52-3.28 (2H, m), 2.12-1.82 (2H, m)〇 實施例1 1 f 4-(N_(4-(2-(4-氯苯基)乙烯基)笨羰基)胺基-2(S) 苄氧甲氧基丁酸 (¾先閱讀背面之注意事項再頊耗本頁) 、j yf\ 部 中 -火 而 消 f: 合 卬
CT CT 0
TU: Rf 0·18(氯仿:甲酵=10:1);
CI 310112 CNS \ A4a^(_2l οχ 297^1 ).......19 3 568897 A7 B7 19 五、發明説明( NMR (d6-DMS〇) : δ 8.52 (1H, t, J=5.4Hz), 7.84 (2H, d, J=8.4Hz), 7.67 (2H, (許先閲讀背面之注意事項再填寫本頁) d, J=8.4Hz), 7.65 (2H, d, J=8.8Hz), 7.44 (2H, d, J=8.8Hz), 7.35-7.28 (7H, m), 4.80 (1H, d, J=8.8Hz), 4.77 (1H, d, J=8.8Hz), 4.63 (1H? d, J=11.8Hz), 4.54 (1H, d, J=11.8Hz), 4.12 (1H, dd, J=4.4, 8.0Hz), 3.50-3.26 (2H, m), 2.10-1.78 (2H, m)〇 簠施例11 ( 4-(N-(4-氯苯羰基)胺基)-2-苄氧甲氧基丁酸
TLC: Rf 〇·32(氯仿:甲醇:乙酸=100:10:1); 'NMR (d6-DMS〇) : δ 8·57 (1Η,U=5.6Hz),7.84 (2Η,d, J=8.8Hz),7.52 (2Η, d,J=8.8Hz),7.30 (5H,s),4.80 (1H,d,J=8.8Hz),4·76 (1H,d,J=8.8Hz),4·63 (1H,d, J=11.8Hz), 4.53 (1H, d, J=11.8Hz), 4.11 (1H, dd, J=4.4, 8.2Hz), 3.49-3.24 (2H, m), 2.08-1.77 (2H,m)。 部 中 -k il _τ f: A ii 印 奮餱例” H-羥基-4- (N- (4-(苯并呋喃 )-羥基丁醃胺
基)苯羰基)胺基)-2 (S
本紙张尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 194 310112 19568897
釗. /Γ: 部 屮 消 合 竹 卬 A7 B7 五、發明説明 使用實®例9製造之化合物替代實施例2製造之化合物 ’ 例3—實_例4所示方法相同操作,得具下列物性 之摞題化合物。 TLC: Rf 0·42(氯仿:甲酵:水=100:2〇:1)·, NMR (d6-DMS0) : δ 10·49 (1Η,brs),8·55 (1Η,ζ J=5.4Hz),8·01 (2Η,d, J=9.0Hz),7.96 (2H,d,J=9.0Hz),7·71-7·62 (2H,m),7·57 (1H,brs),7.39-7.23 (2H, m),3.94 (1H,dd,J=4.2, 8·2Ηζ),3·41-3·31 (2H,m),2.02-1.64 (2H,m)。 置施例1 2 (1 )〜1 2 (fi)— 使用實®例9(D、實施例11及實施例11(1)〜11(3)製 造之化合物替代實施例2製造之化合物,依實施例12所示 方法相同操作,得下列化合物。
奮)fe俐1 2 ( U N-羥基- 4-(H-(4-(苯并呋喃-2-基)苯羰基)胺基)-2( m-羥基丁醢胺 0
TLC: Rf 0·42(氣仿:甲酵:水=100:2〇:1); NMR (d6-DMS〇) : δ 10.49 (1Η, brs), 8.55 (1H, ζ J=5.4Hz), 8.01 (2H, d, J=9.0Hz), 7.96 (2H, d, J=9.〇Hz), 7.71-7.63 (2H, m), 7.57 (1H, brs), 7.39-7.23 (2H, m),3·94 (1H,dd, J=4.2, 8·2Ηζ), 3,41-3.31 (2H, m), 2.02-1.62 (2H,m)。 謇)fe 例 1 2 ( ?·) (讀先閱讀背面之注意事項再楨寫本頁) 本紙張尺度適州中國國家標準(CNS ) A4^i^21〇X 297公釐了 195 310112 568897 A7 B7 五、發明説明(1 9 9 N-羥基-4-(N-(4-(苯并呋喃-2-基)苯羰基)胺基)-2( S)-苄氧甲氧基丁醯胺 〇
(讀先閱讀背面之注意事項再楨寫本頁) TLC : Rf 0· 24 (氯仿:甲酵=10 : 1); NMR (d6-DMS〇) : δ 10.75 (1Η, brs), 8.90 (1H, brs), 8.55 (1H, t, J=5.6Hz)T 8.01 (2H, d, J=8.8Hz)? 7.96 (2H, d, J=8.8Hz), 7.71-7.63 (2H, m), 7.58 (1H, brs), 7.39-7.24 (7H, m), 4.77 (1H, d, J=8.8Hz), 4.68 (1H, d, J=8.8Hz), 4.58 (2H? s), 4.04 (1H,t,J=5.8Hz), 3·49-3·25 (2H,m),1.93 (2H,m)。 窗)fe例12 m N-羥基- 4-(N-(4-(苯并呋喃-2-基)笨羰基)胺基)-2( R)-苄氧甲氧基丁醢胺
本紙張尺度遍州中國國家標準(CNS ) A4規格(210X297公釐) 196 310112 568897 Α7 ___ 一 Β7 五、發明説明(19) TLC: Rf 0.24(氯仿:甲醇=10:1); NMR (drrDMS〇) : δ 10.75 (1Η, brs), 8.90 (1H, brs), 8.55 (1H, ζ J=5.6Hz)? 8.01 (2H, d, J=8.8Hz), 7.96 (2H, d, J=8.8Hz), 7.71-7.63 (2H, m), 7.58 (1H? brs), 7.39-7.24 (7I[, m), 4.77 (1H, d, J=8.8Hz), 4.68 (1H, d, J=8.8Hz), 4.58 (2H, s), 4.04 (1H, t, J=5.HHz), 3.49-3.25 (2H, m), 1.93 (2H, m)〇 奮淪俐1 2 ( 4 ) N-羥基-4-(N-(4-(2-(4-氛苯基)乙烯基)苯羰基)胺基 )-2 (S卜苄氧甲氧基丁醢胺 (¾先閱讀背面之注意事項再填寫本頁)
TLC: Rf 0.22(氯仿:甲酵=10:1); NMR (drrDMS〇) : ί 10.74 (1Η, brs), 8.89 (1H, brs), 8.45 (1H, ζ J=5.6Hz), 7.85 (2H, d, /=8.4Hz), 7.67 (2H, d, J=8.4Hz), 7.65 (2Ht d, J=8.6Hz), 7.45 (2H, d, J=8.6Hz)T 7/^5-7.26 (7H, m), 4.76 (1H, d, J=8.8Hz), 4.67 (1H, d, J=8.8Hz), 4.57 (2H, s),4.02,1H, ζ J=5.8Hz),3.48-3.28 (2H,m), 1.91 (2H, m)。 奮嫵例1 2 ( 5) N-羥基- 4-(N-(4-氯苯羰基)胺基)-2-苄氧甲氧基丁醮 胺 "Fk张尺度適ίΓ中國國家標準(CNS ) Λ4規格(210X297公釐) 1 97 3 1 0 1 1 2 568897 A7 B7 五、發明説明 19
HCT μ 〇 〇Nr^acl TLC: Rf 0.34(氛仿:甲酵=10:1); NMR (d6-DMS〇) : δ 10.73 (1Η,brs),8.89 (1Η,brs),8.52 (1Η,m),7·84 (2Η, ...------ ----- d, J=8.4Hz), 7.52 (2H, d, J=8.4Hz), 7.30 (5H, brs), 4.75 (1H, d, J=8.8Hz), 4.66 (1H, d,J=8.8Hz),4.56 (2H,s),4.01 (1H,ζ J=6.6Hz),3.45-3.25 (2H,m),1·89 (2H,m)。 奮_俐1 3 4-(N-(4-氯苯羰基)胺基)-2-(第三丁氧羰基甲氧基) 丁酸甲酿 CH3〇
(¾先閱讀背面之注意事項再楨寫本頁) 部 中 ik ii ]i .1 消 f: 合 卬 ί: 於含60涔氫化納(2·38克)之四氫呋喃(10奄升)混合物 中•在-7 8 1C下,滴加含4 - ( Ν - ( 4 -氛苯羰基)胺基)-2 -羥基 丁酸甲酗(3克)之四氫呋喃(15奄升)溶液。反應混合物在 0它下攪拌30分鐘後,在-78¾下滴加溴乙酸第三丁釀( 0.975克)。反應混合物在0它攪拌1.5小時。反應混合物中 度適州中國國家摞率(CNS ) A4規格(.210X 297公釐) 198 310112 19568897 A7 B7 五、發明説明( 添加1N塩酸水溶液,Μ乙酸乙_萃取。萃取液以飽和碳酸 氫納水溶液、飽和氯化納水溶液洗淨,Μ無水硫酸納乾燥 後濃縮。殘留物Μ矽膠管柱曆析(正己烷:乙酸乙酯=1:1) 鈍化,得具下列物性之化合物(3.194克)。 TLC: Rf 0·63(正己烷••乙酸乙酯=1:1)。 g淪例1 4 4-(N-(4-氯苯羰基)胺基)-2-(羧基甲氧基)丁酸甲酯 τ (讀先閱讀背面之注意事項再楨寫本頁)
〇…0H 含實施例13製造之化合物(3.194克)之三氟乙酸(50毫 升)溶液在室溫攪拌1小時。反應混合物經湄縮,添加乙醚 而結晶化,K乙醚洗淨、乾嫌,得具下列物性之標題化合 物(2·275克)。 TLC: Rf 0.28(氯仿:甲酵:乙酸=100:10:1)。 窨_例1 5
本紙张尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 199 310112 568897 Α7 Β7 五、發似明($ 含實施例14製造之化合物(0.5克)之二甲基甲醢胺(5 毫升)溶液中,在冰冷却下,添加N -苄基-N -甲基胺(0.213 克)、1_羥基苯并三唑♦水合物(0.27克),1-乙基- 3-(3-二甲胺基丙基)羰二釀胺·塩酸塩(0.337克),於室溫搅拌 1小時。反應混合物中添加1N塩酸水溶液,Μ乙酸乙酯萃 取。萃取液以飽和碳酸氫納水溶液,飽和氛化納水溶液洗 淨,Μ無水硫酸納脫水後濃縮,得具下列物性之標題化合 物(0 · 664克)。 TLC: Rf 0.60(正己烷··乙酸乙酯=1:1)。 啻_例1 6 4 -(N-(4-氯苯羰基)胺基)-2-((N-苄基甲基胺基) 羰基甲氧基)丁酸 --------衣— (麴先閱讀背面之注意事項再填寫本頁)
-鲁 使用實施例例15製造之化合物替代實施例1製造之化 合物,Μ實施例2所示方法相同操作,得具下列物性之標 題化合物。 TLC: Rf 0.21(氯仿·•甲酵:乙酸=100:10:1); 1^1?((16-0»150):5 8.83及8.72(共111,111),7.87及 7·86(共 2H,d,J = 8.8Hz), 7·53,7·23(7Η,ιβ), 4·53 及 4·49( 共 2H,s), 4.38(lH,d,J=15.0Hz), 4.24(lH,d,J=15.0Hz), 本紙張尺度適州中國國家標率(CNS ) Λ4規格(210X 297公釐) 20^ 310112 ,568897 A7 B7 五、發明説明 2 0 1、 3·52-3·37(1Η,πι),2·86 及 2·80(共 3H,s), 2·08-1·72( 2Η , m) 〇 奮淪例及16(2) 使用對應之胺化合物替代N-苄基-N-甲基胺,依實施 例154實施例16所示方法相同操作,得下列化合物。 奮淪例1 fi (1 1 • 4-(N-(4-氛苯羰基)胺基)-2-((N-苯基-N-甲基胺基) 羰基甲氧基)丁酸
Prf u 〇uN、 (翱先閲讀背面之注意事項
Γ 本71C TLC: Rf 0.29(氛仿:甲酵:乙酸=100:10:1); NMR (d6-DMS〇) : δ 8.72 (1Η, t, J=5.8Hz)? 7.88 (2H, d, J=8.4Hz), 7.53 (2H, d, J=8.4Hz), 7.49-7.34 (5H, m), 4.05-3.82 (3H, m), 3.44-3.33 (2H, m), 3.19 (3H, s), 2·04-1·64 (2H,m)。 > a yr. 謇槲例1 fi ( 2 )
I 4二(N-(4 -氯苯羰基)胺基)-2-((N -苯乙基-N -甲基胺基 )羰基甲氧基)丁酸 ί/ί f- 本紙张尺度適W中國國家標準(CNS ) A4規格(210X297公釐) 201 310 112" 568897 A7 B7 五、發明説明 20
CI TLC: Rf 0.32(氯仿:甲酵:乙酸=100:10:1); NMR (d6-DMS〇) : δ 8.83 (0.5Η, t, J=5.5Hz), 8.75 (0.5H, ζ J=5.5Hz), 7.89 (1H, d, J=8.4Hz), 7.86 (1H, d, J=8.4Hz), 7.53 (1H, d, J=8.4Hz), 7.49 (1H, d, J=8.4Hz), 7.30 (5H, s), 4.39 (0.5H, d, J=15.4Hz), 4.17 (0.5H, d, J=15.4Hz), 4.13 (0.5H, d, J=14.6Hz), 3.95 (0.5H, dd, J=8.8, 3.0Hz), 3.90 (0.5H, d, J=14.6Hz), 3.79 (0.5H, dd, J=9.0, 3.6Hz), 3.60-3.30 (4H, m), 2.90-2.70 (2H, m), 2.10-1.60 (2H, m)〇 實 1117 N-羰基- 4-(N-(4-氯苯羰基)胺基)-2-((N-苄基-N-甲 基胺基)羰基甲氧基)釀胺
(許先閱讀背面之注意事項V Γ本頁) r裝- /?'·: 部 屮 -火 消 f
使用實施例16製造之化合物替代實施例2製造之化合 物,依實施例34簧施例4所示方法相同操作,得具下列物 性之摞題化合物。 TLC: Rf 0.39(氯仿:甲酵=10:1);
本紙张尺度適州中國國家標準(CNS ) A4規格(2丨〇、乂297公釐) 202 310112 568897 A7 B7 - - 五、發明説明(1 NMR (d6-DMS〇) :S 10.93 and 10.90(1H, brs, brs), 9Ό5-8.65 (2H, m), 7.87 7.86 ( 2H, d y^d, J=8.8Hz /¾ J=8.8Hz), 7.52 /^7.45 ( ^ 2H, d 及 d,J=8.8Hz 尽 J=8.8Hz),7.37-7.19 (5H,m),4.54 及 4·50 (共 2H,s 及 s), 4·44 冷 4.36(头 1H,d 展d,J=14.2Hz/^J=15.0Hz),4·24 及 4.20(兴 1H,d 反d,J=14.2Hz 及 J=15.0Hz),3·94-3,88 (1H,m),2.84 及2·80 (夹 3H,s /g^s), 2.00-1.68 (2H,m)。 窗濂例17 (1)及17 (2丄 使用實施例16(1)及16(2)製造之化合物替代實施例 16製造之化合物,依實施例17所示方法相同操作,得下列 化合物。 窖淪例1 7 (1 ) N-羥基-4-(N-(4-氯笨羰基)胺基)-2-((N-苯基甲 基胺基)羰甲氧基丁醢胺
TLC: Rf 〇·48(氛仿:甲醇=10:1); NMR (dg-DMSO) : δ 10.79 (1Η, brs), 9.20-8.40 (1H, br)t 8.68 (1H, m), 7.87 (2H, d, J=8.8Hz), 7.53 (2H, d, J=8.8Hz), 7.46-7.34 (5H, m), 4.14-3.67 (3H, m), 3.55-3.25 (2H,m),3·19 (3H, s),1.95-1.60 (2H,m)。 奮)fe 例 1 7 f ?) 本紙张尺度述力]中國國家標準(CNS ) A4規格(210X297公釐) 203 310112 20568897 A7 B7 五、發明説明 標題化合物。 TLC: Rf 0.31(正己烷:乙酸乙 _=1:1); NMR (dg-DMSO) : δ 8.57 (1Η, t, J=6.0Hz), 8.00 (4H, s), 7.71-7.63 (2H, m), 7.57 (1H, brs), 7.40-7.24 (2H, m), 5.13 (1H, d, J=5.6Hz), 4.18-4.00 (1H, m), 3.57 (3H, s), 3.30 (2H, t, J=6.0Hz), 2.55 (1H, dd, J=4.0, 15.0Hz), 2.31 (1H, dd, J=4.0, 15.0Hz)〇 ----------------- 奩淪例1 9 3(S)-羥基-4-(N-(4-(苯并呋喃-2-基)苯羰基)胺基) 丁酸 (讀先閱讀背面之注意事項再硝寫本頁)
0 Hv^r Ο OH
部 屮 •火 u j 消 f: ft 卬 使用實施例18製造之化合物替代實施例1製造之化合 物,依實施例2所示方法相同操作,得具下列物性之標題 化合物。 TLC: Rf 0.24(氯仿:甲酵:乙酸=1〇〇:1〇:1); NMR (d6-DMS0) :δ 8.55 (1Η, ζ J=5.8Hz), 8.00 (4Η, s), 7.71-7.63 (2H, m), 7.58 (1H, brs), 7.39-7.23 (2H, m), 5.16-4.92 (1H, brs), 4.14-4.00 (1H, m), 3.30 (2H, t, J=5.8Hz), 2.46 (1H? dd, J=4.2, 15.0Hz), 2.23 (1H, dd, J=8.4, 15.0Hz)〇 奮淪例19 (1 ) 3(R) -羥基-4-(N-(4-(苯并呋喃-2 -基)苯羰基)胺基) 丁酸 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 205 310112 568897 A7 B7____ 五、發明説明(2” NMR (d6-DMS0) : δ 8.72 (1Η, t, J=5.6Hz), 8.01 (4H, s), 7.70-7.65 (2H, m), 7.61 (1H, brs), 7.40-7.20 (2H, m), 4.62 (2H, s), 4.08 (1H, m), 3.42 (2H, m), 2.40-2.20 (2H,m)。 奮_例21 3(S)-乙醢氧基-4-(N-(4-(苯并呋喃-2-基)笨羰基)胺 基)丁酸甲_ (讀先閱讀背面之注意事項再填寫本頁) Η 、.ϊ /ί· 部 中 H 卑· f' 合 Μ 卬 f 含實施例18製造之化合物(〇·3克)之吡啶(5毫升)溶液 中,在0ΐ!下添加乙酸酐(0.6毫升)。反應混合物於室溫攪 拌2小時。反應混合物中添加1Ν塩酸水溶液,以乙酸乙酗 液W水、鉋和氣化納水溶液洗淨,以無水硫酸 納脫水,濃縮,得具下列物性之檷題化合物(0·325克)。 TLC: Rf 〇·52(正己烷:乙酸乙酯=1:2)。 管施例2 2 4-(ΝΜ4-($并呋喃-2-基)苯羰基)胺基)-3-丁烯酸甲 酷
一 H30 C
之化合物(〇.15克)之四氫呋喃(1奄升
、1T
310112 本紙张幻i制巾_家鮮(^ 20568897 部 中 λ 消 f 卬 A7 B7 五、發明説明 )溶液中,添加1·8 -二吖雙環[5·4·0]十一碳-7-烯[DBU]( 0.13毫升)。反應混合物在50¾攪拌3小時。反應混合物中 添加1H塩酸水溶液,W乙酸乙釀萃取。萃取液以水、飽和 氯化納水溶液洗淨,K無水硫酸納脫水,濃縮,得具下列 物性之檷題化合物(〇·〇96克)。 TLC: Rf 0.70(正己烷··乙酸乙酯=1:2)。 m 23 4 -(N-(4-(苯并呋喃-2-基)苯羰基)胺基卜3-丁烯酸 〇
HO
使用實施例22製造之化合物替代實施例1製造之化合 物,依實施例2所示方法相同操作,得具下列物性之摞題 化合物。 TLC: Rf 0,22(氛仿:甲酵·•乙酸=100:10:1); NMR (d6-DMS〇) :δ 10.39 (1Η, d? J=9.8Hz), 8.05 (4Ht s), 7.72-7.64 (2H, m), 7.61 (1H, d, J=0.6Hz), 7.41-7.24 (2H, m), 6.95 (1H, dd, J=9.8, 14.4Hz), 5.54 (1H, dt,J=14.4, 7·2Ηζ),3·05 (2H,d, J=7.2Hz)。 奩嫌例24 羥基-3(S)_羥基-4-(1(4-(苯并呋喃-2-基)苯羰基 )胺基)丁醃胺 (讀先閱讀背面之注意事項再蛾寫本頁) 本紙张尺度適州中國國家標準(CNS ) Λ4規格(210X297公釐) 20^ ΤΤΊΠΤ7 568897 A7 B7 21 五、發明説明 〇
Η
Her (讀先閱讀背面之注意事項再頊寫本頁) 使用實施例19製造之化合物替代實施例2製造之化合 物,依實施例34實施例4所示方法相同操作,得具下列物 性之標題化合物。 TLC: Rf 0.41(氯仿:甲酵:水=100:20:1); NMR (d6-DMS〇) ·· δ 10.39 (1Η, brs), 8.55 (1H, m), 8.00 (4H, s), 7.71-7.63 (2H, m), 7.57 (1H, brs), 7.39-7.23 (2H, m), 5.50-4.30 (1H, br), 4.12-3.98 (1H, m), 3.40-3.18 (2H, m)? 2.16 (1H, dd, J=4.8, 14.0Hz), 2.03 (1H, dd, J=8.2, 14.0Hz)〇 奮_例24(1)〜24(6) 使用實施例19(1)、實施例20(1)〜20(3)、實施例23 製造之化合物替代實施例19製造之化合物,依實施例24所 示方法相同操作,或使用實_例18製造之化合物,依實施 例104實施例114實施例24所示方法相同操作,得具下列 物性之檷題化合物。 部 '1, ϊ\ _τ 消 f: A 卬 窗?例 24 (1 ) N-羥基-3(R)_羥基-4-(N-(4-(笨并呋喃-2-基)苯羰基 )胺基)丁醢胺 本紙張尺度述州中囤國家標準(CNS ) Λ4規格(210X 297公釐) 210 310112 568897 A7 B7 五、發明説明 21 H0
.N 〇 nr
TLC: Rf〇.41(氯仿:甲酵:水= 1 00:20:1 ); NMR (d6-DMS0) : δ 10.39 (1Η, brs), 8.55 (1H, m)? 8.00 (4H, s), 7.71-7.63 (2H, m), 7.58 (1H7 brs), 7.39-7.24 (2H, m), 5.20-3.80 (1H, br), 4.12-3.98 (1H, m), 3.40-3.18 (2H, m), 2.16 (1H, dd, J=4.8, 14.0Hz), 2.03 (1H, dd, J=8.2, 14.0Hz)〇 啻濂例24 (2) N-羥基- 3(S)_甲氧基甲基氧基-4-(H-(4-(苯并呋喃-2 -基)笨羰基)胺基)丁醢胺 Η
Ο
(鏑先閱讀背面之注意事項再楨寫本頁) 部 中 k il 1\ -T 消 fr TLC:Rf0.19(氛仿·•甲酵=10:1); NMR (d6-DMS〇) : δ 10.47 (1Η, brs), 8.80 (1H, brs), 8.64 (1H, t, J=5.8Hz), 8.02 (2H, d, J=9.2Hz), 7.97 (2H, dt J=9.2Hz), 7.71-7.63 (2H, m), 7.57 (1H, brs), 7.40-7.24 (2H,m),4.60 (2H, s),4· 16-4.04 (1H,m), 3.41 (2H, υ=5·8Ηζ), 3.21 (3H, s),2.22-2.18 (2H,m)。 奮_例 N-羥基- 4-(H-(4-(苯并呋喃-2-基)苯羰基)胺基)-2- .本紙张尺度適W中國國家標率(CNS·.) A4規格(210X 297公釐) 211 310112 11 568897 A7 B7 五、發明议:明 富_例25 21 -苄氧基甲基- 4(N-(4-甲基苯羰基)胺基)丁酸
Μ 'Λ\ 部 中 k 含二異丙胺(0.925毫升)之四氩呋喃(5毫升)與六甲基 磷釀胺(HMPAU3奄升)溶液中,在氣氣中於-78t!下,添加 1.63M正丁基鋰之己烷溶液(4.05毫升)。混合物在-78υ攪 拌15分鐘。於該溶液中在-78TC下,添加含實施例2(1)製 造之化合物(0.442克)之四氫呋喃(3毫升)溶液。反應混合 物於室溫搅拌30分鐘。於反應混合物中在- 78t:下,添加 苄氧基甲基氯(0.313克)。反應混合物在- 781C攪拌2小時 。反應混合物中添加1H塩酸水溶液,Μ乙酸乙酯萃取。萃 取液以飽和氯化納洗淨,Μ無水硫酸鎂脫水並濃縮,得具 下列物性之檷題化合物(0·22克)。 TLC: Rf 0.67(氯仿:甲醇:乙酸=18:2:1)。 奮_例26 H -羥基-2 -苄氧基甲基-4-(N-(4 -甲基苯羰基)胺基)丁 醯胺 (讀先閱讀背面之注意事項再硪寫本頁)
、1T 本紙张尺度通W中國國家標率(CNS ) Λ4規格(210X 297公釐) 214 310112 568897 A7 B7 21 五、發明説明
使用實施例25製造之化合物替代實施例2製造之化合 物,依實施例34實施例4所示方法相同操作,得具下列物 性之標題化合物。 TLC: Rf 0.36(氛仿:甲酵=10:1); NMR (d6-DMS〇) : 5 10.52 (1H, s), 8.86 (1H, s), 8.32 (1H, t, J=8.4Hz), 7.74 (2H, d, J=8.4Hz), 7.31 (5H, m), 7.24 (2H, d, J=8.4Hz)? 4.46 (1H, d, J=12.5Hz), 4.44 (1H, d, J=12.5Hz)t 3.59 (1H, dd, J=8.8, 8.8Hz), 3.41 (1H, dd, J=8.8, 5.5Hz), 3.21 (2H, m),2·44 (1H,m),2.35 (3H,s),1·66 (2H,m)。 奮渝例27 N -羥基-2 -羥基甲基-4-(N-(4 -甲基苯羰基)胺基)丁醣 胺 (讀先閲讀背面之注意事項再^寫本頁} 部 十
A ]| J 消 f Λ 卬 f- 於含實施例26製造之化合物(0·24克)之甲酵(10奄升) 溶液中,在氤氣中,添加10涔鈀-碳(0.024克)。反應混合 物在氫氣中於室溫攪拌2小時。反應混合物通過塞里塑料[ celite(商品名)]過滤,濾液經濃縮。殘留物以矽膠管柱 層析(氯仿··甲醇=10:1)純化,得具有下列物性之標題化 本紙张尺度適川中國國家標率(CNS ) Λ4規格(210X297公釐) 215 310112 568897 A7 五、發明説明(216) 合物(0· 158克)。 TLC: Rf 0.39(乙酸乙酿:乙酸:水=16:3:2); NMR (d6-DMS〇) : δ 8.41 (1Η, m), 7.76 (2H, d, J=8.〇Hz), 7.24 (2H, d, J=8.0Hz), 3.52 (1H, m)? 3.37 (1H, m), 3.20 (2H, m), 2.35 (3H, s), 2.23 (1H, m)? 1.64 (2H,m)。 管_例27⑴及27(2) 使用實施例25製造之化合物經液相層析法分離之化合 物,依實施例34實施例44實施例274所示方法相同操作 ,得下列化合物。 奮嫵例27 (1 ) (謂先閱讀背面之注意事項再硝寫本頁) N-羥基-2-羥基甲基-4-(H-(4-甲基苯羰基)胺基)丁醢 胺
(式中,*表示R或S組態,目前尚未決定其立體構造。 但表示與實施例27(2)相反之立體結構)。 TLC: Rf 0.17(氛仿:甲酵=4:1); NMR(CD3〇D): δ 7,70(2H,d,J=8.2Hz), 7.26(2H,d, J = 8.2Hz), 3·79,3·52(2Η,β), 3·50-3·25(2Η,πι),2·38( 3H,s), 2.38-2.25(lH,m), 1·80(2Η,似 q)。 奮_例27 (2) N-羥基-2-羥基甲基- 4-(N-(4 -甲基苯羰基)胺基)丁醢 胺 ¥紙張尺度適州屮國國家標準(CNS ) Λ4規格(210X 297公釐) 216 310112 568897 A7 B7 21 五、發明説明( H0
(式中,*表示R或S組態,目前尚未決定其立髓構造, 但表示與實施例27(1)相反之立體結構)。 TLC: Rf 0.17(氯仿:甲酵=4:1); NMR(CD3〇D): δ 7.70(2H,d,J=8-2Hz), 7.26(2H,d, J = 8.2Hz), 3.79-3.52(2H,m), 3·50·3·25(2Η, in), 2·38( 3H,s), 2·38-2·25(1Η,ιη), 1·80(2Η,似 q)。 兹者例5 4(S)-甲基胺羧基- 4-(N-苄氧基羰胺基)丁酸第三丁 _ (謂先閱讀背面之注意事項再楨寫本頁)
π 部 中 ik il >7ί 合 卬 使用4(S) -羧基-4-(N -苄氧基羰胺基)丁酸第三丁 _及 甲胺,依實施例15所示方法相同操作,得具下列物性之摞 題化合物。 TLC : Rf 0 · 73 (氛仿:甲酵=9 : 1 ); NMR (CDC13) : δ 7.38-7.31 (5Η, m)7 6.24 (1H, m), 5.65 (1H, m), 5.10 (2H, s), 4.20-4.12 (1H, m), 2.81 (3H, d, J=5.0Hz), 2.49-2.24 (2H, m), 2.17-1.85 (2H, m), 1.44 (9H, s)〇 參者例6 本紙张尺度遍州中1¾國家標準(CNS ) Λ4規格(210X297公釐) 217 310112 568897 A7 B7 五、發明説明(21? 4(S)_甲基胺羰基-4-胺基丁酸第三丁酯
使用參考例5製造之化合物替代實施例26製造之化合 物,依實施例27所示方法相同操作,得具下列物性之標題 化合物。 TLC : Rf 0 · 28(氛仿:甲酵=9: 1 )。 奮淪例28 (翱先閱讀背面之注意事項再硝寫本頁)
十 -火 )i J 〉'/ί Λ 卬 使用參考例6製造之化合物替代參考例4製造之化合物 ,依實施例1所示方法相同操作,得具下列物性之摞題化 合物。 TLC: Rf 0.46(氛仿:甲酵=9:1)。 奮)fe例29 4(S)-甲基胺羰基- 4-(N-(4-甲基笨羰基)胺基)丁酸 本紙张尺度適;丨]中國國家標率(CNS ) Λ4規挣210X297公釐) 218 310112 568897 A7 B7 21 五、發明ii明
使用實施例28製造之化合物替代實施例13製造之化合 物,依實施例14所示方法相同操作,得具下列物性之標題 化合物。 TLC: Rf 0·40(氯仿:甲酵=9:1)。 NMR (dg-DMSO) : δ 12.13 (1Η,brs),8.33 (1Η,d,J=7.8Hz),7.86-7.78 (3Η, m), 7.26 (2H, d, J=8.1Hz), 4.40-4.25 (1H, m), 2.59 (3H, d, J=4.8Hz), 2.36 (3H, s), 2.30-2.23 (2H, m), 2.05-L82 (2H,m)。 簠施例29 (1 )〜29 使用對應之胺化合物替代甲胺化合物,依參考例54 參考例6·*·»實施例284實施例29所示方法相同操作,得下 列化合物。 啻渝例29 Μ ) 4(R)-甲基胺羰基-4-(Ν-(4-甲基苯羰基)胺基)丁酸 CH3 〜〇 0
TLC: Rf 0.20(氯仿:甲酵=5:1); * — -----------------------------------. NMR (CDCI3 + CD3QD) : δ 7.60-7.33 (2Η, m), 7.14-7.22 (2H, m), 4.52-4.66 (1H,m),2·76 (3H,s),2·30-2·56 (2H,m), 2·34 (3H,s),1·84-2·22 (2H,m)。 (誚先閱讀背面之注意事項再功寫本頁) s Λ 部 十 -失 i?. * • f : 合. 卬 1:; 本紙张尺度述W中國國家標率(CNS ) A4規格(210X297公釐) 219 310112 22568897 A7 B7 五、發明説明 奮_例29 (2) 4(S)-苄基胺羰基- 4-(N-(4-甲基苯羰基)胺基)丁酸
A
.T L C : R f 0 · 5 1 (氯仿··甲酵=4 : 1); NMR (dg-DMSO) : δ 12.10 (1Η, brs), 8.44 (2H, d, J=8.0Hz), 7.82 (2H, d, J=8.0Hz), 7.27-7.21 (5H, m), 4.49-4.40 (1H, m), 3.60 (1H, brs), 3.17 (2H, s), 2.36(3H, s),2.40-2.25 (2H, m), 2.20-1 ·95 (2H,m)。 奮_例29 (3) 4(S)-(4-羥基丁基)胺羰基-4-(N-(4-甲基苯羰基)胺 基)丁酸 (謂先閱讀背面之注意事項再楨寫本頁 衣· 訂
OH
部 屮 ik il 消 f: /-々 ii 印 TLC: Rf 0.33(氯仿:甲酵=4:1)。 管浦{例30 N-羥基-4(S)_甲基胺羰基- 4-(N-(4-甲基苯羰基)胺基 )丁醢胺 本紙张尺度適州屮國國家標準( CNS ) Λ4規格(210X297公釐) 220 310112 568897 A7 B7 2 2 lx 五、發明説明 ο Η
使用實施例29製造之化合物替代實施例2製造之化合 物,依實施例34實施例4所示方法相同操作,得具下列物 性之標題化合物。 TLC: Rf 0.69(氯仿:甲醇=4:1); NMR (dg-DMSO) : δ 10.37 (1Η, brs), 8.69 (1H, m), 8.43 (1H, d, J=7.6Hz), 7.85-7.79 (3H, m), 7.25 (2H, d, J=8.0Hz), 4.40-4.25 (1H, m), 2.59 (3H, d, J=4.6Hz), 2.06 (3H,s),2.10-1.85 (4H,m)。 奮 _ 例 30(1)〜3 0(3) 使用實施:例2 9 (1 )〜2 9 ( 3 )製造之化合物替代實施例 29製造之化合物,依實施例30所示方法相同操作,得下列 (謂先閱讀背面之注意事項再硝寫本頁) 物例 合淪 化奮 基 羥 基 羰 胺 基 甲 基 胺 \1/ 基 羰 苯 基 甲 胺 醢 ο
本紙張尺度通州中阔國家標準(CNS ).Α4規格(210Χ297公釐) ΤΖΊ ττσττζ 22568897 A7 B7 五、發明説明 TLC: Rf 0·30(氯仿:甲醇=10:1); NM R (CD3〇D) : 5 7.72 (2H, d, J=8Hz), 7.20 (2H, d, J=8Hz), 4.44-4.50 (1H, m),2·67 (3H,s),2.31 (3H,s), 2.22-1.85 (4H, m)。 富_例3 0 ( 2 ) N-羥基-4(S)_苄基胺羰基-4-(N-(4-甲基苯羰基)胺基 )丁醢胺
TLC: Rf 0.42(氯仿:甲酵=4:1)。 啻_例3 0 m N-羥基-4(S)-(4-羥基丁基)胺羰基-4-(N-(4-甲基苯 羰基)胺基)丁釀胺 (讀先閱讀背面之注意事項再功寫本頁 __ 消 fcii 卬
OH HO
TLC: Rf 0.23(氛仿:甲醇:乙酸=18:2:1); 本紙張尺度通川中國國家標準(CNS ) Λ4規格(210X297公釐) 222 310112 568897 A7 B7 22 五、發明说明 NMR (CDC13) : δ 7.74 (2Η, d, J=7.5Hz), 7.39 (1H, s), 7.25 (2H, d, J=7.5Hz), 4.60-4.43 (1H, m), 3.61-3.56 (2H, m), 3.31-3.15 (2H, m), 2.40 (3H, s), 2.30-2.04 (4H, m), 1.62-1.48 (4H,m)〇 奮_例3 1 4(S)-甲氧羰基-4-[Ν·[4-(4-四氫吡喃-2-基氧基)-1-丁基)苯羰基)胺基)丁酸第三丁酯 >r
〇J〇
(讀先閱讀背面.之注意事項再硝寫本1IC 部 中 •失 i?. 而 )i j 消 f: 合 卬 使用4(S)-甲氧羰基-4-胺基丁酸第三丁酷及對應之醢 鹵化物,依實施例1所示方法相同操作,得具下列物性之 檷題化合物。 TLC: Rf 0.35(正己烷•·乙酸乙酯=1:2); NMR (C〇a3) : s 7.78 (2H, d, J=8.4Hz), 7.44(2H, d, J=8.4Hz), 7.21 (3H, s), 3.70-3.50 (2H, m), 2.75 (2H, ζ J=6.9Hz), 2.42 (2H, m), 2.30-2.00 (2H, m), 2.00-1·50(6Η,m),1.42(9H,s)。 置施例3& 4(S) -甲氧羰基- 4-[N-[4-(4-羥基-1-丁炔基)苯羰基] 胺基]丁酸 本紙张尺度適州中國國家標率(CNS ) A4規格(210X 297公釐) 223 310112 22568897 A7 B7 五、發明説明(
使用實施例31製造之化合物替代實施例13製造之化合 物,依實施例14所示方法相同操作,得下列物性之標題化 合物。 TLC: Rf 0·11(正己烷:乙酸乙 _=1:1); NMR (CDCI3 + CD3OD) : δ 8.02 (1Η, d, J=7.6Hz), 7.77 (2H, d, J=8.6Hz), 7.44 (2H, d, J=8.6Hz), 4.82-4.70 (1H, m), 3.83-3.69 (5H, m), 2.68 (2H, t, J=6.6Hz), 2.41 (2H,U=6.6Hz), 2.26-1.99 (2H, m)。 啻倫例Μ N-羥基-4 (S)-甲氧羰基 苯羰基]胺基)丁醃胺 [H- [4- (4-羥基-1 -丁炔基) (讀先閱讀背面之注意事項再楨寫本頁) 部 屮
消 f: 卬 使用實施例32製造之化合物替代實施例2製造之化合 物,依實施例34實施例4所示方法相同操作,得具下列物 性之檷題化合物。 TLC: Rf 〇.30(氯仿:甲酵:乙酸=18:2:1); 本紙張尺度適州中调國家標準(CNS ) A4規格(210X297公釐) 224 310112 568897 A7 B7 五、發明説明(2 2今 NMR (d6-DMSO):孑 10.44 (1H, s), 10.20 (1H, s), 8.89 (1H, d, J=6.6Hz), 7.87 (2H, d, J=7.8Hz), 7.47 (2H, d, J=7.8Hz), 4.41 (1H, m)7 3.66 (3H, s), 3.65-3.59 (2H, m), 2·58 (2H,ζ J=6.6Hz),2.18-1.95 (2H,m),1.28-1.21 (2H,m)。 (詞先閱讀背面之注意事項再楨寫本頁} 置施例3 ·? m H-經基-4(R)-羰基-4-[N-[4-(3_甲氧基-卜丙炔基)苯 羰基]胺基]丁醢胺
使用4(R)-第三丁氧羰基-4-胺基丁酸甲簾與對應之醢 鹵化物,依實施例314實施例24實施例33->實施例14所 示方法相同操作,得具下列物性之檷題化合物。 TLC: Rf 0·18(氯仿:甲醇:乙酸:水=85:15:1:1); NMR (d6-DMS〇) : δ 7.86(2H, d, J=8.8Hz), 7.53(2H, d, J=8.8Hz), 4.54-4.59(1H,m),4.34(2H, s),3.43(3H,s),2·05-2·36(4Η,m)。 奮_俐3d
本紙张尺度適W中國國家標率(CNS ) Λ4規格(210X297_公釐) 225 310112 568897 A7 B7 22 五、發明説明 使用4(S) -第三丁氧羰基-4 -胺基丁酸苄酯及對應之釀 鹵化物,依實施例1所示方法相同操作,得具下列物性之 標題化合物。 TLC: Rf 0.19(正己烷:乙酸乙酯=4:1)。 例35 4(S)-第三丁氧羰基- 4-(N-(4-甲基苯羰基)胺基)丁酸
(讀先閱讀背面之注意事項再功寫本頁 > ,> 部 '1, •λ il 消 Xvii 卬 使用實施例34製造之化合物替代實施例26製造之化合 物,依實施例27所示方法相同操作,得具下列物性之標題 化合物。 TLC : Rf 0.38(氛仿:甲酵=5:1); NMR (CDa3) : S 7.70 (2H, d, J=8.2Hz), 7.22 (2H, d, J=8,2Hz), 6.97 (1H, d, J=7.5Hz), 4.71 (1H, m), 2.47 (2H, m), 2.38 (3H, s), 2.28 (1H, m), 2.05 (1H, m), 1.49 (9H, s)〇 窨例36 N-羥基- 4(S)_羧基-4 -(N-(4-甲基苯羰基)胺基)丁醢 胺
HO^ JO
、1T
Jm ▲队張又度ii瓜中風國家標率(C>TS ) Μ規格U10X297公釐) 226 310112 568897 22 A7 B7 五、發明説明 使用實施例35製造之化合物替代實施例2製造之化合 物,依實施例34實施例14所示方法相同操作,得具下列 物性之標題化合物。 TLC: Rf (K43(乙酸乙酯:乙酸:水=8:1:1); NM R (CD3OD) : d 7.78 (2H, d, J=8.0Hz), 7.28 (2H, d, J=8.0Hz), 4.56 (1H, m), 2.40 (3H, s),2.00-2.38 (4H,m)。 奮淪例37 (謂先閱讀背面之注意事項再填寫本頁) 4(S)_羧基-4-(H-(4-(苯并呋喃-2-基)苯羰基)胺基) 丁酸甲酿 CH30
•λ 消 f: 合 卬 使用4(S)-羧基-4-胺基丁酸甲酯及參考例4製造之化 合物,依實施例1所示方法相同操作,得具下列物性之標 題化合物。 TLC: Rf 0.64(氯仿:甲醇:乙酸=18:2:1); NMR (CD3OD) : δ 12.74 (1Η, brs), 8.74 (1H, d, J=7.8Hz), 8.04 (4H, s), 7.71-7.58 (3H, m), 7.42-7.26 (2H, m), 4.45 (1H, m), 3.60 (3H, s), 2.51-2.44 (2H, m), 2.26-1.96 (2H,m)〇 y淪例38 4(S)-(嗎啉-1-基)羰基-4-(H-(4-苯并咲喃-2-基)笨 羰基)胺基)丁酸 Ρϋ支通州中國國家標準(CNS ) Λ4規格(21〇>< 297公釐) 227 310112 22568897 A7 B7 五、發明説明
使用實施例37製造之化合物替代實施例14製造之化合 物,依實施例154實施例16所示方法相同操作,得具下列 物性之標題化合物。 TLC: Rf 0.48(氯仿:甲酵=4:1); NMR (d6-DMS0) : δ 12.23 (1Η, brs), 8.72 (1H, d, J=8.0i iz)? 8.05-8.01 (4H, m), 7.74-7.58 (3H, m), 7.42-7.24 (2H, m), 5.03-4.86 (1H, m), ).63.3.45 (gH, m), 2.37 (2H? ζ J=7.0Hz), 2.04-1.84 (2H, m)〇 g _ 例 39 4(S)-羥基甲基-4-(H-(4-苯并呋喃-2-基)苯羰基)胺 基)丁酸甲酯 (許先閱讀背面之注意事項再硝寫本IIC } 、'ΐ η'\ 部 屮 •火 il 導 消 f 合 Μ 卬 CH3〇
含實施例37製造之化合物(5.7克)之四氫呋喃(30毫升 )溶液中,在0 υ下添加Η -羥琥珀醯胺(2 · 2克)及二環己基 羰二醢胺(4.01克)。反應混合物在0¾攪拌5小時。反應混 合物經過濾,在0*1〇下濾液中添加硼氫化納(119克)及水( 本紙张尺度述州中國國家標準(CNS ) Λ4規格(210X297公釐) 228 310112 568897 A7 B7_____ -—-— - --· —·♦“· —»-— *- -- · — 五、發明说明(2 2' 5毫升)。反應混合物在室溫搅拌30分鐘。反應混合物中添 加飽和氯化銨水溶液,以乙酸乙酿萃取。萃取液以飽和氯 化納水溶液洗淨,以無水硫酸鎂脫水、濃縮,得具下列物 性之標題化合物(4.89克)° TLC: Rf 0.21(正己烷:乙酸乙 _=3:7); NMR (d6-DMS〇) : δ 8.14 (1Η, d, J=8.4Hz), 7.99 (4H, s), 7.72-7.60 (2H, m), 7.55 (1H? dt J=0.8Hz), 7.40-7.24 (2H, m), 4.75 (1H, t, J=5.8Hz), 4.10-3.90 (1H, m), 3·56 (3H,s), 3·55-3·39 (2H,m),2.36 (2H,ζ J=7.4Hz), 2.06-1.62 (2H,m)。 窗瀹例40 4(S)_羥基甲基- 苯并呋喃基)笨幾基)胺 基)丁酸 (讀先閱讀背面之注意事項再硝寫本頁)
使用實施例39製造之化合物替代實施例1製造之化合 物,依實施例2所示方法相同操作,得具下列物性之裸題 部 中 •λ 消 IV 合 卬 V. 化合物。 TLC: Rf 0.33(氯仿:甲酵:乙酸=190:10:1); NMR (dg-DMSO) : δ 12.10-11.90 (1Η, br), 8.14 (1H, dy J=8.8Hz), 8.00 (4H, s), 7.73-7.60 (2H, m), 7.55 (1H, s), 7.41-7.22 (2H, m)? 4.80-4.64 (1H, m), 4.10-3.90 (1H,m),3·54-3·35 (2H,m), 2.28 (2H,ζ J=6.8Hz), 2.02-1,60 (2H, m)。
奮 MS M4JL >紙张尺度適州中國國家標率(CNS ) Λ4規格(210X297公釐) 229 310112 568897 A7
B 明 見 、=?·明 义又 \ 五 基 甲 基 氧 基酯 甲甲 基酸 氧丁 甲基 )-胺 S ), 4(基 羰 苯 基 * 2- 喃 呋 并 苯
ο
製氧合 7化 用趙 W使標 但 之 代(ί 性 替作U 物 物操Μ 合同爿 下 化相II 之法II 得 造方 製示 } 39所氯 例10基 施例甲 實施基 用實氧 使依苄 , 代 物替 合氯 化基 之甲 造基 物 (銷先閱讀背面之注意事項再蛾泠本頁) -λ il 消 f: 卬 ί: TLC: Rf 0.65(正己烷:乙酸乙 _=3:7); NMR (C〇a3):d 7.94 (2H, d, J=8.8Hz), 7.87 (2H, d, J=8.8Hz)7.64-7.50 (2H, m), 7.38-7.21 (2H,m),7· 13 (1H,d,J=0.8Hz),6·78 (1H, d, J=7.8Hz), 4·67 (2H,s), 4.46-4.28 (1H, m), 3.78 (1H, dd, J=10.2, 3.4Hz), 3.65 (lHt dd? J=10.2, 4.4Hz), 3.64 (3H,s),3·39 (3H, s), 2.62-2.38 (2H,m), 2.16-2.00 (2H,m)。 謇淪俐A?. 4(S)-甲氧基甲基氧基甲基-4-(NM4-苯并呋喃-2-基) 苯羰基)胺基)丁酸
I 0^ 〇
本紙琢尺度遥州中囤國家標準((^5)六4規格(210\ 297公釐) 2 30 310112 568897 A7 ___ _ B7 五、發明説明(231 使用實施例41製造之化合物替代實施例i製造之化合 物,依實施例2所示方法相同操作,得具下列物性之檷題 化合物。 TLC: Rf 0·19(氯仿:甲酵=19:1); NMR (d6-DMSO) : δ 12.02 (1Η, s), 8.30 (1H, d, J=8.2Hz), 8.00 (4H, s), 7.73-7.60 (2H, m), 7.56 (1H, s), 7.41-7.22 (2H, m), 4.58 (2H, s), 4.26-4.08 (1H, m), 3.62-3.42 (2H, m), 3.32 (3H, s), 3.26 (3H, s), 2.29 (2H, t, J=6.8Hz), 2.02-1.62 (2H, m)〇 奮施例43 2(S)-苄基-4(S)-甲氧基甲基氧基甲基- 4_(N-(4_苯并 呋喃-2-基)苯羰基)胺基)丁酸甲酯 (許先閱讀背面之注意事項再硝寫本頁) η
於含1·0Μ雙(三甲基砂焼基)醣胺鋰之四氧咲喃溶液( 0.695奄升)之四氫呋喃(5奄升)溶液中,在-78<〇下,添加 含實施例41製造之化合物(0.474克)之四氫呋喃(5奄升)溶 液。混合物於-78它攪拌1小時後,添加苄基溴(0.113毫升 )。反應混合物在'7 8t!攪拌3小時。反應混合物中添加飽 和氛化銨水溶液,以乙酸乙_萃取。萃取液以飽和氯化納 本紙iR尺度速州中囤國家標準(CNS ) /\4規格(210X297公釐) 231 310112 568897 A7 B7 _____ 五、發明説明(23j 3.38 (3H, s), 2.70-2.50 (1H, m), 2.23 (1H, ddd, J=14.0, 11.0, 8.2Hz), 1.72 (1H, ddd, J=14.0, 6.0, 4.4Hz), 1.30 (3H, d, J=6.8Hz)〇 (讀先閱讀背面之注意事項再硝寫本頁) 奮施例44 f 2) 2(S)-(3 -苯基-2 -丙烯基>-4(S)_甲氧基甲基氧基甲基 -4-(N-(4-(苯并呋喃-2-基)苯羰基)胺基)丁酸
TLC : Rf 0 · 44 (正己烷:乙酸乙 _ =3 : 7); NMR (dg-DMSO) : δ 12.23 (1Η, s)? 8.34 (1H, d? J=8.4Hz), 8.00 (4H, s), 7.74-7.61 (2H, m), 7.57 (1H, s), 7.41-7.18 (7H, m), 6.43 (1H, d, J=15.6Hz), 6.20 (1H, dt, J=15.6, 6.4Hz), 4.57 (2H, s), 4.40-4.20 (1H, m), 3.62-3.48 (2H, m), 3.23 (3H,s),2.60-2,40 (3H,m), 1.92-1.80 (2H,m)〇 3 /( 4 4 例 管
丙 基 苯喃 A咲 /IV I 并 S)苯 /IV /1* 2 * 4 /V - N 2 基 甲 基 氧 基 甲 基 氧 甲 I S /V 赚 4 麵 )/ 基 4 酸 丁 \—/ 基 胺 \—/ 基 羰 苯 \1/ 基 •本紙张尺度述州中國國家標準(CNS ) Λ4規格(210X.297公t ) 234 310112 568897 A7 R7 --------------------——------------------------- --------------- 五、發明説明(2
(誚先閱讀背面之注意事項再填寫本頁) TLC: Rf 0.44(正己烷:乙酸乙 =3:7); NMR (CDC13) : 7.85 (2H,d,J=8.8Hz),7·79 (2H,d,J=8.8Hz),7.60-7.44 (2H,m),7·34-7·06 (7H, m),7.03 (1H,d,J=0.8Hz),6·69 (1H,d,J=8.8Hz),4·62 (1H, d, J=8.8Hz), 4.60 (1H, d, j=8.8Hz), 4.48-4.28 (1H, m), 3.73 (1H, dd, J=10.2, 3.4Hz), 3.59 (1H, dd7 J=10.2, A 〇Hz)? 3.34 (3H, s), 2.68-2.42 (3H, m), 2.21-2.00 (1H, m), 1.86-1.52 (5H,m)。
置Jfe 例 4AiJLL 2(S) -甲基-5-乙氧基甲氧基-4(S)-[N-(4-氯苯羰基) 胺基)戊酸 och2ch3
TLC: Rf 0.46(氯仿··甲酵=9:1); 张尺度述州中國國家標率(CNS ) A4規格(210X 297公釐) 235 310 1 1 2 23568897 A7 B7 五、發明説明 NM R (d6-DMS0) : δ 12.06 (1Η, s), 8.24 (1H, d, J = 8.7Hz), 7.83 (2H, d, J = 8.4Hz), 7.51 (2H, d, J = 8.4Hz), 4.57 (2H, s), 4.24-4.13 (1H, m), 3.52-3.42 (4H, m), 2.37-2.25 (1H, m), 1.92-1.80 (1H, m), 1.63-1.52 (1H, m), 1.06 (3H, t, J = 6.9Hz), 1.05 (3H, d, J = 6.9Hz)〇 奮_例44 (5) 2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-(4-硝基苯羰基 )胺基]戊酸 〇CH2CH3
N〇2 (讀先閱讀背面之注意事項再填寫本頁) •11^衣. 訂 TLC: Rf 0.45(氯化甲烷:甲酵=9:1); NM R (CDC13) : δ 8.27 (d, J = 9.0Hz, 2H), 7.96 (d, J = 9.0Hz, 2H), 6.89 (brd, J = 9.0Hz, 1H), 4.73 (d, J = 7.0Hz, 1H), 4.68 (d, J = 7.0Hz, 1H), 4.40 (m, 1H)? 3.78 (dd, J = 10.6, 3.2Hz, 1H), 3.68-3.55 (m, 3H), 2.55 (m, 1H)7 2.16 (ddd, J = 14.4, 10.2, 7·6Ηζ,1H),1·70 (ddd, J = 14.4, 5.8, 5·0Ηζ,1H), 1.28 (d,J = 7·0Ηζ,3H), 1.20 a J =7.0Hz, 3H)〇 、0 /Γ, 部 中 -火 實施例4 4 ( ft) 2(S) -甲基-5 -乙氧基甲氧基-4(S)-[N-(4 -溴苯羰基) 胺基)戊酸 消 f: 竹 印 本紙张尺度通州中國國家標率(CNS ) Λ4規格(210X297公釐) 236 310112 568897 A7 B7 五、發明説明 237 ,OCH2CH3 η
Br TLC: Rf 〇·47(二氛甲烷··甲醇=9:1); NMR (0)03) : δ 7.65 (d, J = 8.8Hz? 2H), 7.54 (d, J = 8.8Hz, 2H), 6.67 (brd, J = 9.2Hz, 1H), 4.72 (d, J = 7.0Hz, 1H), 4.67 (d, J = 7.0Hz, 1H)? 4.40 (m, 1H), 3.75 (dd, J = 10.4, 3.2Hz, 1H), 3.66-3.55 (m, 3H), 2.55 (m, 1H), 2.16 (ddd, J = 14.4, 10.2, 7.6Hz, 1H)? 1.70 (ddd, J = 14.4, 6.6, 4.8Hz? 1H), 1.27 (d? J = 7.0Hz, 3H), 1.20 (ζ J =7.0Hz, 3H)〇 奩牖例44 (7 ) 2(S)-烯丙基-5-乙氧基甲氧基-4(S)-[N-(4-硝基苯羰基 )胺基]戊酸 (讀先閱讀背面之注意事項再楨寫本頁} 部 中 •火 消 竹 卬 f.
N〇2 TLC: Rf 0 · 31 (氯仿:甲酵=9:1); NM R (CDC13) : S 8.25 (d, J = 8.7Hz? 2H), 7.94 (d, J = 8.7Hz, 2H), 6.92 (d, J =8.7Hz, 1H), 5.82-5.68 (mt 1H), 5.14-5.06 (m, 2H), 4.73 (d, J = 6.9Hz, 1H), 4.68 (d, J = 6.9Hz, 1H), 4.45-4.32 (m, 1H), 3.79 (dd, J = 10.2, 3.3Hz, 1H), 3.66-3.56 (m, >、紙張尺度適州中國國家標率(CNS ) A4規格(.21 OX 297公釐) 237 310112 568897 A7 B7 五、發明说明( 3H), 2.63-2.31 (m, 3H), 2.14-2.03 (m, 1H), 1.82 (dt, J = 14.1, 5.4Hz, 1H), 1.20 (t J =7.2Hz, 3H)〇 g濂例44 (8) (讀先閱讀背面之注意事項再填寫本頁) 2(R)_甲氧基甲基-5-乙氧基甲氧基-4(s)-[H-(4-硝基 笨羰基)胺基]戊酸 .och2ch3
TLC: Rf 0·24(氯仿:甲酵=19:1);
NMR (CDCI3) : δ 8.25 (d, J = 8.7Hz, 2H), 7.95 (d, J = 8.7Hz, 2H), 7.11 (d, J =8.4Hz, 1H), 4.73 (d, J = 5.7Hz, 1H), 4.67 (d, J = 5.7Hz, 1H), 4.42-4.31 (m, 1H), 3.80 (dd, J= 10.2, 3.3Hz, 1H), 3.69-3.57 (m, 5H), 3.39 (s, 3H), 2.82-2.70 (m, 1H), 2.17 (ddd, J = 14.4, 10.2, 8.1Hz, 1H), 1.88 (dt, J = 14.4, 5.1Hz, 1H), 1.20 (t, J = 7.2Hz, 3H)〇
-本纸张尺度適州中國國家標率(CNS ) A4規格(21〇X2?7公釐) 2 3 8 31 01 1 2 568897 A7 B7 五、發明说明(233 TLC: Rf 〇.41 (氯仿:甲醇=19:1); NMR (CDC13) : δ 8.24 (d, J = 8.8Hz, 2H)t 7.93 (d? J = 8.8Hz, 2H), 7.41-7.20 (m, 5H), 7.01 (d, J = 8.8Hz, 1H), 4.72 (d, J = 7.4Hz, 1H), 4.67 (d, J = 7.4Hz, 1H)? 4.57 (s, 2H), 4.43-4.25 (m, 1H), 3.82-3.52 (mt 6H), 2.89-2.70 (m, 1H), 2.19 (ddd, J =14.8, 10.2, 8.0Hz, 1H), L70 (dt, J = 14.8, 5.0Hzt 1H), 1.19 (t, J = 7.0Hz, 3H)〇 ^ fill 44 (10L· 2(S)_甲基- 5-(2-甲氧基乙氧基)甲氧基_4 (S) - [N_ (4 氰基苯羰基)胺基]戊酸 (讀先閱讀背面之注意事項再頊寫本頁) 0、^och3
CN ;1l; -,屮 中 .失 而 ]1 ,τ 消 f 竹 卬 t: TLC: Rf 0.40(氯仿:甲酵=19:1); NM R (CDa3) : δ 7.91 (d, J = 8.4Hz, 2H), 7.70 (d, J = 8.4Hz, 2H), 7.07 (d, J =9·0Ηζ,1H),4.75 (d, J = 6.9Hz,1H),4.70 (d,J = 6·9Ηζ,1H),4.45-4.34 (m,1H), 3.84 (dd, J = 10.5, 3.3Hz, 1H), 3.78-3.60 (m, 3H), 3.54-3.51(m? 2H), 3.29 (s, 3H), 2.61-2.49 (m, 1H), 2.15 (ddd, J = 14.1, 10.2, 7.5Hz? 1H), 1.70 (ddd, J = 14.1,6.6, 5.1Hz, 1H), 1.20 (d, J = 6.9Hz, 3H)〇 考淪例44 (1 1 ) 2 (R) - (2-甲氧基乙氧基)甲基 [N-(4-硝基苯羰基)胺基]戊酸 乙氧基甲氧基-4 (S) 本紙張尺度適州中國國家標率(CNS ) Λ4規格(210X 297公釐) 239 310112 568897 A7 24' 五、發明说明
HaCO^^ ,OCH2CH3
T L C : R f 0 · 1 7 (氯仿:甲酵=1 9 : 1); NMR (CDCI3) : δ 8.26 (d, J = 8.8Hz, 2H), 7.97 (d, J = 8.8Hz, 2H)7 7.08 (d, J =8.8Hz, 1H), 4.75-4.62 (m, 2H), 4.44-4.28 (m, 1H), 3.82-3.48 (m, 10H), 3.37 (s, 3H), 2.90-2.66 (m, 1H), 2.21 (ddd, J = 14.4, 10.0, 8.6Hz, 1H), 1.92 (dt, J = 14.4, 4.8Hz, 1H), 1.20 (t, J =7.0Hz? 3H)〇 奮嫵例4 4 (1 2 ) 2(S)-(2-丙炔基)-5-乙氧基甲氧基-4(S)-[N-(4-硝基 苯羰基)胺基]戊酸 N〇2 (¾先閱讀背面之注意事項再填寫本頁) /Γ; 部 屮 t 消 t: 合 竹 卬 TLC: Rf 0.30(氯仿··甲酵=9:1); NM R (CX)a3) : δ 8.28 (d, J = 9.0Hz, 2H), 7.96 (d, J = 9.0Hz, 2H), 6.98 (d, J =8.7Hz, lH), 4.75 (d, J = 6.9Hz, 1H), 4.70 (d, J = 6.9Hz, 1H), 4.50-4.38 (m, 1H), 3.84 (dd, J = 10.5, 3.0Hz, 1H), 3.70-3.55 (m, 3H), 2.80-2.40 (m, 3H), 2.28-2.10 (m, 1H), 2.10-L95 (m,2H), 1·21 (U = 7.2Hz,3H)。 窨施例4 4 (1 :n 本紙張尺度通州中國國家標率(CNS ) Λ4規格(210X297公釐) 2 40 310112 568897 A7 B7 •πU___ f 丨·-· ··« 一 _»· 一 一一,. · . —. . 一. 一.—' -----一-一‘一 •…一 _ 丨丨麵· 一 .一-,,,丨·,,·· , _____ 五、發明説明I ί 2(S)_烯丙基-5-(2-甲氧基乙氧基)甲氧基-4(s)_[N-( 4-氰基苯羰基)胺基]戊酸
〇CH3 TLC: Rf 〇· 26 (氯仿:甲酵=19:1);
NMR (CDCI3) : δ 7.90 (d, J = 8.4Hz, 2H), 7.71 (d, J = 8.4Hz, 2H), 7.10 (d, J =9.0Hz, 1H), 5 82-5.66 (m, 1H), 5.16-5.03 (m, 2H), 4.75 (d, J = 6.9Hz, 1H), 4.70 (d, J = 6.9Hz, 1H), 4.38 (m, 1H), 3.85 (dd, J = 10.5, 3.6Hz, 1H), 3.80-3.58 (m, 3H), 3.54 (ζ J = 4.5Hz, 2H), 3.31 (s, 3H), 2.62-2.50 (m, 1H), 2.49-2.30 (m, 2H), 2.07 (dt, J = 14.4, 9.0Hz, 1H), 1.83 (dt, J = 14.4, 5.4Hz, lH)〇 *s m m AA (^ A) 2(S) -甲氧基甲基-5-(2 -甲氧基乙氧基)甲氧基- 4(S) [N-(4-氰基苯羰基)胺基]戊酸 (讀先閱讀背面之注意事項再填寫本頁) H 部 中 h3co 〇〇hV^^Ol
CN 消 合 竹 卬 TLC : Rf 0.35(氯仿:甲酵=9:1 本紙张尺度適W中囤國家標準(C、NS ) Λ4規格~( 210X297公釐〉 241 310112 24568897 A7 B7 五、發明説明 NM R (CD3OD) : ί 7.94 (d,J = 8.7Hz,2H),7·82 (d,J = 8·7Ηζ,2H),4.71(d,J =6.6Ηζ? 1Η), 4.68 (d, J = 6.6Hz, 1H), 4.39-4.31 (m, 1H), 3.68-3.49 (m, 8H), 3.32 (s, 3H),3·31 (s,3H),2.76-2.66 (m,1H),2.08-1.86 (m,2H)〇 奩淪例44 (15L 2(S)-(2-丙炔基)-5-乙氧基甲氧基-4(S>-[H-(4-溴苯 羰基)胺基]戊酸
TLC: Rf 0.36(氣仿:甲醇=9:1); NM R (CDC13) : δ 7.64 (d, J = 8.6Hz, 2H), 7.54 (d, J = 8.6Hz, 2H);*6.82 (d, J =9.0Hz, 1H), 4.72 (d, J = 6.9Hz, 1H), 4.69 (d, J = 6.9Hz, 1H), 4.50-4.35 (m, 1H), 3.80 (dd, J = 10.4, 3.2Hz, 1H), 3.70-3.55 (m, 3H), 2.78-2.45 (m, 3H), 2.25-2.10 (m, 1H), 2.10-1.95 (m, 2H), 1.20 (t, J = 7.2Hz, 3H)〇 (讀先閱讀背面之注意事項再楨寫本頁) 部 中 •火 i?· t: 合 卬 f 窨)fe 例 44 ( 1 fn 2(S)M2-丙炔基)-5-乙氧基甲氧基-4(S)-[N-(4-氣苯 羰基)胺基]戊酸
CI 本紙張尺度述W中國國家標準(CNS ) Λ4規格(210X 297公釐) 242 310112 568897 24; A7 B7 五、發明说明 TLC: Rf 0.36(氯仿:甲酵=9:1);
NMR (CDQ3) : S 7.71 (d, J = 8.7Hz, 2H), 7.38 (d, J = 8.7Hz, 2H), 6.81 (d, J =8.7Hz, 1H), 4.73 (d, J = 6.8Hz, 1H), 4.69 (d, J = 6.8Hz, 1H), 4.50-4.35 (m, 1H), 3.80 (dd, J = 10.2, 3.0Hz, 1H), 3.70-3.55 (m, 3H), 2.78-2.45 (m, 3H), 2.25-2.10 (m, 1H), 2.10-1.95 (m,2H),1.20 (t,J = 7.2Hz, 3H)。 V m m AA (Π) 2(R)_甲氧基甲基-5-乙氧基甲氧基-4(S)-[N-(4 -溴苯 羰基)胺基]戊酸 ^och2ch3
Br TLC:Rf 0.39(氯仿·•甲酵=9:1); NMR (CD3OD) : S 7.73-7.69 (m , 2H), 7.65-7.59 (m, 2H), 4.67 (s, 2H), 4.37-4.28 (m, 1H), 3.63-3.53 (m, 6H), 3.32 (s, 3H), 2.75-2.64 (m,lH), 1.96-1.89 (m, 2H), 1.15 (t, J = 7.2Hz, 3H)〇 -----.---«衣------1T------Φ (讀先閱讀背面之注意事項再填寫本頁) 部 中 火 i). f- 合· 印 f 奮嫵例44 (18) 2 (R)-甲氧基甲基 羰基)胺基]戊酸 乙氧基甲氧基-4(S)-[N-(4 -氛苯
C1 削7國國家標率(rNS ) M規格(210X297公襲) 243 310112 568897 A7 B7 24 五、發明说明 TLC: Rf 0.32(氯仿:甲醇=9:1); NMR (CD3〇D) : δ 7.78 (d, J = 8.7Hz, 2H), 7.45 (d, J = 8.7Hz, 2H), 4.66 (s, 2H), 4.37-4.27 (m, 1H), 3.63-3.54 (m, 6H), 3.32 (s, 3H), 2.74-2.62 (m, 1H), 1.97-1.88 (m, 2H),1.15 (t,J = 7·2Ηζ,3H)。 審淪俐44 (1 9) 2(R)_苄氧基甲基-5(2 -甲氧基乙氧基)甲氧基- 4(S)-[ N-(4-氰基笨羰基)胺基]戊酸 r 〇x-^och3
CN (翱先閱讀背面之注意事項再楨寫本頁) 部 中 -火 H η _τ 消 A A 卬 1'; TLC: Rf 0.48(二氛甲烷:甲醇=9:1); NMR (CDC13) : i 7.87(d,J = 8.4Hz,2H),7.67(d,J = 8.4Hz,2H), 7.31(m, 5H), 7.16 (brd, J = 9.0Hz, 1H), 4.74 (d, J =: 7.2Hz, 1H), 4.69 (d, J = 7.2Hz, 1H), 4.55 (s, 2H), 4.34 (m, 1H), 3.83 (dd, J= 10.2, 3.6Hz, 1H), 3.77-3.66 (m, 4H), 3.62 (dd, J = 10.2? 4.2Hz, 1H), 3.51 (t, J =4.5Hz? 2H), 3.29 (s? 3H), 2.79 (m, 1H), 2.15 (ddd, J = 14.1, 9.6, 7.5Hz, 1H), 1.91 (ddd, J = 14.1, 5.4, 5.4Hz, lH)〇 y 濂例 44 (20) 2(R) -苄氧基甲基-5 -乙氧基甲氧基-4(S)-[H-(4 -氯笨 羰基)胺基]戊酸 本紙張尺度適州中國國家標率(CNS ) A4規格(210X297公釐) 244 310112 568897 A7 B7 五、發明説明 24! ,och2ch3
屮 -失 i?. -Τ 消 f: A ,och2ch3
Cl TLC: Rf 0.50(二氯甲烷:甲酵=9:1); NMR (CDCI3) : 5 7.69 (d,J = 8·8Ηζ,2H),7.35 (d,J = 8·8Ηζ,2H),7.31 (叽 5Η), 6.81 (brd, J = 8.8Hz, 1H), 4.70 (d, J = 7.5Hz, 1H), 4.66 (d, J = 7.5Hz, 1H), 4.55 (s, 2H), 4.33 (m, 1H), 3.80-3.50 (m, 6H), 2.80 (m, 1H), 2.15 (ddd, J =-14.2, 9.8, 7.6Hz, 1H), 1.89 (ddd, J = 14.2, 5.2, 5.2Hz, 1H), 1.17 (t? J = 7.4Hz, 3H)〇 窨)fe例“ m、 , 2(R)-苄氧基甲基-5-乙氧基甲氧基- 4(S)-[N-(4-溴苯 羰基)胺基]戊酸
Br TLC: Rf 〇·50(二氯甲烷:甲酵=9:1); NMR (CDCI3) : δ 7.62 (d, J = 8.8Hz, 2H), 7.51 (d, J = 8.8Hz, 2H), 7.31 (m, 5H), 6.81 (brd, J = 8.8Hz, 1H), 4.70 (d, J = 7.0Hz, 1H), 4.65 (d, J = 7.0Hz, 1H), 4.54 (s, 2H), 4.33 (m, 1H), 3.80-3.50 (m, 6H), 2.79 (m, 1H), 2.15 (ddd, J = 14.2, 9.8, 7.6Hz,1H), 1.89 (ddd,J = 14.2, 5.2, 5.2Hz,1H),U8 (t,J = 7·4Ηζ, 3H)〇 (誚先閱讀背面之注意事項再填荇本頁) . i 本紙张尺度適州中國國家標準(CNS ) Λ4規格(210X297公釐) 245 310112 568897 A7 Β7 五、發明説明(’ g 餱例 44 (22 ) 2(S)_烯丙基-5-乙氧基甲氧基-4(S)-[N-(4 -溴苯羰基 )胺基]戊酸 ,och2ch3
(讀先閱讀背面之注意事項再填寫本lic ) TLC : Rf 0·43 (氯仿:甲酵=9:1);
NMR (CDC13) : 5 7.63 (d,J = 8.7Hz,2H),7.53 (d,J = 8·7Ηζ,2H),6.72 (d,J =9.0Hz, 1H), 5.83-5.65 (m, 1H), 5.18-5.02 (m, 2H), 4.71 (d, J = 6.8Hz, 1H), 4.67 (d," J = 6.8Hz, 1H), 4.45-4.30 (m, 1H), 3.76 (dd, J = 10.4, 3.2Hz, 1H), 3.70-3.50 (m, 3H), 2.62-2.50 (m, 1H), 2.50-2.25 (m, 2H), 2.18-2.00 (m, 1H), 1.81 (td, J= 14.1, 5.1Hz, 1H), 1.20 (t, J = 7.1Hz, 3H)〇 富 _ 例 4 4 ( 2 3) 2(S)-烯丙基-5-乙氧基甲氧基- 4(S)-[N-(4-氯苯羰基 )胺基]戊酸 Μ. N 部 中 ik ;ι'ί 竹
CI TLC: Rf 0·45(氯仿:甲酵=9:1); λ本紙俅尺度適州中國國家標隼(CNS ) Λ4規格( 210X 297公釐) 246 310112 568897 A7 B7 五、發明说明(245
NMR (CDC13) : S 7.70 (d, J = 8.7Hz, 2H), 7.38 (d, J = 8.7Hz, 2H), 6.73 (d, J =9.0Hz, 1H), 5.82-5.65 (m, 1H), 5.18-5.02 (m, 2H), 4.71 (d, J = 6.8Hz, 1H), 4.67 (d, (¾先閱讀背面之注意事項再蛾寫本頁) J = 6.8Hz, 1H), 4.45-4.30 (m, 1H), 3.76 (dd, J = 10.5, 3.3Hz, 1H), 3.70-3.50 (m, 3H), 2.62-2.50 (m, 1H), 2.50-2.25 (m, 2H), 2.18-2.00 (m, 1H), 1.81 (td, J = 14.1, 5.3Hz, 1H), 1.20 (t, J = 6.9Hz, 3H)〇
V m m 44 (24L 2(R)-(2 -甲氧基乙氧基)甲基-乙氧基甲氧基_4(S)_ [H-(4 -溴苯羰基)胺基]戊酸 h3c〇^ rOCH2CH3
TLC: Rf 0.41(氛仿:甲醇=9:1);
NMR (CDa3) : δ 7.65 (d, J = 8.8Hz, 2H), 7.54 (d, J = 8.8Hz, 2H), 6.85 (d, J =8.8Hz? 1H), 4.70 (d, J = 7.0Hz, 1H), 4.66 (d, J = 7.0Hzt 1H), 4.42-4.27 (m, 1H), 3.78-3.50 (m, 10H), 3.35 (s, 3H), 2.83-2.70 (m, 1H), 2.18 (ddd, J = 14.0, 9.8, 7.0Hz, 1H),1.82 (ddd,J = 14·0, 5·6, 4·4Ηζ,1H), 1.18 (t,J = 7·4Ηζ,3H)。 餱例 4 4 ( 2 5J_ 2(R)-(2-甲氧基乙氧基)甲基- 5-(2-甲氧基乙氧基)甲 氧基-4(S)-[N-(4-氰基笨羰基)胺基]戊酸
&^^^]中國國家標率(〔呢)八4規格(210>< 297公釐) 247 310112 568897 A7 ______________________ _ B7 五、發明説明(24, TLC: Rf 0·16(氯仿:甲醇=19:1); NMR (CDCI3) : S 7.91 (d, J = 8.4Hz, 2H), 7.71 (d, J = 8.4Hz, 2H), 7.20 (d, J =8.7Hz, 1H), 4.75 (d, J = 6.9Hz, 1H), 4.70 (d? J = 6.9Hz? 1H), 4.42-4.31 (m, 1H), 3.84 (dd, J= 10.5, 3.9Hz, 1H), 3.78-3.60 (m, 7H), 3.57-3.50 (m, 4H), 3.36 (s, 3H), 3.32 (s,3H),2.82-2.72 (叽 1H),2.18 (ddd,J = 14.4, 10.2, 7.2Hz,1H), 1.85 (吡 J = / 14.4, 5.7Hz,1H)0 1L施例 44 f2fi) 2(R)-2-甲氧基乙氧基)甲基-5-乙氧基甲氧基-4(S)-[ N_(4-氯苯羰基)胺基]戊酸 ^〇CH2CH3
(讀先閱讀背面之注意事項再"寫本石C )
Cl TLC: Rf 0.31(氯仿:甲醇=9:1);
NM R (CDCI3) : δ 1Π2 (d, J = 8.8Hz, 2H), 7.39 (d, J = 8.8Hz, 2H), 6.84 (d, J =9.0Hz, 1H), 4.70 (d, J = 7.0Hz, 1H), 4.66 (d, J = 7.0Hz, 1H), 4.43-4.27 (m, 1H), 3.78-3.50 (m, 10H), 3.35 (s, 3H), 2.82-2.69 (m, 1H), 2.19 (ddd, J = 14.4, 10.6, 7.4Hzt 1H), 1.82 (ddd, J= 14.4, 5.6, 4.4Hz, 1H), 1.19 (t? J = 7.2Hz, 3H)〇 當淪例4 4 ( 7 ) 2(S)-(2-丙炔基)-5-(2-甲氧基乙氧基)甲氧基-4(S) [N-(4-氰基苯廣基)胺基]戊酸 本紙張尺度適州中國國家標準((、NS ) A4規格(210X297公釐) 248 310112 568897 A7 B7
五、發明説明(I
(讀先閱讀背面之注意事項再楨寫本頁} TLC: Rf 0.37(氯仿:甲醇=9:1); NMR (CDCI3) : S 7.92 (d, J = 8.7 Hz, 2H), 7.69 (d, J = 8.7 Hz, 2H), 7.17 (d, J = 9.0 Hz, 1H), 4.77 (d, J = 7.1 Hz, 1H), 4.71 (d, J = 7.1 Hz, 1H), 4.48-4.32 (m, 1H), 3.89 (dd, J = 10·5, 3.6 Hz,1H),3·82·3·60 (m, 3H),3.55 (t J = 4·5 Hz,2H), 3·31 (s,3H),2.78-2.50(m,3H),2.25-2.10 (m,1H),2.10-1.95 (m,2H)〇 奮施锎44 (28)〜“(29) 使用對應化合物替代參考例4製造之化合物,依實施 例374實施例394實施例41(某些情況使用對應化合物替 代甲氧基甲基氯實施例43 (使用對應化合物替代苄基溴 )實施例5—實施例44所示方法相同操作,得具下列之化合 物0 g m m 44 (28 ) 2(S) -甲基-5-乙氧基甲氧基-4(S)-[N -甲基- -溴 苯羰基)胺基]戊酸 och2ch3
TLC: Rf 0.23(氯仿··甲酵=9:1); i紙張尺度4州中國國家標準(CNS ) Λ4規格(210X 297公釐). 2 49 31 0 1 1 2 568897 Α7 Β7 ……一^—— ....·— — ---------- - ... — · " 1" ............ " ............... .. ......... _ '1 _ : 五、發明说明(25為 NMR (d6-DMS〇) : δ 12.15 (1Η, brs), 7.63-7.56 (2H, m), 7.34-7.25 (2H, m), 4.82-4.72&3.79-3.69 (1H, m), 4.59&4.55 (2H, s), 3.61-3.37 (4H, m), 2.76&2.64 (3H, s), 2.08 (1H, sxt, J = 6.9Hz), 2.0M.91&1.5M.41&1.37-1.27 (2H, m), 1.14-1.04 (3H, m), 0.82 (3H, d, J = 6.9Hz)〇 窨淪例44 (2L9) 2(S)_甲基-5-乙氧基甲氧基-4(S)-[N-甲基-N-(4-硝 基笨羰基)胺基]戊酸 7〇CH2CH3 °〇 1 ch3 1!^ ^N〇2 :甲酵= 9:1); 0 TLC: Rf 0·42 (氣仿:甲酵 NMR (CDCI3) : S 8.27 /^8.25 (d d7 J = 8.7HzJ = 8.7Hz, 2H), 7.68 A 7.58 (d J = 8.7Hz = 8.7Hz? 2H), 5.10-4.98 ^3.92-3.80 1H), 4.76-4.63 (m, 2H), 3.72-3.42 (m, 4H), 2.96 /^2.80 (s ^s, 3H), 2.62-2.50 /^2.27-2.21 (m/^ m, 1H), 2.12 1.59 (dddddd, J = 14.4, 10.5, 6.3HZ/^ 14.4, 7.5, 4.2Hz, 1H)? 2.02 ^1.41 (dtdt, J = 14.4, 9.0Hz 14.4, 5.4Hz, 1H), 屮 -火 il 而 )1 J >7ί f: 印 ί; (誚先閱讀背面之注意事項再填寫本頁) 1·32 及 1.08 (d 及d,J = 7·2Ηζ 及 6·9Ηζ,3H),1.23 发 l·22 G 度 t J = 7·2 沒 7·2Ηζ,3H)〇 謇淪例45 4(S)_第三丁基二甲基矽烷氧基甲基- 4-(N-(4-(苯并 呋喃-2-基)苯羰基)胺基)丁酸甲酿 本紙張尺度適州中國國家標率(CNS ) Λ4規格(210X 297公釐) 250 310112 568897 A7 B7 五、發明説明 25 十 一 Si- CH3〇
(讀先閱讀背面之注意事項再楨寫本頁) 於含實施例39製造之化合物(0.294克)之二甲基甲醢 胺(5毫升)溶液中,添加眯唑(0.107克)及第三丁基二甲基 矽基氯(0.241克)。反應混合物在室溫攪拌2小時。反應混 合物以乙酸乙酯稀釋,Μ水、飽和氯化納水溶液洗淨,Μ 無水磙酸鎂脫水並濃释。殘留物以矽膠管柱層析(正己烷!1 乙酸乙酯= 3:1)純化,得具下列物性之檷題化合物(0.361 克)° TLC: Rf 0.83(正己烷:乙酸乙瞻=1:1); NMR (CDC13) : δ 7.94 (2Η, d, J=8.8Hz), 7.84 (2H, d, J=8.8Hz), 7.63-7.52 (2H, m), 7.37-7.20 (3H, m), 7.13 (1H, d, J=0.8Hz), 6.62 (1H, dy J=8.8Hz), 4.30-4.16 (1H, m), 3.74 (2H, d, J=3.6Hz), 3.64 (3H, s), 2.59-2.38 (2H, m)? 2.10-L92 (2H, m), 0·92 (9H, s),0·086 (3H,s),0.066 (3H,s)。 富淪例4ft 2(S)-苄基-4(S)-第三丁基二甲基矽烷氧基甲基-4-(N -(4-(笨并呋喃-2 -基)苯羰基)胺基)丁酸甲酯 不紙張尺度適州中國國家標準(CNS ) A4規格(21〇><297公釐 568897 A7 B7 五、發明説明(25f
(讀先閱讀背面之注意事項再楨寫本頁) 使用實施例45製造之化合物替代實施例41製造之化合 物,依實施例42所示方法相同操作,得具下列物性之標^ 化合物。 TLC: Rf 0.43(正己烷:乙酸乙酯=7:3); NMR (CDC13) : δ 7.93 (2Η, d, J=8.4Hz), 7.83 (2H, d, J=8.4Hz), 7.63-7.50 (2H, m), 7.38-7.10 (8H, m), 6.35 (1H, d, J=8.8Hz), 4.36-4.17 (1H, m), 3.74-3.60 (2H, m), 3.43 (3H, s), 3.02-2.68 (3H, m), 2.20-2.00 (1H, m), 1.90-1.74 (1H, m), 0.88 (9H,s), 0.038 (3H,s), 0.026 (3H,s)。 啻)fe例47 2(S)-苄基-4(S)-第三丁基二甲基矽烷氧基甲基- 4-(H -(4-(苯并呋喃-2 -基)苯羰基)胺基)丁酸
沐紙張X度述州中國國家標率(CNS ) A4現格(210X 297公釐) 252 ' 3 10 112 568897 A7 B7 ______ 五、發明说明(25f 使用實施例46製造之化合物替代實施例1製造之化合 物,依實施例2所示方法相同操作,得具下列物性之標題 化合物。 TLC: Rf 0.44(氯仿:甲醇=19:1); NM R (CD3OD) : δ 7.97 (2Η, d, J=8.4Hz), 7.90 (2H, d, J=8.4Hz), 7.63-7.49 (2H, m), 7.37-7.10 (8H, m), 4.35-4.18 (1H, m), 3.74-3.60 (2H, m), 3.05-2.82 (2H, m),2.80-2.64 (1H,m), 1.93 (2H, m),0·87 (9H,s),0.048 (6H,s)。 啻_例48 2(R)-苄基-4(S)-羥甲基-4-(N-(4-(苯并呋喃-2-基) 苯羰基)胺基)丁酸 (誚先閱讀背面之注意事項再蛾寫本^)
於含實施例47製造之化合物(0·162克)之四氫呋喃(5 毫升)溶液中,在室溫下添加1Μ氯化四丁銨之四氫呋喃溶 液(〇· 4毫升)。反應混合物於室溫攪拌2小時。反應混合物 中添加水,Μ乙酸乙酯萃取。萃取物Μ飽和氯化鈉水溶液 洗淨、Κ無水硫酸鎂脫水並濃縮。殘留物Μ矽膠管柱曆析 (正己烷:乙酸乙酯=9:1〜1:9)純化,得具下列物性之標 題化合物(0 · 0 8 8克)。 TLC: Rf 〇.22(氯仿:甲醇=19:1); 張尺度適州中國國家標準(297-公釐): .之43…3 1立—11 2— 568897 A7 B7 五、發明説明(251 NMR (CD3OD) : ^ 7.92 (4H, s), 7.60-7.42 (2H, m), 7.38-7.06 (8H, m), 4.40-4.20 (1H, m), 3.64 (2H, d, J=5.4Hz), 3.02-2.82 (2H, m), 2:8〇.2.62 (1H, m), 2.10-1.75 (2H, m)。 管_例4 8 ( ΐ ) 2(S)-苄基-4(S)_羥甲基- 4-(N-(4-(3 -甲氧基-1-丙炔 基)苯羰基)胺基)丁酸
使用對應之醢鹵化物替代參考例4製造之化合物,依 實施例374實施例394實施例454實施例46 —實施例47 — 實施例48所示方法相同操作,得具下列物性之標題化合物 Ο (謂先閱讀背面之注意事項再硝寫本頁) TLC : Rf 0.21(氯仿:甲酵=19:1)。
本紙張尺度適W中國國家標準(CNS ) A4規格(210X29?公釐) 254 310112 568897 A7 B7 25 五、發明説明 使用實施例38製造之化合物替代實施例2製造之化合 物,依實施例34實施例4所示方法相同操作,得具下列物 性之標題化合物。 TLC: Rf 0.39(氯仿:甲醇=9:1);,, NMR (dg-DMSO) : δ 10.42 (1Η, s), 8.75 (lHt d, J=7.6Hz), 8.04 (4H, s), 7.74-7.57 (3H, m), 7.42-7.25 (2H, m), 5.00-4.82 (1H, m), 3.71-3.40 (8H, m), 2.19-1.82(4H, m)〇 # 奮淪俐49 (1 )〜49 (8) 使用實施例40、實施例42、實施例44、實施例44(1) 〜44(3)、實施例48、實施例48(1)製造之化合物替代實施 例38製造之化合物,依實施例49所示方法相同操作,得下 列化合物。 管渝例4 9 (η Ν-羥基- 4(S)-羥甲基-4-(H-(4-(苯并呋喃-2-基)苯截 基)胺基)丁醯胺
TLC: Rf0.22(氯仿··甲醇=9:1); NMR(d6-DMS0): 5 10.36 (1H, d, J=1.5Hz), 8.67 (1H, d, J=1.5Hz), 8.19 (1H, d, J=8.4Hz), 8.00 (4H, s), 7.73-7.61 (2H, m)t 7.57 (1H, d, J=0.8Hz), 7.42-7.23 (2H, m),4·73 (1Η,Λ J=5.8Hz), 4.08-3.85 (1H,m),3.58-3.38 (2H,m),2.12-1.60 (4H, m)。 (讀先閱讀背面之注意事項再镇寫本頁) h 、ιϊ 部 屮 •火 消 f: /、 卬 本紙张尺度適州中國國家標準((,NS ) A4規格(210X297公釐) 255 310112 25568897 A7 B7 > 五、發明説明 啻_例4 9 ( 2 ) N-羥基-4(S)_甲氧基甲基氧基-4-(N-(4-(苯并呋喃-2 基)苯羰基)胺基)丁醯胺 〇
(讀先閱讀背面之注意事項再楨寫本頁) TLC: Rf0.47(氯仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.37 (1Η, s), 8.34 (1H, d, J=8.4Hz), 8.00 (4H, s), 7.73-7.61 (2H, m), 7.56 (1H, s), 7.41-7.24 (2H, m), 4.58 (2H, s), 4.23-4.04 (1H, m)? 3·62-3·44 (2H, m),3·26 (3H,s),2.12-1.62 (4H,m)〇 管_例4 9 m N-羥基-2 (S )-苄基-4 (S)-甲氧基甲基氧基甲基-4-(N (4-(笨并呋喃-2-基)笨羰基)胺基)丁醢胺 、ll Ο 1 ; 屮
消 A
0 Ό Ο
1^(::1^0.35(氯仿:甲醇=19:1) 本纸張尺度適州中國國家標準(CNS ) Λ4規格(210X297公釐) 256 310112 25568897 A7 B7
五、發明说明 NMR (dg-DMSO) : δ 10·37 (1Η,s),8·69 (1Η,s),8.25 (1Η,d,Ι=8·6Ηζ),8.01 (4H,s),7.72-7.61 (2H,m),7.57 (1H,s),7.41-7.09 (7H,m), 4.55 (2H,s),4.40-4.20 (1H,m),3·53 (2H,d,J=5.6Hz),3.2 分(3H,s), 2·79 (2H, d,J=7.4Hz),2.50-2.34 (1H, m),1.90-1.60 (2H,m)。 窨_例49 U) N-羥基-2(S) -甲基-4(S) -甲氧基甲基氧基甲基-4-(N (4-(笨并呋喃-2-基)苯羰基)胺基)丁醯胺
I r° 〇 NMR (d6-DMSO): 5 10·41 (1H,d,J=1.6Hz), 8·68 (1H,d,J=1.6Hz),8.20 (1H, d, J=8.4Hz), 8.00 (4H, s\ 7.74-7.60 (2H, m), 7.56 (1H, d, J=0.8Hz), 7.41-7.22^ (2H, m), 4.58 (2H, s), 4.32-4.10 (1H, m), 3.62-3.41 (2H, m), 3.25 (3H, s), 2.30-2.14 (1H, m), 1.82-1.58 (2H, m), 1·05 (3H, d, J=6.6Hz)。 奮)te例4 9 m (讀先閱讀背面之注意事項再^寫本頁) 、o /f. 部 十 k il w'i f A 卬 羥基-2(S)-(3-苯基-2-丙烯基)-4(S)-甲氧基甲基 氧基甲基- 4-(N-(4-(笨并呋喃-2-基)苯羰基)胺基)丁酿胺
本紙張尺度適力]中國國家標準(CNS ) Λ4規格(210X297公釐) 257 310112 568897 B7 五、發明説明(2 5f TLC: Rf0.36(氯仿:甲酵=19:1); NMR (d6-DMS0) : δ 10.50 (1H,s),8·78 (1H,s),8.25 (1H,d,J=8.4Hz),8.00 (4H,s), 7·67 (2H, t J=8.6Hz),7.56 (1H,s),7.40-7.14 (7H,m),6·41 (1H,d, J=16.0Hz), 6.15 (1H, dt, J=16.0, 5.8Hz), 4.57 (2H, s), 4.32-4.14 (1H, m), 3.62-3.45 (2H,m), 3·24 (3H,s),2·46-2·22 (3H,m),1·96-1·78 (2H, m)。 窨淪例49 (fi) N-羥基-2(S)-(3-苯丙基)-4(S)甲氧基甲基氧基甲基 4-(N-(4-(笨并呋喃-2-基)苯羰基)胺基)丁醢胺 (讀先閱讀背面之注意事項再楨寫本頁)
TLC: Rf0.35(氯仿:甲酵=19:1); NMR(d6-DMS0): 5 10.47 (1H, s), 8.82-8.66 (1H, brs), 8.20 (1H, d, J=8.4Hz), 部 屮 1\ 消 f A η 7.99 (4H,s),7.72-7.61 (2H, m),7·57 (1H,d,J=0.6Hz),7·41-7·10 (7H,m),4.57 (2H, s), 4.23-4.02 (1H, m), 3.60-3.42 (2H, m), 3.24 (3H, s), 2.62-2.40 (2H, m), 2.22-2.06 (1H, m), 1.84-1.64 (2H,m),1.60-1.38 (4H,m)。 富淪例49 (7) N-羥基-2(R)_苄基-4(S)_羥甲基-4-(N-(4-(苯并呋喃 -2-基)苯羰基)胺基)丁醢胺 (c:NS..)4轉染奂210Χ297公釐.),—.2 5 8 568897 為 kl B7 五、發明説明(
TLC: Rf0 · 37 (氯仿:甲酵=9 : 1); NMR (d6-DMS〇)-: 5 10.32 (1H, s), 8.68 (1H, s), 8.08 (1H, d, J=8.4Hz)T 8.02 (4H, s), 7.72-7.62 (2H, m), 7.59 (1H? s), 7.41-7.06 (7H, m), 4.82-4.66 (1H, m), 4.24-4.04 (1H, m), 3.60-3.36 (2H, m), 2.92-2.66 (2H, m), 2.50-2.30 (1H, m), 1.92- 1.52(2H,m)〇 一-•一·.—…一…-* — — - —.·· — ·.· 奮施例49 (8) 羥基-2(S)-苄基-4(S)_羥甲基- 4-(N-(4-(3-甲氧基 -1-丙炔基)笨羰基)胺基)丁醢胺 (誚先閱讀背面之注意事項再镇寫本頁)
TLC: Rf0 · 23 (氛仿:甲酵=9 : 1); NMR (dg-DMSO) : δ 10.28 (1Η,brs),8.62 (1Η,brs),8·04 (1Η,d,J=8.4Hz), 7.87 (2H, dt J=8.2Hz), 7.53 (2H, d, J=8.2Hz), 7.24-7.05 (5H, m), 4.69 (1H, t, J=5.7Hz), 4.33 (2Ht s), 4.18-4.02 (1H, m), 3.46-3.34 (2Ht m), 3.31 (3H, s), 2.75 (2H, d,J=7.0Hz), 2.42:26 (1H,m),1·89·1·52 (2H,m)。 瓜t國亂家標準(CNSl A4規格(210X29^^釐):_· 2 5 9 ______________…310112 568897 4 ΑΊ Β7 26 五、發明説明 奮_例49 m N-經基-5 -經基-4(S)-[N-[4-(3-甲氧基-1-丙炔基)笨 羰基]胺基]丁醯胺 (讀先閱讀背面之注意事項再楨寫本頁) H0 使用對應化合物替代參考例4製造之化合物,依實施 例374實施例394實施例40 —實施例49所示方法相同操作 ,得具下列物性之標題化合物。 TLC: Rf0 · 36 (氯仿:甲醇=4 : 1 ); NMR (d6-DMS〇) : S 10.35 (1H? s), 10.18 (1H, s), 8.18 (1H, d, J= 8.4Hz), 7.88 (2H, d, J=:8.4Hz), 7.55 (2H, d, J=8.4Hz), 4.53 (2H, s), 4.02-3.84 (1H, m), 3.73-3.34 (2H,m),3·35 (3H,s),2·07-1·59 (4H,m)。 管 例 49 (1 0) N-羥基-5-羥基-4(R)-[N-[4-(3-甲氧基-1-丙炔基)苯 羰基]胺基]戊醢胺 1: π j ;/ί☆ 合ii 卬 使用4(R) -羧基-4 -胺基丁酸甲酯替代4(S)羧基-4 -胺 本紙张又度適W中揭國家標準(CNS4A4規格(210X.29_7公釐) 2 6 0 310112 568897 A7 B7_________________________ 一 一·,一-‘一 —*- — ...... * *4)^ 五、發明说明(26> 基丁酸甲_以及使用對應化合物替代參考例4製造之化合 物,依實施例374實施例394實施例404實施例49所示方 法相同操作,得具下列物性之標題化合物。 TLC: Rf0.28(氯仿••甲醇:乙酸:水=85:15:1); NMR (CD3CD) : δ 7.83(2H, d, J=8.4Hz), 7.51(2H, d, J=8.4Hz), 4.34(2H, s), 4.03-4.15(1H, m), 3.62(2H, d, J=5.6Hz), 3.43(3H, s), 2.19(2H, t, J=7.4Hz), 1.77-2·10(2Η, m)。 ff 淪锎 A9m)〜49(21) 使用對應化合物替代參考例4之化合物,依實施例37 4實施例38(使用對應胺化合物實施例49所示方法相同 操作,得下列化合物。 g 淪俐 49 (1 1 ) N-羥基- 4(S)-(4-羥基丁基胺甲醸基)-4-[N-[4-(3 -甲 氧基-1-丙块基)笨羰基]胺基]丁醢胺
、j /Γ; 部 '1, -λ i? JI .1 f 合 卬 f (讀先閱讀背面之注意事項再峨寫本ιίο TLC : Rf 0 · 40 (氯仿:甲酵=4 : 1); … -------- NMR (d6-DMS〇) : δ 10.41 (1Η, s), 8.61 (1H, d, J=7.8Hz), 7.98-7.88 (3H, m), 7.55 (2H, d, J=8.4Hz), 4.44-4.27 (3H, m), 3.38 (2H, t, J=6.2Hz), 3.35 (3H, s), 3.13-3.00 (2H,m),2.09-1.83 (4H, m), 1.48-1.34 (4H,m)。 奮油{例4 9 (1 2 ) 中纸砰K度诎m中—國麗本嫖率(CNS_)_ A_4规格JUIOX 297公釐) 261 aiai 12 568897 A7 B7 五、發明説明(2 N-羥基-4(S)-(3-苯基丙基胺甲醯基)-4-[N-[4-(3-甲 氧基-1-丙炔基)笨羰基]胺基]丁醯胺
TLC: Rf 0.38(氯仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.41 (1Η, s), 8.72 (1H, s)t 8.64 (1H, d, J=7.6 Hz), 8.04-7.94 (1H, m), 7-92 (2H, d, J=8.5Hz), 7.55 (2H, d, J=8.5Hz), 7.32-7.14 (5H, m), 4.43-4.35 (3H, m), 3.33 (3H, s), 3.16-3.02 (2H, m), 2.62-2.49 (2H, m), 2.14-1.84 (4H,m),1.80-1.62 (2H,m)。 g 淪例 4 9 (1 3 ) N-羥基-4(S)-丙基胺甲酿基-4-[N-[4-(3-甲氧基-1-丙炔基)苯羰基]胺基]丁醢胺 (翱先閱讀背面之注意事項再楨寫本頁)
T_L C : Rf 0·23(氛仿:甲酵=9:1); NMR (d6-DMS〇) : S 10.40 (1H, s), 8.71 (1H, s), 8.61 (1H, d, J=7.8Hz), 7.96-7.88 (3H? m), 7.55 (2H, d, J=8.3Hz), 4.43-4.26 (3H, m), 3.32 (3H, s), 3.09-2·95 (2H,m), 2.07-1.79 (4H, m),1.41 (2H,六重峯/=7·3Ηζ),0.83 (3H,t,J=7.3Hz)。 —fk張尺度遞3]中國國·家標準(cns)A4說格·υιο.><297公釐) 262 .3 1 01 1 2 568897 A7 B7 五、發明説明(26 奮施例49 (14) 基 -羥基-4(S)-(2-羥乙基胺甲釀基)-4-[Η-[4-(3-甲氧 丙炔基)苯羰基]胺基]丁醯胺 Η
0. TLC:Rf0.09(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.39 (1Η, s), 8.71 (1H, s), 8.63 (1H, d, J=7.6Hz), 7.97-7.87 (3H, m), 7.56 (2H, d, J=8.2Hz), 4.66 (1H, ζ J=5.4Hz), 4.43-4.35 (3H, m)? 3.40 (2H,m), 3·33 (3H, s),3· 19·3·08 (2H, m),2.09-1.83 (4H, m)。 管淪例49 (15) N-羥基- 4(S)-(6-羥己基胺甲醢基)-4-[Ν-[4-(·3 -甲氧 基-1-丙炔基)苯羰基]胺基]丁醢胺
(部先閱讀背面之注意事項再填寫本IJO 部 中 ik 才Γ 义j )1 >/] 合 印 ί:
0, ____________ TLC: Rf 0·42 (氯仿:甲酵=4 : 1); — NMR (d6-DMS〇) : S 10.37 (1H, s), 8.68 (1H, s), 8.57 (1H? d, J=7.6Hz), 7.93-7.83 (3H, m), 7.53 (2H, d, J=8.4Hz), 4.37-4.25 (4HT m)T 3.38-3.29 (5Ht m), 3·09-2·93 (2H,m),2·12-1·78 (4H,m), 1.43-U5 (8H,m)。 度Ϊ4Λ卓國獨家接準(CNW—UlOX.2g公釐) 2 6 3 310112 568897 A7 B7 五、發明説明(26ί 奮)fe 例 49 (1 6 ) 卜羥基- 4(S)-[2-(4-甲氧笨基)乙基胺甲醢基]-4-[H [4-(3-甲氧基-1-丙炔基)苯羰基]胺基]丁醢胺
0 0 TLC: Rf 0·25(氛仿:甲酵=9:1); NMR (d6-DMS0) : δ 10.40 (1Η, s), 8.72 (1H, s), 8.62 (1H, d, J=8.4Hz), 8.00-7.86 (3H, m), 7-60-7.52 (2H, m), 7.10-7.08 (2H, d, J=8.4Hz), 6.82-6.79 (2H, d, J=8.4Hz), 4.40-4.25 (3H, m), 3.70-3.69 (3H, s), 3.35 (3H, s), 3.36-3.15 (2H, m), 2.63 (2H, t, J= 7.3Hz), 2.19-1.82 (4H, m)〇 -...—--—..-一 …一 — —.... g _ 例 49 ( 1 7 ) N -羥基-4(S)-(2 -嗎啉基甲基胺甲醢基)-4-[N-[4-(3 甲氧基-1-丙炔基)苯羰基]胺基]丁醢胺 (讀先閱讀背面之注意事項再填寫本頁) 、1Τ 部
本紙張尺度適用中國國家標準.(CNS ).Λ4規格(210X297公釐)—......2 6 4 __________________________________310 1 1 2 568897 部 'k i?. 合 竹 卬 令:: A7 B7 2 6 5 五、發明説明(f NMR (dg-DMSO) : δ 10.32 (1Η, s), 8.60 (1H, d, J=7.6Hz), 8.32 (1H, s), 7.92 (2H, d, J=8.4Hz), 7.83 (1H, ζ J=5.5Hz), 7.56 (2H, d, J=8.4Hz), 4.42-4.30 (3H, m), 3.55-3.48 (4Ht m), 3.35 (3H, s), 3.23-3.20 (4H, m), 2.39-2.29 (4H, m), 2.2M.83 (4H, m)〇 g渝锎4 9 Π 8 ) N -羥基- 4(S)-[2-(吲睬-3-基)乙基胺甲釀基)-4-[N-[ 4-(3-甲氧基-1-丙炔基)笨羰基]胺基]丁醢胺
TLC: Rf 0 · 33 (氯仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.79 (1Η, s), 10.41 (1H, s), 8.64 (1H, d, J=7*.6Hz), 8.12-8.04 (1H, m), 7.92 (2H, d, J=8.5Hz), 7.61-7.52 (3H, m), 7.32 (1H, d, J=7.6Hz), 7.17-6.92 (3H, m), 4.45-4.35 (3H? m), 3.42-3.33 (4H, m), 2.82 (2H, ζ J=7.4Hz), 2·17-1·84 (4H, m)。 ’ 富 _ 例 49 (1 9) N-羥基- 4(S)-(4-苯基丁基胺甲醢基)-4-[N-[4 -(3-甲 氧基-1-丙炔基)苯羰基]胺基]丁醯胺 (讀先閱讀背面之注意事項再填寫本頁) 本紙张及度適州中國國家標準(CNS ) Λ4規格(210」X 297公釐) 265 310112 26568897 A7 B7 五、發明説明( TLC: Rf 〇·16(氯仿:甲醇=9:1); NMR (dg-DMSO) : δ 10.40 (1Η, s), 8.70 (1H, brs), 8.62 (1H, d, J=7.8Hz), 7.98-7.87 (3H, m), 7.55 (2H, d, J=8.5Hz), 7.30-7.14 (5H, m), 4.40-4.34 (3H, m), 3.35 (3H, s), 3.09 (2H, q, J=6-0Hz), 2.56 (2H, t, J=7.0Hz), 2.12-1.83 (4H, m), L64-1.34 (4H, m)〇 一―…一一 _ g 淪例 49 ( 20 ) N-羥基-4(S)-(2-苯基乙基胺甲醯基)-4-[H-[4-(3-甲 氧基-1-丙炔基)苯羰基]胺基]丁醯胺
TLC:Rf0.36(氯仿:甲酵=9:1); NMR (d6-DMS〇) :S 10.39 (1H, s), 8.72 (1H, s), 8.63 (1H, d, J=8.0Hz), 8.01 (1H, t, J=5.7Hz), 7.92 (2H, d, J=8.4Hz), 7.57 (2H, d, J=8.4Hz), 7.29-7.14 (5H, m), 4.39-4.28 (3H, m), 3.35-3.23 (5H, m), 2.71 (2H, t, J=7.5Hz), 2.09-1.82 (4H, m)〇 Λ: (讀先閱讀背面之注意事項再頊寫本頁) 富淪例49 (21) N-羥基-4(S)-[3-(吡唑-1-基)丙基胺甲醢基]-4-[N-4-(3-甲氧基-1-丙炔基)苯羰基]胺基]丁釀胺 消 竹 卬
Ο
冰紙.張尺政i4瓜—中風國家接為(—CNS—)_ 266 ^ 10 112. 568897 A7 b/ 26 五、發明説明 TLC: Rf 0.23(氯仿··甲醇:乙酸=9:1:0.5); NMR (d6-DMS0) : δ 10.43 (1Η, s), 8.69 (1H, d, J=7.5Hz), 8.06 (1H? t, J=5.6Hz), 7.93 (2H, d, J=8.4Hz), 7.71 (1H, d, J=2.0Hz), 7.56 (2H, d, J=8.4Hz), 7.42 (1H, d? J=2.0Hz), 6.21 (1H, t, J=2.0H z), 4.37-4.27 (3H, m), 4.11 (2H, t, J=6.8Hz), 3.35 (3H, s), 3.09-2.99 (2H, m), 2.12-1.86 (6H, m)〇 奮施例49 (22 ) N-羥基-4 (R) - (3-苯基丙基胺甲醢基) 氧基-1-丙炔基)苯羰基]胺基]丁醯胺 [N- [4_ (3-甲 (詞先閱讀背面之注意事項再楨寫本頁)
I 消 合 ii 卬 ί: 使用4(R)-羧基-4-胺基丁酸甲酯替代4(S)-羧基-4-胺 基丁酸甲酯Μ及使用對應化合物替代參考例4製造之化合 物,依實施例374實施例38(使用對應胺化合物實施例 49所示方法枏同操作,得具下列物性之標題化合物。 TLC: Rf 0.44(氛仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.39(1H, brs), 8.70(1H, brs), 8.63(1H, d, J=7.8Hz), 7.98(1H, t, J=5.6Hz), 7.90(2H, d7 J=8.4Hz), 7.54(2H, d, J=8.4Hz), 7.10-7.28(5¾ m)T 4.42-4.35(3H, m), 3.32(3H, s), 3.11-3.01(2H, m), 2.57-2.47(2H, m), 2.13-1.82(4H, m), 1·74-1·60(2Η, m)。 g _ 例 4 9 ( 2 3) N-羥基-2-(吡啶-3-基)甲基-4(2-苯基乙基胺甲醮基) 本-紙張尺度適州中國國家接準.(丄社d>C29_7公釐 267 26568897 A7 B7 五、發明説明 -4[N-(4-苯氧基笨羰基)胺基]丁醯胺
0
〇X) /Γ; 部 十 -火 ii 消 Aii 印 使用4(S)-第三丁氧羰基-4-(N-苄氧基羰胺基)丁酸甲 酯替代4(S) -羧基-4 -胺基丁酸甲酯Μ及使用對應化合物替 代苄基溴,依實施例434實施例274實施例37(使用對應 化合物替代參考例4之化合物實施例144實施例38 (使用 對應胺化合物)4實施例49所示方法相同操作,得具下列 物性之標題化合物。 TLC: Rf0.30,0.36(氯仿:甲酵:乙酸= 9:1:0·5); NMR (de-DMSO/MeOH) : δ 8 . 33 - 8 . 2 6 ( 2 Η ,m) , 7 · 89-7 . 82(2H,m), 7.48(lH,t,J = 8.1Hz), 7·39-7·31(2Η,ηι), 7· 24-7·06(5Η,πι), 7.02-6.90(6H,m), 4.48(2個異構物之 lH,dd,J=5.0Hz,10.1Hz), 4.29(2個異構物之 lH,dd,J=4· 2Ηζ,10·5Ηζ), 3.20-3·02(2H,m), 2.95-2.84(2個異構物 之 lH,m), 2.79-2.57(2個異構物之 lH+2H,m), 2·51-2·27( 2H,m), 2.04-1.92(2個異構物之 2H,m), 1.88-1.77(2個異 構物之2H,m)。 奮施例49 (24)〜49 ( 35 ) 使用對應化合物替代參考例4之化合物,依實施例37 268 ~3 1 0 112 本紙張尺度適瓜來國國家標率(C 21〇乂297„公釐.) (誚先閱讀背面之注意事項再楨荇本頁) 568897 .och3
A7 B7 ____ 五、發明説明(2 6)9 4實施例394實施例41 (某些情況使用對應化合物替代甲 氧基甲基氯)—實施例42 —實施例49所示方法相同操作, 得下列化合物。 童施例49 (24) N -羥基-5 -甲氧基甲氧基-4(S)-[N-[4-(3 -甲氧基-1-丙炔基)苯羰基]胺基]戊醣胺 0、 TLC: Rf 0 · 22 (氯仿:甲酵=9 : 1 ); —--------- _ . _ 丨 NMR (d6-DMS0) : δ 10.35 (1Η, s), 8.32 (1H, d, J=8.6Hz), 7.87 (2H, d, J=8.4Hz), 7.55 (2H, d, J=8.4Hz), 4.57 (2H, s)y 4.36 (2H, s), 4.20-4.01 (1H, m), 3·55-3·44 (2H,m), 3·35 (3H,s),3·24 (3H, s), 2·09-1·64 (4H, m)。 (翱先閱讀背面之注意事項再填寫本頁) 奮施例49 (25 )
本紙張尺度適州中國國家摞準( CNS ) A4規格(.210X29.7公釐)—….........- 269 310112 27568897 A7 B7 五、發明説明 TLC: Rf 0.24(氯仿:甲醇=9:1); NMR (d&DMSO) : δ 10.37 (1Η, s), 8.36 (1H, d, J=8.8Hz), 7.88 (2H, d, J=8.5Hz),7·55 (2H, d,J=8.5Hz),7·37-7·26 (5H,m), 4.72 (2H,s),4·53 (2H,s), 4.35 (2H, s),4.22-4.07 (1H,m),3 ·63-3·55 (2H,m),3·35 (3H,s),2.09-1.68 (4与,in)。 啻)fe 例 49 ( 26 )— H-羥基-5-(2 -甲氧基乙氧基)甲氧基- 4(S)-[N-[4-(3-甲氧基-1-丙炔基)苯羰基]胺基]戊醢胺 och3
HO
TLC: Rf 0·41(氯仿:甲酵••乙酸:水=100:10:1:1); NMR (d6-DMS〇) : $ 10.32(1H, s), 8.65(1H, s), 8.30(1H, d, J=8.6Hz), 7.84(2H, d, J=8.4Hz), 7.52(2H, d, J=8.4Hz), 7.28-7.36(2H, m), 6.93-7.06(3H, m), 5.04(2H, s), 4.60(2H,s),3·95-4·16(1Η,m), 3.38-3 ·56(6Η,m),3.19(3H,s),1·57-2·08(4Η,m)。 部 屮 (部先閱讀背面之注意事項*楨寫本頁) 窗淪例49 (27 ) 基 炔 丙 基胺 氧醯 甲戊 基丨 氧 甲 5-基 •羰 笨 基 羥 基 胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ΤΓ0 基 氧 苯 ΤΤΊΓΓΤ7 568897 A7 B7 27 ,och3 ο
五、發明説明 °Ό Τ L C : R f 0 . 2 7 (氯仿:甲醇•♦乙酸:水=1 0 0 ·· 1 0 : 1 : 1 ); NMR (d6-DMSO):占 10·31(1Η,brs),8·69(1Η,brs),8·29(1Η,brs),7·83(2Η,d, J=8.7Hz), 7.51(2H, d, J=8.4Hz), 7.16(2H, t, J=8.0Hz), 7.03(2H, d, J=8.7Hz), 6.97(1H, t, J=7.5Hz), 5.05(2H, s), 4.54(2H, s), 3.98-4.13(1H, m), 3.42-3.52(2H, m), 3·21(3Η,s),1.62-2.02(4H,m)。 管 _ 例 49 ( 28 ) N-羥基-5-苄氧基甲氧基-4(S)-[N-[4-(3-苯氧基-1-丙炔基)苯羰基]胺基]戊醢胺 (讀先閱讀背面之注意事項再填寫本頁) 部 屮 lk ;τ 消 fr Aii
P 〇
〇 TLC: Rf 0.27(氯仿:甲酵=9:1); 本紙張尺度適州中國國家標率(CNS ) Λ4規格(210X297公釐) 271 310112 27568897 A7 B7 五、發明説明 NMR (dg-DMSO) : δ 10.34(1H, s), 8.67(1Η, s), 8.35(1Η, d, J=8.0Hz), 7.85(2H, d, J=8.4Hz), 7.52(2H, d, J=8.4Hz)? 7.37-7.25(7H, m), 7.07-6.94(3H, m), 5.06(2H, s), 4.70(2H, s), 4.51(2H, s), 4.01-3.98(lHt m)? 3.56(2H, d, J=6.0Hz), 2.09-1.58(4H, m)〇 實施例49 (29 ) N-羥基-5-甲氧基甲氧基-4(S)-[N-[4-苯氧基苯羰基) 胺基]戊醢胺 (00Η3
CT (讀先閲讀背面之注意事項再硝寫本頁) TLC: Rf 0.36(氯仿:甲酵:乙酸:水=100:10:1:1) NMR (d6-DMS〇) : S 10.33(1H, s), 8.66(1H, s)T 8.16(1H, dT J=8.4Hz), 7.87(2H, dT J=8.8Hz), 7.46-7.38(2H, m), 7.22-7.15(2H, m), 7.07-6.99(3H, m), 4.54(2H? s), 4·19-3·94(1Η,m),3·49-3·45(2Η, m),3.22( 3H, s),2·07-1·57(4Η, m)〇 H-羥基-5-甲氧基甲氧基- 4(S)-[H-[4-(4-氛苯基)苯 羰基]胺基]戊酿胺 部
张尺度適州中國國家標準(CNS ) Λ4規格(210X297公釐) 272 310112 27568897 AI B7 五、發明说明 TLC: Rf 0.28(氯仿:甲醇=9:1);NMR (d6-DMSO) : S 10.37 (1Η, s), 8.31 (1H, d? J=8.2Hz), 7.97 (2H? d,J=8.6Hz)T 7.81-7.75 (4H, m)y 7.55 (2H, d, J=8.6Hz), 4.58 (2H, s), 4.19-4.03 (1HT m), 3.56-3.49 (2H, m),3.25 (3H,s), 2.09-1 ·77 (4H,m)。 管淪俐4 9 ( 3 1 )H-羥基-5-甲氧基甲氧基_4(S)-[N-[4-[2-(4-甲基苯 基)乙炔基)苯羰基]胺基]戊醢胺 ,och3 Ο ο
ch3 (¾先閱讀背面之注意事項再填寫本頁) 消 f: 合 卬 f TLC: Rf 0.27(氯仿:甲酵:乙酸:水=100:10: 1:1); NMR (d6-DMS0) : 5 10·35(1Η,brs·),8·67(1Η,brs·),8·33(1Η,d,J=8.6Hz), 7·89(2Η, d, J=8.4Hz),7·62(2Η,d, J=8.4Hz),7·47(2Η,d,J=8.2Hz),7·25(2Η,d, J=8.2Hz),4·56(2Η,s),4·19-3.98(1Η,m), 3·56-3·42(2Η,m),3.23 (3H,s),2·34(3Η, s),2·09-1·58(4Η,m)。 窨施例4 9 m )N-羥基-5-甲氧基甲氧基-4(S>-[H-[4-[2E-(4-氯苯基 )乙烯基]笨羰基]胺基]戊醢胺 本紙枣尺度適用中國國家標準(CNS )从攀格、·( 210X 297公缘) 273 310112 568897 A7 B7 五、發明说明 27 ,och3 ⑽ V^aACu^ 丨 TLC: Rf 0.38(氯仿:甲酵=9:1); ...-.-—〆, NMR (d^-DMSO) : ί 10·35(1Η, brs·),8·67(1Η,brs·),8·23(1Η,d,J=8.6Hz), 7·87(2Η, d, J=8.2Hz)t 7.68(2Ht d, J=8.4Hz), 7.66(2H, d, J=8.4Hz), 7.41(2H, d? J=8.2Hz), 7.40(lHt d, J=17.8Hz), 7.31(1H, d, J=17.8Hz), 4.56(2H, s), 4.19-3.98(1H, m),3·58-3·41(2Η, m),3·23 (3H,s), 2·11-1·56(4Η,m)。 - —- 「- . Ί — - .] ~~ _ ... * —. ------------- — …一—. 奮)例 4 9 ( 3 3 ) N -羥基-5 -甲氧基甲氧基- 4(S)-[H-[4-(l -庚炔基)苯 羰基]胺基]戊醢胺 ,och3 r"〇 〇 (讀先閲讀背面之注意事項再填寫本1JC )
Μ •γ) 屮 •火 r'J 消 f Aii 卬
TLC: Rf 0.46(氯仿:甲酵=9:1); NMR (d6-DMS〇) : 8 10.34(1H, s), 8.67(1H, s), 8.27(lHt d, J=8.4Hz), 7.82(2H, d,J=8.2Hz),7·45(2Η,d,J=8.2Hz),4.55(2H,s),4.18-3·97(1Η,m),3·57-3·41(2Η,m), 3.22(3H, s), 2.49-2.40(2H, m), 2.04-1.22( 10H, m), 0.88(3H, t, J=6.8Hz)〇 ^^度$财糊年鮮4⑽麵綠;- 二ILLLL^ 568897 A7 B7 27 五、發明説明 奮 _ 例 49 (34 ) N-羥基-5-乙氧基甲氧基-4(S)-[N-(4-苯氧基笨羰基) 胺基]戊醯胺 ,och2ch3 TLC: Rf 0.34(氯仿:甲酵=9:1); NMR (d6-DMSO) : ί 10.36 (s,1H),8.68 (s,1H),8.17 (d,J= 8·4Ηζ,1H), 7·89 (d, J= 8.9Hz, 2H), 7.43 (dd, J= 8.5, 7.5Hz, 2H), 7.20 (t, J= 7.5Hz, 1H), 7.07 (dd, J= 1.1, 8.5Hz, 2H), 7.03 (d, J= 8.9Hz, 2H), 4.61 (s, 2H), 4.15-4.00 (m, 1H), 3.60-3.40 (m, 4H)t 2.10-1.95 (m, 2H)r 1.95-1.80 (m, 1H), 1.80-1.60 (m, 1H), 1.11 (t, J= 7.1Hz, 3H)〇 奮淪例4 9 ( 3 5 ) N-羥基-5-乙氧基甲氧基-4(S)-[N-(4-甲基笨羰基)胺 基]戊醢胺 z〇CH2CH3
ch3 TLC: Rf 0.30(氯仿·•甲醇=9:1); -本紙張尺度適W中國輿家標率(CNS ) Λ.4規格.(21 OX 29J公釐) 275 (讀先閱讀背面之注意事項再"寫本頁) 568897 A 7 B7 ___- 五、發明説明(2Ί NMR (d6-DMS0) : S 10.32 (s, 1H), 8.65 (s, 1H), 8.10 (d, J= 8.4Hz, 1H), 7.73 (dt 8.3Hz, 2H)T 7.22 (d, J=8.3Hz, 2H), 4.57 (s, 2H), 4.10-3.98 (m, 1H), 3.52-3.40 (m, 4H), 2.32 (s, 3H), 2.0M.94 (m, 2H), 1.9M.78 (m, 1H), 1.73-1.61 (m, 1H), 1·05 (t,J=7.1Hz, 3H)。 奮)ife 例 49 (36 )_ H-羥基-5-甲氧基甲氧基_4(R)-[卜[4-(3-甲氧基-1-丙炔基)苯羰基]胺基]戊醸胺 ^och3 (銷先閱讀背面之注意事項再楨寫本頁)
使用4(R)-羧基-4-胺基丁酸甲酯替代4(s)-羧基-4-胺 基丁酸甲_以及使用對應化合物替代參考例4製造之Mb合 物,依實施例374實施例394實施例414實施例424實施 例49所示方法相同操作,得具下列物性之標題化合物。 TLC: Rf 0.25(氯仿:甲酵:乙酸:水=100:10:1:1); NMR (CD3OD) : δ 8.32 (1Η, d, J=8.8Hz), 7.82 (2H, d, J=8.8Hz), 7.52 (2H, d, J=8.8Hz)t 4.62 (2H, s), 4.34 (2H, s), 4.16-4.31 (1H, m), 3.62 (2H, d, J=5.6Hz), 3.43 (3H,s), 3.33 (3H,s), 2.20 (2H,t, J=7.0Hz),1·17·2·11 (2H,m)。 管淪例49 (37)〜49 (67) 使用對應化合物替代參考例4製造之化合物,依實施 例37->實施例394實施例414實施例43(使用碘化甲烷替 代苄基溴實施例444實施例49所示方法相同操作,得 本紙張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 276 310112 27568897 A7 B7 五、發明説明( 下列化合物。 管 _ 例 4 9 ( 3 7 ) N-羥基-2(S) -甲基-5 -甲氧基甲氧基-4(S)-[N-[4-[2 (4-眯唑咐基苯基)乙炔基]苯羰基]胺基]戊醢胺 ο .och3
(讀先閱讀背面之注意事項再楨寫本頁) Ο TLC: Rf 0.33(氯仿:甲酵=10:1); NMR (d6-DMS0) : δ 10.40 (1H, brs), 8.68 (1H, brs), 8.36 (1H, s), 8.24 (1H, d, J=9.0Hz), 7.91 (2H, d, J=8.4Hz), 7.84 (1H, brs), 7.77 (2H, d, J=9.0Hz), 7.72 (2H, d, J=9.0Hz), 7.66 (2H, d, J=8.4Hz), 7.13 (1H, brs), 4.56 (2H, s), 4.22-4.11 (1H? m), 3.54-3.44 (2H, m), 3.23 (3H, s), 2.25-2.14 (lHt m), 1.76-L61 (2H ,m), 1.03 (3H, d, J=6.6Hz)〇 奩 _ 例 4 9 ( 3 8 ) N-羥基-2(S) -甲基-5 -甲氧基甲氧基-4(S)-[N-[4-( 4 -苯基-1,2,5,6 -四氫吡啶-卜基)苯羰基]胺基]戊醢胺 /〇CH3
I 消 fr A n 卬
本紙張尺度適州中國國家標準(〔1^)八4規格(210'乂 297公釐) 277 310112 27568897 A7 B7 五、發明说明 TLC: Rf 0.32(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.39 (1Η, brs), 8.67 (1H, brs), 7.90-7.70 (3H, m), 7.49 (2H, dt J=7.5Hz), 7.37 (2H, t, J=7.5Hz), 7.27 (lHt ζ J=7.5Hz), 6.99 (2H, d, J=9.0Hz), 6.35-6.25 (1H, brs), 4.56 (2H, s), 4.25-4.05 (lHf m), 4.00-3.90 (2H, m), 3.59 (2H, ζ J=5.4Hz), 3.55-3.40 (2Ht m), 3.24 (3H, s), 2.70-2.55 (2H, m), 2.30-2.10 (1H,m),L80-1.60 (2H,m),1.03 (3H, d,J=6.9Hz)。 V m m AQ (2Q) N-羥基- 2(S)_甲基-5 -甲氧基甲氧基-4(S)-[H-(4-苯 氧基笨羰基)胺基]戊醸胺 (¾先閱讀背面之注意事項再硪寫本頁) .och3 〇
邵 中 •λ il 導 义;j f /v ίί 卬 TLC: Rf 0.49(氛仿••甲酵:乙酸:水=100:10:1:1); NMR (d6-DMSO) : δ 10.38(1H, d, J=1.5Hz), 8.66(1H, d, J=1.5Hz), 8.05(1H, d, J=8.4Hz)t 7.88(2H, d, J=8.7Hz), 7.45-7.40(2Ht m), 7.22-7.17(1H, m), 7.08-7.01(4H, m), 4.55(2H, s), 4.21-4.08(1H, m), 3.52-3.44(2H, m), 3.22(3H? s), 2.25-2·09(1Η, m),1.67(2H,t,J=7.2Hz),1.01(3H,d, J=6.6Hz)。 啻施例49 ( 40 ) N-羥基-2(S)-甲基-5-甲氧基甲氧基- 4(S)-[N-[4-[2-(4-氯苯基)乙烯基]苯羰基]胺基]戊醢胺 本紙張尺度適州中國國家標準(CNS ) Λ4規格(210X297公釐) 278 310112 568897 A7 五、發明説明( ,och3 HO- TLC: Rf 0.41(氯仿··甲酵:乙酸:水=100:10:1:1); NMR (d6-DMS0) : δ 10.39(1H, s), 8.67(1H, s), 8.10(1H, d, J=8.6Hz), 7.86(2H, d, J=8.4HzX 7.70-7.63(4H? m), 7.45(2Ht d, J=8.6Hz), 7.40(1H, d, J=16.6Hz), 7.31(1H, d, J=16.6Hz)y 4.56(2H, s), 4.25-4.08 (1H, m), 3.57-3.41(2H, m), 3.23(3H, s),2·25-2·15(1Η, m), 1·68(2Η,t,J=6.6Hz),1·02(3Η,d,J=7.0Hz)〇 實施..拠_4_9J_1.LL. N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4-(4-丙基笨基)苯羰基]胺基]戊醢胺 (誚先閱讀背面之注意事項再填寫本頁
、1T r och3 d 部 十 •ν';
消 A 卬 V TLC ·· Rf 0· 31 (氯仿:甲酵=10 : 1); NMR (dg-DMSO) : δ 10.39 (1Η, brs), 8.67 (1H, brs), 8.14 (1H, d, J=8.7Hz), 7.93 (2H,d,J=8.4Hz),7·73 (2H, d,J=8.4Hz), 7·63 (2H,d, J=8.1Hz), 7.30 (2H,d, J=8.1Hz), 4.56 (2H ,s)t 4.24-4.12 (1H, m), 3.55-3.44 (2H, m), 3.23 (3H, s), 2.59 (2H, t, J=7.2Hz), 2.26-2.35 (1H, m), 1.73-1.65 (2H, m), 1.61 (2H, m), L03 (3H, d, J=6.9Hz), 0·91 (3H,t,J=7.2Hz)。 本紙张尺度適1彳]中围國家標準(CNS ) A4規格(210X297公釐) 279 310112 568897 A7 B7 五、發明説明( 管施例49 (42丄 N-羥基- 2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4-(苯 并I*吩-2-基)笨羰基]胺基]戊醢胺 ,och3
ο TLC : Rf 0.33(氛仿:甲酵=10:1); NMR (d6-DMS0) :δ 10.40 (1H, brs), 8.68 (lHt brs)T 8.19 (1H, d, J=9.0Hz), 8.01-7.94 (4H, m), 7.88-7.85 (3H, m), 7.44-7.35 (2H, m), 4.57 (2H, s), 4.24-4.12 (1H, m), 3.55-3.45 (2H, m), 3.24 (3H, s), 2.26-2.15 (1H, m), 1.77-1.62 (2H, m), 1.04 (3H, d, J=6,6Hz)〇 謇_例4 9 U 3) N-羥基-2(S)-甲基-5 -甲氧基甲氧基-4(S)-[N-[4-(3 甲氧基笨氧基)苯羰基]胺基]戊醢胺 ^och3 〇
0 (讀先閱讀背面之注意事項再楨寫本S ) ‘och3 TLC: Rf 0.38(氛仿:甲酵:乙酸:水=100:10:1:1); 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 280 310112 568897 A 7 ________ Η*7 五、發明説明(28i) —— NMR (d6-DMS〇) : δ 10.36 (s, 1H), 8.67 (s, 1H), 7.87 (d, J= 8.8Hz, 2H), 7.32 (π% 1H), 7.05 (d, J=8.8Hz, 2H), 6.77 (m, 1H), 6.63 (m, 1H)? 6.60 (m? 1H), 4.55 (s, 2H), 4.15 (m, 1H), 3.74 (s, 3H), 3.22 (s, 3H), 2.18 (m, 1H), 1.66 (m, 2H), 1.02 (d, J=6.6Hz? 3H)〇 窨 _ 例 49 (4 A) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[卜[4-M-甲氧基苯氧基)苯羰基]胺基]戊醯胺 ^och3 〇
TLC: Rf 0·45(氛仿:甲醇=9:1); NMR (dg-DMSO) : δ 10.50-10.20 (br, lH)t 8.80-8,50 (br, 1H), 8.01 (d, J=8.4Hz, lH), 7.85 (d, J=8.7Hz, 2H)? 7.05 (d, J=9.2Hz, 2H), 6.99 (d, J=9.2Hz, 2H), 6.94 (d, J=8.7Hz, 2H), 4.56 (s, 2H), 4.25-4.05 (m, 1H), 3.77 (s, 3H)? 3.55-3.40 (m, 2H), 3.23 (s, 3H), 2.30-2.10 (m, 1H), 1.80-1.60 (m, 2H), 1.02 (d, J=6.9Hz, 3H)〇 經濟部中央標準局員工消費合作社印製 例 牖 7 基 基羰 羥苯 N-基 醸 甲
H
苯 o 本紙張尺度適用中國國家標準(CNS) A4規格(210X29祕t ) 281 310112 568897 28
A Η* 五、發明説明( TLC: Rf 〇.36(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.38 (1Η, s), 8.66 (1H, s), 8.31 (1H, d, J=8.1Hz), 7.98 (2H, d, J=8.7Hz), 7.79-7.65 (5H, m), 7.55 (2H, t, J=7.5Hz), 4.55 (2H, s), 4.24-4.12 (1H , m), 3.52-3.42 (2H, m), 3.21 (3H, s), 2.25-2.13 (1H, m), 1.71-1.63 (2H, m), 1.01 (3H,d,J=6.9Hz)。 奮淪例49 (46 )_ N-羥基_2(S) -甲基-5-甲氧基甲氧基-4(S)-[N-[4_( 萘-2-基)苯羰基]胺基]戊醸胺 (請先閱讀背面之注意事項再填寫本頁) ο /〇CH3 Ο
、1T 經濟部中央標準局員工消費合作社印製 282 TLC: Rf 0.31(氯仿:甲酵:乙酸:水=100:10:1:1) NMR (d6-DMS〇) : δ 10.41 (br, 1Η), 8.68 (br, 1H)T 8.30 (s, 1H), 8.05-7.9 (m, 8H), 7.6-7.5 (m, 2H), 4.58 (s, 2H), 4.20 (m, 1H), 3.51 (m, 2H), 3.24 (s, 3H), 2.01 (m, 1H),1.72 (m,2H), 1·04 (d,J=6.6Hz, 3H)〇 謇施例49 U7) N-羥基-2(S)_甲基-5-甲氧基甲氧基-4(S)-[N-[4-[( 4-甲氧基聯苯- 4’-基)氧基]笨羰基]胺基]戊醢胺 .och3
本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公楚) 310112 568897 28 Λ
IV 五、發明説明( TLC: Rf 0.34 (氯仿:甲醇=9 : 1); NMR (d6-DMS0) : δ 10.60-10.35 (br, 1H), 8.80-8.60 (br, 1H), 8.11 (d, J = 8·4Ηζ,1H),7.94 (d,J = 8·4Ηζ,2H), 7.66 (d, J = 8·8Ηζ,2H), 7.59 (d,J = 8.8Hz,2H), 7.20-6.95 (m, 6H), 4.57 (s, 2H), 4.30-4.10 (m, 1H), 3.81 (s, 3H), 3.60-3.40 (m, 2H), 3·25 (s,3H), 2.40-2.10 (m,1H), 1.90-1.60 (m,2H),1.04 (d,J = 6·6Ηζ,3H)〇 奮捕s例49 u?n 卜羥基-2(S)-甲基-5-甲氧基甲氧基-4 (S )-[N-[4-(4 乙氧苯基)苯羰基]胺基]戊醯胺 ,och3 --------·ι裝— (請先閱讀背面之注意事項再填寫本頁) Ο Ο
OCH2CH3 經濟部中央標準局員工消費合作社印裝 TLC: Rf 〇·41 (氯仿:甲酵=10:1); NMR (d6-DMSO) : ^ 10.39(lH,brs),8.67(lH,brs),8.11(lH,d,J=8.7Hz), 7.91 (2H, d, J=8.1Hz), 7.70 (2H, d, J=8.1Hz), 7.66 (2H, d, J=8.7Hz), 7.02 (2H, d, J=8.7Hz), 4.56 (2H, s), 4.24-4.12 (1H, m), 4.07 (2H, q, J=6.9Hz), 3.54-3.44 (2H, m), 3.23 (3H, s), 2.26-2.34 (1H, m), 1.73-1.65 (2H, m), 1.34 (3H, t, J=6.9Hz)? 1.03 (3H, d,J=6.9Hz)。 實胞例4Q Mft丨 H-羥基-2(S) -甲基-5 -甲氧基甲氧基_4(s) 一 [n_[4_(4 笨氧基笨基)苯羰基]胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公势) 283 310112 568897 Λ·? h1 五、發明説明( 2 84 ,OCH3 ο
ο j〇 TLC: Rf 0·43(氯仿:甲醇=10:1); NMR (dg-DMSO) : δ 10.40 (1H, brs), 8.67 (1H, brs), 8.14 (1H, d, J=8.6Hz), 7.94 (2H, d, J=8.4Hz), 7.75 (2H, d, J=8.8Hz), 7.74 (2H, d, J=8.4Hz), 7.46-7.38 (2H, m), 7.21-7.05 (3H, m), 7.10 (2H? d, J=8.8Hz), 4.57 (2H, s), 4.27-4.10 (1H, m), 3.58-3.42 (2H, m), 3.23 (3H, s), 2.29-2.12 (1H, m), 1.73-1.66 (2H, m), 1.03 (3H, d, J=6.6Hz)〇 萱施例4 Q ( S ft) N-羥基- 2(S) -甲基-5 -甲氧基甲氧基-4(S)-[N-[4-(3 氰甲基笨基)苯羰基]胺基]戊醯胺 ,och3 (請先閲讀背面之注意事項再填寫本頁) ·ί裝.
、1T 經濟部中央標準局負工消費合作社印製 ο
TLC: Rf 0.40(氯仿:甲醇=10:1); 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公t ) 284 310112 568897 Λ ? Η" 285 五、發明説明( NMR (d6-DMS0) : δ 10.40 (1H, brs), 8.67 (1H, brs), 8.18 (1H, d, J=8.7Hz), 7.96 (2H, d, J=8.4Hz), 7.76 (2H, d, J=8.4Hz), 7.70 (1H, s), 7.69 (1H, d, J=7.8Hz), 7.52 (1H, t, J=7.8Hz), 7.39 (1H, d, J=7.8Hz), 4.57 (2H, s), 4.24-4.13 (1H, m)? 4.11 (2H, s), 3.52 (1H, dd, J=5.3, 9.9Hz), 3.47 (1H, dd, J=6.0, 9.9Hz), 3.23 (3H? s), 2.27-2.34 (1H, m), 1.77-1.62 (2H, m), 1.03 (3H, d, J=6.6Hz)〇 窨淪例49 (51) 羥基_2(S)_甲基-5-甲氧基甲氧基-4(S)-[N-[4-( 聯苯-4-基)笨羰基]胺基]戊醯胺 (0(ΪΗ3„〇W〇° Ο
(請先閱讀背面之注意事項再填寫本頁) •I裝. 經濟部中央標準局員工消費合作社印製 TLC: Rf 〇·26(氯仿:甲酵:乙酸··水=100:10:1:1); NMR (d6-DMS0) : δ 10.40 (br, 1Η), 8.67 (br, 1H), 8.18 (d, J = 8.8Hz, 1H), 7.96 (d, J = 8.5Hz, 2H), 7.85-7.75 (m, 6H), 7.73 (m, 2H), 7.49 (m, 2H), 7.39 (m, 1H), 4.57 (s, 2H), 4.19 (m, 1H), 3.50 (m, 2H), 3.24 (s, 3H), 2.21 (m, 1H), 1.70 (n% 2H), 1.03 (d, J = 6.6Hz, 3H)〇 宭淪例4 9 ( 5 2丄 N-羥基- 2(S)_甲基甲氧基甲氧基- 4(S)-[N-[4-(3-羥基苯氧基)苯羰基]胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公# ) 285 310112 568897
Λ }V 五、發明説明(286 ) -OCH3 η
TLC: Rf 0.17(氯仿•·甲醇:乙酸:水=100:10:1:1); NMR (d6-DMS〇) : δ 10.32 (br, 1H), 8.67 (br, 1H), 8.04 (d, J = 8.8Hz, 1H), 7.87 (d, J = 8.8Hz, 2H), 7.18 (t, J = 8.2Hz, 1H), 7.02 (d, J = 8.8Hz, 2H), 6.58 (m, 1H), 6.45 (m, 1H), 6.40 (m, 1H), 4.55 (s, 2H), 4.15 (m, 1H), 3.47 (m, 2H), 3.22 (s, 3H)T 2.07 (m7 1H), 1.66 (m, 2H), 1.01 (d, J=6.9Hz, 3H)〇 管 _ 俐 4 9 ( 5 3) N -羥基-2(S)_甲基-5-甲氧基甲氧基-4(S)-[N-[4-[2-(4 -甲基笨基)乙炔基]苯羰基]胺基]戊醢胺 /〇CH3 (請先閱讀背面之注意事項再填寫本頁) ¾衣·
、1T 經濟部中央標準局員工消費合作社印製
ch3 、TLC: Rf 0.23(氛仿:甲酵=19:1); NMR (d6-DMS〇) : S 10.40 (1H, s), 8.21 (1H, d, J=8.4Hz), 7.90 (2H, d, J=8.4Hz)T 7.61 (2H, d, J=8.4Hz), 7.47 (2H, d, J=8.0Hz), 7.25 (2H, d, J=8.0Hz), 4.57 (2H, s)t 4.30- 4.10 (1H, m), 3.60-3.40 (2H, m), 3.24 (3H, s), 2.35 (3H, s)? 2.28-2.10 (1H,m), 1.78-1.60 (2H, m),1.04 (3H,d, J=7.0Hz)。 本紙張尺度適用中國國家標率(CNS ) Α4規格(210Χ 297公籍) 286 310112 568897 A }Γ 2 87 五、發明説明( 實渝例49 (54) N-羥基-2(S)_甲基-5-甲氧基甲氧基-4(S)-[N-[4-(4 羥基苯氧基)苯羰基]胺基]戊醯胺 ,och3 η
TLC: Rf 0.23(氯仿:甲酵=9:1); NMR (d6-DMS〇) : ί 10.38 (s, 1H), 9.41 (s, 1H), 8.67 (s, 1H), 7.98 (d, J = 8.7Hz, 1H), 7.84 (d, J = 8.9Hz, 2H), 6.95-6.85 (m, 4H), 6.81 (d, J = 8.9Hz, 2H), 4.56 (s, 2H), 4.25-4.10 (m, 1H), 3.55-3.40 (m, 2H), 3.24 (s, 3H), 2.25-2.10 (m, 1H), 1.70-1.60 (m, 2H), 1.03 (d, J = 6.9Hz, 3H)〇 窗淪例4 9 ( 5 5 ) N-羥基- 2(S)_甲基-5 -甲氧基甲氧基-4(S)-[N-[4 - ( 4 氯苯基)苯羰基]胺基]戊醯胺 經濟部中央標準局員工消費合作社印製 ,och3 ο ο
Cl TLC: Rf 0.39(氯仿:甲醇=10:1); (請先閲讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公犮) 287 10112 568897 Λ 7 五、發明説明(28δ) NMR (d6-DMS〇) : δ 10.40 (1H, d, J=1.8Hz), 8.67 (1H, d, J=1.8Hz)? 8.18 (1H, d, J=8.4Hz)? 7.95 (2H, d, J=8.4Hz), 7.76 (2H, d, J=8.4Hz), 7.76 (2H, d, J=8.7Hz), 7.54 (2H, d, J=8.7Hz), 4.56 (2H, s), 4.24-4.12 (1H, m), 3.55-3.44 (2H, m); 3.23 (3H, s),2.26-2.14 (1H,m),1·77-1·62 (2H, m),1.03 (3H,d,J=6.9Hz)。, 奮)例 4 9 f R R ) N-羥基-2(S)-甲基-5-甲氧基甲氧基- 4(S)-[N_[[5-( 4-甲氧基苯基)-2-α吩基]羰基]胺基]戊醃胺 r〇cH3
(請先閲讀背面之注意事項再填寫本頁) « ! "s s rr0CHa
Her TLC: Rf 0.29(氯仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.41 (s, 1H), 8.69 (s, 1H), 8.14 (d, J=8.7Hz, 1H), 7.75 (d, J=3.9Hz, lH), 7.63 (d, J=8.7Hz, 2H), 7.39 (d, J=3.9Hz, 1H), 7.00 (d, J=8.7Hz, 2H), 4.57 (s, 2H), 4.20-4.00 (m, 1H), 3.80 (s, 3H), 3.55-3.45 (m, 2H), 3.25 (s, 3H), 2.30-2.15 (m,1H), 1.68 (t,J=7.2Hz,2H),1.04 (d,J=6.9Hz,3H)。 窨施例4 9 ( S 7 ) 經濟部中央標準局員工消費合作社印製 N-羥基-2(S)-甲基-5-甲氧基甲氧基- 4(S)-[N-[4-[( 聯苯-3-基)氧基]苯羰基]胺基]戊醯胺 ^〇CH3 π
本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公髮) 288 310112 568897 A 7 _ Βη五、發明説明(289 ) TLC: Rf 0.42(氯仿·•甲醇:乙酸=100:10:1); NMR (d6-DMS〇) : δ 10.38(1H, s), 8.66(1H, s), 8.06(1H, d, J=8.4Hz), 7.90(2H, d, J=8.4Hz), 7.68-7.63(2H, m), 7.52-7.33(6H, m), 7.12-7.00(3H, m), 4.55(2H, s), 4.24-4.05(1H, m), 3.54-3.40(2H, m), 3.32(3H, s), 2.15-2.25(1H, m), 1.67(2H, ζ J=7.0Hz),1·01(3Η, d, J=7.0Hz)。 謇福例4 9 ( 5 8 ) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4-(l-己炔基)苯羰基]胺基]戊醯胺 .och3 Γ 〇
(請先閱讀背面之注意事項再填寫本頁) :裝- 、\呑 經濟部中央標準局員工消費合作社印製 TLC: Rf 0.49(氯仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.38 (1Η, s), 8.66 (1H, s), 8.13 (1H, d, J=8.8Hz), 7.82 (2H, d, J=8.4Hz), 7.44 (2H, d, J=8.4Hz), 4.56 (2H, s), 4.28-4.06 (1H, m), 3.60-3.40 (2H, m), 3.23 (3H, s), 2.43 (2H, ζ J=6.8Hz), 2.27-2.10 (1H, m), 1.74-1.46 (4H, m), 1.45-1.20 (4H, m), 1.03 (3H, t, J=6.6Hz), 0.90 (3H, t, J=7.0Hz)〇 啻碓例4 9 ( 5 9 ) N-羥基- 2(S)-甲基-5-甲氧基甲氧基- 4(S)-[N-[4-(3-苯氧基-1-丙炔基)苯羰基]胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS)Aet格(210X297公襲) 289 "^ 310 112 568897
Λ' IV 五、發明説明(29(>) ,OCHa Ο
Ο TLC: Rf 0.49(氯仿:甲酵=9:1); NMR (d6-DMS0) : δ 10.38 (1H, s), 8.66 (1H, s), 8.20 (1H, d, J=8.7Hz), 7.85 (2HT d, J=8.4HzX 7.52 (2H, d, J=8.4Hz), 7.37- 7.29 (2H, m), 7.08-6.96 (3H, m), 5.06 (2H, s), 4.55 (2H, s), 4.22-4.10 (1H, m), 3.55-3.40 (2H, m), 3.22 (3H, s), 2.24-2.12 (1H, m), 1.67-1.58 (2H, m), 1.02 (3H, d, J=6.9Hz)〇 審)fe 例 49 (60) N-羥基-2(S) -甲基-5-甲氧基甲氧基-4(S)-[N-[4-(4 氰苯基)苯羰基]胺基]戊醯胺 .och3 (請先閲讀背面之注意事項再填寫本頁) :裝·
、1T 經濟部中央標準局員工消費合作社印製 Ο ο
CN TLC: Rf 0.34(氯仿··甲酵=10:1); 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公楚) 290 310112 568897 五、發明説明(291) NMR (d6-DMS0) : S 10.40 (1H, d, J=1.5Hz), 8.67 (1H, d, J=1.5Hz), 8.22 (1H, d, J=8.7Hz), 7.98 (2H, d, J=8.4Hz), 7.95 (4H, s), 7.85 (2H, d, J=8.4Hz), 4.56 (2H, sX 4.24-4.32 (1H, m), 3.55-3.45 (2H, m), 3.23 (3H, s), 2.26-2.15 (1H, m), 1.77-1.62 (2H, m), 1.03 (3H, dt J=6.9Hz)〇 g _ 俐 4 9 ( 6 1) N-羥基-2(S)_甲基-5-甲氧基甲氧基- 4(S)-[N-[4-(3-氰基苯基)笨羰基]胺基]戊醯胺 (請先閱讀背面之注意事項再填寫本頁) och3
TLC: Rf 0.35(氯仿:甲酵=1〇:1); 經濟部中央標準局員工消費合作社印袋 NMR (dg-DMSO) : δ 10.40 (1Η, d, J=1.5Hz), 8.67 (1H, d, J=1.5Hz), 8.24 (1H, t, J=1.5Hz), 8.21 (1H, d, J=8.7Hz), 8.10-8.07 (1H, m), 7.97 (2H, d, J=8.4Hz), 7.88-7.84 (1H, m), 7.85 (2H? d, J=8.4Hz), 7.69 (1H, t, J=7.8Hz), 4.57 (2H, s), 4.24-4.13 (1H, m), 3.55-3.45 (2H, m), 3.23 (3H, s), 2.26-2.15 (1H, m), 1.77-1.62 (2H, m), 1.03 (3H, d,J=6.9Hz)。 g 倫例 4 9 ( 6 2 ) N-羥基-2(S)_甲基-5-甲氧基甲氧基卞 基苯羰基)胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公赴) 291 310112 568897 A7 ΗΊ 2 9 2 五、發明説明() och3 hct
TLC: Rf 0.43(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.34 (1H, s), 8.64 (1H, s), 7.98 (1H, d, J=8.4Hz), 7.74 (2H, d, J=8.1Hz), 7.30-7.12 (7H, m), 4.52 (2H , s), 4.16-4.07 (1H, m), 3.96 (2H, s), 3.50-3.38 (2H, m), 3.19 (3H , s), 2.19-2.09 (1H, m), 1.64 (2H, t, J=7.4Hz), 0.98 (3H, d, J=6.6Hz)〇 奩)fe 俐 A9 (63) N -羥基-2(S)_甲基-5-甲氧基甲氧基-4(S)-[N-[4-[ 2E-(吡啶-4 -基)乙烯基]苯羰基]胺基]戊醢胺 /OCH3 (請先閲讀背面之注意事項再填寫本頁) 、-口
經濟部中央標準局員工消費合作社印製 TLC: Rf 0.18(氯仿:甲酵··乙酸=100:10:1); NM R (d6-DMS〇) : δ 10.42(1H, s), 8.67(1H, d, J=1.5Hz), 8.56(2H, d, J=6.0Hz), 8.16(1H, d, J=8.4Hz)T 7.89(2H, d, J=8.4Hz), 7.73(2H, d, J=8.4Hz), 7.59(1H, d, J=16.5Hz), 7.57(2H, d, J=6.0Hz)r 7.36(1H, d, J=16.5Hz), 4.56(2H, s), 4.23-4.08(lH, m), 3.54-3.44(2H, m), 3.22(3H, s), 2.28-2.15(1H, m), 1.72-1.66(2H, m), 1.02(3H, d, J=6.6Hz)〇 本紙張尺度適用中國國家標準(CNS ) A4規枱(210X 297公龄) 292 310112 568897 Λ? Η*7 五、發明説明(2 93 ) 實_施锎Λ Q ( 6 4 ) Ν -經基- 2(S)_甲基-5-甲氧基甲氧基- 4(S)-[N-[4-(苯 并嗒唑-2-基)苯羰基])胺基]戊醯胺 ,och3 〇
(請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 TLC: Rf 0.28(氯仿·•甲酵=10:1); NMR (d6-DMS0) : δ 10.41 (1Η, brs), 8.68 (1Η, brs), 8.35 (1Η, d, J=8.8Hz), 8.28 (2H, d, J=8.4Hz), 8.07 (2H, d, J=8.4Hz), 7.86-7.80 (2H, m), 7.51-7.38 (2H? m), 4.57 (2H, s), 4.28-4.11 (1H, m), 3.59-3.42 (2H, m), 3.24 (3H, s), 2.30-2.13 (1H, m), 1.8M.59 (2H, m), 1.04 (3H, d, J=6.6Hz)〇 當 _ 俐 4 9 ( fi ΡΠ N-羥基- 2(S) -甲基-5-甲氧基甲氧基- 4(S)-[N-[4-(3 乙氧基笨基)苯羰基]胺基]戊醯胺 ο ο 少 och3
ο. 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210X297公始) 293 310112 、-口 568897 Λ? _____h1 五、發明説明(294 ) … TLC : Rf 0 · 35 (氯仿:甲醇=1〇 : 1); NMR (d6-DMS0) : δ 10.39 (brs, 1H), 8.67 (brs, 1H), 8.16 (d, J = 8.4Hz, 1H), 7-93 (d, J = 8.12Hz, 2H), 7.75 (d, J = 8.1Hz, 2H), 7.38 (ζ J = 8.1Hz, 1H), 7.26 (br.d, J = 8.1Hz, 1H), 7.22 (brs, 1H)? 6.96 (dd, J = 8.1, 2.1Hz, 1H), 4.57 (s, 2H), 4.24-4.13 (m? 1H), 4.10 (q, J = 7.2Hz, 2H), 3.55-3.45 (m, 2H)? 3.23 (s, 3H), 2.26-2.14 (m, 1H), 1.77-1.62 (m,2H),1·35 (t,J = 7.2Hz,3H), 1.03 (d,J = 6.6Hz,3H)〇 實施例49 (66 ) N-羥基-2(S)-甲基-5-甲氧基甲氧基- 4(S)-[N-[4-(4-甲基苯羰基胺基)笨羰基]胺基]戊醢胺 (請先閱讀背面之注意事項再填寫本頁) :裝· •och3
TLC : Rf 0·22(氯仿:甲醇=9:1); 經濟部中央標準局員工消費合作社印製 NMR (d6-DMS0) : δ 10.38 (brs, 1H), 8.05 (d, J=8.4Hz, 1H), 7.96-7.84 (m, 6H), 7.34 (d, J=8.1Hz, 2H), 4.57 (s, 2H), 4.25-4.10 (m, 1H), 3.60-3.40 (m, 2H), 3.25 (s, 3H), 2.40 (s, 3H), 2.30-2.15 (m, 1H), 1.85-1.60 (m, 2H), 1.04 (d, J=6.9Hz, 3H)〇 實 1例._.4 9 ( 67 ) N-羥基- 2(S)-甲基-5-甲氧基甲氧基- 4(S)-[N-[[5-[ 2-(4-甲基笨基-2-]笨羰基]胺基]戊醸胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公蝥) 294 310112 568897 Λ· ir 五、發明説明( 2 95、
ch3 O TLC: Rf 0·27(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.41 (s, 1H), 8.69 (s, 1H), 8.31 (d, J= 8.7Hz, 1H), 7.77 (d, J= 4.1Hz, 1H), 7.46 (d, J =7.8Hz, 2H), 7.39 (d, J=4.1Hz, 1H), 7.26 (d, J=7.8Hz, 2H), 4.57 (s, 2H), 4.20-4.00 (m, 1H), 3.60-3.40 (m, 2H), 3.24 (s, 3H), 2.35 (s, 2H), 2.20 (m, 1H), 1.68 (t, J=7.2Hz, 2H), 1.03 (d, J=6.9Hz, 3H)〇 (請先閲讀背面之注意事項再填寫本頁) -繫· 經濟部中央標準局員工消費合作社印製 奮淪俐49 (68)〜49 使用對應化合物替代實施例44(4)〜44(6)、44(10)製 造之化合物或參考例4製造之化合物,依實施例374實施 例394實施例41(使用對應化合物替代甲氧基甲基氯4實 施例43(使用碘化甲烷替代苄基溴)-> 實施例44所示方法相 同操作所得之化合物,依實施例49所示方法相同操作所得 下列化合物。 管嫵例49 (68) 羥基- 2(S)_甲基-5-(2-甲氧基乙氧基)甲氧基-4(S) 苯氧基苯羰基)胺基]戊醢胺.0, r och3 ο
、v" 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公飨) 295 310112 568897 Λ 7 Β1五、發明説明(296 ) TLC: Rf 0·43(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.35 (1Η, s), 8.64 (1H, s), 8.01 (1H, d, J=8.7Hz), 7.85 (2H, d, J=8.7Hz), 7.41 (2H, t, J=7.7Hz), 7.17 (1H, t, J=7.7Hz), 7.04 (2H, d, J=7.7Hz), 7.00 (2H, d, J=8.7Hz), 4.59 (2H, s), 4.18-4.06 (1H , m), 3.55-3.37 (6H, m), 3.19 (3H,s), 2·15 (1H,m),1.68-1.60 (2H,m),0.99 (3H,d,J=6.6Hz)。 啻 _ 例 49 (69 ) N-羥基-2(S)-甲基-5-第三丁基羰氧基- 4(S)-[N-(4-苯氧基笨羰基)胺基]戊醢胺
(請先閱讀背面之注意事項再頊寫本頁) :裝·
、1T 經濟部中央標準局員工消費合作社印裝 TLC: Rf 0.52(氯仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.38 (1Η, s), 8.07 (1H, d? J=9.0Hz), 7.82 (2H, d, J=8.7Hz), 7.41 (2H, t, J=7.7Hz), 7.18 (1H, t, J=7*7Hz), 7.07-6.99 (4H, m), 4.30-4.18 (1H, m), 4.07-3.94 (2H, m), 2.20-2.1 1 (1H, m), 1.73-1.49 (2H, m), 1.06 (9H, s), 0.99(3H,d,J=6.6Hz)。 啻施例49 (70) N-羥基-2(S) -甲基-5-苄氧基甲氧基-4(S)-[N-(4-苯 氧基苯羰基)胺基]戊醯胺 本紙張尺度適用中國國家標準(CNS)A4規格(210X 297公漦) 296 ο
TLC: Rf 0·40(氯仿:甲醇:乙酸••水= ι〇〇:ι〇:ι:ι); 經濟部中央標準局員工消費合作社印衆 568897 Λ'' ____ ΙΓ 五、發明説明(297) r〇J〇 NMR (d6-DMS0) : δ 10.38 (s, 1H), 8.64 (s, 1H), 8.07 (d, J = 8.5Hz, 1H), 7.88 (d, J = 8.8Hz, 2H), 7.45-7.4 (m, 2H), 7.35-7.25 (m, 5HX 7.19 (t, J = 7.4Hz, 1H), 7.05 (d, J = 8.8Hz, 2H), 7.01 (d, J = 8.5Hz, 2H), 4.70 (s, 2H), 4.50 (s, 2H), 4.18 (m, 1H), 3.58 (d, J = 11.3Hz, 1H), 3.53 (d, J = 11.3Hz, 1H), 2.19 (m, 1H), 1.30 (m, 2H), 1.01 (d, J = 6.9Hz, 3H)〇 置施例49 (7 1) N-羥基-2(S) -甲基-5-乙氧基甲氧基(反-4-甲基環己羰基)胺基]戊醢胺 OCH2CH3
T L C ·· R f 0 · 3 9 (氯仿:甲酵=1 ο ·· 1 ); NMR (d6-DMS〇) : δ 10.37 (brs, 1H), 8.66 (brs, 1H), 7.39 (d, J=8.4Hz? 1H), 4.56 (s, 2H), 3.89-3.77 (m, 1H), 3.47 (q, J=7.2Hz, 2H), 3.38-3.28 (m, 2H), 2.14-1.92 (m, 2H), 1.74-1.59 (m, 4H), L56-1.46 (m, 2H), 1.40-1.21 (m, 3H), 1.10 (t, J=7.2Hz, 3H), 0.95 (d, J=6.9Hz, 3H), 0.93-0.78 (m, 2H), 0.84 (d, J=6.6Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公# ) 2 9 7 3 1 0 1 1 2 (請先閲讀背面之注意事項再填寫本頁)
568897 A Η* 五、發明説明(298) 啻施例49 (72) N-羥基-2CS)-甲基 基苯羰基)胺基]戊醸胺 -乙氧基甲氧基-4 (S) - [Ν- (4-甲 ,OCH2CH3
ch3 TLC: Rf 0.29(氯仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.35 (s, 1H), 8.63 (brs, 1H), 7.95 (d, J=8.8Hz, 1H), 7.72 (d, J=8.0Hz, 2H), 7.22 (d, J=8.0Hz, 2H), 4.58 (s, 2H), 4.18-4.04 (m, 1H), 3.53-3.39 (m, 4H), 2.32 (s, 3H), 2.15 (m, 1H), 1.64 (t, J=7.4Hz? 2H), 1.06 (ζ J=7.1Hz, 3H), 0.99 (d, J=7.0Hz, 3H)〇 窗)fe 例 4 9 ( 7 3) N-羥基-2(S)-甲基-5-乙氧基甲氧基- 4(S)-[N-(4-氛 苯羰基)胺基]戊醢胺 經濟部中央標準局員工消費合作社印製 ,OCH2CH3 〇
Cl TLC: Rf 0·44(氯仿:甲酵=9:1); (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公魅) 298 310112 568897 Λ? ΪΠ 五、發明説明(2") NMR (d6-DMS0) : δ 10.36 (s, 1H), 8.15 (d, J = 8.4Hz, 1H), 7.83 (d, J = 8.8Hz, 2H), 7.50 (d, J = 8.8Hz, 2H), 4.57 (s, 2H), 4.21-4.06 (m, 1H), 3.53-3.38 (m? 4H), 2.22-2.10 (m, 1H), 1.64 (t, J = 7.0Hz, 2H), 1.06 (ζ J = 6.9Hz, 3H), 0.99 (d, J = 6.6Hz, 3H)〇 奮淪例4 9 ( 7 4 ) N-羥基-2(S)-甲基-5-乙氧基甲氧基- 4(S)-[N-(金剛 烷羰基)胺基]戊醯胺 och2ch3
TLC: Rf 0 ♦ 46 (氯仿:甲酵=9 : 1); NMR (d6-DMSO):汐 1〇·35 (s, 1H),8.63 (s, 1H),6.80 (d, J = 9·0Ηζ,1H),4.54 (s? 2H), 3.94-3.83 (m, 1H), 3.43 (q, J = 7.2Hz, 2H), 3.36-3.24 (m, 2H), 2.14-2.02 (m, 1H), L96-1.88 (m, 3H), 1.76-1.45 (m, 14H), 1.09 (t, J = 7.2Hz, 3H), 0.92 (d, J = 6.6Hz, 3H)〇 (請先閲讀背面之注意事項再填寫本頁)
經濟部中央標準局員工消費合作社印製 基 羥 胺 醯 戊 TJ 基 胺 \J/ 羰 喃 基 氧 甲 基 氧 乙- 5- 基 甲 呋 3 I oc Γο NH HNb Η ο 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公t ) 299 310112 568897 甲醇=9 : 1) r〇CH2CH3 0
經濟部中央標準局員工消费合作社印製 Λ'} Β1 五、發明説明(3〇0) TLC : Rf 〇 . 24 (氯仿 NMR (d6-DMS〇) : δ 10.34 (s, 1H), 8.63 (s, 1H), 7.96 (d, J = 8.4Hz, 1H), 7.80-7.79 (m, 1H), 7.06 (d? J = 3.4Hz, 1H), 6.58 (dd, J = 3.4Hz, 1.7Hz, 1H), 4.56 (s, 2H), 4.15-4.02 (m, 1H), 3.51-3.38 (m, 4H), 2.18-2.04 (m, 1H), 1.61 (t, J=6^Hz, 2H), L06 (t, J = 7·1Ηζ,3H),0.97 (d,J= 6·8Ηζ,3H)。 管淪例49 (76丄 N-羥基_2(S)_甲基-5-乙氧基甲氧基-4(S)-[N-[(苯并 I*唑-6-基)羰基]胺基]戊醯胺 HO’· TLC: Rf 0.34(氯仿:甲酵=9:1); NMR (d6-DMS0) : δ 10.37 (s, 1H), 9.50 (s, 1H), 8.62 (d, J = 1.5 Hz, 1H), 8.23 (d, J = 8.4Hz, 1H), 8.12 (d, J = 8.7Hz, 1H), 7.97 (dd, J = 8.7Hz, 1.9Hz, 1H), 4.59 (s, 2H),4.21-4.11 (π% 1H),3.5 3- 3.42 (m,4H),2.25-2.14 (m,1H),1.72-1.61 (m,2H), 1.06 (t,J = 7.2Hz,3H),1.00 (d,J = 6·6Ηζ,3H)。 g 淪例 49 (77) N-羥基-2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-(4-氟 苯羰基)胺基]戊酿胺 ^och2ch3 (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規栘(210X297公楚) 300 310112 經濟部中央標準局員工消费合作社印製 568897 Λ? Q Λ 1 五、發明説明() TLC: Rf 〇·34(氯仿:甲醇=9:1); NM R (d6-DMS〇) : δ 10.36 (s, 1H), 8.09 (d, J = 8.7Hz, 1H), 7.88 (dd, J =5.7Hz, 9.0Hz, 2H), 7.26 (t, J = 9.0 Hz, 2H), 4.57 (s, 2H), 4.16-4.05 (my 1H), 3.50-3.41 (m, 4H), 2.15 (m, 1H), 1.68-1.61 (mt 2H), 1.06 (ζ J =7.0Hz, 3H), 0.98 (d, J = 6.8HzT 3H)〇 窨施例49 (78) N -羥基- 2(S) -甲基-5 -乙氧基甲氧基-4(S)-[N-[(2 -溴 呋喃-5-基)羰基]胺基]戊醢胺 z〇CH2CH3
TLC: Rf 0.28(氛仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.35 (s, 1H), 9.64 (s, 1H), 8.07 (d, J = 8.7Hz, 1H), 7.10 (d, J = 3.6Hz, 1H), 6.72 (d, J = 3.6Hz, 1H), 4.56 (s, 2H), 4.11-4.00 (m, 1H), 3.49-3.40 (m, 4H), 2.16-2.05 (m, 1H), 1.67-1.53 (m, 2H), 1.06 (t, J =7.2Hz, 3H), 0.97 (d, J = 6.3Hz? 3H)〇 審淪例4 9 f 7 9 1 N-羥基- 2(S) -甲基-5-乙氧基甲氧基- 4(S)-[N-(4-硝 基苯羰基)胺基]戊醯胺 (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公髮) 301 310112 568897
Λ }V 五、發明説明( 30 2 ,och2ch3
N〇2 TLC: Rf 0. 35 (氯仿:甲酵=9 : 1); NMR (d6-DMS〇) : δ 10.39 (brs, 1H), 8.66 (brs, 1H), 8.46 (brd, J = 8.8Hz, 1H), 8.30 (d, J = 8.8Hz, 1H), 8.06 (d, J = 8.8Hz, 2H), 4.59 (s, 2H), 4.15 (m, 1H), 3.50 (d, J = 5.8Hz, 1H), 3.47 (q, J = 6.8Hz? 2H), 2.17 (m, 1H), 1.67 (m, 2H), 1.07 (t, J = 6.8Hz, 3H), L02 (d, J = 6.8Hz, 3H)〇 置施例49 (80 )_ N -經基- 2(S)_甲基-5-乙氧基甲氧基-4(S)-[N-(4 -溴 苯羰基]胺基]戊醸胺 /OCH2CH3
Br (請先閱讀背面之注意事項再填寫本頁) •i裝· 經濟部中央標隼局員工消費合作社印製
TLC :Rf 0.35(二氯甲烷:甲醇= (9:1);
NMR (dg-DMSO) : ^ 1〇.37 (brs? 1H), 8.65 (brs, 1H), 8.17 (brd, J = 8.4Hz, 1H), 7.79 (d, J = 8.8Hzt 2H), 7.66 (d, J = 8.8Hzt 2H), 4.58 (s, 2H), 4.13 (m, 1H), 3.47 (d, J = 7.0Hz, 2H)? 3.47 (q, J = 7.0Hz, 2H), 2.16 (m, 1H), 1.65 (m, 2H), 1.07 (t, J = 7.0Hz, 3H), 1.01 (d, J = 6.6Hz, 3H)〇 V m m 49 CAUL 本紙張尺度適用中國國家標率(CNS ) A4規格(21〇X 297公t ) TOT 310112 568897 A"? Η 7 五、發明説明(3<>3) N-羥基-2(S) -甲基-5-乙氧基甲氧基-4(S)-[N-(4-氰 *笨羰基)胺基]戊醯胺 .OCH2CH3
CN TLC: Rf 0·24(氯仿:甲酵=19 : 1); NMR (dg-DMSO) : δ 10.39 (s, 1H), 8.67 (s, 1H), 8.36 (d, J = 8.7Hz, 1H), 8.00 (d, J = 8.4Hz, 2H), 7.95 (dt J = 8.4Hz, 2H), 4.60 (s, 2H), 4.22-4.08(m, 1H), 3.58-3.40 (m, 4H), 2.23-2.12 (m, 1H), 1.78-1.58 (m, 2H), L09 (t, J = 6.9Hz, 3H), 1.03 (d, J = 6.9Hz, 3H)〇 gJfe m 49(82) N-羥基- 2(S)-甲基-5-乙氧基甲氧基- 4(S)-[N-([4-( 4 -啦啶氧基)苯羰基]胺基]戊醯胺 (請先閲讀背面之注意事項再填寫本頁) •i裝·
、1T 經濟部中央標準局負工消费合作社印製 ,OCH2CH3
TLC: Rf 0.30(氯仿:甲酵=9:1); NM R (dg-DMSO) : δ 10.40 (s, 1H), 8.69 (s, 1H), 8.50 (dd, J = 4.7, 1.5Hz, 2H), 8.15 (d, J = 8.4Hz? 1H), 7.98 (dt J = 8.7Hz, 2H), 7.25 (d, J =: 8.7Hz, 2H), 6.97 (dd, J = 4.7, 1.5Hz, 2H), 4.62 (s, 2H), 4.30-4.10 (m, 1H), 3.60-3.40 (m, 4H), 2.30-2.10 (m, 1H), 1·80-1·60 (m,2H),U1 (t,J = 7·1Ηζ,3H), 1.04 (d,J = 6.9Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公犮) 303 310112
568897 Λ? Η*7 五、發明説明(3<>4) 奩 _ 例 49 ( 8 3 ) Ν-羥基-2(S) -甲基- 5-(2-甲氧基乙氧基)甲氧基- 4(S) -[N-(4-氰基苯羰基)胺基]戊醯胺
^〇v^OCH3 CN TLC: Rf 0.26(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.37 (s? 1H), 8.65 (s, 1H), 8.36 (d, J = 8.7Hz, 1H), 8.00-7.93 (m, 4H), 4.61 (s, 2H), 4.20-4.06 (m, 1H), 3.56-3.52 (m, 2H), 3.49 (d, J = 6.0Hz, 2H), 3.42-3.39 (m, 2H), 3.20 (s, 3H), 2.20-2.12 (m, 1H), 1.75-L58 (m, 2H), 1.01 (t,J = 6.9Hz,3H)〇 管淪例49 (84) N-羥基-2(S)_甲基-5-甲氧基甲氧基- 4(S)-[N-(4-氛 苯羰基)胺基]戊酿基 (請先閱讀背面之注意事項再填寫本頁)
經濟部中央標準局員工消費合作社印製 /OCH3
Cl TLC: Rf 0.50(二氯甲烷:甲酵=9:1); 本紙張尺度適用中國國家標準(CNS ) A4規栘(210X 297公蝥) 304 310112
經濟部中央標準局員工消费合作社印製 568897 A? B1 __ 五、發明説明(3°5) NMR (d6-DMS〇) : δ 10.36 (d, J = 1.8Hz, 1H), 8.64 (d, J = 1.8Hz, 1H), 8.17 (d, J = 8.4Hz, 1H), 7.85 (d, J = 8.4Hz, 2H), 7.51 (d, J = 8.4Hz? 2H), 4.53 (s, 2H), 4.11 (m, 1H), 3.46 (m, 2H), 3.20 (s, 3H), 2.16 (m, 1H), 1.65 (mT 2H), 1.00 (d, J = 6.6Hz, 3H)〇 奮 _ 例 49 (85) N-羥基-2(S)_甲基-5-苄氧基甲氧基-4(S)-[N-(4-氛 苯羧基)胺基]戊醢胺 r〇J〇 〇 TLC: Rf 0.50(二氯甲烷:甲醇=9:1); NMR (d6-DMS〇) : δ 10.36 (s, 1H), 8.64 (s, 1H), 8.19 (d, J = 8.4Hz, 1H), 7.86 (d, J = 9.0Hzt 2H), 7.51 (d, J = 9.0Hz, 2H), 7.28 (m, 5H), 4.69 (s, 2H), 4.49 (s, 2H), 4.15 (m, 1H), 3.54 (d, J = 6.0Hz, 2H), 2.17 (m, 1H), 1.68 (m, 2H), LOO (d, J = 6.9Hz, 3H)〇 g _ 例 49 (8β) N-羥基- 2(S)-甲基- 5-(2-甲氧基乙氧基(甲氧基-4(S) -[N-(4-氯苯羰基)胺基]戊醯胺 (請先閱讀背面之注意事項再填寫本頁) «裝· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公t ) 305 310112 568897 Λ? ηη五、發明説明(3G6)广〇、^〇(^3 〇
TLC: Rf 0·45(二氯甲烷·•甲酵=9:1); NMR (dg-DMSO) : δ 10.36 (s, 1H), 8.64 (s, 1H), 8.16 (d? J = 8.4Hz, 1H), 7.85 (d, J = 9.0Hz, 2H), 7.51 (d, J = 9.0Hz, 2H), 4.60 (s, 2H), 4.13 (m, 1H), 3.55-3.38 (m, 6H),3.19 (s,3H),2.14 (m,1H),1.65 (m,2H),1.00 (d, J = 6·9Ηζ,3H)。 奮淪例49 (87 ) N-羥基- 2(S)-甲基-5-乙氧基甲氧基- 4(S)-[H-(2-硝 基苯羰基)胺基]戊醢胺 (請先閱讀背面之注意事項再填寫本頁) •I裝·
、1T
經濟部中央標準局員工消費合作社印製 TLC : Rf 0.22(氯仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.39 (d, J=1.2Hz, 1H), 8.70 (d, J=1.2Hz, 1H), 8.45 (d, J=8.4Hz, 1H), 8.01 (dd, J=7.8Hzt 1.2Hz, 1H), 7.80-7.60 (m, 3H), 4.62 (s, 2H), 4.08-3.95 (m, 1H), 3.55-3.36 (m, 4H), 2.31-2.19 (m, 1H), 1.65 (t, J=7.2Hz, 2H), 1.12 (t, J=7.2Hzt 3H), 1.03 (d? J=7.2Hz, 3H)〇 奮嘸例49 (88) N-羥基- 2(S)_甲基-5-乙氧基甲氧基-4(S)-[N-(3-硝 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公犮) 306 — 3 1 0 1 1 2 568897 A"? Η*7 五、發明説明(3ί)7) 基苯羰基)胺基]戊醯胺 ^OCHaCh^ 〇
N〇2 TLC : Rf 0· 31 (氛仿:甲酵=9 ·· 1); NMR (d6-DMS〇) :δ 10.38 (s, 1Η), 8.69-8.68 (m, 1Η), 8.64 (brs, 1Η), 8.52 (d, J = 8.7Hz, 1H), 8.39-8.35 (m, 1H), 8.30-8.27 (m, 1H), 7.77 (ζ J = 8.1Hz, 1H), 4.60 (s, 2H), 4.24-4.11 (m, 1H), 3.52-3.44 (m, 4H), 2.22-2.11 (m, 1H), L78-1.60 (m, 2H), 1.08 (t, J = 7.2Hz, 3H), 1.02 (d, J = 6.9Hz, 3H)〇 g 淪俐 49 ( 89 ) N-羥基- 2(S) -甲基-5-乙氧基甲氧基-4(S)-[N-(2 -甲 氧基-4-硝基笨羰基)胺基]戊醢胺 r〇CH2CH3 Ο (請先閱讀背面之注意事項再填寫本頁) €衣·
、1T 經濟部中央標準局員工消費合作社印製 TLC: Rf 0.26(氛仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.38 (s, 1Η), 8.66 (brs, 1H), 8.09 (d, J = 8.4Hzt 1H), 7.87-7.77 (m, 3H), 4.61, (s, 2H), 4.14-4.02 (m, 1H), 3.95 (s, 3H), 3.53-3.43 (m, 4H), 2.25-2.13 (m, 1H), 1.75-1.55 (m, 2H), 1.09 (t, J = 6.9Hz, 3H), 1.02 (d, J = 6.9Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) A4规格(21〇><297公t ) 307 310112 568897
Λ· }V 3 08、 五、發明説明( 窖施例49 ( 9 0 ) N-羥基- 2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-(3-甲 氧基-4-硝基苯羰基)胺基]戊醯胺 ,och2ch3 〇
TLC: Rf 0..26(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.39 (s, 1H), 8.67 (s, 1H), 8.34 (d, J = 8.4Hz, 1H), 7.94 (d, J = 8.7Hz, 1H), 7.70 (d, J - 1.2Hz, 1H), 7.53 (dd, J = 8.7HzT 1.2Hz, 1H), 4.60 (s, 2H), 4.21-4.09 (m, 1H), 3.99 (s, 3H), 3.54-3.45 (m, 4H), 2.22-2.10 (m, 1H), L78-1.62 (m, 2H), 1.08 (t7 J = 6.9Hz, 3H), 1.02 (d, J = 6.9Hz, 3H)〇 奮 _ 例 49 (91) N-羥基-2(S) -甲基-5-乙氧基甲氧基-4(S)-[N-(3-羥 基-4-硝基苯羰基)胺基]戊醢胺 (請先閱讀背面之注意事項再填寫本頁) «裝·
、1T 經濟部中央標準局員工消費合作社印製 .〇CH2CH3 〇
TLC : Rf 0.22(氯仿:甲酵=9:1); 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公髮) 308 310112 經濟部中央標準局員工消費合作社印製 568897 Λ? Η*7 ‘_ 五、發明説明(3Q9) NMR (d6-DMS0) : δ 11.08 (s, 1H), 10.28 (s, 1H), 8.56 (s, 1H), 8.21 (d, J = 8.7Hz, 1H), 7.84 (d, J = 8.4Hz, 1H), 7.43 (d, J = 1.8Hzt 1H), 7.28 (dd, J = 8.4Hz? 1.8Hz, 1H), 4.49 (s, 2H), 4.08-3.95 (m, 1H), 3.41-3.34 (m, 4H), 2.12-2.01 (m, 1H), 1.58-1.53 (m, 2H), 0.99 (t7 J = 6.9Hz, 3H), 0.91 (d, J = 6.9Hz, 3H)〇 啻淪例4 (92) N-羥基-2(S)-甲基-5_乙氧基甲氧基_4(S) - [Ν·([二 羥基硼基笨羰基)胺基]戊醯胺 r〇CH2CH3 Ο
TLC: Rf 0.19:(二氛甲氛:甲酵: =18:1:1); NMR (dg-DMSO) : δ 10.37 (s, 1H), 8.65 (s, 1H), 8.16 (s, 2H), 8.05 (d, J = 8.4Hz, 1H), 7.83 (d, J = 8.4Hz, 2H), 7.77 (d, J = 8.4Hz? 2H), 4.58 (s, 2H), 4.14 (m, 1H), 3.47 (mT 4H), 2.16 (m, 1H), L66 (m, 2H), L07 (t, J =6.9Hz, 3H), 1.01 (d, J = 6.9Hz, 3H)〇 g MS m 49(9 3)-^ 49Π11) 使用對應化合物替代實施例44(7)、44(12)、44(13) 、44(15)、 44(16)、 44(22)、 44(23)、 44(27)或參考例 4 製造之化合物,依實施例374實施例39 —實施例41(使用 對應化合物替代甲氧基甲基氛實施例43 (使用碘化甲烷 替代苄基溴實施例49所示方法相同操作所得之化合物, 本纸張尺度適用中國國家標準(CNS )六4規掐(210X 297公f ) 3 0 9 ΤΠΓΤΤΤ^ (請先閱讀背面之注意事項再填寫本頁) ¾衣·
、1T 568897 Η1 /310 五、發明説明f 依實施例49所示方法相同操作,得下列化合物。 g 淪例 4 9 ( 9 3 ) N-羥基-2(S)-異丁基-5-甲氧基甲氧基- 4(S)-[N-(4-苯 氧基苯羰基)胺基]戊醸胺
〇X) (請先閱讀背面之注意事項再填寫本頁) _#裝· TLC: Rf 0.36(氯仿:甲醇=19:1); 、11 NMR (de-DMSO) : δ 10.46 (1Η, s), 8.72 (1H, s), 8.00 (1H, d, J=8.4Hz), 7.88 (2H, d, J=8.8Hz), 7.48-7.38 (2H, m), 7.23-7.16 (1H, m), 7.10-7.03 (2H, m), 7.01 (2H, d, J= 8.8Hz), 4.56 (2H, s), 4.22-4.01 (1H, m), 3.60-3.40 (2H, m), 3.24 (3H, s), 2.25-2.08 (1H, m), 1.78-1.60 (2H, m), 1.58-1.32 (2H, m), L28-1.07 (1H, m), 0.82 (3H, d, J=6.0Hz), 0.80 (3H, d, J=6.0Hz)〇 經濟部中央標準局員工消費合作社印製 g _ 例 49 (94) N-羥基-2 (S)-甲基-5 氧基苯羰基)胺基]戊醯胺 甲氧基甲氧基-4 (S) - [N- (4-苯 _och3
TLC: Rf 0.60(氯仿:甲酵:乙酸:水= (100:10:1:1
本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公t 31() 3 1 0 1 Z 568897 A7 B"7五、發明説明(311) $ NMR (dg-DMSO) : δ 10.40(1H, s), 8.71(1Η, s), 8.04(1Η, d, J=8.1Hz), 7.87(2H, d, J=9.0Hz), 7.45-7.40(2H, m), 7.22-7.17(1H, m), 7.08-7.00(4H, m), 4.55(2H, s), 4.04-418(1H, m), 3.52-3.23(2H, m), 3.22(3H, s), 2.04-1.92(1H, m), 1.78-1.57(2H, m), 1·52-1·34(2Η,m), 0.77(3H,t,J=7.2Hz)。 奮淪俐4 9 ( 9 5 ) N-羥基-2(S)-丙基-5-甲氧基甲氧基-4(S)-[N-(4-苯 氧基苯羰基)胺基]戊醯胺 r〇cH3 〇
(請先閱讀背面之注意事項再填寫本頁) -•I裝·
、1T 經濟部中央標準局員工消費合作社印製 TLC: Rf 0.60(氯仿:甲酵:乙酸:水=1〇〇:1〇··1:ΐ);NMR (d6-DMS0) : δ 10.40(1H, s), 8.69(1H, s), 8.02(1H, d, J=8.4Hz), 7.86(2H,d, J=8.8Hz), 7.46-7.37(2H, m), 7.23-7.15(1H, m), 7.08-6.98(4H, m), 4.54(2H, s), 4.16-4.00(1H, m), 3.48-3.44(2H, m), 3.21(3H, s), 2.14-1.99(1H, m)7 1.78-1.58(2H, m), 1.45-1.28(2H, m), 1.27-1.07(2H, m), 0.80(3H, t, J=7.2Hz)〇 管 _ 例 49 (96) N -經基-2(R) -第三丁氧鑛基甲基-5 -甲氧基甲氧基-4( S)-[N-(4-苯氧基苯羰基)胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) Λ4規格(21〇Χ297公敍) 311 310112 568897
TLC: Rf 0.54(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.47 (1H, s), 8.75 (1H, s), 8.05 (1H, d, J=8.4Hz), 7.88 (2H, d, J=8.7Hz), 7.47-7.40 (2H, m), 7.23-7.17 (1H, m)? 7.10-7.04 (2H, m), 7.03 (2H, d, J=8.7Hz), 4.55 (2H, s), 4.20-4.03 (1H, m), 3.57-3.43 (2H, m), 3.23 (3H, s), 2·55-2·34 (3H,m),1.74-1.66 (2H, m),1·36 (9H,s)〇 奮)fe 例 49 (97) (請先閲讀背面之.注意事項再填寫本頁) _«裝·
、1T N-羥基- 2(S)-烯丙基-5-甲氧基甲氧基-4(S)-[N-(4-笨氧基笨羰基)胺基]戊醢胺
經濟部中央標準局員工消費合作社印製 TLC: Rf 0.62(氯仿·•甲酵:乙酸=100:5:1); NMR (d6-DMS〇) : 5 10·43(1Η,s),8·66(1Η,brs),8·06(1Η,d,J=8.4Hz), 7.89-7.85(2H, m), 7.47-7.38(2H, m), 7.23-7.15(1H, m), 7.09-6.99(4H, m), 5.73-5·60(1Η, m),5·05-4·92(2Η, m),4·54(2Η,s),4·19-4·05(1Η, m),3.52(1H, dd, J=10.1Hz, 5.2Hz), 3.44(1H, dd, J=10.1Hz, 5.2Hz), 3.22(3H, s), 2.20-2.17(3H, m), 1·82-1·59(2Η,m)。 本紙張尺度適用中國國家標準(CNS ) A4規桔(210X29*7公摄) ΤΓΣ 3T011z 568897 <3 13 經濟部中央標準局員工消費合作社印製 Η*7 五、發明説明c g 淪例 49 ( 9 8 ) U-羥基-2(S)-乙基-5-乙氧基甲氧基-4(S)-[N-(4-笨 氧基苯羰基)胺基]戊醯胺 z〇CH2CH3
TLC: Rf 0.33(氯仿·•甲醇··乙酸=100:5:1); NMR (d6-DMS〇) : δ 10.40(1H, s), 8.70(1H, s), 8.02(1H, d, J=8.4Hz), 7.86(2H, d, J=8.8Hz), 7.46-7.38(2H, m), 7.23-7.15(1H? m), 7.08-6.99(4H, m), 4.59(2H? s), 4.19-4.01(1H, m), 3.52-3.42(2H, m), 3.47(2H, q, J=7.0Hz), 2.05-1.92(1H, m), 1.79-1.32(4H, m), 1.07(3H, t, J=7.2Hz), 0.76(3H, t, J=7.0Hz)〇 奩淪例49 (99) N-羥基-2(S)-乙基-5-(2-甲氧基甲氧基)甲氧基_4(S) -[N-U-苯氧基苯羰基)胺基]戊醢胺 r〇v'^〇cH3
TLC: Rf (K31 (氯仿:甲醇=9:1); (請先閲讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS)Λ4規格.( 210X 297公羧) 313 310112 568897 A*? B? 五、發明説明(314) NMR (de-DMSO) : δ 10.40 (1H, s), 8.71 (1H, s), 8.02 (1H, d, J=8.4Hz), 7.88 (2H, d, J=8.8Hz), 7.48-7.38 (2H, m), 7.23-7.15 (1H, m), 7.10-7.05 (2H, m), 7.02 (2H, d, J=8.8Hz)? 4.62 (2H, m), 4.22-4.00 (1H, m), 3.61-3.38 (6H, m), 3.22 (3H, s), 2.09-1.91 (1H, m), 1.82-1.60 (2H, m), 1.58-1.35 (2H, m), 0.78 (3H? t, J=7.0Hz)〇 奮施例4 9 (1 0 0 ) N-羥基-2(S)-乙基-5-第三丁基羰氧基-4(S)-[N-(4-苯氧基苯羰基)胺基]戊醢胺 (請先閱讀背面之注意事項再填寫本頁)
、1T TLC: Rf 0 · 69 (氯仿:甲酵=9 : 1 ); NMR (d6-DMS〇) :δ 10.41 (1Η, s), 8.71 (1Η, s), 8.07 (1Η, d, J=8.7Hz), 7.81 經濟部中央標準局員工消費合作社印製 (2H, d, J=8.6Hz), 7.41 (2H, t, J=7.6Hz), 7.17 (1H, t, J=7.6Hz), 7.04 (2H, d, J=7.6Hz), 7.00 (2H, d, J=8.6Hz), 4.25-4.13 (1H, m), 4.08-3.94 (2H, m), 2.03-1.91 (1H, m), 1.63 (2H, t, J=6.9Hz), 1.48-1.36 (2H, m), 1.06 (9H, s), 0.75 (3H, ζ J=7.5Hz)〇 奮淪例49 (101 ) N-羥基-2(S)-烯丙基-5-乙氧基甲氧基- 4(S) - [N - (4-甲基苯羰基)胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公楚) 314 0 11 2 568897 Λ? Η*7 五、發明説明( 315 och2ch3
ch3 TLC: Rf 0.49(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.42 (s, 1H), 8.71 (s, 1H), 7.99 (d, J = 8.8Hz, 1H), 7.73 (d, J = 8.0Hz, 2H), 7.24 (d, J = 8.0Hz? 2H), 5.72-5.55 (m, 1H), 5.02-4.91 (m, 2H), 4.58 (s, 2H), 4.19-4.01 (m, 1H), 3.52-3.41 (m, 4H), 2.33 (s, 3H), 2.12 (m, 3H), 1.79- 1.58 (m, 2H),1.07 (t,J = 7.0Hz, 3H)〇 奮 _ 例 4 9 (1 0 2J N -羥基_2(S)_烯丙基-5-乙氧基甲氧基-4(S)-[N-(4_ 硝基笨羰基)胺基]戊醸胺 (請先閱讀背面之注意事項存填寫本I) 、w Γ 經濟部中央標準局員工消費合作社印製 och2ch3
N〇2 TLC: Rf 0.32(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.43 (d, J = 1.5Hz, 1H), 8.71 (d, J = 1.5Hz, 1H), 8.47 (d, J = 8.4Hz, 1H), 8.30-8.27 (m, 2H), 8.07-8.03 (m, 2H)? 5.75-5.59 (m, 1H), 5.03-4.93 (m, 2H), 4.59 (s, 2H), 4.19-4.08 (m, 1H), 3.50 (dy J = 5.1Hz, 2H), 3.47 (q, J = 7.2Hz, 2H), 2.23-2.12 (m, 3H), 1.80-1.60 (m, 2H), 1.07 (t, J = 7.2Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS)A4規格(210X297公犮) 3ΊΤ 310112 568897 經濟部中央標準局負工消費合作社印製 Λ?五、發明説明(316) 啻淪例4 9 ( ΐ Ο 3 ) Ν-羥基-2 -甲叉基-5-乙氧基甲氧基-4(S)-[N-(4-硝基 苯羰基)胺基]戊醯胺 /OCH2CH3N〇2 TLC : Rf 0.50(氯仿:甲醇=9:1); NMR (dg-DMSO) : δ 10.77 (s, 1H), 8.84 (s, 1H), 8.61 (d, J = 8.4Hz, 1H), 8.32-8.27 (m, 2H), 8.05-8.02 (m, 2H), 5.57 (s, 1H), 5.36 (s, 1H), 4.60 (s, 2H), 4.30-4.18 (m, 1H), 3.53-3.45 (m, 4H), 2.61 (dd, J = 14.1Hz, 4 .5Hz, 1H), 2.47-2.40 (m, 1H), 1.07 (t, J = 6.9Hz, 3H)〇 啻 _ 例 4 9 ( 1 0 4 ) N-羥基-2(S)-(2-丙炔基)-5-乙氧基甲氧基-4(S)-[N-(4-硝基苯羰基)胺基]戊醯胺 /OCH2CH3N〇2 TLC: Rf 0.39(氯仿:甲醇=9:1);
(請先閱讀背面之注意事項再填寫本頁) 、11 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公飨) ΤΠο 3 1 0 1 1 Ζ 568897 Λ 7 Η*7 ___ ^17 五、發明説明() NMR (de-DMSO) : 8 10.54 (s, 1H)T 8.81 (s, 1H), 8.49 (d, J = 8.4Hz, 1H), 8.29 (d, J = 8.7Hz, 2H), 8.07 (d, J = 8.7Hz, 2H), 4.59 (s, 2H), 4.20-4.03 (m, 1H), 3.60-3.40 (m, 4H), 2.78 (s, 1H), 2.40-2.20 (m, 3H), 1.95-1.80 (m, 1H), 1.80-1.60 (m, 1H), 1.08 (t,J = 7·1Ηζ,3H)。 窨 _ 例 4 9 (1 fl 5 ) N-羥基-2(S)_烯丙基- 5-(2 -甲氧基乙氧基)甲氧基-4( S)-[N-(4-氰基苯羰基)胺基]戊醯胺 (請先閱讀背面之注意事項再填寫本頁)
、1T
TLC : Rf Ο·22(氯仿:甲酵=9:1); NMR (d6-DMSO) : 5 10.42 (s,1H),8.71 (s,1H),8.36 (d,J =8·7Ηζ,1H),7.98 (d,J = 8·4Ηζ,2Η),7.94 (d,J = 8·4Ηζ,2Η),5·74-5·58 (m,1Η),5.05-4.92 (m,2Η), 4.61 (s, 2H), 4.20-4.04 (m, 1H), 3.58-3.43 (m, 4H), 3.44- 3.37 (m, 2H), 3.19 (s, 3H), 2.22-2.10 (m,3H),1.81-1.58 (m,2H)。 ·· 經濟部中央標準局員工消費合作社印製 啻細例49 (1 06 ) N-羥基-2(S)-(2-丙炔基)-5-乙氧基甲氧基- 4(S)-[N -(4 -溴笨羰基)胺基]戊醯胺 och2ch3
Br 本紙張尺度適用中國國家標準(CNS ) Α4規枯(210Χ 297公漦) ΤΓ7 310112 568897 Λ ? Η"7五、發明説明(318) TLC : Rf Ο · 36 (氯仿:甲醇=9 : 1); NMR (dg-DMSO) : δ 10.52 (s, 1H), 8.80 (s, 1H), 8.20 (d7 J=8.7Hz, 1H), 7.79 (d, 1=8.^ 2H), 7.64 (d, J=8.4Hz, 2H), 4.58 (s, 2H), 4.18-4.02 (m, 1H), 3.58-3.42 (m, 4H), 2.78-2.73 (brs, 1H), 2.38-2.20 (m, 3H), 1.95-L75 (m, 1H), 1.75-1.60 (m, 1H), 1.08 (t, J=6.9Hz, 3H)〇 啻淪例49 (107) N-經基-2(S)-(2-丙炔基)-5-乙氧基甲氧基- 4(S)-[N-(4-氯笨羰基)胺基]戊醯胺
(請先閱讀背面之注意事項再填寫本頁) 、11 經濟部中央標準局員工消費合作社印製 TLC: Rf 0 · 35 (氯仿:甲醇=9 : 1 ); NMR (de-DMSO) : δ 10.52 (s, 1H), 8.80 (s, 1H), 8.20 (d, J=8.7Hz, 1H), 7.86 (d, J=8.6Hz, 2HX 7.51 (d, J=8.6Hz, 2H), 4.58 (s, 2H), 4.20-4.02 (m, 1H), 3.60-3.40 (m, 4H), 2.80-2.75 (brs, 1H), 2.40-2.20 (m, 3H), 1.95-1.78 (m, 1H), 1.78-1.60 (m, 1H), 1.08 (t, J=6.9Hz, 3H)〇 管)fe 例 49 ( 1 08 ) N-羥基-2(S)-烯丙基-5-乙氧基甲氧基-4(S)-[N-(4-溴笨羰基)胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) Λ4規掊(210X297公^ JT8 3ΤΤΠΓΓΖ 568897 A' )Γ 319、 五、發明説明
och2ch3 HO
TLC: Rf 〇·35(氯仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.42 (s, 1H), 8.71 (s, 1H), 8.19 (d, J=8.7Hz? 1H), 7.78 (d, J=8.6Hz, 2H), 7.65 (d, J=8.6Hz, 2H), 5.75-5.58 (m, 1H), 5.05-4.90 (m7 2H), 4.58 (s, 2H), 4.20-4.05 (m, 1H), 3.58-3.40 (m, 4H), 2.25-2.08 (m, 3H), 1.80-1.60 (m, 2H), 1.07 (t, J=7.1Hz,3H)。 管淪例49 M 09) N-羥基- 2(S)-烯丙基-5-乙氧基甲氧基-4(s)-[N - (4 氛苯羰基)胺基]戊醯胺
經濟部中央標準局員工消費合作社印製 TLC ·· Rf 0.36(氯仿:甲酵=9:1); NMR (d6-DMS0) : δ 10.42 (s, 1H), 8.70 (s, 1H), 8.18 (d, J=8.7Hz, 1H), 7.85 (d, J=8.6Hz, 2H), 7.52 (d, J=8.6Hz, 2H), 5.75-5.58 (m, 1H), 5.05-4.90 (m, 2H), 4.58 (s,2H),4.20-4.05 (m,1H),3.58-3.40 (m,4H),2.25-2.08 (m,3H),1.80-1.60 (m,2H), 1·〇7 (t,J=7.1Hz,3H)〇 n m m 49 (110,1. N-羥基- 2(R)_二甲胺基甲基-5-乙氧基甲氧基- 4(S)-[ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公楚) 319 310112 568897
Λ* }Y 320、 五、發明説明( N-(4-硝基笨羰基)胺基]戊醯胺 ,och2ch3
N〇2 TLC: Rf 0.30(氯仿··甲醇:乙酸=10:2:1); NMR (d6-DMS〇) : δ 10.44 (brs, 1H), 8.73 (brs, 1H), 8.48 (d, J=8.4Hz, 1H),8.29 (d, J=8.9Hz, 2H), 8.05 (d, J=8.9Hz, 2H), 4.59 (s, 2H), 4.20-4.05 (m, 1H), 3.60-3.40 (m, 4H), 2.55-2.38 (m, 1H), 2.38-2.20 (m, 1H), 2.20-2.00 (m, 7H), 1.85-1.70 (m,1H),1/70-1.58 (m,1H), 1.08 (t,J=6.9Hz,3H)〇 置施例4 9 (1 1 1 )N-羥基-2(S)-(2-丙炔基)-5-(2-甲氧基乙氧基)甲氧 基-4(S)-[N-(4-氰基苯羰基)胺基]戊醯胺
(請先閲讀背面之注意事項再填寫本頁)
訂 經濟部中央標準局員工消費合作社印製 TLC: Rf 0.35(氯仿:甲酵=9:1); NMR (d6-DMS〇) : 5 10.53 (s,1H),8.81 (s,1H),8·41 (d,J=8.7Hz,1H),7.99 (d, J=8.7Hz, 2H), 7.94 (d, J=8.7Hz, 2H), 4.61 (s, 2H), 4.20-4.05 (m, 1H), 3.60-3.45 (m, 4H), 3.45-3.35 (m, 2H), 3.20 (s, 3H), 2.79 (s, 1H), 2.35-2.00 (m? 3H), 1.92-1.75 (m,1H), 1.75-1.60 (m, 1H)。 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公楚) 320 310112 568897 Λ? Β*7 五、發明説明(321) 奮施例49 m 2)〜49 (1 16) 使用4(R)_羧基-4-胺基丁酸甲酷替代4(S)-羧基-4-胺 基丁酸甲酯以及使用對應化合物替代參考例4之化合物, 依實施例374實施例394實施例41(某些情況,使用對應 化合物替代甲氧基甲基氯實施例43 (使用對應化合物替 代苄基溴實施例44—實施例49所示方法相同操作,得 下列化合物。 n m m aq (^^2) N-羥基-2(R)_苄基-5-甲氧基甲氧基-4(R)-[N-(4-苯 氧基苯羰基)胺基]戊酿胺 (請先閲讀背面之注意事項再填寫本頁) ·'衣·
、1T TLC: Rf 0.39(氛仿:甲醇:乙酸:水=100:10:1:1); NMR (dg-DMSO) : δ 10.34(1H, s), 8.66(1H, s), 8.08(1H, d, J=8.8Hz), 7.89(2H, 經濟部中央標準局員工消費合作社印製 d, J=8.4Hz), 7.43(2H, t, J=8.0Hz), 7.00-7.46(10H, m), 4.53(2H, s), 4.13-4.32(1H, m), 3.48(2H, d, J=5.6Hz), 3.19(3H, s), 2.76(2H, d, J=7.0Hz), 2.29-2.44(lH, m), 1.58-1.84(2H,m)。 管淪例4 9 m :n H-羥基-2(R)_苄基-5-甲氧基甲氧基-4(R)-[N-[4-(3-苯氧基-1-丙炔基)苯氧羰基]胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29?公t ) 568897 Βη 五、發明説明( 3 22)
TLC: Rf 0.39(氯仿:甲醇:乙酸:水=100:10:1:1); NMR (d6-DMS〇) : δ 10.33(1H, s), 8.65(1H, s), 8.22(1H, d, J=8.7Hz), 7.84(2H, d, J=8.4Hz), 7.51(2H, d, J=8.4Hz), 7.32(2H, t, J=7.8Hz), 7.20(2H? t7 J=6.9Hz), 6.97-7.14(6H, m), 5.05(2H, s), 4.50(2H, s), 4.14-4.28(1H, m), 3.46(2H, d,.J=5.7Hz), 3.17(3H, s), 2.74(2H, d, J=7.2Hz), 2.29-2.39(lH, m), 1.60-1.79(2H, m)〇 窨胞例49 f 1 1 4) N-經基-2(R) -甲基乙氧基甲氧基-4(r)_[N-[4_(4_ 基]胺基]戊酿胺 HO"
經濟部中央標準局員工消費合作社印製 r〇CH2CH3 .0 Ο TLC: Rf 0·35(氣仿:
CN ' 8.65 (s, 1H), 8.18 (d, J=8.4Hz, 1H), 7.95 (d, J=8.6Hz, 2H), 7.83 (d, J=8.6Hz ^ 4.59 (s, 2H), 4.16 (m, 1H), 3.60-3.40 (m, 4H), 2.17 (m, 1H), 1.67 (t, 1=6.9¾ ’ 4叶,1.07 (ζ J=7.1Hz,3H),1.01 (d,J=6.9Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) (請先閱讀背面之注意事項再填寫本頁)
297公釐) 322 310112 568897 五、發明説明(323 ) 實 _ 锎 A Q ( 1 1 5 ) 羥基-2 (R)-烯拆 苯氧基笨羰基)胺基]$
Λ' )V 赛、5 韆胺 -乙氧基甲氧基-4 (R) - [N- (4 Η(Τ ,OCH2CH3 I = — 丨ν^α ο
TLC: Rf 0·34 (氡伤. % 15 :甲酵=9 : 1); NMR (d6-DMS〇) : δ ΐ〇 4l , 1Η),8·70 (s,1Η), 8·02 (d,J=8.4Hz,1Η),7·85 (d,J=9.0Hz,2Η), 7·41 (t,J=7.9HZ 如、 取,2H),7·17 (t J=7.9Hz,1H),7·04 (d,J=7.9Hz, 2H), 6.99 (d, J-9.0Hz, 2H), 5.74^ 5.55 1H)^ 5 〇3.4 88 2h), 4.56 (s, 2H), 4.17 4.03 (m, 1H), 3.53-3.40 (m? 4H)> 2.24.2.l〇 (m, 3H), 1.79-1.58 (m, 2H), 1.06 (t, J=7.0Hz, 3H)〇 管 _ 例 49 (1 1 6) N-羥基- 2(R)_甲基-5-乙氧基甲氧基_4(R)-[N-(4-苯 氧基笨羰基)胺基]戊醢胺 經濟部中央標準局員工消費合作社印製 OCH2CH3
TLC: Rf 0.38(氯仿:甲醇=9:1); (請先閲讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A 4¾格(21〇X 297公赞) TZ1~~ ΎΟΎΤΤ 568897 Λ 7 η1 五、發明説明(324) NMR (d6-DMS0) : δ 10.36 (s, 1H), 8.64 (s, 1H), 8.01 (d, J=8.7Hz, 1H), 7.85 (d, J=8.7Hz, 2H)? 7.41 (t, J=7.6Hz, 2H), 7.17 (ζ J=7.6Hz, 1H), 7.04 (d, J=7.6Hz, 2H), 7.00 (d, J=8.7Hz, 2H), 4.57 (s, 2H), 4.18-4.06 (m, 1H), 3.51-3.42 (m, 4H)? 2.15 (m, 1H), 1.64 (t, J=7.1Hz, 2H), 1.06 (t, J=7.2Hz, 3H), 0.99 (d, J=7.1Hz, 3H)〇
奩濂例 49 (117)〜49 (124L 使用對應化合物替代參考例4製造之化合物,依實施 例374實施例39->實旆例414實施例43(使用對應化合物 替代苄基溴)—實施例44 —實施例49所示方法相同操作, 得下列化合物。 奮渝例49 (117) N-羥基-2(S)-苄基-5-甲氧基甲氧基-4(S)-[N-[4-[ 2E-(4-氯苯基)乙烯基]笨羰基]胺基]戊醢胺 (請先閱讀背面之注意事項再填寫本頁)
、1T
經濟部中央標準局員工消費合作社印製 TLC: Rf0.21(氛仿:甲醇=19:1); NMR (d6-DMS〇) : $ 10.37 (1H, s), 8.15 (1H, d, J=8.4Hz), 7.89 (2H, d, J=8.4Hz), 7.68 (2H, d, J=8.4Hz), 7.66 (2H, dt J= 8.8Hz), 7.45 (2H, d, J=8.8Hz), 7.40-7.30 (2H, m), 7.29-7.08 (5H, m), 4.54 (2H, s), 4.38-4.18 (1H, m), 3.60-3.40 (2H, m), 3.21 (3H, s), 2.78 (2H, d, J= 6.6Hz), 2.55-2.30 (1H, m), 1.92-1.60 (2H, m)〇 窨淪例49 (118) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公t ) 324 310112 568897
A )Y ,3 2 5 五、發明説明Γ Ν -羥基- 2(S)_(吲睬-3-基)-5_甲氧基甲氧基-4(S)-[N -[4-[笨并呋喃-2-基)笨羰基]胺基]戊醸胺 Η
OCH3 Ο Ο
TLC: Rf0.28(氯仿: NMR (d6-DMS0) : δ 10.73 (1H, s), 10.37 (1H, s), 8.67 (1H, d, J= 8.6Hz)? 8.01 (4H, s), 7.78-7.48 (4H, m), 7.44-7.20 (3H, m), 7.10-6.80 (3H, m), 4.53 (2H, s), 4-42-4.22 (1H, m), 3.62-3.40 (2H, m), 3.18 (3H, s), 3.00-2.78 (2H, m), 2.62-2 (1H,m),2.00-1.65 (2H,m)。 38 管)fe 俐 49(119) N-羥基-2(S)_苄基-5-甲氧基甲氧基- 4(S)-[N-[4-[ 3-(4-氯笨氧基-1-丙炔基)笨羰基]胺基]戊醯胺 經濟部中央標準局員工消費合作社印製
TLC : Rf0 . 26 (氯仿:甲醇=19 : 1); (請先閲讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公楚) 3 10 11 經濟部中央標準局員工消费合作社印製 568897 B*7 ________ 五、發明説明(326 ) NMR (d6-DMS〇) : 8 10.35 (1H, s), 8.67 (1H, s), 8.24 (1H, d, J=8.4Hz), 7.87 (2H, d, J=8.4Hz), 7.53 (2H, d, J=8.4Hz), 7.38 (2H, d, J=9.2Hz), 7.30-7.00 (7H, m), 5.08 (2H, s), 4.53 (2H, s), 4.25 (1H? m), 3.49 (2H, d, J=5.4Hz), 3.20 (3H, s), 2.77 (2H, d,J=7.0Hz),2·38 (1H,m),1·90-1·60 (2H,m)〇 實施锎4 9 (1 2 0 ) N-羥基- 2(S)_苄基-5-甲氧基甲氧基-4(S)-[H-(4-苯 氧基笨羰基)胺基]戊醯胺
TLC: Rf〇.39(氯仿:甲酵=19:1); NMR (d6-DMS0) : δ 10.36 (1Η, s), 8.09 (1H, d, J=8.6Hz), 7.91 (2H, d, J=8.8Hz),7·50-7·38(2Η,m),7.30-7.08 (8H,m),7.03 (2H,d,J=8.8Hz),4.54 (2H,s), 4.36-4.18 (1H, m), 3.58-3.40 (2H, m), 3.20 (3H, s), 2.84-2.65 (2H, m), 2.45-2.30 (1H, m), 1.88-1.58 (2H,m)。 g _ 例 4 9 (1 2 1 ) _ N-羥基_2(S)_苄基-5-甲氧基甲氧基-4(S)-[N-[4-(4-笨基哌啶-1-基)笨羰基]胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公t ) 326 ΤΠΠΎ2 (請先閱讀背面之注意事項再填寫本頁)
568897
A W 五、發明説明(327)
T L C : R f Ο . 2 6 (氯仿:甲醇=1 9 : 1 ); NMR (dg-DMSO) : δ 10.33 (1H, s), 8.66 (1H, s), 7.82 (1H, d, J=8.8Hz), 1.11 (2H, d, J=8.8Hz), 7.38-7.06 (10H, m), 6.99 (2H, d, J=8.8Hz), 4.54 (2H? s), 4.38-4.16 (1H, m), 4.04-3.90 (2H, m), 3.58-3.40 (2H, m), 3.21 (3H, s), 2.96-2.60 (5H, m), 2·44-2·28 (1H, m),1.95-1.60 (6H,m)。 審淪例4 9 (1 2 2 ) N-羥基-2(S)_苄基-5-甲氧基甲氧基- 4(S)-[N-[4-(6-咪唑基-1-戊炔基)苯羰基]胺基]戊醯胺 (請先閱讀背面之注意事項再填寫本頁)
、1T 經濟部中央標準局員工消費合作社印袋
TLC: Rf0.46(氯仿:甲醇=9:1); 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公f ) 327 〇 310112 經濟部中央標準局員工消費合作社印製 568897 Λ ? Η ________ 五、發明説明() NMR (d6-DMS〇) : δ 10.35 (1H, s), 8.67 (1H, s), 8.18 (1H, d, J=8.4Hz), 7.83 (2H, d, J=8.4Hz), 7.63 (1H, t, J=1.2Hz), 7.44 (2H, d, J=8.4Hz), 7.28-7.07,(6H, m), 6.89 (1H, t, J=1.2Hz), 4.53 (2H, s), 4.36-4.17 (1H, m), 4.01 (2H, t, J=7.0Hz), 3,60-3.40 (2H, m), 3.20 (3H, s), 2.84-2.70 (2H, m), 2.47 (2H, t, J=7.0Hz), 2.46-2.30 (1H, m), 1.96-1.62 (4H,m), 1.58-1.40 (2H,m)。 奮淪俐49 ( 1 23J_ H -羥基-2(S)_(萘-1-基)-5-甲氧基甲氧基-4(S)-[N-( 4-笨氧基苯羰基)胺基]戊醢胺
TLC: Rf0.36(氯仿:甲醇=19:1); NMR (dg-DMSO) : δ 10.26 (1Η, s), 8.63 (1H, s), 8.16 (1H, d, J=8.4Hz), 8.04-7.82 (4H, m), 7.80-7.70 (1H, m), 7.52-7.16 (7H, m), 7.14-6.96 (4H, m), 4.52 (2H, s)? 4.50-4.28 (1H, m), 3.61-3.40 (2H, m), 3.25-3.02 (5H, m), 2.69-2.52 (1H, m), 2.00-1.78 (2H, m)〇 奮 _ 例 49 (ΐ 24) N-羥基- 2(S)-[4-(苯并呋喃-2-基)苄基]-5-甲氧基甲 氧基-4(S)-[H-[4-碘笨羰基)胺基]戊醢胺 (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適财關家標準(CNS ) A4規格(210X297公髮) 321 31 0 112 568897 Λ 7 _____ Η*7 五、發明説明(329)
T L C : R f Ο · 4 9 (氯仿:甲醇=9 : 1); NMR (d6-DMS0) : δ 10.38 (lH,s), 8.70 (1H, s), 8.25 (1H, d, J=8.7Hz), 7.85 (2H, d, J=8.4Hz), 7.79 (2H, d, J=8.1Hz), 7.70-7.56 (4H, m), 7.36 (1H, s), 7.34-7.20 (4H, m), 4.55 (2H, s), 4.35-4.20 (1H, m), 3.60-3.45 (2H, m), 3.21 (3H, s), 2.83 (2H, d, J=6.9Hz), 2.45-2.30 (1H, m), 1.90-1.60 (2Ht m)〇 奮胞例 49 ( 1 25 )〜49 (233 ) 使用對應化合物替代參考例4製造之化合物,依實施 例374實施例39 —實施例41(使用對應化合物替代甲氧基 甲基氯實施例43 (使用對應化合物替代苄基溴)《>實施 例444實施例49所示方法相同操作,得下列化合物。 奮胞例49 ( 1 2 5 )
本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公t ) 329 310112 經濟部中央標準局員工消費合作社印裂 568897 Λ ?
Jr ___ 五、發明説明(330) TLC: Rf 0.36(氯仿:甲醇=9:1); NMR (dg-DMSO) : δ 10.32 (s, 1H), 8.80-8.60 (brs, 1H), 7.43 (d, J = 8.7Hz, 1H), 7.28-7.19 (m, 2H), 7.19-7.07 (m, 3H), 4.54 (s, 2H), 4.05-3.85 (m, 1H), 3.60-3.20 (m, 4H), 2.80-2.60 (m, 2H), 2.38-2.20 (m, 1H), 2.10-L90 (m, 1H), 1.80-1.60 (m, 5H), 1.60-1.45 (m, 1H), 1.45-1.20 (m, 3H), 1.11 (t, J = 6.9Hz? 3H), 1.00-0.80 (m, 5H)〇 奮淪例49 (126) N-羥基-2(S)-(4-硝基苄基)-5-乙氧基甲氧基-4(S)-[ Η -(反-4-甲基環己羰基)胺基]戊醢胺
^och2ch3 Ο TLC: Rf 0.40(氛仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.34 (s, 1H), 8.80-8.60 (brs, 1H), 8.12 (d, J = 8.7Hz, 2H), 7.48 (d, J = 8.7Hz, 1H), 7.37 (d, J = 8.7Hz? 2H), 4.57 (s, 2H), 4.10-3.90 (m, 1H), 3.55-3.25 (m, 4H), 3.00-2.70 (m, 2H), 2.40-2.25 (m, 1H), 2.10-1.95 (m? 1H), 1.85-1.60 (m, 5H), 1.60-1.20 (m, 4H), 1.11 (t, J = 7.2Hz, 3H), 1.00-0.80 (m, 5H)〇 實渝例49 ( 1 27 ) N -羥基- 2(S)-(»3丨睬-3 -基)-5 -乙氧基甲氧基-4(S)-[N -(反-4-甲基環己羰基)胺基]戊醯胺 (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公飨) 330 310112 568897 五、發明説明bi )
TLC: Rf 0.32(氯仿:甲酵=10:1); NMR (d6-DMS〇) : δ 10.73 (brs, 1H), 10.32 (brs, 1H), 8.66 (d, J= 1.5Hz, 1H), 7.49 (d, J = 7.8Hz, 1H), 7.41 (d, J = 8.7Hz, 1H), 7.28 (d, J = 8.1Hz, 1H), 7.05-6.99 (m, 2H), 6.94-6.88 (m, 1H), 4.50 (d, J = 6.9Hz, 1H), 4.47 (d, J = 6.9Hz, 1H), 4.02-3.902 (m, 1H), 3.40 (q, J = 7.2Hz, 2H), 3.37-3.28 (m, 2H), 2.89-2.71 (m, 2H), 2.48-2.34 (m, 1H), 105-1.93 (m, 1H), 1.77-1.50 (m, 6H), 1.45-1.20 (m, 3H), 1.06 (t, J = 7.2Hz, 3H), 0.95-0.80 (m, 2H), 0.84 (d, J = 6.6Hz, 3H)〇 y 淪俐 49 ( 1 28 )— N -羥基_2(S) -苄基-5-乙氧基甲氧基- 比® 一 4-基)羰基]胺基]戊醢胺
經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) TLC: Rf 0.30(氛仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.37 (s, 1H), 8.76-8.63 (m, 3H), 8.43 (d, J = 8.6Hz, 1H), 7·80-7·72 (m, 2H),7.29-7.08 (m,5H),4.58 (s,2H),4.34-4.14 (m,1H), 3.60-3.39 (m, 4H), 2.83-2.65 (m, 2H), 2.42-2.28 (m, 1H), 1.88-1.59 (mt 2H), 1.09 (t, J = 7.0Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 331 310112 568897
___ )V 五、發明説明(332 ) 窖 _ 例 49 (1 29) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4-羥 基苯羰基)胺基]戊醢胺
.och2ch3 0 TLC: Rf 0.57 (氯仿:甲酵=9 : 1 ); NMR (d6-DMS〇) : 8 10.34 (s, 1H), 9.96-9.80 (br, 1H), 7.83 (d, J = 8.4Hz, 1H), 7.74 (d, J = 9.0Hz? 2HX 7.26-7.08 (m, 5H), 6.79 (d, J = 9.0Hz, 2H), 4.57 (s, 2H), 4.30-4.17 (m, 1H), 3.58-3.40 (m, 4H), 2.76 (d, J = 6.6Hz, 2H), 2.42-2.32 (m, 1H), 1.82-1.60 (m,2H),1.09 (t, J = 7·2Ηζ, 3H)。 管淪例4 9(13 0) N-羥基-2(S)-(2-硝基苄基)-5-乙氧基甲氧基- 4(S) (反-4-甲基環己羰基)胺基]戊醢胺
經濟部中央標準局員工消費合作社印製 TLC: Rf 0.23(氯仿:甲酵=9:1); 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公# ) 332 310112 333 568897 五、發明説明( NMR (d6-DMS〇) : δ 10.35 (s, 1H), 8.71 (s, 1H), 7.92 (dd, J = 8.4, 1.2Hz, 1H), 7.61 (td, J = 7.4, 1.2Hz, 1H), 7.50-7.40 (m, 2H)? 7.36 (d, J = 7.4Hz, 1H), 4.55 (s, 2H),3.90-3.75 (m,1H),3.55-3.25 (m,4H,與 DMS〇翻20 重疊),3.10-2.90 (m, 2H),2.55-2.40 (叽 1H,與DMS O 重疊),2.10-1.90 (m,1H),1.80-1.55 (m,6H), 1.50-1.20 (m, 3H), 1.10 (t, J = 7.1Hz, 3H), 1.00-0.75 (m, 5H)〇 V m m 49 (1311, N-羥基-2(S)-(3-硝基苄基)-5-乙氧基甲氧基-4(S) (請先閱讀背面之注意事項再填寫本頁) (反-4-甲基環己羰基)胺基]戊醢胺
,och2ch3 〇 TLC: Rf 0.38(氯仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.30 (s, 1H), 8.67 (s, 1H), 8.10-8.00 (m, 1H), 7.98 (s,
1H),7.60-7.46 (π% 3H),4·56 (s,2H),4.10-3.95 (πν 1H), 3.55-3.30 (m,4H,與 DMSC 經濟部中央標準局員工消費合作社印裝 中 H 2 O 重疊),2·94 (dd,J = 13·0, 4·7Ηζ,1H),2.80 (dd,J = 13.0, 9·9Ηζ,1H), 2.30-2.20 (m, 1H), 2.10-1.95 (m, lH)t 1.85-1.60 (m, 5H), 1.60-1.20 (m, 4H), Lll (ζ J = 7· 1Hz,3H),1.00-0.80 (m,5H)〇 奮 _ 例 49 (1 32 ) N-羥基- 2(S)_苄基-5-乙氧基甲氧基- 4(S)-[N-[(1-甲 基吡咯-2-基)羰基]胺基]戊醢胺 310112 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 568897 334、
0 經濟部中央標準局員工消費合作社印製 Λ'
)V 五、發明説明(
,OCH2CH3 0 TLC: Rf 0.31(氯仿:甲醇=9:1); NMR (dg-DMSO) : δ 1031 (s, 1H), 8.65 (d, J = 1.2Hz, 1H), 7.59 (d, J = 8.8Hz, 1H), 7.25-7.10 (m, 5H), 6.85-6.90 (m, 1H), 6.78-6.76 (m, 1H), 5.98 (t, J = 3.2Hz, 1H), 4.57 (s, 2H), 4.25-4.08 (mt 1H), 3.83 (s, 3H), 3.50-3.39 (m, 4H), 2.75 (d, J = 7.0Hz, 2H), 2.45-2.29 (m, 1H), L82-1.52 (m, 2H), 1.08 (t, J = 7.0Hz, 3H)〇 奮淪俐49 (133) H-羥基- 2(S)_苄基-5-乙氧基甲氧基-4(S)-[N-(苯羰 基)胺基]戊釀胺 .〇CH2CH3 TLC: Rf 0.34(氯仿:甲酵=9:1); NMR (d6-DMS〇) : a 10.34 (s, 1H), 8.60 (d, J = 1.6Hz, 1H), 8.12 (dt J = 8.8Hz, 1H), 7.85 (dd, J = 8.0Hz, 1.8Hz, 2H), 7.52-7.40 (m, 3H), 7.26-7.09 (m, 5H), 4.57 (s, 2H), 4.33-4.15 (m, 1H), 3.49 (d, J = 5.4Hz, 2H), 3.45 (q, J = 7.0Hz, 2H), 2.76 (d, J =7·0Ηζ, 2H),2.44-2.28 (m,1H),1.85-1.59 (m,2H),1.07 (t,J = 7·0Ηζ,3H)。 g 嫵例 49 Π34) (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公t ) 334 310112 568897 Λ 7 Η*7 _____ 五、發明説明(33 5) Ν-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4-乙 基苯羰基)胺基]戊醸胺
TLC: Rf 0.50(氯仿··甲醇=9:1); NM R (d6-DMS0) : δ 10.33 (d, J = 1.2Hz, 1H), 8.65 (s, 1H), 8.02 (d, J = 8.4Hz, 1H), 7.78 (d, J = 8.2Hz, 2H), 7.30-7.09 (m, 7H), 4.57 (s, 2H), 4.15-4.32 (m, 1H), 3.50-3.39 (m, 4H), 2.76 (d, J = 7.4Hz, 2H), 2.64 (q, J = 7.4Hz, 2H), 2.42-2.25 (m, 1H), 1.58-1.82 (m, 2H), 1.17 (t, J = 7.6Hz, 3H), 1.07 (t, J = 7.4Hz, 3H)〇 奮 _ 例 49 (135) N-羥基-2 (S)-苄基 基笨羰基)胺基]戊醢胺 乙氧基甲氧基-4 (S) - [N- (4-甲
,och2ch3 0 0 (請先閱讀背面之注意事項再填寫本頁) r裝-
、1T 經濟部中央標準局員工消費合作社印製 TLC : Rf 0 · 56 (氯仿:甲酵=9 : 1 ); NMR (d6-DMS〇) : δ 10.32 (s, 1H), 8.64 (s, 1H), 8.00 (d, J = 8.7Hz, 1H), 7.73 (d, J = 8.1Hz, 2H), 7.26-7.05 (m, 7H), 4.54 (s, 2H), 4.26-4.15 (m, 1H), 3.51-3.37 (m, 4H), 2.73 (d, J = 7.2Hz, 2H), 2.32 (s, 3H), 2.39-2.25 (m, 1H), 1.80-1.58 (m, 2H), 1.05 (t,J = 7.1Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公潑) 335 310112 568897 Λ? Β*7 _五、發明説明(3 36) 當瓶例4 9 ( 1 3 6 ) N-羥基-2(S)_苄基-5-乙氧基甲氧基-4(S)-[N-(4-硝 基苯羰基)胺基]戊醸胺
N〇2 TLC: Rf 0.25(二氯甲烷:甲酵=19:1); NMR (dg-DMSO) : δ 10.36 (d, J = 1.5Hz, 1H), 8.67 (d, J J = 8.4Hz, 1H), 8.30 (d, J = 9.0Hz, 2H), 8.08 (d, J = 9.0Hz, 2H), 7.25-7.11 (m, 5H), 4.56 (s, 2H), 4.23 (m, 1H), 3.50 (d, J = 5.7Hz, 2H), 3.43 (q, J = 7.2Hz, 2H), 2.75 (m, 2H),2.36 (in, 1H),1·72 (m,2H),1.07 (t, J = 7·2Ηζ,3H)。 奮 _ 例 4 9 Π 3 7 ) N-羥基- 2(S)-苄基-5-乙氧基甲氧基- 4(S)-[N-(2,2, 3,3-四甲基環丙基羰基)胺基]戊醃胺 1.5Hz, 1H), 8.50 (d, (請先閱讀背面之注意事項再填寫本頁) :裝·
、1T 經濟部中央標準局員工消費合作社印製
TLC: Rf 0.53(氛仿:甲醇=9:1); 本紙張尺度適用中國國家標準(CNS)Λ4規格( 210X 297公t) 336 310112 568897 A7 Η*7 五、發明説明(337) NMR (dg-DMSO) : δ 10.32 (d? J = 1.2Hz, 1H), 8.69 (d, J = 1.2Hz, 1H), 7.49 (d, J = 8.4Hz, 1H)? 7.24-7.09 (m, 5H), 4.53 (s, 2H), 3.98-3.88 (m, 1H), 3.45 (q, J = 7.2Hz? 2H), 3.37-3.35 (m, 2H), 2.73-2.66 (m, 3H)t 2.35-2.25 (m, 1H), 1.70-1.43 (m, 2H),1· 18-1.04 (m,15H)〇 g m m 4 9(138) N-羥基-2(S)-(3-甲氧基苄基-5-乙氧基甲氧基-4(S)_ [N-(4-甲基苯羰基)胺基]戊醯胺 (請先閱讀背面之注意事項再填寫本頁)
、1T
TLC: Rf 0.53(氯仿:甲酵=9:1); 丨龜 NMR (d6-DMS〇) : δ 10.33 (d, J = 1.8Hz, 1H)? 8.67 (d, J = 1.8Hz, 1H), 8.06 (d, J = 9.0Hz? 1H), 7.76 (d, J = 8.4Hz? 2H), 7.24 (d, J = 8.4Hz, 2H), 7.13-7.08 (m, 1H), 6.71-6.66 (m, 3H), 4.56 (s, 2H), 4.17-4.30 (m, 1H), 3.65 (s, 3H), 3.53-3.41 (m, 4H), 2.72 (d, J = 7.2Hz, 2H), 2.40-2.30 (m, 1H), 2.34 (s, 3H), 1.8M.59 (m, 2H), 1.07 (t, J = 7.2Hz, 3H)〇 經濟部中央標準局員工消費合作社印製 基 氧 甲 基 氧 乙 ?胺 基酿 苄戊 麟 I—Ϊ S)基 2 胺 讎 基基 羥 羰 N-基 烯 己 瓌 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公漦) 310112 568897 A Η" 3 3 8、
,OCH2CH3 0 0 0 五、發明説明( ηνΑΌ TLC: Rf 0.25(二氯甲烷:甲醇=19:1); NMR (d6-DMS〇) : S 10.31 (brs, 1H), 8.65 (brs, 1H), 7.28-7.08 (m, 6H), 6.49 (brs, 1H), 453 (s, 2H), 4.05 (m, 1H)7 3.43 (q, J = 7.2Hz, 2H), 3.47-3.35 (m, 2H), 2.69 (m, 2H), 2,28 (m, 1H), 2.20-2.04 (m, 4H), 1.74^1.46 (m, 6H), 1.09 (t, J = 7.2Hz, 3H)〇 gL 施例 4 9(14 0 ) N-羥基- 2(S)-苄基-5-乙氧基甲氧基-4(S)-[N[U-環 己烯-4-基)羰基]胺基]戊醢胺 (請先閲讀背面之注意事項再填寫本頁)
經濟部中央標準局負工消費合作社印製 TLC: Rf 〇·25(二氛甲烷:甲醇=19:1); NMR (d6-DMS〇) : δ 10.31 (brs, 1H), 8.67 (brs, 1H), 7.54 (d, J = 8.4Hz? 1H), 7.24-7.08 (m, 5H), 5.64 (m, 2H)r 4.53 (s, 2H), 3.95 (m, 1H), 3.43 (q, J = 7.2Hz, 2H), 3.47-3.28 (m, 2H), 2.75-2.63 (m, 2H), 2.33-1.44 (m, 10H), 1.09 (t? J = 7.2Hz, 3H)〇 奮 _ 例 49 (1 羥基-2(S)-苄基-5-乙氧基甲氧基-4(s)-[n_(4-: 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公婊) 338 310112 568897
A' }V 五、發明説明(339 ) 甲胺基苯羰基)胺基]戊醸胺
N(CH3)2 TLC :Rf0.63(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.33 (s, 1H), 8.65 (s, 1H), 7.78-7.69 (m, 3H), 7.25-7.08 (m, 5H), 6.69 (d, J = 9.0Hz, 2H), 4.58 (s, 2H), 4.29-4.18 (m, 1H), 3.56-3.41 (m, 4H), 2.97 (s, 6H), 2.77 (d, J = 7.2Hz, 2H), 2.42-2.32 (m, 1H), 1.82-1.62 (m 2H), 1.10 (t, J = 6.9Hz, 3H)〇 奮)fe 例 49 (1 42) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4-胺 甲醢基笨羰基)胺基]戊醸胺 (請先閱讀背面之注意事項再填寫本頁)
、1T 經濟部中央標準局員工消費合作社印製
NH2 0 TLC: Rf 0.37(氯仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.37 (s, 1Η), 8.68 (s, 1H), 8.24 (d, J = 8.7Hz, 1H), 8.08 (s, 1H), 7.98-7.87 (m, 4H), 7.48 (s, 1H), 7.28-7.10 (m, 5H), 4.58 (s, 2H), 4.32-4.19 (m, 1H), 3.58-3.40 (m, 4H), 2.77 (d, J = 6.9Hz, 2H), 2.42-2.32 (m, 1H), 1.83-1.61 (m,2H), 1·09 (t,J == 7.2Hz,3H)。
本紙張尺度適用中國國家標準(CNS ) Λ4規格(21 OX 297公t ) 339 TDTTT 568897 Λ? Βη 五、發明説明(3 40) 富餱例4 9 (1 4 3) Ν -羥基- 2(S)-节基-5_乙氧基甲氧基-4(S)-[N-(4 -甲 氧基羰基笨羰基)胺基]戊醯胺 ,och2ch3
0 0 0 丨Vi '>x^Y〇CH3 ο TLC: Rf 0·31 (氯仿:甲醇=19 : 1); NMR (d6-DMS〇) : δ 10.38 (s, 1H), 8.69 (s, 1H), 8.35 (d, J = 8.4Hz, 1H), 8.04 (d, J = 8.8Hz, 2H), 7.98 (d, J = 8.8Hz, 2H), 7.28-7.06 (m, 5H), 4.58 (s, 2H), 4.35-4.18 (m, 1H), 3.89 (s, 3H), 3.60-3.39 (m? 4H), 2.77 (d, J = 7.0Hz, 2H), 2.42-2.28 (m, 1H), 1.88-1.59 (m, 2H), 1·09 (t,J = 7.0Hz,3H)〇 奮嫵例49 (144) N-羥基-2(S)-苄基-5-乙氧基甲氧基- 4(S)-[N-(環戊 .OCH2CH3 (請先閱讀背面之注意事項再填寫本頁)
、1T 經濟部中央標準局員工消費合作社印製
ο TLC: Rf 0.51(二氯甲烷:甲醇=9:1); NMR (d6-DMS〇) : δ 10.32 (brs, 1H), 8.68 (brs, 1H), 7.49 (d, J = 8.7Hz, 1H), 7.25-7.08 (m,5H),4.53 (s,2H),3.92 (m,1H),3·43 (q,J = 7·2Ηζ,2H),3.40-3.35 (m, 2H), 2.72 (dd, J = 13.5, 8.7Hz, 1H), 2.65 (dd, J = 13.5, 5.6Hz, 1H), 2.49 (m, 1H), 2.29 (m, 1H), 1.80-1.40 (m, 10H), 1.09 (t, J = 7.2Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ 297公釐) 340 310112 568897 ίΓ 五、發明説明(341 ) 置施俐49 (1 45) N-羥基-2(S)_(萘-2-基)-5-乙氧基甲氧基-4(S)-[N-( 反-4-甲基環己羰基)胺基]戊醢胺
,och2ch3 0 TLC: R’f 0.31(氯仿:甲醇=19:1); NMR (d6-DMS0) : δ 10.33 (s, 1H), 7.90-7.73 (m, 3H), 7.60 (s, 1H), 7.54-7.37 (m, 3H), 7.34-7.22 (m, 1H), 4.60-4.46 (m, 2H), 4.12-3.90 (m, 1H), 3.52-3.22 (m? 4H), 2.87 (d, J = 6.6Hz, 2H), 2.45-2.28 (m, 1H), 2.17-1.94 (m, 1H), 1.88-1.18 (m, 10H), 1.09 (t, J = 7.0Hz, 3H), 1.00-0.72 (m, 4H)〇 奮)例 49 (146) N-羥基- 2(S)_苄基-5-乙氧基甲氧基-4(S)-[N-(4-三 氟甲基笨羰基)胺基]戊醸胺 (請先閱讀背面之注意事項再填寫本頁)
經濟部中央標準局員工消費合作社印製
CF3 TLC : Rf 0.58(氯仿:甲酵=9:1); 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公龄) T4T ΤΠΓΤΤΖ 568897
Λ· }V ,3 4 2 五、發明説明Γ NMR (d6-DMS0) : δ 10.34 (s, 1H), 8.67 (d, J = 2.1Hz, 1H), 8.38 (d, J = 8.7Hz, 1H), 8.04 (d, J = 8.4Hz, 2H), 7.83(d, J = 8.4Hz, 2H), 7.25-7.10 (m, 5H), 4.56(s, 2H), 4.30-4.18 (m, 1H), 3.50-3.36 (m , 4H), 2.76-2.74 (m, 2H), 2.41-2.30 (m, 1H), 1.81-1.62 (m,2H), 1.07 (t,J = 7.2Hz,3H)〇 g 淪俐 4 9 (1 4 1) N-羥基-2 (S)-苄基 笨羰基)胺基]戊醢胺
,och2ch3 Ο TLC: Rf 0.45(氯仿:甲酵=9:1); NMR (d6-DMS0) : δ 10.33 (s, 1H), 8.65 (brs, 1H), 8.19 (d, J = 8.4Hz, 1H), 7.83 (d, J = 8.4Hz, 2H), 7.63 (d, J = 8.4Hz, 2H), 7.24-7.09 (m, 5H), 4.55 (s, 2H), 4.28-4.15 (m, 1H), 3.48-3.39 (m, 4H), 2.74 (d, J = 7.2Hz, 2H), 2.38-2.29 (m, 1H), 1.79-1.59 (m, 2H), 1.06 (t, J = 7.2Hz, 3H)〇 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 富 _ 例 4 9 (1 4 8 ) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[4-(2 碘乙炔基)苯羰基]胺基]戊醢胺 ,och2ch3 °0
0 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公t ) T42 經濟部中央標準局員工消费合作社印製 乙氧基甲氧基-4 (S) - [N- (2-噬
0 568897 Η*7 五、發明説明(343) TLC: Rf 0 , 37 (氯仿:甲醇=9 : 1); NMR (dg-DMSO) : δ 10.35 (s, 1H), 8.66 (d, J = 1.5Hz, 1H), 8.28 (d, J = 8.4Hz, 1H), 7.90 (d, J = 8.4Hz, 2H), 7.71 (d, J = 8.4Hz, 2H), 7.24-7.10 (m, 5H), 4.56 (s, 2H), 4.29-4.18 (m, 1H), 3.50-3.35 (m, 4H), 2.75 (d, J = 6.9Hz, 2H), 2.40-2.31 (m, 1H),1·81·1·61 (m,2H),1.07 (t,J = 6·9Ηζ,3H)〇 管餱例49 ( 1 49 ) N-羥基-2(S)_苄基-5-乙氧基甲氧基-4(S)-[N-(環庚 羰基)胺基]戊醢胺
TLC: Rf 0.26(二氯甲烷:甲酵=19:1); NMR (d6-DMS〇) : δ 10.32 (brs, 1H), 8.68 (brs, 1H), 7.41 (d, J = 8.7Hz, 1H), 7·25·7·08 (m, 5H),4.53 (s,2H),3.90 (m,1H),3.43 (q,J = 7·2Ηζ,2H),3.40-3.30 (m, 2H),2.68 (m,2H),2·33-2·20 (m,2H),1.80-1.30 (m,14H),1.09 (t,J = 7·2Ηζ,3H)〇 當 _ 例 4 9 ( 1 5 0 ) N-羥基-2 (S)-苄基 吩基羰基)胺基]戊醢胺 ,och2ch3 (請先閲讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公t 343 310112
經濟部中央標準局員工消費合作社印製 568897 五、發明説明(3 44 ) TLC: Rf 0.48(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.35 (s, 1H), 8.17 (d, J = 9.0Hz? 1H), 7.79-7.76 (m, 1H), 7.72-7.69 (m,1H),7.23-7.06 (m,6H),4.54 (s,2H),4.19-4.08 (m,1H),3.50-3‘38 (m, 4H), 2.76-2.67 (m, 2H), 2.40-2.30 (m, 1H), 1.79-1.57 (m, 2H)? 1.05 (t, J = 7.2Hz, 3H)〇 奮)fe 例 49 M 51 ) N -羥基-2(R)-(3,4,4-三甲基-2,5-二氧代眯唑啶-l-基)-5-乙氧基甲氧基-4(S)·[N-(4-甲基苯羰基)胺基]戊醢 胺 CH3 TLC: Rf 0.41(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.63 (s, 1H), 8.78 (s, 1H), 7.99 (d, J = 7.8Hz, 1H), 7.73 (d, J = 8.1Hz, 2H), 7.24(d, J = 8.1Hz, 2H), 4.57 (s, 2H), 4.10-3.95 (m, 1H), 3.60-3.30 (取 6H,與DMSO中H20 重疊),2.78 (s, 3H),2.70-2.50 (m,1H), 2.35 (s, 3H), 1·72 a J = 6.9Hz,2H),1.30 (s,3H), 1.28 (s,3H),1.08 (t,J = 6.9Hz,3H)〇 窗淪例4 9 M S 2 ) N -羥基-2(S)_苄基-5-乙氧基甲氧基-4(S)-[N-[(2 -溴 -5 -噬吩基)羰基]胺基]戊醸胺 (請先閲讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規栘(210X29?公t ) 344 310112 568897 A? h1 五、發明説明( 345、
,OCH2CH3
Br ο TLC: Rf 〇·38(氯仿·•甲醇=9:1); NM R (d6-DMS〇) : δ 10.35 (s, 1H), 8.27 (d, J = 8.7Hz, 1H), 7.60 (d, J = 3.9Hz, 1H), 7.27-7.17 (m, 3H), 7.17-7.06 (m, 3H), 4.53 (s, 2H), 4.14-4.03 (m, 1H), 3.49- 3.36 (π% 4H), 2.78-2.63 (m, 2H), 2.38-2.27 (m, 1H), 1.77-1.56 (m, 2H), 1.05 (t, J = 6·9Ηζ,3H)〇 (請先閱讀背面之注意事項再填寫本頁) g Ife 锎 4 9 ( 1 5 3丄 N -羥基_2(S) -苄基-5-乙氧基甲氧基-4(S)-[N_(4 -漠 笨羰基)胺基]戊酿胺
Br 經濟部中央標準局員工消费合作社印製 TLC: Rf 0.46(氯仿·•甲醇=9··1); ΝΜ R (d6-DMS〇) : δ 10.32 (s, 1Η), 8.19 (d, J = 8.4Hz? 1H), 7.78 (d, J = 8.5Hz, 2H), 7.64 (d, J = 8.5Hz, 2H), 7.23-7.06 (m, 5H), 4.54 (s, 2H), 4.24-4.13 (m, 1H), 3.50-3.36 (m, 4H), 2.76-2.69 (m, 2H), 2.38- 2.27 (m? 1H), 1.79-1.58 (m, 2H), 1.05 (t, J =7.0Hz, 3H)〇 p ffll 49 ( 1 5 4)ΤΓζ 本紙張尺度適用中國國家標準(CNS ) A4規格(210x 297公發) 310112 568897 經濟部中央標準局員工消費合作社印裝 <346 五、發明説明(' Ν-羥基-2(S)_苄基-5-乙氧基甲氧基- 4(S)-[N-(4-羥 ¥基苯羰基)胺基]戊醯胺
TLC: Rf 0· 25 (氯仿:甲酵=9 : 1);
^OH NMR (d6-DMS〇) : δ 10.32 (s, 1H), 8.65 (s, 1H), 8.04 (d, J = 8.4Hz, 1H), 7.79 (d, J = 7.8Hz, 2H), 7.35 (d, J = 7.8Hz? 2H), 7.23-7.06 (m, 5H), 5.26 (t, J = 5.7Hz, 1H), 4.55 (s, 2H), 4.52 (d, J =5.7Hz, 2H), 4.27-4.15 (m, 1H), 3.55-3.37 (m, 4H), 2.76-2.70 (m, 2H), 2.34 (m? 1H)? 1.81-1.59 (m, 2H), 1.06 (t, J = 7.2Hz, 3H)〇 簠施例49 Π55) K-羥基-2(S)_(苯并I*吩-3-基)-5-乙氧基甲氧基- 4(S )-[N-(反-4-甲基環己羰基)胺基]戊醢胺 c xoch2ch3ο
ο TLC: Rf 0.37(氯仿:甲醇=19:1); NMR (d6-DMS〇) : δ 10.39 (s, 1H), 8.72 (s, 1H), 7.95-7.90 (m, 1H), 7.83-7.76 (m, 1H), 7.48 (d, J = 8.7Hz, 1H), 7.40-7.30 (m? 2H), 7.29 (s, 1H), 4.56-4.48 (m, 2H), 4.12-3.97 (m, lH)t 3.47-3.28 (m, 4H), 3.01 (dd, J = 14.4, 9.3Hz, 1H), 2.93 (dd, J = 14.4, 5.1Hz, 1H), 2.56-2.41 (m, 1H), 2.09-1.96 (m, lH)t 1.82-1.53 (m, 6H), 1.48-1.20 (m, 3H), 1.09 (t, J = 6.9Hz, 3H), 0.98-0.78 (m, 5H)〇 本紙張尺度適用中國國家標準(CNS ) Λ4規掊(210X 297公釐) 346 310112 (請先閱讀背面之注意事項再填寫本頁)
568897 Λ? 五、發明説明(3 47 ) 奮 _ 例 49 Π 56 ) N-羥基- 2(S)_苄基-5-乙氧基甲氧基-4(S)-[N-(4-氰 基苯羰基)胺基]戊釀胺
TLC: Rf 0.32(氯仿:甲醇=19:1); NMR (dg-DMSO) : δ 10.38 (s, 1H), 8.69 (s? 1H), 8.42 (d, J = 8.7Hz, 1H), 8.02 (d, J = 8.4Hz, 2H), 7.94 (d, J = 8.4Hz, 2H), 7.30-7.09 (m, 5H), 4.58 (s, 2H), 4.31-3.97 (m, 1H), 3.57-3.39 (m, 4H), 2. 83-2.68 (m, 2H), 2.42- 2.30 (m, 1H), 1.83-1.61 (m, 2H), 1.09 (t, J =7·2Ηζ, 3H)。 g _ 例 49 ( 1 57 ) N-羥基- 2(S)-苄基-5-乙氧基甲氧基- 4(S)-[N-([(1-乙醯基瞅啶-4-基)羰基]胺基]戊醢胺 (請先閱讀背面之注意事項再填寫本頁)
經濟部中央標準局員工消費合作社印t
TLC : Rf 0·64(氯仿:甲酵=5:1); 本紙張尺度適用中國國家標準(CNS ) Λ4規掊(210'/ 297公敲) 347 310112 568897 ,3 4 8 Λ? Η*7
五、發明説明C NMR (d6-DMS0) : δ 10.32 (brs, 1H), 7.58 (brd, J = 9.0Hz, 1H), 7.25-7.08 (m, 5H),4.53 (s,2H),4.32 (brd,J = 9.6Hz,1H), 3·93 (m, 1H),3.79 (brd,J = 12.6Hz, 1H), 3.43 (q, J = 6.9Hz, 2H), 3.35 (m, 2H), 2.98 (brt, J = 12.0Hz, 1H), 2.68 (m, 2H), 2.49 (m,1H),2·40-2.20 (m, 2H),1.98 (s,3H),1.75-1.30 (m,6H),1.09 (t,J = 6.9Hz, 3H)〇 蓳」^例4 9(158) H-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[(1-甲 基噘啶-4-基)羰基]胺基]戊醯胺 請 先 閱 讀 背 面 之 注 意 項 再 填 % 本 頁
經濟部中央標準局員工消費合作社印製
TLC: Rf 0·39(氯仿:甲醇:乙酸=7:2:1); NMR (d6-DMS0) : δ 10.30 (brs, 1H), 8.67 (brs, 1H), 7.48 (brd, J = 9.0Hz, 1H), 7.24-7.07 (m, 5H), 4.52 (s, 2H), 3.93 (m, 1H), 3.42 (q, J = 7.2Hz, 2H), 3.34 (m, 2H), 2.70 (m, 4H), 2.26 (m, 1H), 2.00 (m, 1H), 2.10 (s, 3H), 1.81-1.45 (m, 8H),1.08 (t, J =7.2Hz, 3H)〇 謇牖例49 ( 1 59 ) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4-甲 醯基苯羰基)胺基]戊醢胺
CHO 本紙張尺度適用中國國家標準(CNS) 規格(210X297公漦) 348 310112 568897 to w 3 4 Q五、發明説明() TLC: Rf 0.36(氯仿 甲醇=9 : 1) NMR (d6-DMS0) : δ 10.38 (s, 1H), 10.09 (s, 1H), 8.69 (s, 1H), 8.38 (d, J = 8.4Hz, 1H), 8.05 (d, J = 8.4Hz, 2H), 7.99 (d, J = 8.4Hz, 2H), 7.30-7.20 (m, 2H), 7.20-7.10 (m, 3H), 4.58 (s, 2H), 4.32-4.20 (m, 1H), 3.60-3.40 (m, 4H), 2.83-2.70 (m, 2H), 2.45-2.32 (m, 1H), L85-1.62 (m, 2H), 1.09 (t, J = 6.9Hz, 3H)〇 W m m 49 ( 1 60 ) N-羥基-2(S)-(3-甲氧基苄基卜5-乙氧基甲氧基-4(5) -[N-(4-硝基苯羰基)胺基]戊醢胺 och3
,och2ch3 ο Ν〇2 經濟部中央標準局員工消費合作社印製 TLC: Rf 0.40(氯仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.38 (d, J = 1.8Hz, 1H), 8.70 (d? J = 1.8Hz, 1H), 8.51 (d, J = 8.4Hz, 1H), 8.31 (d, J = 8.9Hz, 2H), 8.09 (d, J = 8.9Hz? 2H), 7.18-7.10 (m, 1H), 6.75-6.65 (m, 3H), 4.58 (s, 2H), 4.30-4.20 (m, 1H), 3.69 (s, 3H), 3.60-3.40 (m, 4H), 2.80-2.65 (m, 2H), 2.45-2.30 (m, 1H), 1.85-1.60 (m, 2H), 1.09 (t, J = 7.1Hz, 3H)〇 管 _ 例 49 (1 61 ) N-羥基-2(S)- (3-甲氧基苄基)-5-乙氧基甲氧基_4(S) -[N-(4-氯苯羰基)胺基]戊醢胺 (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS)A4規格( 210X 297公釐) 349 310112 568897 經濟部中央標準局員工消費合作社印製 五、發明説明( 350 ΥΤ〇~ϊ 1 2
Cl TLC: Rf 0·47 (氯仿:甲醇=9 : 1); NMR (d6-DMS〇) : δ 10.36 (s, 1H), 8.23 (d, J = 8.4Hz, 1H), 7.89 (d, J = 8.6Hz, 2H), 7.53 (d, J = 8.6Hz, 2H), 7.17-7.08 (m, 1H), 6.80-6.65 (m, 3H), 4.58 (s, 2H)? 4.30-4.18 (巩 1H), 3·68 (s, 3H),3.60-3.35 (巩 4Η*^ϋΜΒ0 中 H20 重疊), 2.80-2.65 (mt 2H), 2.42-2.30 (m, 1H), 1.85-1.60 (m, 2H), 1.09 (t, J = 6.9Hz, 3H)〇 n m m AQ (1621, N-羥基- 2(S)-(4-甲氧基苄基) -[N-(4-甲基笨羰基)胺基]戊醯胺 乙氧基甲氧基-4 (S)
ch3 TLC: Rf 0.49(氯仿:甲醇=9:1); NMR (d6-DMS〇) : S 10.30 (s, 1Η), 8.64 (s, 1H), 8.02 (d, J = 8.8Hz, 1H), 7.75 (d, J = 8.4Hz, 2H), 7.24 (d, J = 8.4Hz, 2H), 7.02 (d, J = 8.4Hz, 2H), 6.76 (d, J = 8.4Hz, 2H), 4.56 (s, 2H), 4.12-4. 30 (mt 1H), 3.68 (s, 3H), 3.49-3.38 (m, 4H), 2.68 (d,J = 7·4Ηζ,2H), 2.39-2.22 (m,1H),2.34 (s,3H), 1.82-1.58 (m,2H), 1·07 (t,J = 7.2Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公t ) 350 31011 (誚先閱讀背面之注意事項再填寫本頁)
568897 A"? h1 _ R 1五、發明説明() 奮 _ 例 49 ( 1 6 3 ) N-羥基-2(S)-(2-甲氧基苄基)-5-乙氧基甲氧基-4(S) - [( 4 -甲基笨羰基)胺基]戊醯胺
TLC: Rf 0·51 (氯仿:甲醇=9 : 1 ); NM R (dg-DMSO) : δ 10.30 (s, 1H), 8.63 (d, J = 1.5Hz, 1H), 7.93 (d, J = 8.4Hz, 1H), 7.74 (d, J = 8.4Hz, 2H), 7.23 (d, J = 8.4Hz, 2H)? 7.16-6.76 (m, 4H), 4.55 (s, 2H), 4.19-4.08 (m, 1H), 3.62 (s, 3H), 3.48-3.38 (m, 4H), 2.71-2.62 (m, 2H), 2.51-2.40 (m, 1H), 2.33 (s, 3H), 1.75-1.70 (m, 2H), 1.06 (t, J = 7.2Hz, 3H)〇 g _ 例 49 (164) N-羥基- 2(S)-(萘-1-基甲基)-5-乙氧基甲氧基- 4(S)-[N-(4-甲基苯羰基)胺基]戊醯胺 (請先閲讀背面之注意事項再填寫本頁 訂 , 經濟部中央標準.局員工消費合作社印聚
TLC: Rf 0.44(氯仿:甲醇=9:1); 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公飨) 351 310112 568897 A7 Η"7 一一 ... 锤·塞》W»· 111—丨_ · - . 11 一··’ ^ ς ? 五、發明説明() NMR (dg-DMSO) : δ 10.24 (s? 1H), 8.61 (s, 1H)? 8.11 (d, J = 8.4Hz, 1H), 7.98 (d, J = 8.4Hz, 1H), 7.86-7.79 (m, 4H), 7.74-7.71 (d, J = 8.4Hz, 1H), 7.44-7.23 (m, 5H), 4.54 (s, 2H), 4.30-4.20 (m, 1H), 3.50-3.47 (m, 2H), 3.95 (q, J = 7.2Hz, 2H), 3.29-3.10 (m, 2H), 2.62-2.51 (m, 1H), 1.95-1.75 (m, 2H), 1.04 (t, J = 7.2Hz, 3H)〇 奮淪例4 9 (1 fi ?n N-羥基-2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基- 4(S) -[N-(反-4-甲基環己羰基)胺基]戊醸胺
NMR (d6-DMS0) : δ 10.31 (s, 1H), 9.00-8.30 (brs, 1H), 7.44 (d, J = 8.7Hz, 1H), 7.13 (t, J = 8.0Hz, 1H), 6.80-6.65 (m, 3H), 4.55 (d, J = 6.6HzT 1H), 4.51 (d, J = 6.6Hz, 1H), 4.00-3.85 (m, 1H), 3.70 (s, 3H), 3.44 (q, J = 7.1Hz, 2H), 3.50-3.20 (m, 2H), 2.75-2.50 (m, 2H), 2.30-2.20 (m, 1H), 2.10-1.90 (m, 1H)? 1.80-1.20 (m, 9H), 1.09 (t, J = 7.1Hz, 3H), 0.84 (d, J = 6.6Hz, 3H), 1.00-0.80 (m, 2H)〇 窗)fe 例 49 (1 fifi) 經濟部中央標準局員工消費合作社印製 N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4 -甲 氧基環己羰基)胺基]戊醢胺
本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公飨) 352 310112 568897 A7 h1 ,3 5 3 五、發明説明Γ TLC: Rf 0·40(二氯甲烷:甲醇=9:1); NMR (d6-DMS〇) : δ 10.30 (brs, 1H), 8.67 (brs, 1H), 7.48 (brd, J = 8.4Hz, 0·4Η), 7.41 (brd, J = 8.4Hz, 0.6H), 7.24-7.08 (m, 5H), 4.53 (s, 2H), 3.93 (mt 1H), 3.43 (q, J = 7.2Hz, 2H), 3.34 (m, 3H), 3.21 (s, L2H), 3.18 (s, 1.8H), 2.67 (m, 2H), 2.30-1.30 (m, 12H), 1.09 (t, J = 7.2Hz, 3H)〇 y 實施例4 9 (1 ft 7 ) H-羥基-2(S)-(苯并儒吩-3-基)-5-乙氧基甲氧基-4(S )-[N-(4-溴苯羰基)胺基]戊醃胺
,0CH2CH3 0 經濟部中央標準局員工消费合作社印製
Br TLC: Rf 〇·43(氯仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.38 (d, J = 1.2Hz, 1H), 8.68 (d, J = 1.2Hz, 1H), 8.27 (d, J = 8.4Hz, 1H), 7.91 (d, J = 7.5Hz, 1H), 7.83-7.76 (m, 3H), 7.69-7.66 (m, 2H), 7.34-7.22 (m, 3H), 4.55 (s? 2H)? 4.38-4.25 (m, 1H)? 3.49 (d, J = 5.1Hz, 2H), 3.41 (q7 J = 7.2Hz, 2H), 3.02-2.98 (m, 2H), 2.56-2.48 (m, 1H), 1.91-1.70 (π% 2H), 1.04 (t, J = 7.2Hz, 3H)〇 實施例49 (1 M ) N-羥基-2(S)-(苯并I*吩-3-基)-5-乙氧基甲氧基- 4(s )- [N-U-氯笨羰基)胺基]戊醯胺 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公羧) 353 310112 568897 A' Η 五、發明説明(354)
•〇CH2CH3 0 TLC: Rf 0.44(氯仿:甲酵=9:1); NM R (d6-DMS〇) : δ 10.38 (d, J = 1.5Hz, 1H), 8.68 (d, J = L5Hz? 1H), 8.27 (d, J = 8.4Hz, 1H), 7.93-7.87 (m, 3H), 7.78 (dj = 7.5Hz, 1H), 7.55-7.52 (m, 2H), 7.34- 7.22 (m, 3H), 4.55 (s, 2H), 4.38-4.24 (m, 1H), 3.49 (d, J = 5.4Hz, 2H), 3.41 (q, J = 7.2Hz, 2H), 3.04-2.92 (m, 2H), 2.58-2.42 (m, 1H), L90-1.70 (m, 2H), 1.05 (ζ J = 7·2Ηζ,3H)〇 奮施例49 ( 1 69 ) N-羥基- 2(S)-苄基-5-乙氧基甲氧基- 4(S)-[N-[(2-氯 吡啶-5 -基)羰基]胺基]戊醯胺 OCH2CH3 經濟部中央標準局員工消費合作社印製
Ο «ν〇. TLC: Rf 0.36(氯仿:甲醇=9:1); NMR (dg-DMSO) : δ 10.35 (s, 1H), 8.81 (d, J = 2.4Hz, 1H), 8.65 (s, 1H), 8.43 (d, J = 9.0Hz, 1H), 8.21 (dd, J = 2.4Hz, 8.5Hz, 1H), 7.61 (d, J = 8.5Hz. 1H), 7.24-7.07 (m, 5H), 4.54 (s, 2H), 4. 24-4.14 (m, 1H), 3.50-3.37 (m, 4H), 2.79-2.66 (m, 2H), 2.39-2.28 (m, 1H), 1.79-1.60 (m, 2H), 1.05 (t, J = 7.1Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公羧) 354 310112 568897 Λ? 五、發明説明(3 55 ) n m m aq (\7〇) N-羥基-2(S)-(3,5-二甲氧基苄基)-5-乙氧基甲氧基-4(S)-[N-((4-甲基笨羰基)胺基]戊醸胺
TLC: Rf 0.33(氯仿:甲醇=9:1); NMR (dg-DMSO) : δ 10.33 (brs, 1H), 8.67 (brs, 1H), 8.02 (brd, J = 8.7Hz, 1H), 7.76 (d, J = 8.1Hz, 2H), 7.25 (d, J = 8.1Hz, 2H), 6.26 (s, 3H), 4.57 (s, 2H), 4.24 (m, 1H), 3.63 (s? 6H), 3.49 (m, 2H), 3.45 (q, J = 7.2Hz, 2H), 2.68 (brd, J = 7.2Hzt 2H), 2.34 (s,3H), 2·34 (m,1H),1.80-1.59 (m, 2H),1·07 (t,J = 7·2Ηζ, 3H)〇 啻)fe 例 49 (171) N-羥基- 2(S)_苄基-5-乙氧基甲氧基- 4(S)-[N-(4-甲 基環己羰基)胺基]戊醸胺
經濟部中央標準局員工消費合作社印製 TLC: Rf 0.38(氛仿··甲醇=9:1); 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公蝥) 355 J10I12 568897 Λ? ΗΊ — ________ 五、發明説明(356) NMR (dg-DMSO) : δ 10.29 (d, J = 1.5Hz, 1H), 8.65 (d, J = L5Hz, 1H), 7.42 (brd, J = 8.4Hz, 0.16H), 7.34 (brd, J = 8.4Hz, 0.84H), 7.23-7.08 (m, 5H), 4.52 (s, 2H)t 3.95 (mt 1H), 3.43 (q, J = 7.2Hz, 2H), 3.35 (m, 2H), 2.68 (m, 2H)r 2.30-2.10 (m, 2H), 1.80-1.30 (m, 11H), 1.08 (t, J = 7.2Hz, 3H), 0.88 (d, J = 6.6Hz, 2.5H), 0.83 (d, J = 6.6Hz, 0.5H)〇 管施例4 9 Π 7 2 ) N-羥基-2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基-4(S) -[NM4-氰基苯羰基)胺基]戊醸胺
,och2ch3 Ο
CN TLC: Rf 0.32(氯仿··甲醇=19:1); NMR (d6-DMS〇) : δ 10.37 (s, 1H), 8.68 (s, 1H), 8.42 (d, J = 8.4Hz, 1H), 8.02 經濟部中央標準局員工消費合作社印裝 (d, J = 8.4Hz, 2H), 7.95 (d, J = 8.4Hz, 2H), 7.20-7.08 (m, 1H)V 6.76-6.65 (m, 3H), 4.58 (s, 2H), 4.33-4.15 (m, 1H), 3. 68 (s, 3H), 3.55-3.39 (m, 4H), 2.80-2.56 (m, 2H), 2.43-2.28 (m,1H), 1.88-1.58 (m,2H), 1.09 (t, J = 7·2Ηζ,3H)。 奮淪例4 9 (1 7 3 ) N -羥基-2(R)-(3,4,4 -三甲基- 2,5-二氧代咪唑啶-l-基)甲基-5-乙氧基甲氧基-4(S)-[H-(反-4-甲基環己羰基) 胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公t ) 356 310112 568897 Λ }Γ 五、發明説明( 357 -VN^〇 广 〇ch2ch3 ch3 TLC: Rf 0.47(氯仿:甲醇=19:1); NMR (dg-DMSO) : δ 10.59 (s, 1H), 8.78 (s, 1H), 7.43 (d, J = 8.4Hz, 1H), 4.52 (d, J= 6.9Hz, 1HX 4.50 (d, J = 6.9Hz, 1H), 3.77-3.65 (m, 1H), 3.48-3.33 (m, 4H), 2.76 (s, 3H), 2.52-2.41 (m, 1H), 2.0 3-1.92 (m, 1H), 1.45-1.71 (m, 6H), 1.37-L20 (m, 1H), 1.27 (s, 3H), 1.26 (s, 3H), 1.08 (t, J = 7.2Hz, 3H), 0.89-0.78 (m, 2H), 0.83 (d, J = 6.3Hz, 3H)〇 奮 _ 例 4Q (1 74) N-羥基-2(R)_(笨并呋喃-2-基)甲基-5-乙氧基甲氧基 -4(S)-[N-(反-4-甲基環己羰基)胺基]戊醢胺
經濟部中央標準局員工消费合作社印製 CH3 TLC: Rf 0.42(氯仿:甲酵=19:1); NMR (d6-DMS〇) : δ 10.52 (s, 1H), 8.78 (s, 1H), 7.52-7.42 (m, 3H), 7.23-7.13 (m, 2H), 6.53 (s, 1H), 4.54 (d, J= 6.6Hz, 1H), 4.51 (d, J = 6.6Hz, 1H), 3.95-3.82 (m, 1H), 3.46-3.33 (mt 4H), 2.97-2.81 (m, 2H), 2.55-2.42 (mT 1H), 2.04-1.95 (m, 1H), 1.74-1.56 (m, 7H), 1.39-1.26 (m, 4H), 1.07 (t, J = 7.2Hz, 3H), 0.84 (d, J = 6.6Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公籍)
T5T 568897 π Η, ^_ 五、發明説明(3 58) 當例 49 (175) N-羥基_2(S)_ (苯并1*吩-3-基)甲基-5-乙氧基甲氧基 -4(S)-[N-(4-硝基苯羰基)胺基]戊醯胺
(請先閲讀背面之注意事項再填寫本頁) TLC: Rf 0·36(氛仿:甲醇=19:1); NMR (d6-DMSO) : 5 10.42 (S,1H),8.70 (brs,lH),8.55(d,J = 8·4Ηζ,1H), 8.32-8.29 (m, 2H), 8.11-8.08 (m, 2H), 7.93-7.90 (m, 1H), 7.81-7.78 7.34- 7.25 (m, 3H), 4.55 (s, 2H), 4.38-4.25 (m, 1H), 3.51 (d, J = 5.7Hz, 2H), 3.41 (q, J = 7.2Hz, 2H), 3.05-2.94 (m, 2H), 2.57-2.53 (m, 1H), 1.9M.72 (m, 2H), 1.04 (t, J = 7.2Hz, 3H)〇 g 淪俐 49 ( 1 76 ) N-羥基-2(S)_苄基-5-乙氧基甲氧基- 4(S)-[N-(4-氰 基笨羰基)胺基]戊醢胺 經濟部中央標準局員工消費合作社印製
TLC: Rf 0.47(氯仿:甲醇=9:1); 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公摄) 358 310112 568897 Λ Η" ,3 5 9 五、發明説明Γ NMR (d6-DMS0) : δ 10.34 (s, 1H), 8.66 (s, 1H), 8.22 (d, J=8.4Hz, 1H), 7.85 (d, J=8.4Hz, 2H), 7.55 (d, J=8.4Hz, 2H), 7.24-7.09 (m, 5H), 4.56 (s, 2H), 4.35 (s, 1H), 4.28-4.16 (m, 1H), 3.48 (d, J=6.0Hz? 2H), 3.43 (q, J=6.9Hz? 2H), 2.75 (d, J=7.2Hz, 2H), 2.40-2.29 (m, 1H), 1.81-1.61 (m, 2H), 1.07 (t, J=6.9Hz, 3H).
y 濂俐 4 9 (1 7 7 L N-羥基_2(S)-苄基-5-乙氧基甲氧基-4(S)-[H-(4-甲 叉基環己羰基)胺基]戊醯胺
,och2ch3 0 TLC: Rf 0.40(二氯甲烷:甲醇=9:1); NMR (d6-DMS〇) : δ 10.31 (s, 1H), 8.67 (s, 1H), 7.50 (brd, J=8.7Hz, 1H), 1.25-1 m (m, 5H), 4.61 (s, 2H), 4.53 (s, 2H), 3.93 (m, 1H), 3.43 (q, J=6.9Hz, 2H), 3.35 (m, 2H), 2.68 (m, 2H)? 2.25 (m, 4H), 2.05-1.30 (m, 8H), 1.09 (t, J=6.9Hz, 3H)〇
568897 Λ? ____ 五、發明説明(36<>) TLC: Rf 0.38(二氯甲烷:甲酵=9:1); NMR (d6-DMS〇) : δ 10.32 (s, 1H), 8.68 (s, 1H), 7.96 (s, 1H), 7.58 (brd, J=8.7Hz, 1H), 7.25-7.08 (m, 5H), 4.53 (s, 2H), 4.13 (brd, J=12.3Hz, 1H), 3.93 (m, 1H), 3.67 (brd, J=10.5Hz, 1H), 3.43 (q, J=6.9H2; 2H), 3.35 (m, 2H), 3.00 (brt J=12.3Hz, 1H), 2.75-2.20 (m, 5H), 1.80-1.30 (m, 6H)? 1.09 (t7 J=6.9Hz, 3H)〇 g 锎在9 M 79) 羥基- 2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[(1-甲 基-卜環己烯-4-基)羰基]胺基]戊醢胺
TLC: Rf 0.30(氯仿:甲酵=10:1); NMR (d6-DMS0) : δ 10.33 (brs, 1H), 7.53 (d, J=8.4Hz, 1H), 7.30-7.05 (mt 5H), 5.35 (brs, 1H), 4.54 (s, 2H), 4.00-3.85 (mt 1H), 3.60-3.20 (m, 4H), 2.80-2.60 (m, 2H), 2.40-1.40 (m, 10H), 1.60 (s, 3H), 1.10 (t? J=7 .2Hz, 3H)〇 經濟部中央標準局員工消费合作社印製 管 _ 例 49 ( 1 80 ) N-羥基- 2(S)-苄基-5-乙氧基甲氧基- 4(S)-[N-[(4-甲 基-1-環己烯基)羰基]胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公楚) 360 310112 568897
A' }V 五、發明説明( 361
ch3 TLC: Rf 0.35(氯仿:甲醇=10:1); NMR (d6-DMS0) : δ 10.32 (s, 1H), 8.65 (s, 1H), 7.35-7.00(m, 6H), 6.46 (brs, 1H), 4.54 (s, 2H), 4.20-3.90 (m, 1H), 3.50-3.20 (m, 4H), 2.80-2.60 (m, 2H), 2.40-2.20 (m, 4H), 1.80-1.50 (m, 5H), 1.20-1.00 (m, lH)t 1.09 (t, J=7.1Hz, 3H-), 0.93 (d, J=6.3Hz, 3H)〇 富餱例49 (181 ) N -經基-2(S)_节基乙氧基甲氧基-4(S)-[N-(4 -氟 笨羰基)胺基]戊醸胺
經濟部中央標準局員工消費合作社印製 TLC: Rf 0.45(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.36 (s, 1H)? 8.60-8.55 (br, 1H), 8.16 (d, J=8.7Hz, 1H), 7.94 (dd, J=9.0, 5.4Hz, 2H), 7.35-7.20 (m, 4H), 7.20-7.08 (m, 3H), 4.58 (s, 2H), 4.30-4.18 (m, 1H), 3.60-3.40 (m, 4H)? 2.82-2.70 (m, 2H), 2.42-2.30 (m, 1H), 1.82-1.60(m,2H),1.09 (t,J=6.9Hz,3H)〇 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公漦) 361 3 1 0 112
568897 ί\丨 ίΓ 五、發明説明(3 6 2) 謇 _ 例 49 (1 82) Ν-羥基-2(S)_苄基-5-乙氧基甲氧基- 4(S)-[N-(4-氯 笨羰基)胺基]戊醢胺
CI 請 閲 讀 背 ιέ 意 事 項 再 t TLC: Rf 0.38(氯仿:甲醇=9:1); NMR (dg-DMSO) : 8 10.36 (s, 1H), 8.80-8.55 (br, 1H), 8.22 (d, J=8.4Hz, 1H), 7.89 (d, J=8.7Hz, 2H), 7.53 (d, J=8.7Hz, 2H), 7.30-7.10 (m, 5H), 4.57 (s, 2H), 4.30-4.15 (m, 1H), 3.60-3.40 (m, 4H), 2.82-2.70 (m, 2H), 2.42-2.30 (m, 1H), 1.82-1.60 (m,2H),1.09 (t,J=7.1Hz,3H)。 管旛例4 9 ( 1 8 3 ) N-羥基-2(S)-苄基-5-乙氧基甲氧基- 4(S)-[N-(4-羥 基環己羰基)胺基]戊釀胺 經濟部中央標準局員工消費合作社印製
OH TLC: Rf 0.38(氯仿:甲醇··乙酸=9:1:0·5); 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公蝥) 362 310112 568897 π' Η"7 五、發明説明f ) NMR (d6-DMS〇) : δ 10.29 (s, 1H), 7.44 (d, J=8.8Hz, 0.4H), 7.35 (d, J=8.8Hz, 0.6H), 7.26-7.03 (m, 5H), 4.51 (s, 2H), 4.02-3.82 (m, 1H)? 3.76-3.67 (m, 1H), 3.41 (q, J=7.1Hz, 2H), 3.39-3.26 (m, 2H), 2.72-2.62 (m, 2H), 133-2.19 (m, lH)t 2.15-1.90 (m, 1H), 1.87-1.24 (m? 10H), 1.07 (t? J=7.1Hz, 3H)〇
ff m m 4 9 ( 1 8 4 L
TLC: Rf 0.33(氯仿:甲醇=19:1); NMR (dg-DMSO) : δ 10.41 (s, 1H), 8.74 (s, 1H), 7.76-7.56 (m, 2H), 7.55-7.38 (π% 2H), 7.37-7.15 (m, 2H), 4.58-4.46 (m, 2H), 4.13-3.90 (m, 1H), 3.58-3.30 (m, 4H), 2.92-2.62 (m? 2H), 2.50-2.34 (m? 1H), 2.12-1.92 (m, 1H), 1.82-1.50 (m? 6H), 1.48-U8 (m, 3H), 1.09 (t, J=7.0Hz, 3H), 1.00-0.70 (m, 5H)〇 經濟部中央標隼局員工消f合作社印製 奮 _ 例 49 (185)一 N -經基-2(S)-(3 -甲氧基节基)-5 -乙氧基甲氧基- 4(S) -[N-(4-三氟甲基笨羰基)胺基]戊醢胺
—— ............- ...................g ^ -------- Q 1 A 1 1 Ο 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公漦) 568897 五、發明説明( TLC : Rf 364 .41 (氯仿:甲醇=9 :工) NMR (d6-DMSO) : (5 10.34 (s,lH),8.67 (s,lH),8.39 (d,J=8.7Hz,.1H),8.05 (d, J=8.〇Hz, 2H), 7.83 (d, J=8.0Hz, 2H), 7.12 (t, J=8.4Hz, 1H), 6.72-6.68 (m, 3H), 4-57 (S, 2H), 4 .32-4.15 (m, 1H), 3.66 (s, 3H), 3.51-3.39 (m, 4H), 2.73 (d, J=7.0Hz, 2H), 2.41-2.27 (m, 1H), 1.82-1.59 (m, 2H), 1.07 (t, J=7.0Hz, 3H)〇 置Jfe 例 49 (186) N-經基- 2(S)-(1-甲基時丨睬-3-基)甲基-5-(2-甲氧基 甲氧基)甲氧基- 4(S)-[N-(反-4-甲基環己羰基)胺基]戊酿 胺 叫 (請先閱讀背面之注意事項再填寫本頁) .€衣·
、1T TLC: Rf 0.33(氯仿:甲酵=19:1); 經濟部中央標準局員工消費合作社印製 NMR (d6-DMS〇) : δ 10.30 (s, 1H), 8.64 (s, 1H), 7.52 (d, J=7.8Hz, 1H), 7.42 (d, J=8.4Hz, 1H), 7.32 (d, J=7.8Hz, 1H), 7.11 (U J=7.8Hz, 1H)? 6.98 (s, 1H)? 6.96 (t, J=7.8Hzt 1H), 4.58-4.48 (m, 2H), 4.03-3.92 (m, 1H), 3.70 (s, 3H), 3.51-3.25 (m, 6H), 3.23 (s, 3H), 2.89-2.70 (mT 2H), 2.43-2.34 (m? 1H), 2.08-1.95 (m, 1H), 1.80-1.48 (m, 6H), 1.47-1.20 (m, 3H), 0.96-0.78 (mt 5H)〇 窗 _ 例 4 9 (ΐ 8 7 ) N -羥基- 2(S)_苄基-5 -乙氧基甲氧基-4(S)-[N-[(1,3 二硫雜環己烷-2 -基)羰基]胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公t ) 364 310112 568897 Λ? h1 五、發明説明(365 )
TLC: Rf 0.39(氯仿:甲醇=9:1)·, NMR (de-DMSO) : δ 10.33 (s, 1H), 8.71 (brs, 1H), 7.81 (d, J=8.1Hz, 1H), 7.25-7.08 (m, 5H), 4.51 (s, 2H), 4.41 (sT 1H), 3.47-3.17 (m, 6H), 2.78-2.56 (m, 4H)T 2·38-2·27 (m,1H),1·98-1·82 (m,2H), 1.67-1.49 (m,2H),1.08 (t,J=7.0Hz,3H)〇 (請先閱讀背面之注意事項再填寫本頁) 奩渝锎49 ( 1 88 ) N-羥基_2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基_4(S) -[N-(4 -溴苯羰基)胺基]戊醸胺
TLC: Rf 0.47(氯仿:甲醇=9:1); 經濟部中央標準局員工消费合作社印製 NMR (d6-DMSO) : δ 10.34 (s, 1H), 8.68 (brs, 1H), 8.22 (d, J=8.7Hz? 1H), 7.81-7.68 (m, 2H), 7.68-7.64 (m, 2H), 7.12 (t, J=8.1Hz, 1H), 6.71-6.66 (m, 3H), 4.56 (s, 2H), 4.16-4.27 (m, 1H), 3.66 (s, 3H), 3.48 (d, J=5.7Hz, 2H), 3.43 (q7 J=6.9Hz, 2H), 2.71 (d, J=6.0Hz, 2H), 2.39-2.28 (m, 1H)? 1.79-1.59 (m, 2H), 1.07 (t, J=6.9Hz, 3H)〇 奩淪俐49 Π89) 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公敍) 365 310112 )V568897 經濟部中央標準局員工消费合作社印製 66 五、發明説明f Η-羥基_2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基-4 (S) -[N-[(2-溴·*吩-卜基)黎基]胺基]戊釀胺 ,och2ch3
0 0
Br TLC: Rf Ο.46(氯仿:甲醇= 9:1); NMR (dg-DMSO) : δ 10.35 (s, 1H), 8.68 (s, 1H), 8.28 (d, J=8.7Hz, 1H), 7.62 (d, J=4.2Hz, 1H), 7.26 (d, J=4.2Hz, 1H), 7.12 (t, J=7.8Hz, 1H), 6.72-6.66 (m, 3H), 4.55 (s, 2H), 4.18-4.05 (m, 1H), 3.68 (s, 3H), 3.49-3.38 (m, 4H), 2.75-2.62 (m, 2H), 2·38-2·26 (m,1H), 1·78-1·58 (m,2H),1.07 (t,J=7.2Hz,1H)。 旃 fill 49 (19QJ_ H-羥基_2(S)-(2_甲氧基苄基)4-乙氧基甲氧基-4(S) -[Η-(反-4-甲基瓌己羰基)胺基]戊釀胺
TLC: Rf 0.30(氛仿··甲醇=19:1); NMR (d6-DMS0) : δ 10.31 (s, 1H), 8.67 (s, 1H), 7.36 (d, J=8.0Hz, 1H), 7.21-7.09 (m, 1H), 7.08-7.00 (m, 1H), 6.89 (d, J=7.4Hz, 1H), 6.81 (t, J=7.4Hz, 1H), 4.56-4.48 (m? 2H), 3.90-3.75 (m, 1H), 3.74 (s, 3H), 3.43 (q, J=7.0Hz? 2H), 3.40-3.24 (m, 2H), 2.80- 2.56 (m, 2H), 2.44-2.28 (m, 1H), 2.09-1.89 (π% 1H), 1.78-L48 (m, 6H), 1.44-1.17 (m,3H), UO (t,J=7.0Hz,3H), 1·00-0·70 (m, 5H)〇 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公t )
TFT
3101H (請先閱讀背面之注意事項再填寫本頁) ·裂·
、1T 568897 Λ? Η*7 五、發明説明(367) 奮施例49 ( 1 9 1 ) N-羥基-2(S)_苄基-5-乙氧基甲氧基-4(S)-[N-[(2-甲 基吡啶-5 -基)羰基]胺基]戊醯胺
CH3 TLC: Rf 0.22(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.33 (s, 1H), 8.86 (d, J=2.0Hz, 1H), 8.64 (s, 1H), 8.24 (d, J=8.8Hz, 1H), 8.06 (dd7 J=8.0Hz, 2.0Hz, 1H), 7.31 (d, J=8.0Hz, 1H), 7.26- 7.06 (m, 5H), 4.55 (s, 2H), 4.30-4.12 (m, 1H), 3.50-3.43 (m, 2H), 3.42 (q, J=7.0Hz, 2H), 2.78- 2.66 (m, 2H), 2.49 (s, 3H), 2.44-2.27 (m, 1H), 1.83-1.56 (m, 2H), 1.05 (t, J=7.0Hz, 3H)〇 ' 管)fe 例 49 (192) N -羥基- 2(S)-(苯并呋喃-3-基)甲基-5 -乙氧基甲氧基 -4(S)-[N-(4-硝基苯羰基)胺基]戊醯胺 (請先閱讀背面之注意事項再填寫本頁) ·裝· 經濟部中央標準局員工消費合作社印製
N〇2 TLC: Rf 0.45(氯仿:甲醇=9:1); 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公鐘) 367 3101 1^ 568897 Λ'? Β*7 五、發明説明(368 ) NMR (d6-DMS0) : δ 10.43 (s, 1H), 8.71 (brs? 1H), 8.54 (d, J=8.4Hz, 1H), 8.31 (d, J=8.8Hz, 2H), 8.09 (d, J=8.8Hz, 2H), 7.63-7.60 (m, 1H), 7.49 (d, J=7.6Hz, 1H), 7.29-7.13 (m, 2H), 4.55 (s, 2H), 4.38-4.21 (m, 1H), 3.51 (d, J=5.6Hz, 2H), 3.42 (q, J=7.0Hz, 2H), 2.84 (d? J=7.4Hz, 2H), 2.40-2.20 (m, 1H), 1.91-1.63 (m, 2H), L05 (t, J=7.0Hz, 3H)〇 實 life 例 4 Q (1 9 3 ) N-羥基-2(S)-苄基-5-乙氧基甲氧基_4(S)-[N-(反-4-羥基環己羰基)胺基]戊醯胺
(請先閱讀背面之注意事項再填寫本頁) 衣·
、1T TLC: Rf 0.41(氯仿:甲酵:乙酸=9:1:0·5); NMR (d6-DMSO) : δ 10.29 (s, 1H), 8.62 (brs, 1H), 7.42 (d, J=8.7Hz, lH)t 7.24-7.05 (m, 5H), 4.51 (s, 2H), 3.96- 3.85 (m, 1H), 3.51-3.25 (m, 5H), 2.73-2.50 (m, 2H), 2.30-2.19 (m, 1H), 2.03-1.91 (m , 1H), 1.85-1.56 (m, 5H), 1.53-1.24 (m, 3H), 1.13-1.03 (m,5H)。 經濟部中央標準局員工消费合作社印製 奮淪例49 (194) N-羥基-2(S)-(3-氯苄基)-5-乙氧基甲氧基-4(S)_[卜 (4-甲基笨羰基)胺基]戊醸胺 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公蝥) ΤΓ0ΎΤ2 568897 Η*7
Cl
五、發明説明f 69 ) ch3 TLC: Rf 0.50(二氯甲烷:甲醇=9:1); NMR (de-DMSO) : δ 10.34 (s, 1H), 8.06 (brd, J=8.8Hz, 1H), 7.77 (d, J=8.4Hz, 2H), 7.27-7.03 (m, 6H), 4.57 (s, 2H), 4.23 (η% 1H), 3.50 (m, 2H), 3.44 (q, J=7.0Hz, 2H), 2.90 (m, 2H), 2.34 (s, 3H), 2.34 (m, 1H), 1.80-L60 (m, 2H), 1.08 (t, J=7.0Hz, 3H)〇 管 _ 锎 4 9 (1 9 5 )— N-羥基- 2(S)-苄基-5-乙氧基甲氧基- 4(S)-[N-[(2-羥 基吡啶-5 -基)羰基]胺基]戊醯胺 --------·裝-- (請先閲讀背面之注意事項再填寫本頁) 訂
OH 經濟部中央標準局員工消費合作社印製 TLC: Rf 0·42(氛仿:甲酵··乙酸=9:1:0.5); NMR (dg-DMSO) : S 11.93 (brs, 1H), 10.32 (s, 1H), 7.98 (d, J=2.4Hz, 1H), 7.90 (d, J=8.4Hz, 1H), 7.84 (dd, 8.4Hz, 1H), 7.24-7.06 (m, 5H), 6.31 (d, J=9.6Hz, 1H), 4.53 (st 2H), 4.18-4.02 (m, 1H), 3.45-3.33 (m, 4H), 2.75-2.64 (m, 2H), 2.36-2.25 (m, 1H), 1.73-1.53 (m, 2H), 1.06 (t, J=7.0Hz, 3H)〇 管 Jfe 例 4 9 ( 1 9 6 ) 本紙張尺度適用中國國家標準(CNS ) Ad規格(21〇>< 297公^ -3^0112 經濟部中央標準局員工消費合作社印製 568897 Λ 7 ΙΓ 3 7 0 ~ 五、發明説明() 料-羥基-2(1〇-(3,4,4-三甲基-2,5-二氧代眯唑啶-1-基)甲基-5-乙氧基甲氧基- 4(S)-[N-(4-溴笨羰基)胺基]戊 醯胺
TLC: Rf 0.53(氯仿:甲醇=9:1); NMR (d6-DMSO) : δ 10.60 (s, 1H), 8.75 (brs, 1H), 8.19 (d? J=7.8Hz, 1H), 7.77-7.74 (m, 2H), 7.66-7.62 (m7 2H), 4.54 (s, 2H), 4.06-3.96 (m, 1H), 3.50-3.37 (m, 6H), 2.75 (s, 3H), 2.64-2.51 (m, 1H), 1.69 (ζ J=7.2Hz, 2H), 1.27 (s, 3H), 1.26 (s, 3H), 1.05 (t, J=6.9Hz, 3H)〇 管 _ 例 49 M 97) N-羥基- 2(S)-(3 -甲氧基苄基)-5-乙氧基甲氧基-4(S) -[N-(4-二甲氧基甲基苯羰基)胺基]戊醯胺
TLC: Rf 0·50(氯仿:甲酵=9:1); 本紙張尺度適用中國國家標準(CNS ) Α4規格(.210X2^7公釐) 3 7 0~~ 310112 (請先閲讀背面之注意事項再填寫本頁)
568897 Β"7 五、發明説明(371 ) NMR (d6-DMS〇) :δ 10.36(s,lH), 8.68 (s,lH), 8.16 (d,J=8.4Hz, 1H), 7.89 (d, J=8.2Hz, 2H), 7.46 (d, J=8.2Hz, 2H), 7.13 (t, J=8.0Hz, 1H), 6.80-6.65 (m, 3H), 5.44 (s, 1H), 4.58 (s, 2H), 4.35-4.20 (m, 1H), 3.66 (s, 3H), 3.60-3.35 (m, 4H), 3.25 (s, 6H), 2.74 (d, J=6.9Hz, 2H), 2.45-2.30 (m, 1H), 1.85-1.60 (m, 2H), 1.09 (t, J=6.9Hz, 3H)〇 奮淪例49 (1 98) N-羥基- 2(S)-(3-三氟甲氧基苄基)-5-乙氧基甲氧基_ 4(S)-[N-(4-氯苯羰基)胺基]戊醯胺 ocf3 .OCH2CH3 (請先閲讀背面之注意事項再填寫本頁) ·.裝·
*1Τ TLC: Rf 0.38(氯仿:甲醇=9:1); NMR (dg-DMSO) : δ 10.38 (s, 1H), 8.70 (s, 1H), 8.24 (d, J=8.7Hz, 1H), 7.89 經濟部中央標準局員工消費合作社印製 (d, J=8.7Hz, 2H), 7.53 (d, J=8.7Hz, 2H), 7.36 (t, J=7.8Hz, 1H), 7.20-7.06 (m? 3H), 4.58 (s, 2H), 4.32-4.18 (m, 1H), 3.60-3.40 (m, 4H), 2.90-2.75 (m, 2H), 2.42-2.30 (m, 1H), 1.85-1.60 (m,2H), 1·09 (t,J=7.1Hz,3H)。 g _ 例 49 (1 99) H-羥基-2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基- 4(S) -[H-[2-硝基α吩-5-基)羰基]胺基]戊醸胺 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公犮) 371 310112 568897 Λ
,och2ch3 0 五、發明説明(372 N〇2 TLC: Rf 0.46(氯仿·•甲醇=9:1), NMR (d6-DMS0) : δ 10.38 (s, 1H), 8.73-8.69 (m, 2H), 8.13 (d, J=4.5Hz, 1H), 7.83((1,1=4.5«^111),7.16-7.11(111,11*1),6.73-6.67 (叽3印,4.56(3,211),4.18-4.09 (m, 1H), 3.69 (s, 3H), 3.49 (d, J=8.1Hz, 2H), 3.43 (q, J=7.2Hz, 2H), 2.79-2.63 (m, 2H), 2.29-2.40 (m, 1H), 1.80-1.59 (m, 2H), 1.07 (t, J=7.2Hz, 3H)〇
g m <gil A9(20 0L H-羥基_2(R)-(笨并三唑-卜基)甲基 -4(S)-[N-(4-硝基笨羰基)胺基]戊醸胺 乙氧基甲氧基 (請先閱讀背面之注意事項再填寫本頁)
_OCH2CH3 0 經濟部中央標準局員工消費合作社印製 Ν〇2 TLC: Rf 0.29(氯仿··甲醇=9:1); NMR (d6-DMS〇) : S 10.52 (s, 1H), 8.62 (d, J=8.4Hz, 1H), 8.32 (d, J=9.0Hz, 2H), 8.08 (dt J=9.0Hz, 2H), 8.00 (d, J=8.1Hz, 1H), 7.80 (d? J=8.1Hz? 1H), 7.51 (t, J=8.1Hz, 1H), 7.34 (t, J=8.1Hz, 1H), 4.88 (dd, J=14.1Hz, 9.0Hz, 1H), 4.75 (dd, J=14.1Hz, 5.7Hz, 1H), 4.54 (s, 2H), 4.35-4.24 (m, 1H), 3.51 (d, J=5.1Hz;*2H), 3.41 (q, J=7.2Hz, 2H), 2.95-2.86 (m, 1H)? 1.86-1.81 (m, 2H), 1.05 (t, J=7.2Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公# ) 372 3ΊΓ0ΊΓΓΖ 568897 A"? Η*7 Ί 7 3五、發明説明() g _ 例 4 9 ( 2 0 1 ) N -羥基-2(R)-(3,4,4 -三甲基-2,5-二氧代眯唑啶-l-基)甲基-5-乙氧基甲氧基-4(S)-[N-(4-硝基苯羰基)胺基] 戊醯胺
TLC: Rf 0.40(氯仿:甲酵=9:1); NMR (d6-DMSO) : δ 10.63 (s, 1H), 8.76 (s, 1H), 8.47 (d, J=8.1Hz, 1H), 8.28 (d, J=8.9Hz, 2H), 8.03 (d, J=8.9Hz, 2H), 4.56 (s, 2H), 4.10-3.98 (m, 1H), 3.60-3.32 (m, 6H), 2.76 (s, 3H), 2.65-2.50 (m, 1H), 1.80-1.65 (m, 2H), 1.28 (s, 3H), 1.27 (s, 3H),1.06 (t,J=7.2Hz,3H)。 啻淪例49 ( 20 2 ) 1羥基-2(1〇-(3,4,4-三甲基-2,5-二氧代眯唑啶-1-基)甲基-5-乙氧基甲氧基- 4(S)-[N-(4-氯苯羰基)胺基]戊 醢胺 (請先閱讀背面之注意事項再填寫本頁 訂 經濟部中央標準局員工消費合作社印製
TLC: Rf 0· 40 (氯仿:甲醇=9: 1); 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公漦) 373 310112 568897 J, ' "" "" "' 一 " — 〜.一 .一一 .一 ___ 五、發明説明f74) NMR (d6-DMS〇) : δ 10.61 (s, 1H), 8.75 (s, 1H), 8.18 (d, J=8.1Hz, 1H), 7.82 (d? J=8.6Hz, 2H), 7.50 (d, J=8.6Hzt 2H), 4.55 (s, 2H), 4.10-3.95 (m, 1H), 3.60-3.35 (m, 6H), 2.76 (s, 3H), 2.65-2.45 (m, 1H), 1.80-1.62 (mt 2H), 1.28 (s, 3H), 1.26 (s, 3H), 1.06 (t, J=6.9Hz, 3H)〇 g _ 例 49 ( 203 ) K-羥基-2(S)-(3-苯基丙基)-5-甲氧基甲氧基-4(S)-[ N-(4-笨氧基苯羰基)胺基]戊醢胺
TLC: Rf 0.57(氯仿:甲酵=10:1); NMR (d6-DMS〇) : 5 10.44 (1H, brs), 8.72 (1H, brs), 8.04 (1H, d, J=8.1Hz), 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 7.87 (2H, d, J=8.8Hz)? 7.45-7.40 (2H? m), 7.27-7.12 (6H, m), 7.08-7.04 (2H, m), 7.01 (2H, d, J=8.8Hz), 4.54 (2H, s), 4.14-4.03 (1H, m), 3.53-3.42 (2H, m), 3.21 (3H, s), 2.60-2.40 (2H, m), 2.16-2.06 (1H, m), L78-1.60 (2H, m), 1.52-1.38 (4H, m)〇 管)fe 例 49 (204) N-羥基-2(S)-(3-苯基丙基)-5 -甲氧基甲氧基-4(S)-[ H-[4-[2E-(4-氯笨基)乙烯基]苯羰基)胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規栘(21〇X 297:i>f ) 一 ---"3-10112 568897 ____ h1五、發明説明(375)
TLC: Rf 0·58(氯仿:甲醇=1〇··ΐ); NMR (d6-DMS〇) : δ 10.46 (1Η, brs), 8.74 (1H, brs), 8.10 (1H, d, J=8.7HzX 7.86 (2H, d, J=8.3Hz), 7.67 (2H, d, J=8.3Hz), 7.65 (2H, d, J=8.8Hz), 7.44 (2H, d, J=8.8Hz), 7.38 (1H, d, J=16.5Hz), 7.32 (1H? d, J=16.5Hz), 7.27-7.22 (2H, m), 7.16-7.12 (3H, m), 4.55 (2H, s), 4.16-4.05 (1H, m), 3.55-3.46 (2H, m), 3.22 (3H, s), 2.59-2.42 (2H,m),2.17-2.07 (1H, m),1.79-1.62 (2H,m), 1.53-1.41 (4H, m)。 g m Μ 49(20 5) H-羥基-2(S)-(3-笨基丙基)-5-甲氧基甲氧基- 4(S)-[ N-[4-(4 -笨基-1,2,5,6-四氫吡啶-1-基)笨羰基]胺基]戊 醢胺 (請先閲讀背面之注意事項再填寫本頁) «裝· 、-5口
568897 ,376 五、發明説明Γ TLC: Rf 0.31(氯仿: 甲醇=2 (Τ· 1) -I m . NM R (d6-DMSO) : 8 10.45 (1Η, brs), 8.73 (1H, brs), 7.80 (1H, d, J=8.3Hz), 7.77 (2H, d, J=9.0Hz), 7.48 (2H, d, J=7.2Hz), 7.36 (2H, t, J=7.2Hz), 7.28-7.22 (3H, m), 7.16-7.12 (3H, m), 6.98 (2H, d, J=9.0Hz), 6.29 (1H, brs), 4.54 (2H, s), 4.13-4.02 (1H, m), 3.94 (2H, s), 3.58 (2H, ζ J=5.7Hz), 3.53-3.42 (2H, m), 3.21 (3H, s), 2.66-2.58 (2H, m), 2.58-2.43 (2Ht m), 2.18-2.07 (1H, m), 1.78-L60 (2H, m), 1.52-1·40 (4H,m)。
p m 49(20 6 L N-羥基_2(S)_(3-苯基-2-丙烯基)-卜乙氧基甲氧基 (S)-[H-(反_4_甲基環己羰基)胺基]戊酿胺
• —I - - .....I ------·裝-- (請先閱讀背面之注意事項再填寫本I )
ch3 訂 TLC: Rf 0.41(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.43 (s, 1H), 8.73 (brs, 1H), 7.43 (d, J=8.4Hz, 1H), 7.33-7.24 (m, 4H), 7.20-7.14 (π% 1H), 6.33 (d, J=15.9Hz, 1H), 6.08 (dt, J=15.9, 6.9Hz, 1H), 4.53 (s, 2H), 3.90-3.78 (m, 1H), 3.44 (q, J=7.1Hz? 2H), 3.40-3.31 (m, 2H), 2.31-2.22 (m, 2H), 2.19-2.08 (π% 1H), 2.03-1.92 (m, 1H), L74-1.58 (m, 5H), 1.56-1.43 (m? 1H), 1.40-U8 (m, 3H)T 1.06 (t, J=7.1Hz, 3H), 0.91-0.81 (m? 5H)〇 g _ 俐 49 ( 20 7 ) N-羥基-2(S)-(3-苯基丙基)-5-乙氧基甲氧基- 4(S)-[ Η-(反_4_甲基環己羰基)胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公f ) ~ ΤΠΓΓΓΖ 568897 Λ? 五、發明説明(3 7 7
TLC: Rf 0.51(氯仿·♦甲醇=9:1); CH3 NMR (de-DMSO) : δ 10.40 (s, 1H), 8.65 (brs, 1H), 7.38 (d, J=8.4Hz? 1H), 7.26-7.20 (m, 2H), 7.16-7.08 (m, 3H), 4.53 (s, 2H), 3.83-3.72 (m, 1H), 3.49-3.27 (m, 4H), 2.58-2.38 (m, 2H), 2.04-1.89 (m , 2H), 1.77-1.52 (m, 5H), 1.50-1.21 (m, 8H), 1.07 (t,J=6.9Hz,3H),0.91-0.77 (m,5H)。 g _ 例 4 9 ( 2 0 &)—N-羥基_2(S)-(2-笨基乙基)4-(2-甲氧基乙氧基)甲 氧基- 4(S)-[N-(反-4-甲基環己羰基)胺基]戊釀胺 (請先閲讀背面之注意事項再填寫本頁) «裝·
、1T
經濟部中央標準局員工消費合作社印製 NMR (d6-DMS〇) : δ 10.45 (s, 1H), 9.20-8.40 (brs, 1H), 7.39 (d, J=8.4Hz, 1H), 7.28-7.23 (m, 2H), 7.20-7.10 (m, 3H), 4.57 (s, 2H). 3.90-3.80 (m, 1H), 3.60-3.20 (m, 6H)7 3.22 (s, 3H), 2.60-2.30 (m, 2H), 2.10-2.00 (m , 1H), 2.05-1.90 (m, 1H), 1.80-1.40 (m, 9H), 1.40-1.20 (m, 2H), 0.95-0.75 (m, 2H), 0.84 (d, J=6,6Hz, 3H)〇 實淪例49 ( 209 ) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公赴) 37 7 310112 568897 A Η 五、發明説明(3 78) N -經基-2(S)-(4 -苯基丁基)-5-(2 -甲氧基乙氧基)甲 氧基- 4(S)-[N_(反-4-甲基環己羰基)胺基]戊醸胺
TLC: Rf 0.36(氯仿:甲醇=9:1); NMR (dg-DMSO) : δ 10.38 (s, 1H), 7.39 (d, J=8.4Hz, 1H), 7.30-7.20 (m, 2H), 7.20-7.10 (m, 3H), 4.57 (s, 2H), 3.90-3.75 (m, 1H), 3.65-3.15 (m? 6H), 3.22 (s, 3H), 2.60-2.40 (m, 2H), 2.05-1.90 (m, 2H), 1.85-1.05 (m, 15H), 0.95-0.75 (m, 2H), 0.84 (d, J=6.3Hz, 3H)〇 V m A Q f 2 1 0 ) N-羥基-2(S)-(3-苯基丙基)-5-乙氧基甲氧基- 4(S)-[ N-(4 -溴笨羰基)胺基]戊醢胺 .och2ch3 (請先閲讀背面之注意事項再填寫本頁) 、v 一口 經濟部中央標準局員工消費合作社印製
0
Br T L C : R f 0 . 3 3 (氯仿:甲醇=1 9 : 1); NMR (d6-DMS〇) : δ 10.44 (s, 1H), 8.72 (s, 1H), 8.16 (d, J=8.2Hz? 1H), 7.79 (d, J=8.4Hz? 2H), 7.65 (d, J=8.4Hz, 2H), 7.32-7.08 (m, 5H), 4.59 (s7 2H), 4,20-3.98 (m, 1H), 3.63-3.40 (m, 4H), 2.68-2.38 (m, 2H), 2.20- 2.01 (m, 1H), L82-1.61 (m, 2H), 1.60-1.30 (m? 4H), 1.08 (t, J=7.0Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公飨) 378 310112 568897 /3 7 9
Λ? Β1 五、發明説明 g 淪例 49 (211 ) N-羥基-2(S)-(3-苯基丙基卜5-乙氧基甲氧基- 4(S)-[ N-(4-硝基苯羰基)胺基]戊醯胺 N〇2 TLC: Rf 0.29(氯仿:甲醇=19:1); NMR (dg-DMSO) : δ 10.45 (s, 1H), 8.72 (s, 1H), 8.45 (d, J =8.4Hz, 1H), 8.29 (d, J = 9.0Hz, 2H), 8.06 (d, J = 9.0Hz, 2H), 7.29-7.20 (m, 2H), 7.19-7.09 (m, 3H), 4.59 (s, 2H), 4.17-4.01 (m, 1H), 3.56-3.40 (m, 4H), 2.61-2.40 (m, 2H), 2.16-2.03 (m, 1H), 1.80-1.60 (m, 2H), 1.58-1.32 (m, 4H), 1.07 (t, J = 7.2Hz, 3H)〇 窗淪例4 9 ( 2 1 2 ) H-羥基-2(R)-(2-笨氧基乙基)-5-乙氧基甲氧基-4(S) -[N-(4-硝基苯羰基)胺基]戊酿胺 (請先閲讀背面之注意事項再填寫本頁) "口 經濟部中央標準局員工消費合作社印製
TLC: Rf 0.35(氯仿·•甲醇=9:1); 本紙張尺度適用中國國家標準(CNS ) A4規掊(210X29?公飨) N〇2 379 310112 568897 ΗΊ —— * _____ - - - - -- - - - - ---------- ι-τ- ----- - - - -·ζ. — ...... 五、發明説明(3 80) NMR (d6-DMS0) : δ 10.51 (s, 1H), 8.76 (s, 1H), 8.47 (d, J=8.4Hz, 1H), 8.29 (d, J=8.9Hz, 2H), 8.07 (d? J=8.9Hz, 2H), 7.30-7.20 (m, 2H), 6.95-6.80 (m, 3H), 4.59 (s, 2H), 4.25-4.12 (m, 1H), 3.95-3.78 (m, 2H), 3.60-3.40 (m, 4H), 2.40-2.25 (m, 1H), 2.00-1.65 (m,4H),1.07 (t,J=7.1Hz, 3H)。 管)fe 例 4 9 ( 2 1 3 ) N-羥基- 2(R)-(2-吡啶基)甲基-5-甲氧基甲氧基-4(S) -[N-(4-苯氧基笨羰基)胺基]戊釀胺 (請先閱讀背面之注意事項再填寫本頁) •I裂·
、1T
TLC: Rf 0.20(氯仿:甲醇=19:1); NMR (d6-DMS〇) : δ 10.44 (1H? s), 8.69 (1H, s), 8.48-8.40 (1H, m), 8.06 (1H? d,J=8.4Hz),7·88 (2H,d,J=8.8Hz),7·65 (1H,td,J=7.8, 1.8Hz),7.50-7.38 (2H,m), 7.24- 7.12 (3H, m), 7.11-7.04 (2H, m), 7.02 (2H, d, J=8.8Hz), 4.52 (2H, s), 4.23-4.02 (1H, m), 3.49 (2H, d, J=5.6Hz), 3.19 (3H, s), 2.96 (1H, dd, J=13.8, 8.4Hz), 2.85 (1H, dd, J=13.8, 6.6Hz), 2.75^2.60 (1H, m), 1.77 (2H, t, J=7.0Hz)〇 經濟部中央標準局員工消費合作社印製 g 淪例 49 (214) N -羥基- 2(R)-(2 -吡啶基)甲基-5-甲氧基甲氧基- 4(S) -[N-(4-(笨并呋喃-2-基)笨羰基)胺基]戊醯胺 本紙張尺度適用中國國家標準(CNS ) Μ規格(210X297次羧)
TSU 7Τ0ΤΊΓΖ 568897 Λ? __1Γ 五、發明説明(381)
TLC: Rf 0·45(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.70-10.40 (1Η, brs), 9.00-8.60 (1H, brs), 8.50-8.25 (2H, m), 7.99 (4H, s), 7.80-7.44 (4H, m), 7.41-7.06 (4H, m), 4.52 (2H, s), 4.31-4.10 (1H, m), 3.64-3.46 (2H, m), 3.19 (3H, s), 3.06-2.82 (2H, m), 2.80-2.63 (1H, m), 2.00-1.70 (2H,m)。 奮 Ife 例 49 (21 5) K -羥基- 2(S)-(3 -吡啶基)甲基-5-甲氧基甲氧基-4(S) -[N-(4-笨氧基笨羰基)胺基]戊醯胺 (請先閲讀背面之注意事項再填寫本頁)
、1T
經濟部中央標準局員工消費合作社印製 TLC : Rf 0.43(氯仿:甲酵=9:1); NMR (d6-DMS〇) : δ 10.36 (1Η, s), 8.69 (1H, s), 8.40-8.32 (2H, m), 8.12 (1H, d, J=9.4Hz), 7.91 (2H, d, J=8.8Hz), 7.54-7.38 (3H, m), 7.29-7.17 (2H, m)T 7,12-7.06 (2H, m), 7.03 (2H, d, J=8.8Hz), 4.56 (2H, s), 4.40-4.20 (1H, m), 3.60-3.4 (2H, m), 3.22 (3H, s), 2.87 (1H, dd, J=13.6, 4.8Hz), 2.75 (1H, dd, J=13.6, 9.6Hz), 2.43-2.28 (1H,m),1.90-1.59 (2H,m)。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公犮) ~ ~ΤΠΓΓΓΖ 568897 Βη 五、發明説明(382 ) 管施例4 9 m 6 ) (請先閲讀背面之注意事項再填寫本頁) N-羥基-2(S)-(3 -吡啶基)甲基-5 -甲氧基甲氧基_4(S) -[H-[4-[2-(4-甲基苯基)乙炔基]笨羰基]胺基]戊醃胺
TLC: Rf 0.40(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.37 (1Η, s), 8.70 (1H, s), 8.40-8.33 (2H, m), 8.29 (1H, d, J=8.0Hz), 7.92 (2H, d, J=8.4Hz), 7.63 (2H, d, J=8.4Hz), 7.57-7.42 (3H, m), 7.31-7.20 (3H, m), 4.56 (2H, s), 4.40-4.20 (1H, m), 3.62-3.44 (2H, m), 3.22 (3H, s), 2.87 (1H, dd, J=13.6, 4.8Hz), 2.76 (1H, dd, J=13.6, 9.2Hz), 2.42-2.26 (4H, m), 1.91-1.59 (2H,m)。
本紙張尺度適用中國國家標準(CNS ) Λ4規栘(210X297公t ) 382 310112 568897 ____Β1 五、發明説明(383) TLC: Rf 0·34(氯仿:甲酵;乙酸:水= l〇〇:i〇:1:1); NMR (d6-DMS0) : δ 10.35(1H, brs), 8.69(1Η? brs), 8.37-8.33(2Η, m), 8.23(1Η, d,J=8.4Hz),7·83(2Η,d,J=8.0Hz),7·51-7·43(3Η,m),7·25(1Η,dd,J=7.8Hz,4·8Ηζ), 4.54(2H, s), 4.38-4.15(lH, m), 3.50(2H, d, J=5.4Hz), 3. 20(3H, s), 2.92-2.68(2H, m), 2.49-2.39(lH, m), 1.91-1.20(10H, m), 0.88(3H, t, J=7.0Hz)〇 實淪例49 (218) N -羥基-2(S)-(3 -吡啶基)甲基-5-甲氧基甲氧基- 4(S) -[N-(4-[2E-(4-氯苯基)乙烯基]笨羰基]胺基]戊醢胺
經濟部中央標準局員工消费合作社印製 NMR (d6-DMS〇) :δ 10.40(1H, brs), 8.72(1H, brs), 8.35(2H, s), 8.21(1H, d, J=8.7Hz), 7.89(2H, d, J=8.4Hz), 7.68(2H, d, 8.4Hz), 7.65(2H, d, J=8.7Hz), 7.51(1H, d, J=7.2Hz), 7.44(2H, d, J=8.7Hz), 7.39( 1H, d, J=16.8Hz), 7.32(1H, d, J=16.8Hz), 7.27-7.23(lH, m), 4.55(2H, s), 4.39-4.21(lH, m), 3.61-3.42(2H, m), 3.21(3H, s), 2.91-2.69(2H, m), 2.45-2.31(lH, m), 1.91-1.60(2H, m)〇 y 嫵例 49(2191_ N-羥基_2(S)-(3-吡啶基)甲基-卜甲氧基甲氧基_4(S) -[N-(反-4-甲基環己羰基)胺基]戊醢胺 本紙張^1適财_家辟(CNS)成格(21GX297公摄) 383 310112 568897 Η*7 "" ? 8 4 五、發明説明()
TLC: Rf 0.34(氯仿:甲醇=9:1); NMR (d6-DMS0) : δ 10.34 (1Η, brs), 8.72 (1H, brs), 8.36 (1H, dd, J=4.8, 1.5Hz),8.32-8.30(lH,m),7.52-7.45 (2H,m),7.29-7.22(lH,m),4.51(2H,s),4.05-3.93 (1H, m), 3.44-3.35 (2H, m), 3.22 (3H, s), 2.77 (1H, dd, J=13.2, 4.8Hz), 2.69 (1H, dd, J=13.2, 9.6Hz), 2.35-2.22 (1H, m), 2.10-1.97 (1H, m), 1.82-1.61 (5H, m), 1·60·1·44 (1H,m), 1.43-1.20 (3H, m),0.97-0.79 (5H,m)。 奮淪例49 ( 22 0 ) N-羥基- 2(S)-(4-吡啶基)甲基-5-甲氧基甲氧基_4(S) -[N-(4-苯氧基笨羰基)胺基]戊醯胺
經濟部中央標準局員工消費合作社印製 TLC·· Rf 0.27(氯仿··甲醇=9:1); NMR (d6-DMS〇) : δ 10.44-10.30 (1Η, brs), 8.75-8.62 (1H, brs), 8.40 (2H, d, J=6.0Hz),8·13 (1H,d,J=8.4Hz),7·91 (2H,d,J=8.7Hz),7.48-7.38 (2H,m),7.22- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297次漦) ^"3~ 2 1 0 112 568897 五、發明説明(38 5) 7.18 (1H,m),7·13 (2H,d,J=6.0Hz),7·06 (2H,d,J=7.8Hz),7·02 (2H,d,J=8.7Hz), 4.55 (2H, s), 4.34-4.21 (1H, m), 3.58-3.42 (2H, m), 3.22 (3H, s), 2.91-2.71 (2H, m), 2·46-2·32 (1H, m), 1·85-1·61 (2H, m)。 置施例49 ) N-羥基-2(R)-(2-吡啶基)甲基- 5- (2 -甲氧基乙氧基) 甲氧基-4(S)-[N-(4-苯氧基苯羰基)胺基]戊醢胺
TLC: Rf 0.38(氯仿:甲酵··乙酸:水=100:10:1:1); NMR (dg-DMSO) : δ 10.43(1H, s), 8.69(1H, s), 8.45(1H, d, J=4.5Hz); 8.60(1H, 經濟部中央標準局員工消費合作社印製 d, J=8.4Hz), 7.87(2H, d, J=8.4Hz), 7.65(1H, t, J=7.5Hz), 7.42(2H, t, J=8.1Hz), 7.21-7.15(3H, m), 7.08-7.00(4H? m), 4.58(2H, s), 4.06-4.22(lH , m), 3.43-3.60(4H? m), 3.42-3.38(2H, m), 3.20(3H, s), 2.98-2.81(2H, m)? 2.61-2.78(1H, m), 1.75(2Η, ζ J=7.2Hz)〇 實施 H-羥基-2(S)-(3-吡啶基)甲基-5-乙氧基甲氧基- 4(s) -U-(2-甲基苯羰基)胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公飨) 568897 Λ? h1 386 五、發明説明(
Ο •OCH2CH3 0 CH3 Ο TLC: Rf 0. 38 (氯仿:甲醇=9 : 1); NMR (d6-DMSOCD3〇D(5 drops)) : δ 8.36-8.32 (m, 2H), 7.50 (d, J=7.5Hz, 1H), 7.34 (d, J=7.5Hz, 1H), 7.31-7.14 (m, 4H), 4.59 (2H, s), 4.26-4.16 (m, 1H), 3.52-3.43 (m? 4H), 2.87- 2.69 (m, 2H), 2.43-2.34 (m? 1H), 2.31 (s, 3H), 1.77-1.57 (m, 2H), 1.09 (t, J=6.9Hz, 3H).〇 蓳L _ 例 4 9 ( 2 2 3 ) N-羥基- 2(S)-(3-吡啶基)甲基-5-乙氧基甲氧基-4(S) -[NM3-甲基苯羰基)胺基]戊醯胺
經濟部中央標準局員工消费合作社印製 TLC: Rf 0.38(氯仿:甲酵=9:1); NMR (CD30D) :S 8.44-8.37 (m, 2H), 7.75-7.66 (m, 3H), 7.42-7.34 (m, 3H), 4.73 (s, 2H), 4.52-4.41 (m, 1H), 3.71- 3.57 (m, 4H), 3.13-2.88 (m, 2H), 2.55-2.42 (m, 4H), 2.06-1.90 (m, 2H), 1.21 (t, J=7 .2Hz, 3H)〇 y 淪俐 49 ( 22 4 ) N -羥基-2(S)-(3 -吡啶基)甲基-5 -乙氧基甲氧基- 4(S) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公t ) 386 310112 568897 Λ / h1 ,387 五、發明説明f -[N-(4-甲基苯羰基)胺基]戊醯胺
,OCH2CH3 0 kX€l ch3
0 經濟部中央標準局員工消费合作社印製 TLC: Rf 0·38(氯仿:甲醇= 9:1); NM R (CD30D+d6-DMS0(5 drops)) : δ 8.46-8.42 (m, 2H), 7.84 (d, J=8.4Hz, 2H), 7.72 (d, J=7.8Hz, 1H), 7.42^7.33 (m, 3H), 4.75 (s, 2H), 4.53-4.44 (m, 1H), 3.71-3.59 (m? 4H), 3.13- 2.88 (m, 2H), 2.57-2.45 (m, 4H), 2.09-1.88 (m, 2H), 1.23 (t, J=7.2Hz, 3H)〇 啻)fe 例 49 ( 2 2 5 ) N-羥基- 2(S)-(3-吡啶基)甲基-5-乙氧基甲氧基-4(S) - [N-(4-甲氧基苯羰基)胺基]戊酿胺 ,och2ch3 och3 TLC :Rf 0.30(氛仿:甲酵=9:1); NMR (dg-DMSO) : δ 10.35 (s, 1H), 8.68 (s, 1H), 8.40-8.30 (m, 2H), 8.00 (d, J=8.8Hz, 1H), 7.86 (d, J=8.8Hz, 2H), 7.53-7.44 (m, 1H), 7.28-7.20 (m, 1H), 6.99 (d, J=8.8Hz, 2H), 4.59 (s, 2H)T 4.38-4.17 (m, 1H), 3.81 (s, 3H)? 3.60-3.40 (m, 4H), 2.86 (dd, J=13.2, 5.2Hz, 1H), 2.74 (dd, J=13.2, 9.2Hz, 1H), 2.44-2.28 (m, 1H), 1.90-1.58 (m,2H),1.09 (t, J=6.8Hz,3H)〇 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公漦) 3F7 3 10 11 ? 568897 Λ? ΒΊ _五、發明説明(388 ) g _ 俐 49 ( 226 ) N -羥基- 2(S)-(3 -吡啶基)甲基-5-甲氧基甲氧基- 4(S) -[Η-環己羰基)戊醯胺
TLC: Rf 0.21(氯仿:甲醇=10:1); NMR (dg-DMSO) : δ 10.33 (brs, 1H), 8.70 (brs, 1H), 8.36 (dd, J=1.8, 4.5Hz, 1H), 8.30 (d, J=1.8Hz, 1H), 7.48-7.45 (m, 2H), 7.26 (dd, J=4.5, 7.6Hz, 1H), 4.55 (s, 2H), 4.40-3.51 (m, 1H), 3.45 (q, J=7.2Hz, 2H), 3.83-3.32 (m, 2H), 2.80-2.63 (m, 2H), 2.32-2.21 (m, 1H), 2.14-2.03 (m? 1H), 1.78-1.45 (m, 7H), 1.40-1.06 (m, 5H), 1.10 (t, J=6.9Hz, 3H)〇 (請先閱讀背面之注意事項再填寫本頁) ,裝·
、1T 經濟部中央標準局員工消費合作社印製 啻淪俐49 ( 2 2 7 ) N -羥基- 2(S)-(3-吡啶基)甲基 -[N-(4-硝基苯羰基)胺基]戊醯胺 乙氧基甲氧基-4 (S)
N〇2 TLC : Rf 0.22(氯仿:甲醇=9:1); 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公f ) T7T 310112 568897 Λ h1 ,3 8 9 五、發明説明c NMR (d6-DMS0) : δ 10.36 (s? 1H), 8.69 (s, 1H), 8.53 (d, J=8.7Hz, 1H), 8.37-8.29 (m, 3H), 8.10-8.06 (m, 2H), 7.52-7.48 (m, 1H), 7.28-7.23 (m, 1H), 4.58 (s, 2H), 4.21-4.32, (m, 1H), 3.52 (d, J=5.7Hz, 2H), 3.45 ( q, J=7.2Hz, 2H), 2.86-2.69 (m, 2H), 2·42·2·23 (m,1H), 1.85-1.62 (m2H),1.08 (t,J=7.2Hz,3H)。 g _ 例 49(228) N -羥基- 2(S)-(3 -吡啶基)甲基-5 -乙氧基甲氧基-4(S) -[N-(4 -溴笨羰基)胺基]戊醯胺 ,〇CH2CH3 0 / Η [ Γ η〇^νίΛ 0 32 (氯仿: 甲醇
Br 經濟部中央標準局員工消費合作社印製 NMR (d6-DMS〇) : δ 10.34 (s, 1H), 8.68 (s, 1H), 8.37-8.24 (m, 3H), 7.80 (d, J=8.7Hzt 2H), 7.67 (d, J=8.7Hz, 2H), 7.49 (dt, J=8.1Hz, 1.8Hz, 1H), 4.57 (s, 2H), 4.31-4.18 (m, 1H), 3.50 (d, J=6.0Hz, 2H), 3.45 (q, J=7.2Hz, 2H), 2.87-2.68 (m, 2H), 2.40-2.24(m, lH)t 1.82-1.59 (m, 2H), 1.07 (t, J=7.2Hz, 3H)〇 ^ m m AQ ( 229 ) H-羥基_2(S)-(3-〇f咐基)甲基-5-乙氧基甲氧基_4(S) -[N-(反-4-甲基環己羰基)胺基]戊醃胺 ,och2ch3
0 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐) ch32T9 310112 568897 ___ ___________ 五、發明説明(39^ TLC: Rf 〇.37 (氯仿:甲醇=9 : 1 ); NMR (d6-DMS〇) : δ 10.31 (s, 1H)? 8.67-8.65 (m, 2H), 7.98-7.83 (m, 3H), 7.73-7.49 (m, 3H), 4.55 (s, 2H), 4.13-3.97 (m, 1H), 3.43 (q, J=7.0Hz, 2H), 3.42-3.36 (m, 2H), 3.06-2.80 (m, 2H), 2.48-2.30 (m, 1H), 2.15-1.98 (m, 1H), 1.81-1.26 (m9H), L08 (t, J=7.0Hz, 3H), 0.99-0.79 (m, 2H), 0.85(d, J=7.0Hz, 3H)〇
TLC·· Rf 0.27(氯仿:甲醇:乙酸=100:5:1); NMR (d6-DMS0) : δ 10.69(1H, s), 8.97(1H, s), 8.17(1H, d, J=8.0Hz), 7.86(2H, d, J=8.8Hz), 7.47-7.39(4H, m), 7.34-7.16(4H, m), 7.08-6.99(4H, m), 4.53(2H, s), 4.38-4.25(lH, m), 3.62-3.35(3H, m), 3.19( 3H, s), 2.02(2H, t, J=6.8Hz)〇 經濟部中央標準局負工消費合作社印製 羥基- 2(S)-苯硫基-5-乙氧基甲氧基-4(S)-[N-(反 4-甲基環己羰基)胺基]戊醯胺
Γ |1 I ,och2ch3 本紙張尺度適用中國國家標準(CNS ) A4規掐(210X 297公獻) 390 310112 568897 A7 Η*7 五、發明説明(391) TLC: Rf 0·37(氯仿·•甲醇=9:1); NMR (d6-DMSO) : S 10.67 (s, 1H), 8.94 (brs, 1H), 7.52 (d? Ι=8:ΪΗζ, 1H), 7.38-7.22 (m, 5H), 4.52 (s, 2H), 4.04-3.93 (m, 1H), 3.52-3.24 (m, 5H), 2.01-1.78 (m, 3H), 1.69-1.55 (m, 4H), 1.36-1.19 (m , 3H), L07 (t, J=7.0Hz, 3H), 0.91-0.75 (m, 5H)〇 奮 _ 例 49(2 3 2) H-羥基- 2(S)-甲硫基-5-乙氧基甲氧基-4(S)-[N-(反-4-甲基環己羰基)胺基]戊醸胺
TLC: Rf 0· 38 (氯仿:甲醇=9 : 1); NMR (d6-DMS〇) :δ 10.56 (s, 1Η), 8.88 (s, 1Η), 7.48 (d, J=8.4H^, 1Η), 4.55 (s, 2H), 4.04-3.90 (m, 1H), 3.46 (q, J=7.1Hz? 2H), 3.39-3.25 (m, 2H), 2^6-2.87 (m, 1H),2·04-1·91 (π% 4H),1.90-1.77 (m,1H), L76-1.55 (m,5H),1.40-U8 (m,3H), 經濟部中央標準局員工消費合作社印製 1.08 (t, J=7.1Hz, 3H), 0.92-0.74 (m, 5H)〇 g m m 49(2 3 3) 羥基-2(S)-(4-吡啶基)硫基-5-乙氧基甲氧基- 4(S) -[N-(反-4-甲基環己羰基)胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公t ) 391 310112 568897 Λ }Γ 五、發明説明( 392)
ch3 TLC: Rf Ο · 29 (氯仿:甲醇=9 : 1); NMR (d6-DMS〇) :(J 10.87 (s, 1H), 9Ό8 (s, 1H), 835 (d, J=6.0Hz? 2H), 7.58 (d, J=8.1Hz, 1H), 7.27 (d, J=6.0Hz, 2H), 4.56 (s, 2H), 3.99-3.88 (m, 1H), 3.78 (ζ J=7.4Hz, 1H), 3.45 (q? J=7.2Hz, 2H), 3.42-3.31 (m, 2H), 2.02-1.87 (m, 3H), 1.71-1.56 (m,4H), 1.35-1.17 (m, 3H),1.07 (t, J=7.2Hz,3H),0.91-0.76 (m, 5H)〇 g m m 49 ( 2 3 4 )- 49 ( 25 3 ) 使用對應化合物替代實施例44(8)、44(9)、44(11)、 44(14)、44(17)〜44(21)、44(24)〜44(26)製造之化合物 或參考例4製造之化合物,依實施例例374實施例394實 施例41 4實施例43 (使用對應化合物替代苄基溴)-> 實施例 44所示方法相同操作所得之化合物,依實施例49所示方法 相同操作,得下列化合物。
本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公势) 392 310112 568897 Λ? 五、發明説明(393) TLC: Rf 0.57(氯仿:甲醇:乙酸=85:15:1); NMR (d6-DMS0) : δ 10.44(1Η, s), 8.69(1Η, brs), 8.19(1Η? d, J=8.4Hz)? 8.89(2Η, d, J=8.8Hz), 7.48-7.38(2H, m), 7.22-7.16(1H, m), 7.09-7.01(4H, m), 5.36(1H, brs), 4.55(2H, s), 4.41-4.24(1H, m), 3.87(1H, dd, J=9.8Hz? 2.6Hz), 3.56-3·42(2Η, m), 3.22(3H,s),1·96-1·66(2Η,m)〇 簠施例49 (235) N-羥基-2(R)-羥甲基-5-乙氧基甲氧基-4(S)-[N -(4 氯笨羰基)胺基]戊醢胺 ,och2ch3 (請先閱讀背面之注意事項再填寫本頁) r裝·
、1T TLC: Rf 0.23(氯仿:甲酵··乙酸= 90:10:1); NMR (de-DMSO) : δ 10.55-10.10 (brs, 1Η), 8.90-8.50 (brs, 1H)? 8.21 (d, J=8.4Hz, 1HX 7.86 (d, J=8.7Hz, 2H), 7.52 (d, J=8.7Hz, 2H), 4.59 (s, 2H), 4.20-4.00 (m, 1H), 3.60-3.38 (m, 6H), 2.30-2.18 (m, 1H), 1.85-1.70 (m, 1H), 1.70-1.55 (m, 1H), 1.09 (t, J=7.1Hz, 3H)〇 經濟部中央標準局員工消費合作社印製 g m m 49(2
N-羥基- 2(R)-甲氧基甲基-5-乙氧基甲氧基- 4(S)-[N (4-硝基苯羰基)胺基]戊醸胺 ,och2ch3 hhc〇1 r〇i Ν〇2 ΗσΝΤ^» l〇l 本紙張尺度適用中國國家標準(CNS ) 規格(210X 297公# ) 393 310112 568897 Λ . }Γ 五、發明説明(394) TLC: Rf Ο · 22 (氯仿:甲醇=19 : 1); NMR (dg-DMSO) : δ 10.46 (s, 1Η), 8.75 (s, 1H), 8.48 (d, J=8.4Hz, 1H), 8.29 (d, J=8.8Hz, 2H), 8.06 (d? J=8.8Hz, 2H), 4.59 (s, 2H), 4.22-4.00 (m, 1H), 3.58-3.25 (m,6H), 3.18 (s,3H),2.43-2.31 (m,1H),1.83-1.54 (m,2H), 1·08 (t, J=7.0Hz,3H)〇 m AQ (2 7) N-羥基-2(R)_苄氧基甲基-5-乙氧基甲氧基- 4(S)-[N_ (4-硝基苯羰基)胺基]戊醯胺 ,och2ch3
Ν〇2 請 先 閲 讀 背 之 注 意 事 項 再 填 寫 本 頁 經濟部中央標準局員工消費合作社印製 TLC: Rf 0.35(氯仿:甲酵=19:1); NMR (dg-DMSO) : δ 10.52 (s, 1H), 8.79 (s, 1H)? 8.50 (d, J=8.7Hz, *1H), 8.30 (d,J=8.7Hz,2H),8.07 (d,J=8.7Hz,2H),7.40-7.22 (m,5H),4·60 (s,2H),4.47 (d, J=12.0Hz, 1H), 4.41 (d, J=12.0Hz7 1H), 4.20-4.07 (m, 1H), 3.61-3.42 (m, 6H), 2.53-2.40 (m, 1H), 1.89-1.78 (m, 1H), L77-1.62 (m, 1H), 1.08 (t, J=7.2Hz, 3H)〇 管 _ 例 49 ( 2 3 8 ) N-羥基-2(R)-(2-甲氧基乙氧基)甲基-5-乙氧基甲氧 基-4(S)-[N-(4-硝基笨羰基)胺基]戊醸胺 Η3〇0^ ,och2ch3 N〇2 本紙張尺度適用中國國家標準(CNS ) A4規格(2】0X297公# ) 310112 568897 Λ / Η*7 五、發明説明(395) TLC: Rf 0.24(氯仿:甲醇=19:1); NMR (dg-DMSO) : δ 10.47 (s, 1H), 8.77 (s, 1H), 8.49 (d, J=8.1Hz, 1H), 8.30 (d, J = 8.7Hz, 2H), 8.08 (d, J =8.7Hz, 2H), 4.61 (s, 2H), 4.20-4.07 (m, 1H), 3.58-3.38 (m, 10H), 3.23 (s, 3H), 2.47-2.36 (m, 1H), 1.83-1.58 (m, 2H), 1.10 (t, J = 7.2Hz, 3H)〇 管施例49(239) 羥基-2(R)_甲氧基甲基- 5-(2-甲氧基乙氧基)甲氧 基- 4(S)-[N-(4-氰基苯羰基)胺基]戊醯胺 r〇x^〇cH3
私1〇L
CN TLC: Rf 0.26(氯仿:甲酵=19:1); NMR (d6-DMS〇) : $ 10.45 (s, 1H), 8.74 (s, 1H), 8.40 (d, J = 8.4Hz, 1H), 7.98 (d, J = 8.8Hz, 2H), 7.93 (d, J = 8·8Ηζ, 2H), 4.61 (s, 2H), 4.20-4.00 (mv.lH), 3.60-3.24 (m, 8H), 3.20 (s, 3H), 3.17 (s, 3H), 2.43-2.29 (m, 1H), L82-1.50 (m, 2H)〇 經濟部中央標準局員工消費合作社印製 g 例 49 (240) N-羥基-2(R) -甲氧基甲基-5-乙氧基甲氧基-4(S)-[N (反-4 -甲基環己羰基)胺基]戊醢胺 nCH2CH3 H3„c〇lr°i ηο^Υ^κΥΊ Ο vch3 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公蝥) 395 310112 568897 Λ ;
)V 五、發明説明(396) TLC: Rf 0.27(氯仿:甲醇=19:1); NMR (d6-DMS〇) : δ 10.41 (s, 1H), 8.75 (s, 1H), 7.43 (d, J = 8.7Hz, 1H), 4.56 (s, 2H), 3.86-3.72 (m, 1H), 3.47 (q, J = 7.2Hz, 2H),3.41-3.20 (m, 4H), 3.15 (s, 3H), 2.36-2.24 (m, 1H),2.05-1.93 (m, 1H), 1.77-1.56 (m, 5H), 1.49-1.18 (m, 4H), 1.10 (ζ J = 7·2Ηζ,3H),0·95- 0·77 (m,5H)。 管嫵例49 (241) N-羥基-2(R)-甲氧基甲基-5-乙氧基甲氧基- 4(S)-[N-(4 -溴苯羰基)胺基]戊醯胺
TLC: Rf 0.31(氯仿··甲醇=9:1); NMR (d6-DMS〇) : S 10.43 (s, 1H), 8.74 (brs, 1H), 8.21 (d, J=8.4Hz, 1H), 7.78 (d, J=8.7Hz? 2H), 7.66 (d, J=8.7Hz, 2H), 4.58 (s, 2H), 4.13-4.01 (m, 1H), 3.50-3.31 (m, 6H), 3.16 (s, 3H), 2.42-2.12 (m, 1H), 1.79-1.53 (m, 2H), 1.07 (tT J=7.2Hz, 3H)〇 經濟部中央標準局員工消費合作社印製 管 _ 例 49 (242) N-羥基- 2(R)_甲氧基甲基-5-乙氧基甲氧基-4(S)-[N-(4-氯苯羰基)胺基]戊醯胺
本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 396 310112 568897 五、發明説明( 39 7) TLC: Rf 0.31(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.44 (s, 1H), 8.74 (s, 1H), 8.21 (d, J=8.4Hz, 1H), 7.76 (d, J=8.7Hz, 2H), 7.52 (d, J=8.7Hz, 2H), 4.58 (s, 2H), 4.16-4.02 (m, 1H), 3.50-3.33 (m, 6H), 3·16 (s,3H),2.42-2.32 (m,1H), 1.79-1.55 (m,2H),1.07 (t,J=7.2Hz, 3H)〇 奮 _ 例 49 (243) N-羥基-2(R)_苄氧基甲基- 5-(2 -甲氧基乙氧基)甲氧 基- 4(S)-[N-(4-氰基苯羰基)胺基]戊醸胺 r (請先閱讀背面之注意事項再填寫本頁) 〇N^"OCHa
TLC: Rf 0.30(二氛甲烷:甲醇=19:1); NMR (d6-DMS〇) : δ 10.49 (d, J = 1.5Hz, 1H), 8.77 (d, J = 1.5Hz, 1H), 8.41 (d, J = 8.4Hz, 1H), 7.98 (d, J - 8.7Hz, 2H), 7.94 (d, J = 8.7Hz, 2H), 7.29 (m, 5H), 4.60 (s, 2H), 4.45 (d, J = 12.0Hz, 1H), 4.39 (d, J = 12.0Hz, 1H), 4.10 (m, 1H), 3.60-3.36 (m,8H),3.18 (s,3H),2.45 (m,1H),1.78 (m, 1H), 1.63 (m, lH)〇 經濟部中央標準局員工消費合作社印製 當_例49(2“) N-羥基- 2(R)_苄氧基甲基-5-乙氧基甲氧基_4(S)- [N (4-氯笨羰基)胺基]戊醯胺 ,OCH2CH3
本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公飨) 397 310112 568897 Λ / 3 9 8、 五、發明説明( TLC: Rf 0.32(二氯甲烷··甲醇=19: 1); NMR (d6-DMS〇) : δ 10.48 (s, 1H), 8.76 (s, 1H), 8.22 (d, J = 8.4Hz, 1H), 7.85 (d, J = 8.7Hz, 2H), 7.52 (d, J = 8.7Hz, 2H), 7.29 (π\ 5H), 4.57 (s, 2H), 4.44 (d7 J = 12.0Hz, 1H), 4.39 (d, J = 12.0Hz, 1H), 4.08 (m, 1H), 3.55-3.40 (m, 6H)? 2.45 (m, 1H),1.78 (m, 1H),1.62 (m,1H),1.05 (t, J = 7·2Ηζ,3H)。 窗淪例49(245) N-羥基- 2(R)_苄氧基甲基-5-乙氧基甲氧基“(S)-[N (4-溴笨羰基)胺基]戊醯胺 ,OCH2CH3
TLC: Rf 0.32(二氛甲烷:甲醇=19:1);
Br (請先閱讀背面之注意事項再填寫本頁} 經濟部中央標準局員工消费合作社印製 NMR (d6-DMS〇) : δ 10.49 (d, J = 1.8Hz, 1H), 8.77 (d, J = 1.8Hz, 1H), 8.22 (d, J = 8.4Hz, 1H), 7.78 (dT J = 8.7Hz, 2H), 7.66 (d, J = 8.7Hz? 2H)t 7.29 (m7 5H), 4.57 (St 2H), 4.44 (d, J = 12.0Hz, 1H), 4.39 (d, J = 12.0Hz, 1H), 4.08 (m, 1H), 3.55-3.40 (m, 6H), 2.45 (m? 1H), 1.78 (m, 1H), 1.62 (m, 1H), 1.05 (t, J = 7.2Hz, 3H)〇 n m m aq (2αά) H-羥基-2(R)-[2-(3 -甲氧基苯氧基)乙基卜5-乙氧基 甲氧基- 4(S)-[N-(4-硝基苯羰基)胺基]戊醯胺 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公飨) T98 310112 568897
Ν〇2 經濟部中央標準局員工消費合作社印製 Η"7 五、發明説明(39 Ν〇2 TLC: Rf 0.40(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.50 (s, 1H), 8.76 (s, 1H), 8.48 (d, J=8.4Hz, 1H), 8.30 (d, J=8.6Hz, 2H), 8.06 (d, J=8.6Hz, 2H), 7.13 (t, J=8.3Hz, 1H), 6.52-6.35 (m, 3H), 4.59 (s, 2H), 4.25-4.12 (m, 1H), 3.95-3.75 (m, 2H), 3.68 (s, 3H), 3.60-3.40 (m, 4H), 2.40-2.25 (m, 1H), 2.00-1.65 (m, 4H), 1.07 (t, J=7.1Hz, 3H)〇 管施例49 (247) N-羥基-2(R)-甲氧基甲基-5-乙氧基甲氧基-4(S)-[N [(2-硝基0;吩-5-基)羰基]胺基]戊醃胺 .och2ch3 h3co 0 〇 TLC: Rf 0.37(氯仿:甲酵= 9:1); NMR (d6-DMS〇) : δ 10.46 (s, 1H), 8.75 (brs, 1H), 8.71 (d, J=8.4Hz, 1H), 8.13 (d, J=4.2Hz, 1H), 7.82 (d, J=4.2Hz, 1H), 4.58 (s, 2H), 3.97-4.09 (m, 1H), 3.50-3.38 (m,6H),3.17 (s,3H), 2.41-2.32 (m,1H), 1.79-1.55 (m, 2H), 1·07 (t,J=7.2Hz,3H)。 啻 _ 例 49 (248) (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公飨) 399 310112 568897 A . ίΓ 400、 五、發明説明(H -經基-2(R) -甲氧基甲基-5-乙氧基甲氧基-4(S)-[N [(2 -溴I*吩-5 -基)羰基]胺基]戊醯胺 /OCH2CH3
Br TLC: Rf 0.34(氯仿:甲醇=9:1); NMR (d6-DMS〇) : S 10.44 (s, 1H), 8.75 (s, 1H), 8.27 (d, J=8.1Hz, 1H)? 7.61 (d, J=4.2Hz, 1H), 7.27 (d, J=4.2Hz, 1H), 4.57 (s, 2H), 4.05-3.91 (m, 1H), 3.50-3.37 (m,6H), 3.16 (s, 3H), 2.41-2.31 (m, 1H),1.78-1.51 (m,2H),1.07 (t,J=7.2Hz, 3H)。 y m 49(24 9 LH -羥基_2(R)-(2-甲氧基乙氧基)甲基 基- 4(S)_[N-(4 -溴苯羰基)胺基]戊醢胺 乙氧基甲氧 經濟部中央標準局員工消費合作社印製 ^〇CH2CH3
Br TLC: Rf 0.31(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.43 (s, 1H), 8.74 (s, 1H), 8.20 (d, J=8.6Hz, 1H), 7.78 (d, J=8.6Hz, 2H), 7.65 (d, J=8.6Hz, 2H), 4.58 (s, 2H), 4.18-4.01 (m, 1H), 3.50-3.36 (m, 10H), 3.20 (s, 3H), 2.44-2.39 (m, 1H), 1.8M.52 (m, 2H), 1.07 (t, J=7.0Hz? 3H)〇 本紙張尺度適用中國國家標準(CNS ) M規格(210x297公飨) 400 310112 (請先閱讀背面之注意事項再填寫本頁)
經濟部中央標準局員工消費合作社印製 568897 __ ΙΓ 五、發明説明(4〇1) N-羥基-2(R)-(2-甲氧基乙氧基)甲基-5-(2-甲氧基乙 氧基)甲氧基- 4(S)-[N-(4-氰基苯羰基)胺基]戊醯胺
TLC : Rf 0· 24 (氯仿:甲醇=19 : 1); NMR (dg-DMSO) : δ 10.45 (brs, 1H), 8.78 (brs, 1H), 8.43 (d, J=8.1Hz, 1H), 7.99 (d, J=8.4Hz, 2H), 7.94 (d, J=8.4Hz, 2H), 4.61 (s, 2H), 4.16-4.02 (m, 1H), 3.57-3.35 (m,12H),3.21 (s,3H),3.20 (s,3H),2.42-2.32 (m,1H),1.80-1.56 (m,2H)〇 啻 _ 俐 49 (251) N-羥基-2(R)-(2-甲氧基乙氧基)甲基-5-乙氧基甲氧 基- 4(S)-[N-(4-氯笨羰基)胺基]戊醯胺 H3CO^| ^〇ch2ch3
TLC : Rf 0.34(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.43 (s, 1Η), 8.74 (brs, 1H), 8.20 (d, J=8.4Hz, 1H), 7.87-7.83 (m, 2H), 7.54-7.49 (m, 2H) 4.58 (s, 2H), 4.18-4.10 (m, 1H), 3.52-3.36 (m, 10H),3·20 (s,3H),2·42-2·29 (m,1H),1.81-1.53 (m,2H),1.07 (U=7.0Hz, 3H)。 y m m 49(2 5 2) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公t ) 4 0厂 ΤΗΓΥΤί (請先閲讀背面之注意事項再填寫本頁)
568897 Λ7 h1 五、發明説明( 402) N-羥基- 2(R)_苄氧基甲基-5-乙氧基甲氧基-4(S)-[N (反-4-甲基環己羰基)胺基]戊醯胺
,och2ch3 Ο TLC: Rf 0.34(氯仿:甲醇=19:1); NMR (d6-DMS〇) : δ 10.46 (s, 1H), 8.78 (s, 1H), 7.44 (dy J=8.4Hz, 1H), 7.38-7.21 (m, 5H), 4.59-4.52 (m? 2H), 4.43 (d, J=12.0Hz, 1H), 4.37 (d, J=12.0Hz, r 1H), 3.85-3.72 (m, 1H), 3.54-3.28 (m, 6H), 2.43-2.30 (m, 1H),2.06-1.92 (m, 1H), 1.76-1.59 (m, 5H)? 1.52-1.20 (m,4H), 1.09 (t, J=6.9Hz, 3H), 0.93-0.75 (m, 5H)〇 奮)fe 例 49 (253 ) 經濟部中央標準局員工消費合作社印製 H-羥基- 2(R)-(3-i«吩基)甲氧基甲基-5-乙氧基甲氧 基- 4(S)-[N-(4 -硝基苯羰基)胺基]戊醯胺
(請先閱讀背面之注意事項再填寫本頁) N〇2 TLC: Rf 0.34(氯仿:甲醇=19:1); NMR (d6-DMS〇) : 5 10.49 (s, 1H), 8.76 (s, 1H), 8.49 (d, J=8.4Hz, 1H), 8.30 (d, J=8.8Hz, 2H), 8.06 (d, J=8.8Hz, 2H), 7.49 (dd, J=5.2, 2.8Hz, 1H), 7.40-7.36 (m, 1H), 7.03 (dd, J=5.2, 1.6Hz, 1H), 4.59 (s, 2H), 4.50-4.36 (m, 2H), 4.21-4.00 (m, 1H), 3.60-3.36 (m, 6H), 2.52-2.38 (m, 1H), 1.88-1.56 (m, 2H), 1.07 (t, J=7.0Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS)Λ4規格( 210X297公t) 402 310112 568897 Λ? Η*7 五、發明説明(4〇3) 藍Jfe 例 49(254)〜49(263 ) 使用對應化合物替代參考例4製造之化合物,依實施 例374實施例39 —實施例45«>實施例46(使用對應化合物 替代苄基溴)—實施例47 —實施例48 —實施例49所示方法 相同操作,得下列化合物。 gLIfe m A9 f 2R4) N-羥基- 2(R)-(2-吡啶基)甲基-5-羥基-4(S)-[M-(4-苯氧基笨羰基)胺基]戊醯胺
TLC: Rf 0·17(氯仿:甲醇:乙酸:水=100:10:1:1); NMR (dg.DMSO) 10.35(lH,brs), 8.63(1H, brs), 8.42-8.40(lH7mX 7.91- 7.86(3H, m), 7.64(1H, dt, J=7.8Hz, 1.8Hz), 7.45-7.39(2H, m), 7.25-7.14(3H, m), 7.07-7.00(4H, m), 4.67(1H, brs), 4.15-3.94(1H, m), 3.50-3.34(2H, m), 2.97-2.81(2H, m), 2·71-2·62(1Η,m), 1·82-1·65(2Η,m)。 經濟部中央標準局負工消费合作社印製 (請先閱讀背面之注意事項再填寫本頁) g MS m 49(2 5 5) 羥基- 2(S)-甲基-5-羥基-4(S)-[N-(4-苯氧基笨羰 基)胺基]戊醯胺
本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公羧) 403 3 1 0 1 1 2 568897 ts' Η1 '— — - 一 -一一··,—- —— -— -— — 五、發明説明(4〇4) TLC: Rf 0.14(氯仿:甲醇= 9:1); NMR (d6-DMS0) : δ 10.33 (1Η, s), 8.62 (1H, s), 7.89-7.83 (3H, m), 7.41 (2H, t, J=7.6Hz), 7.17 (1H , t, J=7.6Hz), 7.04 (2H, d, J=7.6Hz), 7.00 (2H, d, J=8.7Hz), 4.68 (1H, t, J=5.7Hz), 4.02-3.91 (1H, m), 3.45-3.28 (2H , m), 2.2M08 (1H, m), 1.72- 1.55 (2H, m), 0.98 (3H, d, J=6.6Hz)〇 實L施例M (25fi) N-羥基-2(S)_甲基-5 -羥基-4(S)-[N-(4-渙苯羰基)胺 基]戊醯胺
8r TLC: Rf 0.25(氯仿··甲醇=9:1); NMR (d6-DMS〇) : δ 10.37 (s, 1H), 8.64 (s, 1H), 8.02 (d, J=8.6Hz, 1H), 7.81 (d, J=8.4Hz, 2H), 7.65 (d, J=8.4Hz, 2H), 4.80-4.64 (m, 1H), 4.10-3.88 (m, 1H)? 3.60- 3.10 (m, 2H), 2.26-2.06 (m, 1H), 1.80-1.56 (m, 2H), 1.02 (d, J=6.8Hz, 3H)〇 g m m 49(2 5 7) 經濟部中央標準局員工消費合作社印製 N-羥基-2(S)-(3-甲氧基苄基)-5-羥基- 4(S)-[N-(4-溴笨羰基)胺基]戊醯胺
(請先閱讀背面之注意事項再填寫本頁)
Br 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公羧) 404 310112 經濟部中央標準局員工消費合作社印製 568897 Λ7 Η, _ 五、發明説明(40 5) TLC: Rf 0·45(二氯甲烷:甲醇=9:1); NMR (d6-DMS〇) : δ 10.28 (s, 1H), 8.63 (s, 1H), 8.04 (brd, J=8.4Hz, 1H), 7.82 (d, J=8.4Hz, 2H), 7.66 (d, J=8.4Hz, 2H), 7.11 (ζ J=8.0Hz, 1H), 6.67 (m, 3H), 4.69 (brt, J=5.8Hz, 1H), 4.09 (m, 1H), 3.65 (s, 3H), 3.44 (m, 2H), 2.75 (brd, J=7.2Hz, 2H), 2.33 (m,1H),1·85-1·50 (m, 2H)。 實施例49 ( 2 58 ) N-羥基-2(S)-(3-甲氧基苄基)-5 -羥基-4(S)-[N-(4-硝基苯羰基)胺基]戊醯胺 och3
TLC: Rf 0.52(二氯甲烷:甲醇=9:1); NMR (d6-DMS〇) : δ 10.31 (s, 1H), 8.64 (s, 1H), 8.34 (brd, J=8.4Hz, 1H), 8.30 (d,J=9.2Hz,2H),8.09 (d,J=9.2Hz,2H),7·11 a J=8.8Hz,1H),6.70(11% 3H),4·73 (brt,J=5.8Hz,1H),4·10 (m,1H),3.67 (s,3H),3.43 (m,2H),2.73 (brd,J=7.0Hz, 2H),2.35 (m,1H),1.85-1.55 (m,2H)〇 富)fe例4 9 ( 2⑷ N-羥基-2(S)-(3-甲氧基〒基)-5-經基-4(S)-[N-(4-氯苯羰基)胺基]戊醸胺 (請先閲讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公t ) 405 310112 568897 π Βη五、發明説明(4()6)
TLC: Rf 〇.52(二氯甲烷:甲醇=9:1); NMR (dg-DMSO) : δ 10.28 (s, 1H), 8.63 (s, 1H), 8.06 (brd, J=8.4Hz, 1H), 7.89 (d, J=8.7Hz, 2H), 7.52 (d, J=8.7Hz, 2H), 7.11 (t, J=8.4Hz, 1H)? 6.67 (m, 3H), 4.70 (brt, J=5,7Hz, 1H), 4.10 (m, 1H), 3.65 (s, 3H), 3.41 (m, 2H), 2.72 (brd, J=7.2Hz, 2H)? 2.33 (m, 1H), 1.82-1.55 (m, 2H)〇 富淪例4 9 ( 2 6 0丄 N-羥基-2(S)-(3-甲氧基〒基)-5-經基-4(S)-[H-[(2-溴睡吩-5 -基)羰基]胺基]戊釀胺 (請先閱讀背面之注意事項再填寫本頁) r裝·
、1T 經濟部中央標準局員工消費合作社印製
TLC: Rf 0.52(二氯甲烷:甲醇=9:1); NMR (d6-DMS〇) : δ 10.30 (s, 1H), 8.64 (s, 1H)7 8.13 (brd7 J=8.8Hz? 1H), 7.63 (d, J=4.0Hz, 1H), 7.27 (d, J=4.0Hz, 1H)? 7.12 (t, J=8.4Hz, 1H), 6.69 (m, 3H)T 4.72 (brs, 1H), 4.00 (m, 1H), 3.68 (s, 3H), 3.39 (m, 2H), 2.71 (brd, J=7.2Hz, 2H), 2.32 (m,1H),1.83-1.49 (m,2H)。 本紙張尺度適用中國國家標準(〇灿)八4規格(210'/ 297公釐) 406 310112 568897 Λ 7 Η"7 五、發明説明(4<)7) 啻 _ 例 49 ( 2 6 ΐ ) N-羥基-2(S)-(3-甲氧基苄基)-5-羥基-4(S)-[N-[(2 硝基I*吩-5-基)羰基]胺基]戊醯胺 och3
請 kj 閱 讀 背 1¾ 之 注 意 事 項 再 填 寫 本 頁 NMR (d6-DMS〇) : δ 10.32 (s, 1H), 8.65 (s, 1H), 8.57 (brd, J=9.0Hz, 1H), 8.14 (d, J=4.5Hz, 1H), 7.84 (d, J=4.5Hz, 1H), 7.12 (t, J=8.4Hz? 1H), 6.69 (m, 3H), 4.78 (brs, 1H), 4.01 (m, 1H), 3.69 (s, 3H), 3.42 (m, 2H), 2.71 (m, 2H), 2.33 (m, 1H), 1.81-1.54 (m, 2H)〇 管 _ 例 49 ( 2 6 2 ) N-羥基- 2(S)-(3-甲氧基节基)-5-經基- 4(S)-[N-(4-氰基苯羰基)胺基]戊醯胺 經濟部中央標準局員工消費合作社印製
TLC: Rf 0.39(氯仿:甲醇= 9:1); 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)
CN 407 310112 經濟部中央樣举局員工消費合作社印製 568897
A Η*7 ι _ .一一 — . * - - •一- 一 玉、發明説明(408) NMR (d6-DMS〇) : δ 10.31 (s, 1H), 8.64 (s, 1H), 8.23 (d, J=8.8Hz, 1H), 8.03 (d, J=8.4Hz, 2H), 7.93 (d, J=8.4Hz, 2H), 7.18-7.06 (m? 1H), 6.75-6.64 (m, 3H), 4.71 (t, J=5.8Hz, 1H), 4.21-4.00 (m, 1H), 3.67 (s, 3H), 3.57-3.37 (m, 2H), 2.74 (d? >7·0Ηζ,2H),2·42- 2·25 (m,1H),1.90-1.52 (m, 2H)〇 濂俐 49(263) N-羥基- 2(R)_苄氧基甲基羥基_4(S)-[N-(4-硝基 笨羰基)胺基]戊醸胺
TLC: Rf 0.62(二氛甲烷:甲醇=9:1)·, NMR (d6-DMS〇) : δ 10.47 (s, 1H), 8.74 (s, 1H), 8.33 (d, J = 8.8Hz, 1H), 8.29 (d, J = 8.6Hz, 2H), 8.06 (d, J = 8.6Hz, 2H), 7.29 (m, 5H), 4.72 (t, J = 5.6Hz, 1H), 4.45 (d, J = 12.4Hz, 1H), 4.38 (d, J = 12.0Hz, 1H), 3.95 (m, 1H), 3.60-3.35 (m, 4H), 2.45 (m,1H), 1.78 (m, 1H),1.62 (m, 1H)。
W. Μ 49( 2 64) - 4 9(26 9 L 使用對應化合物,依實施例374實施例394實施例 41(使用對應化合物替代甲氧基甲基氯)◊實施例43(使用 對應化合物替代苄基溴實施例實施例444實施例 49所示方法相同操作,得下列化合物。 實_例49(26 4丄 _ _____ (請先閲讀背面之注意事項再填寫本頁)
、1T 本紙張尺度適用中國國家標準(CNS)A4規格(21〇X 297々# ) 408 310112 568897 Λ
W 五、發明説明(4(>9) Ν-羥基-5-甲氧基甲氧基- 4(S)-[N-甲基- Ν-[4-(4-氯 笨基)笨羰基]胺基]戊醸胺 ,〇ch3 〇
NMR (d^-DMSO) : δ 10.36 (1Η, s), 7.75-7.65 (4H, m), 7.54-7.37 (4H, m), 4.66-3.68 (3H, m), 3.64-3.35 (2H, m), 3.25, 3.21 (3H, s), 2.81, 2.74 (3H, s), 2.07-1.55 (4H,m)。 g _ 例 49 (2fi5) N -羥基- 2(S)-(3 -啦啶基)甲基-5-甲氧基甲氧基_4(S) -[N-甲基-N-[4-(4-氯苯基)苯羰基]胺基]戊醯基 經濟部中央標準局員工消費合作社印製
CI TLC: Rf 0.42(氯仿:甲醇··乙酸=9:1:0·5); 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公摄)
Tog 310112 568897 五、發明説明(410) NMR (d6-DMS〇) : δ 10.43 (1Η, s), 8.72 (1H, s), 8.45-8.29 (2H, m), 7.78-7.60 (5H, m), 7.58-7.40 (4H, m), 7.33- 7.22 (1H, m), 4.97-4.84 (0.6H, m), 4.56-4.44 (2H? m), 3.94-3.84 (0.4H, m), 3.64-3.30 (2H, m), 3.25, 3.20 (3H, s), 2.82, 2.73 (3H, s), 2,85-2.21 (3H,m), 1.88-1.49 (2H,m)。 管倫例49 (266 ) N-羥基- 2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-甲基-N -(4 -溴苯羰基)胺基]戊醯胺 r〇CH2CH3 '〇 ch3 H^Br (請先閱讀背面之注意事項再填寫本頁) r裝· 訂 TLC: Rf 0.36(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.47&10.45 (s, 1H), 8.72&8.69 (s, 1H), 7.63& 7.60 (d, J=8.4Hz, 2H), 7.32&7.30 (d, J=8.4Hz, 2H), 4.79-4.67&3.77-3.64 (m, 1H), 4.61& 4.56 (s, 2HX 3.60-3.36 (m, 4H), 2.78&2.65 (s, 3H), 2.18-2.06&2.03-1.92 (m, 1H), 1.85-1.67 (m, 1H), 1.54-1.43&1.38-1.27 (m, 1H), 1.10(q, J=6.6Hz, 3H)? 1.03&0.73 (d, J=6.9Hz, 3H)〇 經濟部中央標準局員工消费合作社印製 淪例 4 9 ( 2 6 7 )— N-羥基_2(S)-(3-甲氧基苄基)_5_乙氧基甲氧基- 4(S) -[N -甲基- N- (4-溴笨羰基)胺基]戊醯胺 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公漦) 410 310112 568897 Λ? ΗΊ 五、發明説明(411)
TLC: Rf 0.47(氯仿:甲醇=9:1); NMR (d6-DMSO): 10.44&10.42 (s,1H),8.71 (s,1H),7·66&7·53 (d, J=8.1Hz, 2H), 7.36&7.29 (d, J=8.1Hz, 2H), 7.14 (t, J=8.0Hz, 1H), 6.80-6.58 (m, 3H), 4.89-4.79&3.75-3.63 (m, 1H), 4.60&4.5 2 (s, 2H), 3.71&3.67 (s, 3H)? 3.58-3.36 (m, 4H), 2.78&2.68 (s, 3H), 2.77-2.56 (m, 2H), 2.33-2.15 (π% 1H), 1.85-1.72 (m, 1H), 1.66-1.57&1.54-1.43 (m, 1H), U5-1.04 (m, 3H)〇 審输{例49 ( 26 8 ) N-羥基-2(S)_甲基-5-乙氧基甲氧基- 4(S)-[N-甲基-N- (4-硝基笨羰基)胺基]戊醢胺 /〇CH2CH3 σ Η
TLC: Rf 0.27(氛仿:甲醇=19:1); NMR (d6-DMS〇) :δ 10.51 10.45 (s, 1Η), 8.76 ^8.70 (s, 1H), 8.29 8.26 (d, J=8.8Hz, 2H), 7.64 7.60 (d, J=8.8Hz, 2H), 4.86-4.51 (m, 3H), 3.70-3.36 (m, 4H), 2.84 2.65 (s, 3H), 2.2M.65 (m, 2H), 1.60-1.20 (m, 1H), 1.15/^ 1.12 (t, J=7.0Hz, 3H), 1.07 ^ 〇-79 (d, J=7.0Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公f ) (請先閱讀背面之注意事項再填寫本頁)
02 N 經濟部中央標準局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 568897 ΒΊ 五、發明説明(412) 窨 _ 例 49 (269) Ν-羥基-2(S)_甲基_5_苄氧基甲氧基- 4(S)-[N-甲基-Ν -(4-硝基笨羰基)胺基]戊醯胺
TLC: Rf 0.43(氯仿:甲醇= 9:1); r NMR (d6-DMS0) : 5 10.50&10.43 (s,1H),8·75&8·69 (d,J=1.5Hz,1H), 8.27&8.25 (d, J=8.9Hz, 2H), 7.63&7.60 (d, J=8.9Hz, 2H)T 7.37-7.26 (m, 5H), 4.83-4.67 (m, 2.5H), 4.58-4.46 (m, 2H), 3.69-3 .56&3.48- 3.37 (m, 2.5H), 2.83(5:2.63 (s, 3H), 2.20-2.10& 2.06-1.95 (m, 1H), 1.90-1.72 (m, 1H), 1.55-1.44 &1.39-1.29 (m, 1H), 1.05&0.76 (d, J=6.8Hz, 3H)〇 管淪例 49(270)〜49(277) 使用對應化合物替代參考例4製造之化合物,依實施 例例374實施例394實施例454實施例46(使用對應化合 物替代苄基溴實施例54實施例474實施例44實施例 49所示方法相同操作所得之化合物,依實施例49所示方法 相同操作,得下列化合物。 富_例49(270) N-羥基- 2(S)-(3-甲氧基苯基)-5-羥基- 4(S)-[N-甲基 (4-氯苯羰基)胺基]戊醯胺 (請先閱讀背面之注意事項再填寫本頁)
本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) 412 310112 568897 A7 B7 五、發明説明(41
TLC : Rf 0 · 51 (二氯甲烷 CI 甲醇=9 : 1); NMR (d6-DMS〇) : δ 10.40 (s, 0.45H), 10.38 (s, 0.55H), 8.67 (s, 1H), 7.53- 7.35 (mr 3.45H), 7.24-7.10 (m, 1.55H), 6.73-6.56 (m, 3H), 4.94 (brt, J=5.2Hz, 0.45H), 4.79 (brt, J=5.2Hz, 0.55H), 4.72 (m, 0.55H), 3.70 (s, 1.65H), 3.67 (s, 1.35H), 3.70-3.30 (m, 2.45H), 2.78 (s, 1.35H), 2.66 (s, 1.65H), 2.80-2.10 (m, 4H), 1.80-1.35 (m,2H)。 ’ 奮 _ 例 49 ( 2 7 1 ) N-羥基-2(S)-(3-甲氧基苄基)-5-羥基-4(S)-[N -甲基 N- (4-硝基苯羰基)胺基]戊釀胺 ("先閱讀背面之注意事項再楨寫本頁) "'':;"、""^~* θ / i^
N〇2 TLC: Rf 0.56(二氯甲烷:甲醇=9:1); NMR (d6-DMS〇) : δ 10.39 (s, 0.5H), 10.37 (s, 0.5H), 8.69 (s, 0.5H), 8.64 (s, 0.5H), 8.28 (d, J=8.8Hz, 1H), 8.17 (d, J=8.8Hz, 1H), 7.68 (d, J=8.8Hz, 1H), 7.59 (d, 本紙张尺度適中國國家標準(CNS ) A4規格(210X297公釐) 413 310112 568897 部 屮 ik il 消 合 Μ 卬
Ο A7 B7 五、發明说明(4 1 j J=8.8Hzy lH)y 7.11 (m, 1H), 6.72 (m, 2H), 6.57 (m, 1H), 4.95 (brt, J=5.2Hz, 0.5H), 4.82 (brt, J=5.2Hz, 0.5H), 4.69 (m, 0.5H), 3.68 (s, 3H), 3.60-3.30 (m, 2.5H), 3.55-3.25 (m, 2H), 2.80 (s, 1.5H), 2.63 (s, 1.5H), 2.80-2.10 (m, 4H), 1.80-L35 (m, 2H)〇 審渝例49 (272 ) N-羥基-2(S)-(3-甲氧基苄基)-5-羥基-4(S)-[N-甲基 -N-(4 -溴苯羰基)胺基]戊醯胺 0¾ ch3 UBr TLC: Rf 0·45(二氯甲烷·•甲酵=9:1); NMR (d6-DMS〇) : δ 10.41 (s, 0.45H), 10.38 (s, 0.55H), 8.67 (s, 1H), 7.64 (d, J=8.4Hz, 1.1H), 7.53 (d, J=8.4Hz, 0.9H), 7.39 (d, J=8.4Hz, 1.1H), 7.35 (d? J=8.4Hz, 0.9H), 7.13 (t, J=7.8Hz, 1H), 6.70 (m, 2.1H), 6.57 (m, 0.9H), 4.94 (brt, J=5.1Hz, 0.45H), 4.79 (brt, J=5.7Hz, 0.55H), 4.70 (mT 0.55H), 3.70 (s, 1.65H), 3.67 (s, 1.35H), 3.70-3.60 (m, 0.45H), 3.55-3.25 (π% 2H), 2.78 (s, 1.35H), 2.66 (s, 1.65H), 2.80-2.10 (m,4H),1.80-1.35 (m,2H)〇 g m m 49(27 3 ) N -經基-2(S) -甲基-5 -經基-4(S)-[N -甲基- N- (4 -硝基 苯羰基)胺基]戊醯胺 (謂先閲讀背面之注意事項再硝寫本頁) 本紙张尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 414 310112 568897 A7 B7 五、發明説明(41g
TLC: Rf 0·16(氯仿:甲醇=9:1); NMR (d6-DMSO) : δ 10.49&10.42 (s, 1H), 8.72&8.67 (d, J=1.5Hz, 1H), 8.27&8.25 (d, J=8.8Hz, 2H)? 7.65&7.62 (d, J=8.8Hz, 2H), 5.01&4.83(t, J=5.4Hz, 1H), 4.65-4.54&3.51-3.40 (m, 1H), 3.53-3 .27 (m, 2H), 2.81&2.62 (s, 3H), 2.17-2.09&2.03-1.91 (m, 1H), 1.80-1.63 (π% 1H), L52-L42&1.33-1.22 (m? 1H), 奮)fe 例/19 (274) r N-羥基- 2(S)-苄基-5-羥基-4(S)-[N-甲基- N-(4-硝基 苯羰基)胺基]戊醸胺 (讀先閱讀背面之注意事項再«寫本頁)
N〇2 ·1 ^';^";':|中^;^^碑而f 合 Μ ,^ T L C : R f 0 · 2 5 (氯仿··甲酵·•水=9 ·· 1 ·· 0 · 1 ); NMR (dg-DMSO) : δ 10.40 及 10.37 (s,1H),8·70 及8·65 (brs,1H),8.29/¾ 8.19(d,J=8.7Hz,2H), 7.69/灵 7.60(d,J=8.7Hz,2H),7.30-7.01 机 5H),4.91/g/ 4.84 (ζ J=5.4Hz, 1H), 4.75-4.64/^3.54-3.44 (m, 1H)? 3.49-3.25 (m, 2H), 2.81/¾ 2.65 (s, 3H), 2.84-2.51 (m, 2H), 2.35-2.12 (m, 1H), 1.84-1.56/^ 1.47-1.36 (m, 2H)〇
⑽中關家標淨-(CNS ) Λ4規格(210X297公f ) 415 568897 kl
五、發明说明(I 羰基)胺基]戊酿胺
Br TLC: Rf 〇417(氯仿:甲酵:水:9:1:0·1)* NMR (d6-DMS0) : S 10.43 (s, 1H), 8.66 (s, 1H), 7.62 7.59 (d, J=8.1Hz, 2H), 7.35 (d, J=8.1Hzt 2H), 4.98-4.92 4.81-4.73 (m, 1H), 4.63-4.52 ^ 3.64- 3.52 (m, 1H), 3.52-3.39 (m, 2H), 2.77 /¾ 2.64 (s, 3H), 2.15-2.05/¾^ 2.00-1.89 (m, 1H), 1.77-1.58 1.53-1.43/^ 1.32-1.21 (m? 2H), 1.04/^ 0.68 (d, J=6.7Hz, 3H)〇 啻_例 49(276) ’ N -羥基-2(S) -节基-5 -羥基-4(S)_[N -甲基- N- (4 -漠苯 羰基)胺基]戊醸胺 (讀先閲讀背面之注意事項再填寫本頁)
、1T 部 中
··· h _τ 消 f: 合 竹 卬 NMR (d6-DMSO) : 5 10.40 and 10.37 (s,1H),8.66 (s, 1H), 7·64 /灸7·54 (d, J=8.6Hz, 2H), 7.39 ^ 7.36 (d, J=8.6Hz, 2H), 7.28-6.97 (π% 5H), 4.95/¾ 4·79 J=5.4Hz, 1H), 4.75-4.65/^ 3.69-3.60 (m, 1H), 3.52-3.26 (m, 2H), 2.78^ 2*66 ^ 3H),2.82-2.55 (m,2H), 2.31-2.12 (m,1H), 1.80-1.56 ^ 1.67-1.35 (m,2H)。 啻施例49 ( 277 ) 本紙張尺度適州中國國家標率((:灿)八4規格(210\ 297公釐) 416 310112 41568897 A7 五、發明说明 N-羥基_2(S)_甲基-5-經基- 4(S)-[N -甲基-N-(4-氯苯 羰基)胺基]戊醯胺
CI TLC: Rf 〇.17(氯仿··甲醇:水=9:1:0·1); NMR (dyDMSO) : 5 10.45 及 10.43 (s,1Η),8.69 及 8.66 (s,1Η), 7.53-7.38 (π% 4H), 4.96 及 4·77 化 J=5.3Hz,1H),4.63-4.52 々 3.65-3.51 (m,1H),3.51-3.40 (m, 2H), 2.78 /^2.64 (s, 3H), 2.15-2.05 1.98-1.88 (m, 1H), L77-1.54 (m, 1H), 1.54-1.43 /¾ 1.32-L21 (m, 1H),1.03 及 0.67 (d, J=6.8Hz, 3H)。 g _ 俐 50 2(S)_苄氧基_3(S)_羥基-4-(N-(4-(3-甲氧基-1-丙炔 基)苯羰基)胺基)丁酸乙酯 (誚先閱讀背面之注意事項再蛾寫本頁) 、>) >rr, 部 十 •火 才i 消 f: 么、 印 C2Hs0yS^n Ο
och3 使用2(S)-苄氧基-3(s)-羥基-4-胺基丁酸乙酯(依 Bioorg. Med. Chem. Lett,匕 515(1992)所述方法製造 替代4-胺基丁酸乙酯,使用對應之酿化物替代參考例4製 造之化合物,依實施例1所示方法相同操作,得具下列物 性之標題化合物。 本紙張尺度適州中國國家標準(CNS ) Λ4規格(210X 297公釐) 417 310112 418、568897 A7 B7 五、發明説明 TLC: Rf 0.20(正己烷:乙酸乙酯=3:2)。 啻_例51 (讀先閱讀背面之注意事項再頊寫本頁) 2(S)-苄氧基- 3(S)_羥基- 4-(N-(4-(3-甲氧基-1-丙炔 基)苯羰基)胺基)丁酸
OCH3 使用實施例50製造’之化合物替代實施例1製造之化合 物,依實施例2所示方法相同操作,得具有下列物質之標 題化合物。 TLC: Rf 0.22(氯仿:甲醇=9:1)。 啻)fe例52 2(S)-苄氧基-3(S)-第三丁基羰氧基-4-(N-(4-(3-甲 氧基-1-丙炔基)笨羰基)胺基)丁酸乙酿 部 屮 k il 而 消 f A 印
C2H5C
och3 使用實施例50製造之化合物替代4 -胺基丁酸乙酯,依 本紙張尺度適;1]中國國家標準(CNS ) Λ4規格(210X 297公釐) 418 310112 568897 A7 B7 五、發明说明(4ld 實施例1(使用三甲基乙醸胺替代參考例4製造之化合物)所 示方法相同操作,得具有下列物性之標題化合物。 TLC: Rf 0.44(正己烷:乙酸乙酯=7:3)。 NMR (CDC13) : δ 7.49 (2Η, d, J=8.8Hz), 7.43-7.30 (7H, m), 6.80-6.68 (1H, m), 5.36 (1H, td, J=5.6, 3.8Hz), 4.87 (1HT d, J=11.4Hz)? 4.43 (1H, d, J=11.4Hz), 4.34 (2H, s), 4.25 (1H, d, J=3.8Hz), 4.22 (2H, q, J=7.0Hz), 3.90 (1H, dt, J=14.2, 5.6Hz), 3.66 (1H, dt, J=14.2, 5.6Hz), 3.46 (3H, s), 1.29 (3H, t, J=7.0Hz), 1.14 (9H, s)〇 奮施例53 2-苄氧基-4-(N-(4-(3-甲氧基-1-丙炔基)苯羰基)胺 r 基-2-丁烯酸 (ίί先閱讀背面之注意事項再楨寫本頁)
OCH3 部 十 k \\ JT % fr 合 竹 卬 使用實施例52製造之化合物替代實施例1製造之化合 物,依實施例2所示方法相同操作,得具有下列物質之標 題化合物。 TLC ·· Rf 0 · 36 (氯仿·•甲醇=9 : 1)。 奮_例54 N -羥基-2(S)_苄氧基- 3(S)_羥基4-(N-(4-(3 -甲氧基 本紙張尺度遥州中國國家標準(CNS ) Α4規格(210X297公釐) 419 310112 568897 A7 B7 五、發明説明(421) 使用實施例53製造之化合物替代實施例51製造之化合 物,依實施例54所示方法相同操作,得具下列物性之標題 化合物。 TLC : Rf 0 · 37 (氯仿:甲醇=9 : 1 ); NMR. (CD3OD) : δ 8.52-8.40 (1Η, m), 7.74 (2H, d, J=8.4Hz), 7.49 (2H? d, J=8.4Hz), 7.45-7.20 (5H, m), 5.89 (1H, t, J=6.6Hz), 4.88 (2H? s), 4.33 (2H, s), 4.02-3.90 (2H,m),3·43 (3H, s)〇 啻)fe例55 順-1-羧甲基-2-(N-(4-(3 -甲氧基-卜丙炔基)苯羰基) 胺基)環戊烷 (銷先閱讀背面之注意事項再楨寫本頁) 衣·
#. 使用順-1-羧甲基-2-胺基環戊烷(J. Cheio,Soc., Perkintrans 1, UL, 2553(1982)所逑之化合物)替代 4 -胺 基丁酸甲酯,使用對應之醢鹵化物替代參考例4製造之化 合物,依實施例1所示方法相同操作,得具下列物性之標 題化合物。 TLC: Rf 0.80(氯仿:甲酵:乙酸=18:2:1)。 g-JLA 5 5 ⑴〜π m 使用反-1-羧甲基-2-胺基環戊烷、順-3-胺基環成烷 酸、反-3-胺基環戊酸Chera.Ber., LQJL, 1 5 5 ( 1 9 6 8 )所述化 合物)Μ及2 -胺基甲基環戊烷酸替代順-1-羧甲基-2 -胺基 ^紙張尺度適州中國國家標準(CNS ) Α4規格(210X 297公釐) 421 310112 42568897 A7 五、發明説明 環戊烷,依實施例55所述方法相同操作,得下列化合物。 管施例5 5 (1 ) 反-卜羧甲基-2-(Ν-(4-(3-甲氧基-1-丙炔基)笨羰基) 胺基)環己烷
OCH3 TLC: Rf 0·36(氯 fe :甲醇=10:1; NMR (CDC13) : δ 7.72 (2Η, d, J=8.4Hz), 7.49 (2H, d, J=8.4Hz), 6.49 (1H, d, J=7.4Hz), 4.34 (2H, s), 4.04 (1H, m), 3.46 (3H, s), 2.56 (2H, m), 2.25 (2H, m), 1.99 (1H, m), 1.75 (2H,m),1.50 (2H,m)。 奮施例55 (2 ) 反- 3-(N-(4-(3-甲氧基-卜丙炔基)苯羰基)胺基)環戊 烷酸 (讀先閱讀背面之注意事項再楨寫本s
、1T 部 十 i 導 〇
〇CH3 消 f: Λ TLC: Rf 0.21(氯仿:甲醇=9:1); 本紙張尺度適中國國家標率(CNS ) A4規格(210X297公釐) 4 2 2 310112 568897 A7 B7 42 五、發明説明 NMR (d6-DMS〇) : δ 12.09 (1Η,s),8.40 (1Η,d,J=6.8Hz),7·85 (2Η,d, J=8.4Hz), 7.53 (2H, d, J=8.4Hz), 4.42-4.22 (3H, m), 3.34 (3H? s), 3.30-2.82 (1H, m), 2.20-1.48 (6H,m)。 管)fe 例 5 5 ( 3 ) 順-3-(N-(4-(3-甲氧基-1-丙炔基)苯羰基)胺基)環戊 烷酸
OCH3 TLC: Rf 0.32(氯仿:甲醇=9:1); NMR (d6-DMSO) : δ 12.11 (1Η, s), 8.45 (1H, d, J=7.4Hz), 7.85 (2H, d, J=8.8Hz), 7.52 (2H, d, J=8.8Hz), 4.34 (2H, s), 4.33-4.18 (1H, m), 3.34 (3H, s), 2.84-2.66 (1H, m),2.18 (1H,m),2.00-1.50 (5H,m)。 奮施例55 U) 反-2-(N-(4-(3 -甲氧基-l-丙炔基)本鑛基)胺甲基)瓌 戊烷酸〇 η
och3 TLC: Rf 0.26(氯仿:甲酵=19:1); 本紙張尺度適州中國國家標率(cNs ) Λ4規格(21 OX 297公釐) 4 2 3 310112 (讀先閱讀背面之注意事項再硝寫本頁) 568897 A7 B7 五、發明説明(42 f NMR (CDCI3) : δ 7.72 (2Η, d, J=8.2Hz), 7.46 (2H, d, J=8.2Hz), 7.08-6.98 (1H, m), 4.33 (2H, s), 3.69 (1H, dt, J=13.8, 5.4Hz), 3.45 (3H, s), 3.34 (1H, ddd, (謂先閱讀背面之注意事項再楨寫本頁) J=13.8, 8.8, 5.4Hz), 2.62-2.30 (2H, m), 2.06-1.84 (3H, m), L80-1.62 (2H, m), 1.52-1·32(1Η,m)。
奮嫵例SR 順-1-(N-羥基胺基羰甲基)-2-(N-(4-(3-甲氧基-1-丙 炔基)苯羰基)胺基)環戊烷
使用實施例55製造之化合物替代實施例2製造之化合 物,依實施例3"»實施例4所示方法相同操作,得具下列物 性之標題化合物。 TLC: Rf 0.33(氯仿··甲醇=10:1); NMR (d6-DMSO) : δ 10.40 (1Η, s), 8.37 (1H, d, J=7.8Hz), 7.86 (2H, d, J=8.4Hz), 7.54 (2H, d, J=8.4Hz), 4.38 (1H, m), 4.35 (2H, s), 3.35 (3H, s),*2.35 (1H, m), 2.09 (1H, dd, J=14.6, 4.6Hz), 1.91 (1H, m), 1.83 (1H, m), L80-1.50 (4H, m), 1.44(1H,m)。 例 施 奮 例 施 實 用 使 例 施 實 依 , 物 合 化 之 。 造物 製合 55化 例列 施下 實得 代 , 替作 物操 合 同 化相 之法 造方 製示 4)所 例 施 啻 本紙張尺度適州中國國家標準(CNS ) Λ4規格(210Χ 297公釐) 424 310112 568897 A7 B7 五、發明说明(4 2δ) 反-1-(Ν -羥基胺基羰甲基)-炔基)苯羰基)胺基)環己烷 (Ν- (4- (3-甲氧基-卜丙
och3 TLC: Rf: 0.43(氯仿:甲醇=10:1); NMR (d6-DMSO) : S 10.37 (1H, s), 8.41 (1H, d, J=8.0Hz), 7.87 (2H, d, J=8.4Hz), 7.53 (2H, d, J=8.4Hz), 4.35 (2H, s), 3.90 (1H, m), 3.35 (3H, s), 2.19 (2H, m),1·87 (3H,m), 1.58 (3H,n〇, 1.24 (1H,m)。 r g倫例5 fi ( 2 ) 反-1-(N-羥基胺基羰基)-2-(N-(4-(3-甲氧基-1-丙 炔基)笨羰基)胺基)環己烷 r\
〇ch3 (讀先閱讀背面之注意事項再頊寫本頁) 部 ii >/] f: 竹 印 NMR (d6-DMS〇) 10.42 (1H, s), 8.80-8.60 (1H, br), 8.37 (1H, d, J=7.0Hz), 7.85 (2H, d, J=8.4Hz), 7.53 (2H, d, J=8.4Hz), 4.44-4.24 (3H, m), 3.35 (3H, s), 2.78-2.68 (1H, m), 2.10-1.50 (6H, m)〇 奮)fe 例 5 6 (:n 順羥基胺羰基)-3-(N-(4-(3-甲氧基-1-丙快基 )苯羰基)胺基)環戊烷 本紙张尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 425 310112 568897 A7 B7 五、發明説明(42 1
HCTNvif^^vN
I H
OCHa TLC: Rf: 〇·38(氯仿:甲醇= 9:1); NMR (dg-DMSO) 10.62 (1H, s), 8.94-8.76 (1H, br), 8.82 (1H, d, J=7.8Hz), 7.87 (2H, d, J=8.4Hz)t 7.53 (2Hy d, J=8.4Hz), 4.34 (2H, s), 4.42-4.22 (1H, m), 3.35 (3H,s),2·70-2·55 (1H, m),2·14-1·95 (1H,m),1.92-1.62 (5H,m)。 g _ 例 5 fi U ) 反-1-(N-經基胺基幾基)-2-(N-(4-(3-甲氧基-1-丙炔 基)苯羰基)胺甲基)環伐烷 (許先閱讀背面之注意事項再頊寫本頁) 〇 HO、
Λ、、
och3 T L C ·· R f : 0 · 3 1 (氯仿:甲醇=9 ·· 1); NMR (d6-DMS〇) : S 10.39 (1H, s), 8.50 (1H, ζ J=5.6Hz), 7.83 (2Η, d, J=8.2Hz), 7.52 (2H, d, J=8.2Hz), 4.34 (2H, s), 3.35 (3H, s), 3.32-3.14 (2H, m), 2.40-2.22 (1H,m),2·20-2·04 (1H,m), 1.90-1.50 (5H,m),1.48-1.24 (1H, m)。 奮_例57 2(R)-烯丙基-5-乙氧基甲氧基_4(S)-[N-(4-笨氧基笨 羰基)胺基]戊酸 本紙张尺度述W中囤國家標準(CNS ) A4規格(210X297公釐) 426 310112 368897 A7 B7 五、發明説明 42
〇JO 勿. 部 十 •火 消 於 λ; 印 使用對應化合物替代參考例4製造之化合物,依實施 例374實施例394實施例41(使用乙氧基甲基氯替代甲氧 基甲基氯實施例43(使用烯丙基溴替代苄基溴)所示方 法相同操作所得之2(S)-2-丙烯基-4(S)-乙氧基甲氧基甲 基-4-(N-(4-苯氧基苯羰基)胺基丁酸甲酯(1·06克)之四氫 呋喃(4毫升溶液,在-έΟΙ下,滴加至二異丙基醯胺鋰( 3.6毫升)之四氫呋喃(20毫升)溶液中。混合物在-15*0搅 拌30分鐘。於反應混合物中,添加飽和氯化銨溶液及水, Μ乙酸乙酯萃取。萃取液Μ飽和氯化納水溶液洗淨,Μ無 水硫酸納脫水並濃縮。殘留物Μ矽膠管柱層析(甲苯·•乙 酸乙酯= 87:13)純化。使用純化之化合物(200毫克),依實 施例2所述方法相同操作,得具下列物性之標題化合物( 193毫克)。 TLC: Rf 0.19(氯仿:甲醇=9:1)。 窨_例58 N-羥基- 2(R)_烯丙基-5-乙氧基甲氧基- 4(S)-[N-(4-苯氧基苯羰基)胺基}戊醯胺 (讀先閱讀背面之注意事項再楨寫本頁} 本紙張尺度適/1]中國國家標準(CNS ) A4規格(210X297公釐) 427 310112 568897 A7 五、發明説明(4 ^
使用實施例57製造之化合物,依實施例34實施例4所 示方法相同操作,得具下列物性之標題化合物。 TLC: Rf 0·23(氯仿:甲醇=10:1); NMR (d6-DMS〇) : δ 10.37 (s, 1H), 8.74 (brs, 1H), 8.13 (d, J=8.1Hz, 1H), 7.90-7.85 (m, 2H), 7.45-7.39 (m, 2H), 7.19 (t, J=7.2Hz, 1H), 7.07-6.99 (m, 4H), 5.69-5.60 (m, 1H), 5.02-4.93 (m, 2E), 4.56 (s, 2H), 3.99-3.89 (m, 1H), 3.80-3.39 (m, 4H), 2.26-2.01 (m? 3H), 1.85-1.79 (m, 1H), 1.61-1.54 (m, 1H), 1.07 (t, J=7.2Hz, 3H)〇 奮 _ 例 58 h)〜 (讀先閱讀背面之注意事項馮楨寫本頁}
、紙张尺度適州中囤國家標準(CNS ) A4規格(210X297公釐) 428 310112 568897 A7 B7 ______________ — ------- .— ·—> —--------- 五、發明说明(421 TLC: Rf 〇·35(氯仿:甲醇=19:1); NMR (dg-DMSO) :δ 10.37 (1Η, s), 8.72 (1Η, s), 8.28 (1Η, d, J=7.2Hz), 8.02 (2H, d, J=8.8Hz), 7.97 (2H, d, J=8.8Hz), 7.74- 7.62 (2H, m), 7.57 (1H, d, J=0.6Hz), 7.41-7.10 (7H, m)? 4.56 (2H, s), 4.18-3.98 (1H, m), 3.57-3.39 (2H, m), 3.23 (3H, s), 2.85 (1H, dd, J=13.6, 8.4Hz), 2.64 (1H, dd, J=13.6, 6.0Hz), 2.54-2.40 (1H, m), 2·03-1·80 (1H,m), 1.72-1.52 (1H,m)。 g 淪例 58 (2)一 N-羥基- 2U)_甲基-5-乙氧基甲氧基_4(S)-[N-(4-苯 氧基苯羰基)胺基]戊醯胺 (讀先閱讀背面之注意事項再填寫本頁) och2ch3 HO"
TLC: Rf 0.29(氯仿:甲醇:乙酸=1〇〇:1〇:1); 部 )1 :τ ';« 竹 ή: t. NMR (d6-DMS〇) : δ 10.35 (s, 1H), 8.70 (s, 1H), 8.13 (d, J=8.1Hz, 1H), 7.88 (d, J=8.4Hz, 2H), 7.45-7.39 (π\ 2H), 7.19 (t, J=7.2HzT 1H), 7.07-7.01 (m, 4H), 4.57 (s, 2H), 401-3.88 (m, 1H), 3.47 (q, J=7.2Hz? 2H), 3.44-3.38 (m, 2H)t 2.30-2.18 (m, 1H), 1.91-L82(m, 1H), 1.55-1.46 (m, 1H), 1.07 (t, J=7.2Hz, 3H), 0.99 (d, J=6.9Hz, 3H)〇 謇)fe 例 58 (3) N-羥基- 2(R)_甲基-5-乙氧基甲氧基_4(S)-[N-[4-(4 氰基笨基)笨羰基]胺基]戊醯胺 本紙張尺度適州中國國家標率(CNS ) Λ4規格(210X297公釐) 429 310112 43568897 A7 B7 五、發明説明 Ο ο ,och2ch3
CN 部 屮 Λ 卬 TLC: Rf 0.49(氯仿:甲醇=9:1); NMR (dg-DMSO) : 8 10.36 (s, 1H), 8.69 (s, 1H), 8.28 (d, J=8.2Hz, 1H), 8.00-7.94 (m, 6H), 7.84 (d, J=8.4Hz, 2H), 4.57 (s, 2H), 4.06-3.88 (m, 1H), 3.52-3.42 (m, 4H), 2.34-2.18 (m, 1H), 1.95-1 .81 (m, 1H), 1.60-1.45 (m, 1H), 1.07 (ζ J=7.2Hz, 3H), 1.00 (d, J=6.6Hz)〇, 管?例 5 9(1)〜59(2) 使用4(R) -羧基-4-胺基丁酸甲酯替代4(S)_狻基- 4-胺基丁酸甲酯,Μ及使用對應化合物替代參考例4製造之 化合物,依實施例374實施例394實施例41(有些情況使 用對應化合物替代甲氧基甲基氯實施例43(使用對應化 合物替代苄基溴)所示方法相同操作所得之化合物,再依 實施例574實施例24實施例34實施例4所示方法相同操 作,得下列化合物。 奮餱例5 9 (1 ) Ν-羥基-2 (S)-苄基- 甲氧基甲氧基-4 ( R ) - [ Ν - ( 4 -苯 (讀先閱讀背面之注意事項再楨寫本1JC ) 氧基苯羰基)胺基]戊醯胺 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 430 310112 43568897 A7 B7 五、發明説明
TLC: Rf 0.41(氯仿:甲醇:乙酸:水=100:10:1:1) ;NMR (d6-DMS〇) : δ 10.33(1H, s), 8.69(1H, s), 8.12(1H, d, J=8.0Hz), 7.85(2H, d, J=8.8Hz), 7.37-7.46(2H, m), 6.99-7.27(10H, m), 4.52(2H, s), 3.90-4.13(1H, m), 3.38-3.44(2H, m), 3.20(3H, s), 2.81(1H, dd, J=13.2Hz, 6.2Hz), 2.59(1H, dd, J=13.2Hz, 6.2Hz), 2.38-2.52(lH, m), 1.79-1.93(1H, m), 1.50-1.63(1H, m).〇 * 管嫵例( 2 ) N-羥基-2(S)-苄基-5-甲氧基甲氧基- 4(R)-[N-(4-(3-苯氧基-1-丙炔基)苯羰基)胺基]戊醯胺 (¾先閱讀背面之注意事項再楨寫本頁)
0 •火 \ ^ 消 1- 印 ¥ ,och3
TLC: Rf 0·41(氯仿:甲醇••乙酸:水=100:10:1:1) 本紙張尺度適用中國國家標率(CNS ) A4規格(210X297公釐) 431 310112 43568897 A7 五、發明説明 NMR (dg-DMSO) : δ 10.31(1H, s), 8.68(1Η, s), 8.24(1Η, d, J=8.1Hz)7 7.81(2H, d, J=7.8Hz), 7.51(2H, d, J=7.8Hz), 7.32(2H, t, J=7.8Hz), 6.95-7.24(8H, m), 5.05(2H, s), 4.50(2H, s), 3.90-4.07(lH, m), 3.37-3.42(2H, m), 3.18(3H, s), 2.79(1H, dd, J=13.5Hz, 6.2Hz), 2.58(1H? dd, J=13.5Hz, 6.2Hz), 2.43-2.52(lH, m), 1.82-1.89(1H, m), 1.54-1.62(1H, m)〇 管 _ 例 60 (1)〜60 (5) 使用對應化合物替代參考例4製造之化合物,依實施 例37 —實施例34實施例41(使用對應化合物替代甲氧基甲 基氯實施例43 (使用對應化合物替代苄基溴實施例2 4實施例34實施例44實施例27所示方法相同操作,得具 下列物性之標題化合#。 當掄例60 (1 ) N-羥基2(S)-(3-胺基苄基)-5-乙氧基甲氧基-4(S)-[ Η-(反-4-甲基環己羰基)胺基]戊釀胺
,och2ch3 0 (誦先閱讀背面之注意事項再填寫本頁) KVCH3 TLC: Rf 0.27(氯仿:甲醇=9:1); NMR (d6-DMS〇) : δ 10.45-10.10 (brs, 1H), 8.80-8.45 (brs, 1H), 7.40 (d, J=8.1Hz, 1HX 6.86 (t, J=7.7Hz, 1H), 6.35 (d, J=7.7Hz, 1H), 6.32 (s, 1H), 6.28 (d, J=7.7Hz,1H),4.85 (s,2H),4.54 (s,2H), 3·95-3·80 (m,1H), 3.55-3.20 (m,4H,與 DMSQ之 H20 重疊),2.59 (dd,J=13.2, 8·4Ηζ^ 1H),2.45 (dd,J=13.2, 5.7Hz, >、紙张尺度述州中國國家標準(CNS ) A4規格(210X297公釐) 432 310112 568897 A7 B7 ~ 4^3 五、發明説明() 1H), 2.32-2.20 (m, 1H), 2.08-1.92 (m, 1H), 1.80-1.57 (m, 5H), 1.57-1.44 (m, 1H), 1.44-1.20 (m,3H),1.11 (t,J=7.1Hz,3H),0.96-0.76 (m,5H)。 啻施例β〇 (2) (讀先閲讀背面之注意事項再楨寫本IJC > N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[H-(4-搂 基苯羰基)胺基]戊醯胺
TLC: Rf 0·22(氯彷:甲酵:乙酸=90:10:1); NMR (d6-DMS〇) : δ 13.50-12.70 (br, 1H), 10.37 (s, 1H), 8.82-8.58 (br, 1H), 8.31 (d, J=8.7Hz, 1H), 8.01 (d, J=8.7Hz, 2H), 7.95 (d, J=8.7Hz, 2H), 7.27-7.08 (m, 5H), 4.58 (s, 2H), 4.34-4.19 (m, 1H), 3.60-3.40 (m, 4H), 2.77 (d, J=7.2, 2H), 2.42- 2·32 (m,1H), 1.85-1.62 (m,2H),L09 (t,J=6.9Hz,3H)〇 奮淪例6 0 ( N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4-胺 基苯羰基)胺基]戊醯胺
TLC: Rf 0·36(二氯甲烷:甲醇=19:1); 本紙張尺度適州中國國家標準(CNS ) Α4規格(210X297公釐) 433 310112 568897 A7 B7 五、發明説明( 434) NMR (d6-DMS〇) : δ 10.34 (brs, 1H), 8.65 (brs, 1H), 7.61 (brd, J=9.0Hz, 1H), 7.58 (dT J=8.4Hz, 2H), 7.22-7.08 (m, 5H), 6.52 (d, J=8.4Hz? 2H), 5.57 (brs, 2H), 4.55 (s, 2H), 4.20 (m, 1H), 3.50-3.40 (m, 4H), 2.74 (d, J=7.2Hz, 2H), 2.35 (m, 1H), 1.80-1.59 (m,2H), 1.07 (t,J=7.2Hz,3H)。 g 淪例 6 0 ( 4 乙氧基甲氧基-4(S)-[N-(4-呢 N-羥基-2 (S)-苄基 啶羰基)胺基]戊醸胺
TLC: Rf 0.50(氯仿:甲醇:乙酸=7: 2:1); NMR (d6-DMS〇) :δ 10.30 (brs, 1Η), 7.47 (brd, J=9.0Hz, 1Η), 7.25-7.08 (m, 5H), 4.53 (s, 2H), 3.93 (m, 1H), 3.43 (q, J=6.9Hz, 2H), 3.35 (m, 2H), 2.94 (brd, J=12.0Hz, 2H), 2.68 (m, 2H), 2.49 (m, 2H), 2.35-2.10 (m, 2H), 1.70-1.40 (m, 6H), 1.09 (t, J=6.9Hz, 3H)〇 奮施例6 0 ( 5 ) N-羥基-2(S)-(3-羥基苄基)-5-乙氧基甲氧基- 4(S)-[ N-(4-甲基苯羰基)胺基]戊釀胺
OH
(謂先閱讀背面之注意事項再楨寫本頁) CH3 本紙张尺度適W中國國家標準(CNS ) Λ4規格(210X297公釐) 434 310112 568897 A7 R7 — -—---------.…., d ! 五、發明説明(4 TLC: Rf 〇·45(二氯甲烷··甲醇=9:1) ,· NMR (dg-DMSO) : δ 10.33 (s, 1H), 9.16 (s, 1H), 8.64 (s, 1H), 7.99 (brd, J=8.4Hz, 1H), 7.75 (d, J=8.4Hz, 2H), 7.23 (d, J=8.4Hz, 2H), 6.97 (t, J=7.2Hz, 1H), 6.51 (m, 3H), 4.55 (s, 2H), 4.17 (m, 1H), 3.50 (m, 2H), 3.44 (q, J=7.2Hz, 2H), 2.62 (m,2H), 2.33 (s,3H), 2.33 (m,1H),1·8(Μ·60 (m, 2H),1.06 (t,J=7.2Hz,3H)〇 實施例fi彳(彳)〜pi丨彳卩丨 使用實施例1製造之化合物或以對應化合物依實施例 1所不方法相同操作所得之化合物以及使用苄基溴或對應 化合物,依實施例434實施例2—實施例3—實施例4所示 方法相同操作,得見下列物性之摞題化合物。 啻施例fi ” N-羥基-2-苄基- 4-[N-[4-(苯并呋喃_2-基)笨羰基]胺 基]丁醢胺
TLC: Rf 〇·39(氯仿··甲醇=1〇:1); NMR (d6-DMS〇) : δ 10.43 (1Η, s), 8.52 (1H, t, J=5.6Hz), 8.00 (2H, d, J=8.8Hz), 7.94 (2H, d, J=8.8Hz), 7.71-7.63 (2H, m), 7.57 (1H, s), 7.39-7.16 (7H, m 3.30-3.15 (2H, m), 2.83 (1H, dd, J=8.6, 13.6Hz), 2.66 (1H, dd, J=6.2? 13.6Hz), 2.44-2.31 (1H, m),1·88-1·53 (2H,m)。 本紙張尺度適用中國國表標準(CNS ) Λ4規格(210X 297公釐) 435 310112 43568897 ΑΊ B7 五、發明説明 啻淪例61 ( 2 ) 基 胺 I-1 基 羰 N-羥基-2-(3-苯基丙基)-4-[N-[4-笨并呋喃-2-基)苯
(^先閲讀背面之注意事項再楨寫本頁) TLC:Rf 0.41(氯仿··甲醇=10:1); NMR (dg-DMSO) : δ 10.48 (1H, s)7 8.50 (1H, t, J=5.6Hz), 8.01 (2H, d, J=8.8Hz), 7.95 (2H, d, J=8.8Hz), 7.71-7.63 (2H, m), 7.57 (1H, s), 7.39-7.11 (7H, m), 3.25-3.15 (2H, m),2.59-2.47 (2H,m),2·18-2·02 (1H, m),1.82-L36 (6H,m)。 審_例fi 1 (:n N-羥基-2-(2-苯基乙基)-4-[N-[4-苯并呋喃-2-基)笨 羰基]胺基]丁醯胺
本纸張尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 436 310112 568897 A7 B7 五、發明説明(43) TLC:Rf 0·47(氯仿:甲醇=10:1); NMR (CD3OD) : δ 7.98 (2Η, d, J=8.4Hz), 7.89 (2H, d, J=8.4Hz), 7.64-7.60 (讀先閱讀背面之注意事項再楨寫本頁) (1H, m), 7.56-7.52 (1H, m), 7.36-7.09 (7H, m), 7.32 (1H, brs), 3.51-3.24 (2H, m), 2.68-2.50 (2H, m), 2.28-2.14 (1H,m),2.04-1.69 (4H,m)。 管施例61 (4) N-羥基-2-苯基-4-[N-[4-[2E-(4-氯苯基)乙烯基]苯 羰基]胺基]丁醢胺
TLC:Rf 0.46(氯仿:甲醇=1〇··1); NMR (d6-DMS〇) : S 10.41 (1H, brs), 8.76 (1H? brs), 8.41 (1H, ζ J=5.4Hz), 7.83 (2H, d, J=8.4Hz), 7.66 (2H, d, J=8.4Hz), 7.65 (2H, d, J=8.8Hz), 7.44 (2H, d, J=8.8Hz), 7.35-7.12 (7H, m), 3.28-3.15 (2H, m), 2.83 (1H, dd, J=8.4, 13.2Hz), 2.65 (1H,dd· J=5.8, 13.2Hz),2·46-2·30 (1H,m),1·86·1·51 (2H, m)。 管施例6 1 ( N-經基-2-苄基卜4-[N-(4-苯氧基苯羰基]胺基]丁醯 胺 本紙张尺度適力]中國國家標準((:呢)八4規格(210\297公釐) 437 310112 43568897 A7 B7 五、發明説明
TLC:Rf 0.45(氯仿:甲酵=ΐ〇··ΐ); NMR (d6-DMS〇) : δ 10.40 (1Η, s), 8.75 (1H, brs), 8.35 (1H, t, J=5.6Hz), 7.84 (2H, d, J=8.8Hz), 7. 47-7.38 (2H, m), 7.30-6.99 (10H, m), 3.26-3.14 (2H, m), 2.82 (1H, dd, J=8.4, 13.6Hz), 2.64 (1H, dd, J=6.2, 13.6Hz), 2.43-128 (1H, m), 1.84-1.49 (2H,m)。 實施例61 (fi) r N-羥基-2-(萘-1-基)甲基 基]丁醯胺 [N- (4-苯氧基苯羰基]胺 (¾先閱讀背面之注意事項再¾寫本頁)
Ο 齡 /Γ, 部'1, -火 % k \\ _τ 消 f: 合 卬
TLC:Rf 〇·45(氯仿:甲酵= i〇:i); NMR (d6-DMS0) : δ 10.39 (1Η, brs), 8.74 (1H, brs), 8.33 (1H, t, J=5.4Hz), 8.08-8.03 (1H, m), 7.92-7.75 (2H, m), 7.81 (2H, d, J=8.8Hz), 7.54-7.40 (9H, m), 7.00 (2H,d, J=8.8Hz),3·33-3·07 (4H, m), 2.63-2.45 (1H,m), 1.96-1.56 (2H,m)。 實施例f 7、 本紙张尺度適ifl中國國家標率(CNS ) Λ4規格(210X297公釐) 438 310112 43568897 A7 B7 五、發明説明 N-羥基-2-異丙基- 4-[H-(4-苯氧基苯鑛基)胺基]丁醸 胺
TLC:Rf 0.35(氯仿:甲醇=1〇:1); NMR (d6-DMS〇) : (5 10.39 (1H, brs), 8.34 (1H, t, J=5.6Hz), 7.90 (2H, d, J=8.8Hz), 7.43 (2H, J=7.4Hz), 7.19 (1H, t, J=7.4Hz), 7.09-7.04 (2H, m), 7.01 (2H, d, J=8.8Hz), 3.22-3.06 (2H, m), 1.78-1.61 (4H, m), 0.87 (3H, d, J=6.8Hz), 0.83 (3H, d,J=6.0Hz)。 當淪例tn (8) N-羥基-2-(〇f咐-4-基)甲基-4-[N_(4-苯氧基苯羰基) 胺基]丁醢胺 (辞先閱讀背面之注意事項再填寫本頁) 部 '1) lk 义;j
消 f· 合 竹 卬 TLC:Rf 0.38(氯仿·•甲醇=10:1 本紙张尺度適州中國國家標準(CNS ) A4規格(210X297公釐) 439 310112 568897 A7 B7 — —— —------------- — " 1 ——’ 五、發明说明(4” NMR (d6-DMSO) : ί 10.41 (1Η, brs), 8.76 (1H, brs), 8.76 (1H, d, J=4.4Hz), (掮先閱讀背面之注意事項再填寫本頁) 8.37 (1H, t, J=5.6Hz), 8.15 (1H, br.d, 7.6Hz), 8.00 (1H, d, J=7.4Hz), 7.83 (2H, d, J=8.8Hz), 7.77-7.69 (1H, m), 7.62-7.54 (1H, m), 7.47-7.38 (2H, m), 7.30 (1H, d, J=4.4Hz), 7.23-7.16 (1H, m), 7.08-7.05 (2H, m), 7.01 (2H, d, J=8.8Hz), 3.33-3.14 (4H,m), 2.64-2.50 (1H,m),1.98-1.58 (2H,m)。 g淪例fi 1 ( 9 ) N-羥基-2-(2-吡啶基)甲基-4-[N-(4-苯氧基苯羰基) 胺基]丁醯胺
TLC:Rf 0.34(氯仿··甲酵=10:1); NMR (d6-DMS〇) : δ 10.47 (1Η, brs), 8.76 (1H, s), 8.47-8.43 (1H, m), 8.34 (1H, t, J=5.6HzX 7.83 (2H, d, J=8.8Hz), 7.66 (1H, dt, J=1.8, 7.6Hz), 7.46-7.39 (2H, m), 7.23-7.15 (3H, m), 7.09-7.03 (2H? m), 7.01 (2H, d, J=8.8Hz), 3.25-3.12 (2H, m), 2.97 (1H, dd, J=7.6, 13.6Hz), 2.78 (1H, dd, J=6.6, 13.6Hz), 2.76-2.56 (1H, m), 1.85-1.46 (2H, m)。 奮施例6 1 (1 0) N -羥基- 2- (3 -Btt啶基)甲基-4-[N-(4 -笨氧基苯羰基) 胺基]丁醯胺 本紙張尺度適W中國國家標準(CNS ) Λ4規格(210X297公釐) 440 310112 44568897 A7 B7 五、發明説明( Μ
NMR (d6-DMS〇) : δ 10.41 (1Η, brs), 8.76 (1H, s), 8.40-8.37 (3H, m), 7.85 (2H, d, J=8.8Hz), 7.56 (1H, dU J=7.6, 2.2Hz), 7.47-7.38 (2H, m), 7.30-7.16 (2H, m), 7.10-7.04 (2H, m), 7.02 (2H, d, J=8.8Hz), 3.30-3.13 (2H, m), 2.87-2.66 (2H, m), 2.44-2.30 (1H,m),1·86-1·52 (2H, m)。 啻嫵俐6 1 (11)一 ’ N -經基- 2- (萘-2-基)甲基-4-[N-(4-笨氧基朱辕基)胺 基]丁醸胺 -------- (賴先閱讀背面之注意事項再填寫本I) 訂
部 中 -λ i?· 外 Λ )5 消 ϋ: 竹 卬 TLC:Rf 0.45(氯仿:甲醇=10:1); NMR (d6-DMS〇) : δ 10.40 (1Η, d, J=1.4Hz), 8.74 (1H, d, J=1.4Hz), 8.36 (1H, t, J=5.6Hz), 7.84 (2H, d, J=8.8Hz), 7.83-7.79 (3H, m), 7.65 (1H, brs), 7.50-7.33 (5H, m), 7.19 (1H, tt, J=1.8, 7.4Hz), 7.09-7.04 (2H, m), 7.01 (2H, d, J=8.8Hz), 3.30-3.12 (2H, m), 2.98 (1H, dd, J=8.8, 13.6Hz), 2.83 (1H, dd? J=6.0, 13.6Hz), 2.50-2.40 (1H, m),1.90-1.54 (2H,m)。 张尺度通州十國國家標牟(CNS)A4規格(210x297公釐) 441 310112 568897 A7 B7 五、發明説明(ί 啻 _ 例 61 (12) Ν -羥基-2-(4 -吡啶基)甲基- 4- [Ν-(4 -苯氧基苯羰基) 胺基]丁醯胺
(讀先閱讀背面之注意事項再填寫本頁) TLC:Rf 0·17(氯仿:甲醇=10:1); NMR (dg-DMSO) : δ 10.44 (1Η, brs), 8.78 (1H, brs), 8.42 (2H, d, J=5.8Hz), r 8.38 (1H, ζ J=5.6Hz)t 7.85 (2H, d, J=8.8Hz), 7.47-7.38 (2H, m), 7.23-7.15 (3H, m), 7.10-7.05 (2H, m), 7.02 (2H, d, J=8.8Hz), 3.30-3.13 (2H? m), 2.87-2.66 (2H, m), 2.48-2.33 (1H, m), 1.85-1.52 (2H, m)〇 管淪例6 1 (1 3 ) N-羥基-2-(3-甲氧基苄基)-4-[1^(4-苯氧基苯羰基) 胺基]丁醯胺
TLC:Rf 0.41(氯仿:甲醇=10:1); ~本紙张尺度適州十囤國家標率(CNS ) A4規格(210X297公釐) 442 310112 44568897 A7 B7 五、發明説明 NMR (d6-DMS〇) : δ 10.40 (1Η, s), 8.76 (1H, brs), 8.35 (1H, t, J=5.6Hz), 7.84 (2H, d, J=8.8Hz), 7.47-7.39 (2H, m), 7.24-7.04 (4H, m), 7.01 (2H, d, J=8.8Hz), 6.75-6.70 (3H, m), 3.70 (3H? s), 3.30-3.10 (2H, m), 2.79 (1H, dd, J=8.8, 13.4Hz), 2·61 (1H, dd,J=6.2, 13.4Hz),2·43-2·29 (1H,m),1·83-1·48 (2H,m)〇 管)fe例 N-經基-2-異丁基- 4- [N-(4-苯氧基笨鑛基)胺基]丁醸 胺
(請先閱讀背面之注意事項再楨寫本頁) J〇 使用對應化合物依實施例1所示方法相同操作所得之 化合物與3-溴-2-甲基丙烷,依實施例434實施例27—實 施例24實施例34實施例4所示方法相同操作,得具下列 物性之題題化合物。 TLC: Rf0.33(氯仿:甲醇=10:1); 部 中 •火 樣 1\ -T A 卬 ¥ NMR (d6-DMS〇) : δ 10.47 (1Η, s)? 9.10-8.41 (1H, brs)? 8.33 (1H, t? J=5.2Hz), 7.85 (2H, dt J=8.8Hz), 7.23 (2H, t? J=7.4Hz), 7.19 (1H, t, J=7.4Hz), 7.09-7.04 (2H, m), 7.01 (2H, d, J=8.8Hz), 3.21-3.11 (2H, m), 2.22-2.04 (1H, m), 1.76-1.34 (4H, m), U6-1.02 (1H,m),0.84 (3H,d,J=5.4Hz),0.81 (3H,d,J=5.8Hz)。 啻施例 5-甲氧基-4(S)-[N-[4-(4-氯苯基)苯羰基]胺基]戊酸 本紙張尺度通州屮囤國家標率(CNS ) ( 210X 297/^f 443 310112 568897 Μ Β7 五、發明説明(44‘
Cl 部 中 消 Ait 卬 使用對應化合物,依實施例374實施例38所示方法相 同操作所得之5-羥基- 4(S)-[N-(4〜氯聯苯-4-基)羥基]胺 基戊酸甲酯(1·7克)之四氫呋喃(5毫升)溶液中,添加矽膠 (500毫克)及重氮甲烷之乙醚(4毫升)溶液。混合物於室溫 攪拌10分鐘。反應溶液經濃縮。含殘留物之四氫呋喃(5毫 升)溶液中,添加重氮甲、之乙醚(4毫升)溶液,搅拌10分 鐘。該操作重複10次。殘留物Μ矽膠管柱層析(己烷:乙酸 乙酯= 9:143:1)純化,得標題化合物之甲酯(1.42克)。使 用此甲酯(1 . 4克),依實施例2所示方法相同操作,得具下 列物性之標題化合物(1·2克)。 TLC: Rf 0·50(二氯甲烷:甲醇=9:1)。 管_例6 4 Ν-羥基-5-甲氧基-4(S)-[N-[4-(4-氯苯基)笨羰基]胺 基]戊醯胺 Ο PCH3 Ο
Cl (讀先閱讀背面之注意事項再镇寫本頁) 本紙張尺度適州中國國家標率(CNS ) A4規格(210X 297公釐) 444 310112 568897 A7 B7 _ — · ..一 … * 4 4 5 五、發明説明(》 使用實施例63製造之化合物,依實施例34實施例4所 示方法相同操作,得具下列物性之標題化合物。 TLC: Rf 〇·38(氯仿:甲醇=10:1); (讀先閱讀背面之注意事項再填寫本頁) NMR (d6-DMS〇) : 10.35 (1H, brs), 8.27 (1H, d, J=8.4Hz), 7.95 (2H, d, J=8.4Hz), 7·77 (2H,d, J=8.4Hz),7.76 (2H,d,J=8.8Hz),7.54 (2H, d,J=8.8Hz), 4.20-4.03 (1H,m),3.42 (1H,dd,J=6.2, 9·6Ηζ),3.33 (1H,dd,J=6.2, 9.6Hz),3.26 (3H,s),2.08-1.95 (2H,m),1.94-1.58 (2H,m)。 參者例7 2(S) -甲基-5-羥基-4(S)-(N -苄氧基羰基)胺基戊酸第 三丁酯 ν/Λ'Χ) 使用4(S)-羧基- 4-(Ν-苄氧基羰基胺基]丁酸第三丁酯 ,依實施例394實施例454實施例46(使用碘化甲烷替代 苄基溴)《>實施例48所示方法相同操作,得具下列物性之 標題化合物。 TLC: Rf 0.36(己烷:乙酸乙酯=3:1)。 y _ 例 2(S) -甲基-5-琥珀醸亞胺-4(S)-[N-(4-氯苯羰基)胺 基]戊酸 4]氏张尺度適则’國國家標率(CNS ) A4規格(210X297公釐) 445 310112 568897 A7 B7 五、發明説明(44含
(讀先閱讀背面之注意事項再镇寫本頁) 參考例7製造之化合物(1.42克)、琥珀醯亞胺(521毫 克)及三苯膦(1·38克)溶於無水四氫呋喃(20毫升)中,冷 却至01C。於混合物中滴加偶氮二羧酸二乙酯(2.3毫升; 4 0涔甲苯溶液),於0 1C搜拌2小時。反應混合物經濃縮。 殘留物經矽膠管柱層析(己烷:丙酮=9:1,己烷··乙酸乙 r 酯= 3:142:1)純化2次,得目的物與三苯膦氧化物之混合 物(2.09克)。於該混合物之甲醇(20毫升)溶液中,添加10 谇鈀/碳( 400毫克),於氫氧中在室溫搜拌1小時,反應混 合物以塞里塑料(商品名)過瀘,濾液經濃縮。殘留物溶於 二氯甲烷(20毫升)中,冷却至01C。該溶液中添加三乙胺( 2毫升)及對-氯苯甲醯氯(1.10克),於〇它攪拌2小時。反 應混合物以乙酸乙酯稀釋,依序K1N塩酸、水、飽和碳酸 納水溶液、水及飽和食塩水洗淨,K無水硫酸鈉脫水後, 濃縮。殘留物以矽膠管柱層析(己烷:乙酸乙酯= 3:142:1 ->3:2)純化,得標題化合物之第三丁酯(1.29克)。使用此 第三丁酯(1.07克)依實施例29所示方法相同操作,得具下 列物性之標題化合物(845毫克)。 TLC: Rf 0·40(二氯甲烷··甲醇= 9:1); ^紙張尺度通州中國國家標率(CNS ) Α4規格(210X 297公釐) 446 310112
經濟部中央標準局員工消費合作社印製 568897 Λ 7 五、發明説明(447) NMR (CDa3) : S 7.64 (d, J = 9.0Hz, 2H), 7.35 (d, J = 9.0Hz, 2H), 6.55 (dT J =8.7Hz, 1H), 4.51 (m, 1H), 3.69 (dd, J = 13.8, 9.3Hz, 1H), 3.62 (dd, .J = 13.8, 4.2Hz, 1H), 2.75-2.51 (m, 5H), 1.97 (ddd, J = 14.4, 10.8, 7.2Hz, 1H), 1.65 (ddd, J = 144, 6.3, 4.2Hz,1H), 1·26 (d,J = 7.2Hz,3H)。 g _ 例 N-羥基-2(S)-甲基-5-琥珀醢亞胺- 4(S)-[N-(4-氯苯 羰基)胺基]戊醢胺
CI 使用實施例65製造之化合物,依實施例34實施例4所 示方法相同操作,得具下列物性之標題化合物。 TLC: Rf 0·42(二氯甲烷:甲醇=9:1); NMR (d6-DMS0) : δ 10.35 (d, J=1.5Hz, 1H), 8.65 (d, J=1.5Hz, 1H), 8.12 (d, J=9.0Hz,1H),7.75 (d,J=8.4Hz,2H),7.51 (d,J=8.4Hz,2H),4.22 (m,1H),3.49 (m, 2H),2.53 (叽 4H),2.17 (m,1H),1.70 (ddd,J=13.8, 10.5, 5.4Hz,1H),1.50 (ddd, J=13.8, 9·0, 4·5Ηζ,1H),0.96 (d,J=6.9Hz,3H)。 啻淪例(1 ) N-羥基-2(S) -甲基-5-琥珀醢亞胺基氧基- 4(S)-[N -甲 基-N-(4-硝基苯羰基)胺基]戊醢胺 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公# ) " 447 310112 (請先閱讀背面之注意事項再填寫本頁) 、1Τ 568897 Λ? Η*7 44 五、發明説明(
之標題化合物。 TLC: Rf 0·45(二氯甲烷:甲醇=9:1); 訂 NMR (dg-DMSO) : δ 10.50 (s, 0.7H), 10.45 (s, 0.3H), 8.28 (d, J=9.0Hz, 1.4H), 8.24 (d, J=9.0Hz, 0.6H), 7.69 (d, J=9.0Hz, 1.4H), 7.61 (d, J=9.0Hz, 0.6H), 4.86 (m, 0.7H), 4.20-4.00 (m, 2H), 3.72 (m, 0.3H), 2.89 (s, 0.9H), 2.71 (s, 2.1H), 2.60 (m, 4H)T 2.20-1.70 (m, 2H), 1.60-1.30 (m, 1H), 1.05 (d? J=6.9Hz, 2.1H), 0.74 (d, J=6.9Hz? 0.9H)〇 參考例8
本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 448 310112 經濟部中央標準局員工消費合作社印製 568897 Λ? Η"7 五、發明説明(449) 4實施例394實施例414實施例42所示方法相同操作所得 之5-乙氧基甲氧基- 4(S)-(N-(4-苯氧基苯羰基)胺基戊酸( 3·62克)之四氫呋喃(100毫升)溶液冷却至01C後,滴加三 乙胺(1.69毫升)及氯甲酸乙酯(1.2毫升)。混合物在01C授 拌1 · 5小時。反應混合物中添加硼氫化納(〇 . 5當量),搅拌 30分鐘後,滴加乙酸(5毫升),攪拌30分鐘。反應溶液經 澹縮。殘留物中添加乙酸乙酯及水,分離有機層。有機層 以水及飽和氯化鈉水溶液洗淨,Μ無水硫酸納脫水後,濃 縮。殘留物經矽膠管柱層析(乙酸乙醮:己烷= 2:1(含 三乙胺)44:1)純化,得具下列物性之標題化合物(1.84克 )° ’ TLC: Rf 0.52(乙酸乙酯:己烷=4:1)。 參者例9 1-溴-5 -乙氧基甲氧基-4(S)-[N-(4 -苯氧基苯羰基)胺 基]戊烷 OCH2CH3
參考例8製造之化合物(490毫克)之二氯甲烷(10毫升) 溶液中,添加三笨膦( 40 9毫克)及碳酸氫納(328毫克),泠 却至。於混合物中滴加四溴化碳(647毫克)之二氯甲烷 (5毫升)溶液,在〇υ搅拌15分鐘。反應混合物注入水中, (請先閱讀背面之注意事項再填寫本頁) 、1Τ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210>< 297公釐) 449 310112 經濟部中央標準局員工消費合作社印製 568897 五、發明説明(45 〇) Μ乙酸乙酯萃取。萃取液Μ水及飽和氯化納洗淨,以無水 硫酸納脫水後,濃縮。殘留物Κ矽膠管柱層析(己烷:乙 酸乙酯=3:1)純化,得具下列物性之標題化合物(293克)。 TLC: Rf 0·41(己烷:乙酸乙酯=2:1)。 复施例R7 1-乙醢硫基-5-乙氧基甲氧基- 4(S)-[N-(4-苯氧基苯 羰基)胺基]戊烷 广 OCH2CH3
於參考例9製造之化合物(290毫克)之丙酮(8毫升)溶 液中,添加硫乙酸鉀(113毫克),回流2小時。冷却後,反 應溶液注入水中,Μ乙酸乙酯萃取。萃取液以水及飽和氛 化鈉水溶液洗淨,Κ無水硫酸納脫水後濃縮。殘留物以矽 膠管柱層析(己烷:乙酸乙酯= 3:1)純化,得具下列物性之 摞題化合物(268毫克)。 TLC: Rf 〇·28(己烷:乙酸乙酯=2:1); NMR (CDC13) : δ 7.77 (d, J=8.7Hz, 2H), 7.38 (ζ J=7.5Hz? 2H), 7.17 (ζ J=7.5Hz,1H), 7·05 (d,J=7.5Hz)及7.01 (d,J=8.7Hz)共 4H,6·54 (d,J=8.7Hz, 1H)T 4.72 (d, J=6.9Hz, 1H), 4.68 (d, J=6.9Hz, 1H), 4.35-4.25 (m, 1H), 3.74 (dd, J=10, 3Hz,1H),3.63-3.58 (m,3H), 2.92 (t,J=6.9Hz,2H),2.32(s, 3H),L80-1.65 (m, 4H),1.21 (t,J=7.2Hz,3H)。 ·· (請先閱讀背面之注意事項再填寫本頁) 衣· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 450 310112 經濟部中央標準局員工消費合作社印製 568897 Λ7 _ B*7 五、發明説明(451) 實」SL例6 8 5-乙氧基甲氧基- 4(S)-[N-(4-苯氧基苯羰基)胺基]戊 硫醇 OCH2CH3
實施例67製造之化合物(230毫克)之甲醇(5毫升)溶液 中,在室溫添加碳酸鉀(146毫克),撹拌2小時。反應溶液 注入冰/1N塩酸中,Μ乙酸乙酯萃取。萃取液Μ水及飽和 氯化鈉水溶液洗淨,/無水硫酸鈉脫水後濃縮。殘留物以 矽膠管柱層析(己烷:乙酸乙酯= 3:1)純化,得具下列物性 之標題化合物(1 7 0毫克)。 TLC: Rf 0.27(己烷:乙酸乙酯= 2:1); NMR (CDCI3) : 5 7.77 (d,J=9Hz,2H),7.40-7.34 (m,2H),7· 17 a J=7.5Hz, 1Η), 7.08-6.96 (m, 4H), 6.54 (d, J=9Hz, 1H), 4.73 (dy J=6.9Hz, 1H), 4.69 (d, J=6.9Hz? 1H), 4.34-4.24 (m, 1H), 3.77 (dd, J=10.2, 3Hz, 1H), 3.66-3.56 (m, 3H)? 2.63- 2.53 (m, 2H), 1.83-1.65 (m, 4H), 1.37 (t, J=7.5Hz, 1H), 1.22 (t, J=7.2Hz, 3H). 奮?fe例69 5-乙氧基甲氧基- 4(S)[N-(4-苯氧基苯羰基)胺基]戊 (請先閲讀背面之注意事項再填寫本頁) «水·
、1T
本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 451 310112 568897 五、發明説明(45 3) 物性之標題化合物。 TLC: Rf 〇·45(氯仿:甲醇:乙酸:水=1〇〇:1〇:1:1); NM R (DMSO-d6) : δ 7.75(2H? d, J=8.8Hz), 7.37(2H, m), 7.17(1H, t, J=7.4Hz), 7.03(2H, m), 6.97(2H, d, J=8.8Hz), 6.58(1H, d, J=9.1Hz), 4.71(1H, d, J=6.9Hz), 4.68(1H, d, J=6.9Hz), 4.43(1H, m), 3.74(1H, dd, J=3.0, 10.2Hz), 3.65-3.55(3H, m), 2·56(1Η,m),2.16(1H,m),1.68(1H, m), 1·27(3Η,d,J=6.9Hz), U8(3H, t,J=7.1Hz)。 管渝例70(1)〜70(2) 使用對應化合物,依實施例694實施例70所述方法相 同操作,得下列化合物。 奮_例70 (1 ) r 2(S)-烯丙基-5-乙氧基甲氧基-4(S)-[N-(4-苯氧基苯 羰基)胺基]戊酸 (請先閱讀背面之注意事項再填寫本頁)
TLC: Rf 0.49(氯仿:甲醇:乙酸=1〇〇:1〇:1)。 經濟部中央標準局員工消費合作社印製 奮施^例7 0 ( 2 ) 2(S)_甲基-5-乙氧基甲氧基- 4(S)-[N-([4-(4-氰基 基苯基)笨羰基]胺基]戊酸 r〇vcH3 ch3 ^ 0 HO 丫 〇 Ο
CN 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 453 310112 568897 五、發明説明( 454) TLC : Rf NMR (DMSOd6) :δ 12·7(1Η,s),8·29-8·25(2Η,m),7.97-7·92(6Η, m),7·83(2Η, d, J=8.4Hz), 4.59(2Η, s), 4.28-4.16(1Η, m), 3.53-3.42(4Η, m), 2.39-2.30(1Η, m), 1·95-1·84(1Η,m),1·64-1·54(1Η,m),1·12-1·04(6Η,m)。 啻_例7 1 N-羥基- 2(S)_甲基-5-乙氧基甲氧基- 4(S)-[N-(4-苯氧 基笨羰基)胺基]戊醸胺 (請先閲讀背面之注意事項再填寫本頁) ^〇v^〇H3
使用實施例70製造之化合物,依實施例34實施例4所 示方法相同操作,得具下列物性之標題化合物。 TLC: Rf 0.40(氯仿:甲酵:乙酸:水=100:10:1:1); NMR (DMSO-d6) : δ 10.37(1H, brs), 8.66(1H, brs), 8.03(1H, d, J=8.8Hz), 經濟部中央標準局員工消費合作社印製 7.87(2H, d, J=8.8Hz), 7.43(2H, dd, J=7.4, 8.5Hz), 7.20(1H, t? J=7.4Hz), 7.06(2H? d, J=8.5Hz), 7.02(2H, d, J=8.8Hz), 4.59(2H, s), 4.14(1H, m), 3.50-3.45(4H, m), 2.17(1H, m), 1.66(2H, m), 1.09(3H, t, J=7.1Hz), 1.01(3H, d, J=6.9Hz)〇 管淪例71(1)〜71(2) 使用實施例70(1)或70(2)製造之化合物,依實施例 7 1所示方法相同操作,得下列化合物。 管)例 71 (1) 羥基-2(S)_烯丙基-5-乙氧基甲氧基- 4(S)-[N-(4- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公t ) 454 310112 568897 A7 Η 7 五、發明説明( 45 5) 苯氧基笨羰基)胺基]戊醯胺
och2ch3 HO
TLC: Rf 0·26(氯仿:甲醇:乙酸=100:10:1); NMR (dg-DMSO) : δ 10.42(1H, s), 8.70(1H, s), 8.03(1H, d, J=8.8Hz), 7.89- 7.85(2H, m), 7.47-7.37(2H, m), 7.23-7.15(lH, m), 7.09-6.99(4H, m), 5.77-5.55(lH, m), 5.03-4.92(2H, m), 4.58(2H, s), 419-405 (1H, m), 3.53-3.42(2H, m), 3.47(2H, q, J=7.0Hz), 2.19-2.17(3H, m), 1.38-1.82(2H, m)? 1.08(3H, t, J=7.0Hz)〇 窨腧例7 1 ( 2 ) H-羥基- 2(S) -甲基-5-乙氧基甲氧基-4(S)-[N-[4-(4-氰基笨基)笨羰基)胺基]戊釀胺
HO
(請先閱讀背面之注意事項再填寫本頁) ,«衣·
、1T 經濟部中央標準局員工消費合作社印製 ,och2ch3
CN TLC: Rf 0.48(氯仿:甲醇= 9:1); NMR (d6-DMS〇) : δ 10.37 (1H, s), 8.18 (1H, d, J=8.4Hz), 7.99-7.91 (6H, m), 7.83 (2H , d, J=8.2Hz), 4.58 (2H, s), 4.24-4.07 (1H, m), 3.54-3.41 (4H, m), 2.26- 2·10 (1H,m),1·74-1·62 (2H,m),U2-0.97 (6H,m)。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 455 310112 568897 A7 Η*7 五、發明説明( 456) [製劑例] 靱割例1 (請先閱讀背面之注意事項再填寫本頁) K下各成分依常法混合後打錠,製得100錠每錠含50 毫克活性成分之錠劑。 ♦卜羥基- 2(S)-甲基-5-乙氧基甲氧基-4(S)[N-(4-苯氧基 苯羰基)胺基]戊醯胺..............................5.0克 •羧甲基纖維素鈣(崩解劑)........................〇· 2克 •硬脂酸鎂(潤滑劑)..............................0.1克 ♦微晶纖維素....................................... 4.7克 靱割例2 Μ下各成份依常法混合後,溶液依常法滅菌,每5毫 升充填入安瓿中,依常法凍結乾燥,得100支每安瓿含20 毫克活性成分之安瓿。 • Ν-羥基- 2(S) -甲基-5-乙氧基甲氧基-4(S)-[N-(4-苯氧 基笨羰基)胺基]戊醯胺...........................2.0克 •甘露糖醇.............................................20克 •蒸餾水................................................500毫升 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 456 310112
Claims (9)
- 568897附件 2 經濟部中央標準局員工福利委員會印製 第87 1 1 6686號專利申請案 申請專利範圍修正本 (92年6月20日) 1. 一種一般式(I)所示之化合物、或其非毒性鹽: R2 R3R6 R7 〇 人 R9 ⑴ R4 R5 rS [K*,RW-COOR】0、-(CH2)mCONH〇m-(CH2)nSR50、 R1。示⑴氫原子、(ii)Cl〜6烷基或(iii)經選自苯基及甲氧 基之基所取代之C 1〜4烷基、 m示0、1或2之整數、 η示1、 R5Q示(i)氫原子或(Π)乙醯基、 R3、R5、R7示氣原子、 (1 ) R2、R4、R6各自獨立示 1) 氫原子、 2) C1〜6烷基、 3) C2〜6鏈烯基、
- 4) -OR1】、 5) 甲硫基、苯硫基或吡啶基硫基、 6) 經-OR111取代之C1〜2烷基、
- 7) -CH2-NR12R13、
- 8) -CH2C0〇-(Cl 〜4 烷基)、 9卜(CH2 ) q-Cycl 或 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 310112 568897 ---------H3 i〇)經苯基取代之C2〜6鏈烯基、或者 R2基與R4基共同形成-(CH2 ) s-,R4基與R6基共同形成 -(CH2) t -或R2基與R6基共同形成-(CH2) U-,或者 (2 ) R2示2-丙炔基, R4、R6各自獨立示: 1) 氫原子、 2) C1〜6烷基、 3) C2〜6鏈燒基、 4) -〇R〗i、 5) 甲硫基、苯硫基或吡啶基硫基、 6) 經-OR111取代之C1〜2烷基、
- 7) -CH2-NR12R13、
- 8) -CH2COO- ( Cl 〜4 烷基)、 9) - ( CH2 ) q-Cycl 或 10) 經苯基取代之C2〜6鏈烯基、或者 R4基與R6基共同形成-(CH2) t-; 上述各基中,R11示氫原子、乙醯基、-CH2OR15、-ch2_ COOH、-CH2-COOtBu 或-CH2-CONR20R2 丨、 經濟部中央標準局員工福利委員會印製 R15示甲基或苄基、 R2()及R21各自獨立示甲基、苯基或經苯基取代之Cl〜2 烷基、 R"】示 (a)氫原子、 (b ) C 1〜4烷基、 (c )可經甲氧基取代之苯基、 本紙張尺度適用中國國家標準(CNS) A4規格(210χ 297&ΐ3 \ 310112 568897 H3 經濟部中央標準局員工福利委員會印製 (d )琥珀醯亞胺基、 (e)苄基、 (f )噻吩基甲基、 (g) C2〜7醯基或 (h) - (C1〜2烷基)-0-W (基中W示可經選自苯基及 甲氧基之基所取代之C1〜4烷基)、 R12、Ri3各自獨立示氫原子或甲基、 q示1至4之整數、 Cycl 示 (1) 苯基、萘基、呋喃基、噻吩基、吡啶基、苯并呋喃 基、苯并噻吩基、吲哚基、喹啉基或苯并噻唑基、 (2) 經(Z1) r基所取代之苯基(基中,Z1示甲氧基、 硝基、鹵原子、羥基、胺基、苯并呋喃基或三氟甲氧基, r示1或2之整數)、 (3) 經甲基取代之吲哚基或 (4) 下式所示之基: 0 L (式中,X示NCH3或CH2,z2、Z3各自獨立示氫原子或 甲基)、 S示3或4之整數、 t示3或4之整數、 u示2之整數、 R8示氫原子或甲基、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 3 310112 568897 -- --- H3 __ R9示下式所示之基 (R25)P > 該環A示苯基、C3〜7環烷基 '環己烯基、金剛烷基、 呋喃基、噻吩基、吡咯基、吡啶基、哌啶基、1,3-二噻 烷、苯并呋喃基、吲哚基、苯并噻唑基或2-噁雙環[1,0, 4]庚基、 R25示 1) G] > 2) -CONH2、 3) -NHCO-G2 (基中,G2示可經甲基取代之苯基)、 4) -CO-〇-G3 (基中,G3示氫原子或甲基)、 5) -CO-G4(基中,G4示氫原子、甲基或苯基)、
- 6) -HC = CH-G5 (基中,G5示吡啶基或可經鹵原子取代之 苯基)、 7) -C = C-G6 (基中,G6示 經濟部中央標準局員工福利委員會印製 (a) 氫原子、 (b) C4〜6烷基、 (c) 鹵原子、 (d) 可經選自甲基及咪唑基之基所取代之苯基、 (e) 可經選自咪唑基及-OR35 (基中,OR35示氫原子、 甲基或可經鹵原子取代之苯基)之基所取代之C 1〜4烷 基)、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 4 310112 568897 H3 8) -S02-NH-G7 (基中,G7示可經鹵原子取代之苯基)、 或 9) 甲叉基、 G1示 1) 氫原子、 2) C1〜6烷基、 3) 環己基、萘基、呋喃基、吡咯基、苯并呋喃基、苯并 噻吩基或苯并喹唑基、 4) 經選自(i)Cl〜4烷基、(ii)Cl〜2烷氧基、(iii)鹵原 子、(iv)硝醯基、(v)羥基、(vi)苯氧基、(vii)-OCH2CONH2、 (viii)-CH2CN及(xi)苯基之基取代之苯基、 5) 經選自苯基及苯氧基之基所取代之哌啶基、 6) 經苯基取代之1,2,5,6-四氫吡啶基、
- 7) -OR 3 5 5、 8) 鹵原子、 9) 硝基、 10) 硝醯基、或
- 11) -NR36R37、 經濟部中央標準局員工福利委員會印製 R 3 5 5 示 (1 )氫原子、 (2 ) C 1〜4烷基、 (3 )苯基、 (4 )吡啶基、 (5)苄基或 (6 )經Z4基所取代之苯基(基中,Z4示羥基、甲氧基、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 5 310112 568897 經濟部中央標準局員工福利委員會印製 H3 _— 苯基或甲氧基所取代之苯基)、 R36示氫原子或甲基、 R37示氫原子或甲基、 P示1至4之整數, 爲單鍵,或當R2、R3、R4、R5、R6、中非結合在 同一碳原子之兩個相鄰基爲氫時,係代表其脫離後之雙 鍵,(但是,(1)當係示R2基與R4基共同形成CH2) s-, R4基與R6基共同形成-(CH2) t-或r2基與R6基共同形 成-(CH2 ) u- ( s、t、u係與前述記號具相同意義)時, 則不代表雙鍵,(2)而當環A爲苯環時,rm不爲氫 原子,(3) m 爲 1 或 2 時,- (CH2) mCONHOR1。中之 R1C 係氫原子’且R2、R3、R4、R5、R6、R7及R8爲氫原子, .......爲單鍵,且R9爲4-(苯并D夫喃-2_基)苯基)]。 2.如申請專利範圍第1項之化合物,其ψ R2、R4、R6係各自獨立示 1) 氫原子、 2) C1〜6烷基、 3) C2〜6鏈烯基、 4) -OR11、 5) 甲硫基、苯硫基或吡啶基硫基、 6) 經-OR111取代之C1〜2烷基、 7) -CH2-NR12R丨3、 8) -CH2COO- ( C1 〜4 烷基)、 9) - ( CH2) q-Cycl 或 10) 經苯基取代之C2〜6鏈烯基、或者 本紙張尺度適用中國國家標準(CNS) A4規格(210 X297公釐) 6 310112 568897 H3 經濟部中央標準局員工福利委員會印製 R2基與R4基共同形成-(CH2 ) s-,R4基與R6基共同形 成-(CH2) t_ 或R2基與R6基共同形成-(Ch2) u-者。 3 .如申請專利範圍第1項之化合物,其中 R2示2-丙炔基、R4、R6係各自獨立示 1) 氫原子、 2) C1〜6烷基、 3) C2〜6鏈烯基、 4) -0Rn、 5) 甲硫基、苯硫基或吡啶基硫基、 6) 經-OR111取代之C1〜2烷基、 7) -CH2-NR12R13、 8) -CH2COO- ( Cl 〜4 烷基)、 9) - ( CH2 ) q-Cycl 或 10) 經苯基取代之C2〜6鏈烯基、或者R4基與R6基共同 形成-(CH2) t-者。 4. 如申請專利範圍第1項之化合物,其中R1爲-COO R1()基 者。 5. 如申請專利範圍第1項之化合物,其中R1爲-CONHOR1Q基 者。 6. 如申請專利範圍第1項之化合物,其中R2、R4、R6係各自 獨立示 1) 氫原子、 2) C 1〜6烷基、 3) 經-OR111取代之C1〜2烷基或 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 7 310112 568897 經濟部中央標準局員工福利委員會印製 4) - ( CH2 ) q-Cycl 者。 7 .如申請專利範圍第2項之化合物,其中之化合物爲下列 化合物以及其甲酯、乙酯、第三丁酯或其無毒性之鹽 者: (1) 4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基)丁酸、 (2) 4-(N-(4-甲基苯基羰基)胺基)丁酸、 (3) 4-(N-(4-丁氧基苯基羰基)胺基)丁酸、 (4) 4-(N-(3-丁氧基苯基羰基)胺基)丁酸、 (5) 4-[Ν-[4·(2-(4-甲基苯基)乙炔基)呋喃-2-基羰基 ]胺基]丁酸、 (6) 4-(Ν-(4-(吡咯-1-基)苯基羰基)胺基)丁酸、 (7) 4-(Ν-(反-4-甲基環己基羰基)胺基)丁酸、 (8) 4-(Ν-(4-(3-甲氧基-1-丙炔基)苯基羰基)胺基)丁 酸、 (9) 4-(Ν-(4-丁基苯基羰基)胺基)丁酸、 (10) 4-(Ν-(苯并呋喃-2-基羰基)胺基)丁酸、 (11) 4-[Ν· [4-(2-(4-氯苯基)乙烯基)苯基羰基]胺基] 丁酸、 (12) 4-[N-[4-(2-(4-(咪唑-1-基)苯基)乙炔基)苯基 羰基]胺基]丁酸、 (13) 4-(N-(反-4-丙基環己基羰基)胺基)丁酸、 (14) 4-[N-[4-(2-(4-甲基苯基)乙炔基)苯基羰基]胺 基]丁酸、 (15) 4-[N-[4-((4-溴苯基)胺基磺醯基)苯基羰基]胺 基]丁酸、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 8 310112 568897 H3_ (16) 4-[N-(4-環己基苯基羰基)胺基]丁酸、 (17) 4-[N-[4-(4-丙基苯基)苯基羰基]胺基]丁酸、 (18) 心[N-[4-(4-羥基苯基)苯基羰基]胺基]丁酸、 (19) 4-[N-[4-(4-氯苯基)呋喃-2-基羰基]胺基]丁酸 (20) 4·[Ν-[4-(4-庚基苯基)苯基羰基]胺基]丁酸、 (21) 4-[Ν-[4-(4-甲氧基苯基)苯基羰基]胺基]丁酸、 (22) 4-[N-[4-(4-氯苯基)苯基羰基]胺基]丁酸、 (23) 4-[N-[5-苄氧基吲哚-2-基羰基]胺基]丁酸、 (24) 4-[N-[5-(2-(4-氯苯基)乙烯基)呋喃-2-基羰基] 胺基]丁酸、 (25) 4·[Ν-(4-苯氧基苯基羰基)胺基]丁酸、 (26) 4-(Ν-甲基-Ν-(4-(苯并呋喃-2-基)苯基羰基)胺 基)丁酸、 (27) 4-(Ν-(4-(苯并呋喃-2-基)苯基羰基)胺基)-2(S )-羥基丁酸、 (2 8) MN-(4-(苯并呋喃-2-基)苯基羰基)胺基)-2(R )-羥基丁酸、 經濟部中央標準局員工福利委員會印製 (29) 4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基)-2(S )-▼氧基甲氧基丁酸、 (3 0) 4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基)-2(R )-Τ基氧基甲氧基丁酸、 (31) 4-(N-(4-(2-(4-氯苯基)乙烯基)苯基羰基)胺基) -2(S)-T基氧基甲氧基丁酸、 (32) 4-(N-(4-氯苯基羰基)胺基)-2-苄基氧基甲氧基 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 9 310112 568897 ________H3 經濟部中央標準局員工福利委員會印製 丁酸、 (33) 4-(N-(4-氯苯基簾基)胺基)-2-((N -卞基-N-甲基 胺基)羰基甲氧基)丁酸、 (34) 4-(N-(4-氯苯基羰基)胺基)-2-((N-苯基-N-甲基 胺基)羰基甲氧基)丁酸、 (35) 4-(N-(4 -氯苯基鑛基)胺基)-2-((Ν·苯基乙基- N_ 甲基胺基)羰基甲氧基)丁酸、 (3 6) 3(S)-羥基-4-(Ν·(4-(苯并呋喃·2-基)苯基羰基) 胺基)丁酸、 (37) 3(R)-羥基-4-(Ν-(4-(苯并呋喃-2-基)苯基羰基) 胺基)丁酸、 (3 8) 3(S)-甲氧基甲基氧基-4-(Ν-(4-(苯并呋喃-2-基 )苯基羰基)胺基)丁酸、 (3 9) 4-(Ν-(4-(苯并呋喃-2-基)苯基羰基)胺基)-2-丁 酸、 (40) 3(R)-甲氧基甲基氧基-4-(Ν-(4·(苯并呋喃-2-基 )苯基羰基)胺基)丁酸、 (41) 4-(Ν-(4-(苯并呋喃-2-基)苯基羰基)胺基)-3·丁 酸、 (42) 2-苄基氧基甲基-4-(Ν-(4-甲基苯基羰基)胺基 )丁酸、 (46) 4(S)-(4-經丁基)胺基鑛基- 4- (Ν-(4 -甲基苯基 羰基)胺基)丁酸、 (47) 4(S)-甲氧基羰基-4-[Ν-[4-(4-羥基-1-丁炔基) 苯基羰基]胺基]丁酸、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 10 310112 568897 -________ H3 經濟部中央標準局員工福利委員會印制衣 (4 8) 4(S)-第三丁氧羰基-4-(N-(4-甲基苯基羰基)胺 基)丁酸、 (49) 4(S)-(嗎啉-卜基)羰基-4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基)丁酸、 (50) 4(S)-羥甲基-4-(N-(4-(苯并呋喃-2-基)苯基羰 基)胺基)丁酸、 (51) 4(S)-甲氧基甲基氧基甲基-4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基)丁酸、 (5 2) 2(S)-苄基-4(S)-甲氧基甲基氧基甲基·4-(Ν-(4 •(苯并呋喃-2-基)苯基羰基)胺基)丁酸、 (5 3) 2(S)-甲基-4(S)-甲氧基甲基氧基甲基-4-(Ν-(4 -(苯并呋喃-2_基)苯基羰基)胺基)丁酸、 (54) 2(S)-(3-苯基-2-丙烯基)-4(S)-甲氧基甲基氧基 甲基-4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基) 丁酸、 (55) 2(S)-(3-苯基丙基- 4(S)·甲氧基甲基氧基甲基-4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基)丁酸 (5 6) 2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-(4-氯苯 基羰基)胺基]戊酸、 (57) 2(S)-甲基-5-乙氧基甲氧基- 4(S)-[N-(4-硝基 苯基羰基)胺基]戊酸、 (5 8) 2(S)-甲基-5-乙氧基甲氧基-4(S)e[N-(心溴苯 基羰基)胺基]戊酸、 (59) 2(S)-烯丙基-5-乙氧基甲氧^4(S)-[N-(4·硝 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 11 310112 568897 ___^ 基苯基羰基)胺基]戊酸、 (60) 2(R)-甲氧基甲基-5-乙氧基甲氧基-4(S)-[N-(4 -硝基苯基羰基)胺基]戊酸、 (61) 2(R)-苄氧基甲基-5-乙氧基甲氧基-4(S)-[ + (4 -硝基苯基羰基)胺基]戊酸、 (62) 2(3)-甲基-5-(2-甲氧基乙氧基)甲氧基-4(~_[ N-(4-氰基苯基羰基)胺基]戊酸、 (63) 2(R)-(2-甲氧基乙氧基)甲基-5-乙氧基甲氧基 (S)-[N-(4-硝基苯基羰基)胺基]戊酸、 (65) 2(3)-烯丙基-5-(2-甲氧基乙氧基)甲氧基-4〇 •[N-(4-氰基苯基羰基)胺基]戊酸、 (66) 2(S)-甲氧基甲基- 5-(2-甲氧基乙氧基)甲氧基_4 (S)-[N-(4-氰基苯基羰基)胺基]戊酸、 (69) 2(R)-甲氧基甲基-5-乙氧基甲氧基-4(3)-[Ν·(4 •溴苯基羰基)胺基]戊酸、 (7 0) 2(R)-甲氧基甲基-5-乙氧基甲氧基-4(S)-[N-(4 -氯苯基羰基)胺基]戊酸、 經濟部中央標準局員工福利委員會印制衣 (7 1) 2(R)-T氧基甲基-5-(2-甲氧基乙氧基)甲氧基-4 (S)_[N-(4-氰基苯基羰基)胺基]戊酸、 (72) 2(R)-T氧基甲基-5-乙氧基甲氧基-4(SMM“4 -氯苯基羰基)胺基]戊酸、 (73) 2(R)-T氧基甲基-5-乙氧基甲氧基-4(S)-[M“4 -溴苯基羰基)胺基]戊酸、 (74) 2(S)-烯丙基-5-乙氧基甲氧基-4(S)-[N-(4-溴 苯基羰基)胺基]戊酸、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 12 310112 97 8 8 6 5 經濟部中央標準局員工福利委員會印製 H3__ (75) 2(S)-烯丙基-5-乙氧基甲氧基-4(S)-[N-(4-氯 苯基羰基)胺基]戊酸、 (76) 2(R)-(2-甲氧基乙氧基)甲基-5-乙氧基甲氧基-4 (S)-[N-(4-溴苯基羰基)胺基]戊酸、 (77) 2(11)-(2-甲氧基乙氧基)甲基-5-(2-甲氧基乙氧 基)甲氧基-4(S)-[N-(4-氰基苯基羰基)胺基]戊 酸、 (78) 2(R)-(2·甲氧基乙氧基)甲基-5-乙氧基甲氧基-4 (S)-[N-(4-氯苯基羰基)胺基]戊酸、 (80) 2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-甲基-N-( 4-溴苯基羰基)胺基]戊酸、 (81) 2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-甲基-N-( 4-硝基苯基羰基)胺基]戊酸、 (82) 2(S)-T基-4(S)-第三丁基二甲基矽烷基氧基甲 基- 4- (N-(4-(苯并咲喃-2-基)苯基鑛基)胺基) 丁酸、 (8 3) 2(R)-苄基-4(S)-羥基甲基-4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基)丁酸、 (84) 2(S)-T 基-4(S)-羥基甲基-4-(N-(4-(3-甲氧基 -1-丙炔基)苯基羰基)胺基)丁酸、 (85) 2(S)-T基氧基-3(S)-羥基-4-(N-(4-(3-甲氧基 -1-丙炔基)苯基羰基)胺基)丁酸、 (86) 2-T基氧基-4-(N-(4-(3-甲氧基-1-丙炔基)苯基 羰基)胺基)-2-丁酸、 (87) 順-1-殘甲基·2-(Ν-(4-(3 -甲氧基-1-丙快基)苯 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 13 310112 7 9 8 8 6 經濟部中央標準局員工福利委員會印製 ___Η3_ 基羰基)胺基)環戊烷、 (88)反-1-羧甲基-2-(N-(4-(3-甲氧基-卜丙炔基)苯 基羰基)胺基)環戊烷、 (8 9)反-3-(N-(4-(3-甲氧基-卜丙炔基)苯基羰基)胺 基)環戊酸、 (9 0)順-3-(N-(4-(3-甲氧基-卜丙炔基)苯基羰基)胺 基)環戊酸、 (91) 反- 2-(N-(4-(3-甲氧基-卜丙炔基)苯基羰基)胺 基甲基)環戊酸、 (92) 2(R)-烯丙基-5·乙氧基甲氧基-4(S)-[N-(4-苯 氧基苯基羰基)胺基]戊酸、 (93) 5-甲氧基-4(S)-[N-[4-(4-氯苯基)苯基羰基]胺 基]戊酸、 (94) 2(S)-甲基-5-琥珀醯亞胺基-4(S)-[N-(4-氯苯 基羰基)胺基]戊酸、 (9 5) 2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-(4-苯氧 基苯基羰基)胺基]戊酸、 (96) 2(S)-烯丙基-5-乙氧基甲氧基-4(S)-[N-(4-苯 氧基苯基羰基)胺基]戊酸、 (97) 2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-[4-(4-氰 基苯基)苯基羰基]胺基]戊酸。 8.如申請專利範圍第2項之化合物,其中之化合物爲下列 化合物或其無毒性之鹽者: (1) N-羥基- 4-(Ν·(4-苯并呋喃-2-基)苯基鑛基)胺基) 丁醯胺、 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 14 310112 568897 經濟部中央標準局員工福利委員會印製 H3_ (2) N_羥基-4-(N-(4-甲基苯基羰基)胺基)丁醯胺、 (3) N-羥基-4-(N-(4-丁氧基苯基羰基)胺基)丁醯胺、 (4) N-羥基_4-(N-(3-丁氧基苯基羰基)胺基)丁醯胺、 (5) N-羥基-4-[N-[4-((4-甲基苯基)乙炔基)呋喃-2-基羰基]胺基]丁醯胺、 (6) N-羥基-4-(N-(4-(吡咯-1-基)苯基羰基)胺基)丁醯 胺、 (7) N-羥基-4-(N-(反-4-甲基環己基羰基)胺基)丁醯 胺、 (8) N-羥基-4-(N-(4-(3-甲氧基-1-丙炔基)苯基羰基) 胺基)丁醯胺、 (9) N-羥基-4-[N-[4-丁基苯基羰基]胺基]丁醯胺、 (1〇)Ν-羥基-4-(N-(苯并呋喃-2-基羰基)胺基)丁醯胺、 (11 )N-羥基-4-[N-[4-(2-(4-氯苯基)乙烯基)苯基羰基 ]胺基]丁醯胺、 (12) 小羥基-4-[1[4-((4-(咪唑-1-基)苯基)乙炔基) 苯基羰基]胺基]丁醯胺、 (13) N-羥基-4-(N-(反-4-丙基環己基羰基)胺基)丁醯 胺、 (14) 1^羥基-4-[1^[4-((4-甲基苯基)乙炔基)苯基羰基 ]胺基]丁醯胺、 (15) N-羥基-4-[N-[4-((4-溴苯基)胺基磺醯基)苯基羰 基]胺基]丁醯胺、 (16) N-羥基- 4-[N-(4-環己基苯基羰基)胺基]丁醯胺、 (17) N-經基- 4-[N-[4-(4-丙基苯基)苯基羯基]胺基]丁 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 15 310112 568897 ______ H3 經濟部中央標準局員工福利委員會印製 醯胺、 (18) N-羥基-4-[N-[4-(4-羥基苯基)苯基羰基]胺基]丁 醯胺、 (19) N-羥基-4-[N-[4-(4-氯苯基)呋喃-2-基羰基]胺基 ]丁醯胺、 (20) N-羥基-4-[N-[4-(4-庚基苯基)苯基羰基]胺基]丁 醯胺、 (21) N-羥基-4·[Ν-[4-(4·甲氧基苯基)苯基羰基]胺基] 丁醯胺、 (22) Ν-羥基-4-[Ν-[4-(4-氯苯基)苯基羰基]胺基]丁醯 胺、 (23) Ν-羥基-4-[Ν-(5-苄氧基吲哚-2-基羰基)胺基] 丁醯胺、 (24) Ν-羥基-4-[Ν-[5-(2-(4-氯苯基)乙烯基)呋喃-2-基羰基]胺基]丁醯胺、 (25) Ν-羥基-4_[Ν-(4-苯氧基苯基羰基)胺基]丁醯胺、 (28) Ν-羥基-4-[N-[[(4l安基甲醯基甲氧基)聯苯-4-基]羰基]胺基]丁醯胺、 (29) Ν·羥基-4-[Ν-[4-(4-苯基哌啶-1-基)苯基羰基]胺 基]丁醯胺、 (30) Ν-羥基-4-[Ν-[4-[3-(4-氯苯氧基)-1-丙炔基]苯 基羰基]胺基]丁醯胺、 (3 1)N-羥基-4-[N-[4-(3-苯氧基小丙炔基)苯基羰基] 胺基]丁醯胺、 (32)N-羥基-4-[N-[4-(4-甲氧基苯氧基)苯基羰基]胺 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 16 310112 568897 經濟部中央標準局員工福利委員會印製 _____H3_ 基]丁醯胺、 (33) N-羥基-4-[N-[4-(4-羥基苯氧基)苯基羰基]胺基] 丁醯胺、 (34) N-羥基-4-[N-[4-(4-苯氧基哌啶-1-基)苯基羰基] 胺基]丁醯胺、 (3 5)卜羥基-4-[心[4-(4-苯基-1,2,5,6-四氫吡啶-1-基)苯基羰基]胺基]丁醯胺、 (3 6)N-羥基-4-[N·[4-(1-庚炔基)苯基羰基]胺基]丁醯 胺、 (37)N-羥基-4-[N“4-T氧基苯基羰基)胺基]丁醯胺、 (3 8)N-羥基-4-(N-甲基-N-(4-(苯并呋喃-2-基)苯基羰 基)胺基)丁醯胺、 (3 9)N-羥基-4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基 )-2(S)·羥基丁醯胺、 (40) N-羥基-4-(N-(4-(苯并呋喃-2·基)苯基羰基)胺基 )-2(R)-羥基丁醯胺、 (41) N-羥基苯并呋喃-2-基)苯基羰基)胺基 )-2(S)-T氧基甲氧基丁醯胺、 (42) N-羥基-4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基 )-2(R)-T氧基甲氧基丁醯胺、 (4 3)N-羥基-4-(N-(4-(2-(4-氯苯基)乙烯基)苯基羰基 )胺基)-2(S)-苄氧基甲氧基丁醯胺、 (44)N-羥基-4-(Ν-(4·氯苯基羰基)胺基)-2-苄氧基甲 氧基丁醯胺、 (4 5)小羥基-4-(心(4-氯苯基羰基)胺基)-2-((1苄基- 本紙張尺度適用中國國家標準(CNS) Α4規格(210x297公釐) 17 310112 568897 Η3 經濟部中央標準局員工福利委員會印製 N-甲基胺基)羰基甲氧基)丁醯胺、 (46) N-羥基4-(N-(4-氯苯基羰基)胺基)-2-((N-苯基-N -甲基胺基)羰基甲氧基)丁醯胺、 (47) N-羥基-4-(N-(4-氯苯基羰基)胺基)·2-((Ν-苯基 乙基-Ν-甲基胺基)羰基甲氧基)丁醯胺、 (48) Ν-羥基- 3(S)-羥基-4-(Ν-(4-(苯并呋喃-2-基)苯 基羰基)胺基)丁醯胺、 (49) Ν-羥基- 3(R)-羥基-4-(Ν-(4-(苯并呋喃-2-基)苯 基羰基)胺基)丁醯胺、 (50) Ν-羥基-3(S)-甲氧基甲基氧基-4-(Ν-(4·(苯并呋 喃-2-基)苯基羰基)胺基)丁醯胺、 (51) Ν·羥基-4-(Ν-(4-(苯并呋喃-2-基)苯基羰基)胺基 )-2-丁烯醯胺、 (5 2)N-羥基-3(R)-甲氧基甲基氧基-4-(N-(4-(苯并呋 喃-2_基)苯基羰基)胺基)丁醯胺、 (5 3)N-羥基-4·(Ν-(4-(苯并呋喃-2-基)苯基羰基)胺基 )-3-丁烯醯胺、 (5 4)N-羥基-4-[N-[4_(苯并呋喃-2-基)苯基羰基]胺基 ]-3(S)-苄氧基甲氧基丁醯胺\ (55)N-羥基-2-苄氧基甲基-4-(N-(4-甲基苯基羰基)胺 基)丁醯胺、 (5 6)N-羥基-2(RS)-羥基甲基-4-(N-(4-甲基苯基羰基) 胺基)丁醯胺、 (57)N-羥基-2(R)-羥基甲基甲基苯基羰基) 胺基)丁醯胺、 本紙張尺度適用中國國家標準(CNS) Α4規袼(210 Χ 297公楚、) 18 310112 568897 H3 經濟部中央標準局員工福利委員會印製 (5 8)N-羥基-2(S)-羥基甲基-4-(N-(4-甲基苯基羰基) 胺基)丁醯胺、 (63川-羥基-4(3)-甲氧基羰基-4-[1[4-(4-羥基-1-丁 炔基)苯基羰基]胺基]丁醯胺、 (64) N-羥基-4(R)_羰基-4-[N-[4-(3-甲氧基-卜丙炔基 )苯基羰基]胺基]丁醯胺、 (65) N -經基- 4(S) -殘基- 4- (Ν-(4·甲基苯基鑛基)胺基 )丁醯胺、 (67) Ν-羥基-4(S)-羥甲基-4-(Ν-(4-(苯并呋喃-2-基) 苯基羰基)胺基)丁醯胺、 (68) Ν-羥基-4(S)-甲氧基甲基氧基甲基-4-(Ν-(4-(苯 并D夫喃-2-基)苯基羰基)胺基)丁醯胺、 (69) Ν-羥基-2(S)-苄基-4(S)·甲氧基甲基氧基甲基· 4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基)丁醯胺 \ (7 0)N-羥基- 2(S)_甲基-4(S)_甲氧基甲基氧基甲基-4 _(N-(4-(苯并呋喃-2-基)苯基羰基)胺基)丁醯胺 (71) N-羥基- 2(S)-(3-苯基-2-丙烯基- 4(S)-甲氧基甲 基氧基甲基-4-(N-(4-(苯并呋喃-2-基)苯基羰基) 胺基)丁醯胺、 (72) N-羥基- 2(S)-(3-苯基丙基)_4(s)-甲氧基甲基氧 基甲基_4-(N-(4-(苯并呋喃-2-基)苯基羰基)胺基 )丁醯胺、 (7 3)N-羥基-2(R)-〒基-4(S)·羥基甲基-4-(N-(4-(苯 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 19 310112 568897 H3 經濟部中央標準局員工福利委員會印製 并呋喃-2-基)苯基羰基)胺基)丁醯胺、 (74)Ν-羥基-2(S)-苄基-4(S)-羥基甲基-4-(Ν-(4-(3-甲氧基-1-丙炔基)苯基羰基)胺基)丁醯胺、 (7 5)Ν-羥基-5-羥基-4(S)-[N-[4-(3-甲氧基-卜丙炔基 )苯基羰基]胺基]戊醯胺、 (7 6)小羥基-5-羥基-4(1〇-[1^[4-(3-甲氧基-卜丙炔 基)苯基羰基]胺基]戊醯胺、 (90) N-羥基-5-甲氧基甲氧基-4(3)-[屮[4-(3-甲氧基 -1-丙炔基)苯基羰基]胺基]戊醯胺、 (91) N-羥基-5-苄氧基甲氧基-4(S)-[N-[4-(3-甲氧基 -1-丙炔基)苯基羰基]胺基]戊醯胺、 (92) N-羥基-5-(2-甲氧基乙氧基)甲氧基-4(S)-[N-[4- (3-苯氧基-1-丙炔基)苯基羰基]胺基]戊醯胺、 (93) N -經基-5-甲氧基甲氧基- 4(S)-[N-[4-(3 -苯氧基 -1-丙炔基)苯基羰基]胺基]戊醯胺、 (94) N-羥基-5-苄氧基甲氧基一^-…-^-^-苯氧基 -1-丙炔基)苯基羰基]胺基]戊醯胺、 (95) N -羥基-5-甲氧基甲氧基- 4(S)-[N-(4-苯氧基苯 基羰基)胺基]戊醯胺、 (96) 心羥基-5-甲氧基甲氧基-4(3)-[『[4-(4-氯苯基 )苯基羰基]胺基]戊醯胺、 (97) N-羥基-5-甲氧基甲氧基-4(S)-[N-[4-[2-(4·甲 基苯基)乙炔基]苯基羰基]胺基]戊醯胺、 (98) N -經基-5-甲氧基甲氧基- 4(S)-[N-[4-[2E-(4 -氯 苯基)乙烯基]苯基羰基]胺基]戊醯胺、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公f ) 310112 568897 H3 (99)N-羥基-5-甲氧基甲氧基-4(S)-[N-[4-(卜庚炔基 )苯基羰基]胺基]戊醯胺、 (100) N-羥基-5-乙氧基甲氧基-4(S)-[N-[4-苯氧基苯 基羰基]胺基]戊醯胺、 (101) N-羥基-5-乙氧基甲氧基-4(S)-[N-(4-甲基苯基 幾基)胺基]戊醯胺、 (102) N-羥基·5-甲氧基甲氧基-4(ΙΙ)-[Ν-[4·(3-甲氧基 -1-丙炔基)苯基羰基]胺基]戊醯胺、 (103) Ν-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 咪唑基苯基)乙炔基]苯基羰基]胺基]戊醯 胺、 (104) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(4-苯基-1,2,5,6-四氫吡啶-1-基)苯基羰基]胺 基]戊醯胺、 (105) N·羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-(4 -苯氧基苯基羰基)胺基]戊醯胺、 (106) N-羥基-2(S)·甲基-5-甲氧基甲氧基-4(S)-[N-[4 氯苯基)乙烯基]苯基羰基]胺基]戊醯胺、 經濟部中央標準局員工福利委員會印製 (107) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(SMN-[4 -(4-丙基苯基)苯基羰基]胺基]戊醯胺、 (108) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(苯并噻吩-2-基)苯基羰基]胺基]戊醯胺' (109) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(3-甲氧基苯氧基)苯基羰基]胺基]戊醯胺、 (110) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 21 310112 568897 ______ H3 經濟部中央標準局員工福利委員會印製 -(4-甲氧基苯氧基)苯基羰基]胺基]戊醯胺、 (111) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-(4 •苯醯基苯基羰基)胺基]戊醯胺、 (112) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(萘-2-基)苯基羰基]胺基]戊醯胺、 (113) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -[(4-甲氧基聯苯-4··基)氧基]苯基羰基]胺基]戊 醯胺、 (114) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(4-乙氧基苯基)苯基羰基]胺基]戊醯胺、 (115) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(4-苯氧基苯基)苯基羰基]胺基]戊醯胺、 (116) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(3-氰甲基苯基)苯基羰基]胺基]戊醯胺、 (117) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(聯苯-4-基)苯基羰基]胺基]戊醯胺、 (118) N-羥基-2(S)·甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(3-羥基苯氧基)苯基羰基]胺基]戊醯胺、 (119) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -[2-(4-甲基苯基)乙炔基]苯基羰基]胺基]戊醯 胺、 (120) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(4-羥基苯氧基)苯基羰基]胺基]戊醯胺' (121) N-羥基-2(S)·甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(4-氯苯基)苯基羰基]胺基]戊醯胺、 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 22 310112 568897 _ H3 經濟部中央標準局員工福利委員會印製 (122) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[[ 5-(4-甲氧基苯基)-2-噻吩基]羰基]胺基]戊醯胺 、 (123) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -[(聯苯-3-基)氧基]苯基羰基]胺基]戊醯胺、 (124) N-羥基- 2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(1-庚炔基)苯基羰基]胺基]戊醯胺、 (125) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(3-苯氧基-1-丙炔基)苯基羰基]胺基]戊醯胺、 (126) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(4-氰苯基)苯基羰基]胺基]戊醯胺、 (127) N-羥基-2(S)·甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(3-氰苯基)苯基羰基]胺基]戊醯胺、 (128) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-(4 -苄基苯基羰基)胺基]戊醯胺、 (129) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -[2E-(吡啶-4-基)乙烯基]苯基羰基]胺基]戊醯胺 \ (130) N·羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(苯并噚唑-2-基)苯基羰基]胺基]戊醯胺、 (131) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 _(3_乙氧基苯基)苯基羰基]胺基]戊醯胺、 (132) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[4 -(4-甲基苯基羰基胺基)苯基羰基]胺基]戊醯胺、 (133) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-[[ 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 23 310112 568897 H3 5-[2-(4-甲基苯基)乙炔基]-2-噻吩基]羰基]胺基 ]戊醯胺、 (134) N-羥基-2(S)-甲基-5-(2·甲氧基乙氧基)甲氧基-4(S)-[N-(4-苯氧基苯基羰基)胺基]戊醯胺、 (135) N-羥基-2(S)-甲基-5-第三丁基羰基氧基-4(S)-[ N-(4-苯氧基苯基羰基)胺基]戊醯胺、 (136) N-羥基-2(S)-甲基-5-〒氧基甲氧基-4(S)-[N-(4 -苯氧基苯基羰基)胺基]戊醯胺、 (137) N-羥基-2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-( 反-4-甲基環己基羰基)胺基]戊醯胺、 (138) N·羥基-2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-(4 -甲基苯基羰基)胺基]戊醯胺、 (139) N·羥基-2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-(4 -氯苯基羰基)胺基]戊醯胺、 (140) N -經基- 2(S) -甲基-5-乙氧基甲氧基- 4(S)-[N ( 金鋼烷基羰基)胺基]戊醯胺、 (141) N-羥基-2(S)-甲基-5-乙氧基甲氧基-4(3)·[Ι^·( 2-呋喃基羰基)胺基]戊醯胺、 經濟部中夬標準局員工福利委員會印製 (142) Ν-羥基-2(S)-甲基-5-乙氧基甲氧基-4(3)_[Ν·[( 苯并噻唑基)羰基]胺基]戊醯胺、 (143) Ν-羥基-2(S)-甲基-5-乙氧基甲氧基 -氟苯基羰基)胺基]戊醯胺、 (144) N-羥基-2(S)-甲基-5-乙氧基甲氧基-4(δ)-[Ν-[( 2-溴呋喃-5-基)羰基]胺基]戊醯胺、 (145) Ν-羥基-2(S)-甲基-5-乙氧基甲氧基 本紙張尺度適用中國國家標準(CNS) Α4規格(210 Χ 297公釐) 24 310112 568897-硝基苯基羰基)胺基]戊醯胺、 (146) N-羥基- 2(S)-甲基-5-乙氧基甲氧基-4(S)-[N_(4 -溴苯基羰基)胺基]戊醯胺、 (147) N-羥基-2(S)-甲基-5-乙氧基甲氧基-4(S)-[N^4 -氰苯基羰基)胺基]戊醯胺、 (148) N-羥基-2(S)·甲基-5-乙氧基甲氧基-4(S)-[N-[4 -(4-吡啶基氧基)苯基羰基]胺基]戊醯胺' (149) N-羥基- 2(S)-甲基-5-(2-甲氧基乙氧基)甲氧基· 4(S)-[N-(4-氰苯基羰基)胺基]戊醯胺、 (150) N-羥基-2(S)-甲基-5-甲氧基甲氧基-4(S)-[N-(4 -氯苯基羰基)胺基]戊醯胺、 (151) N-羥基-2(S)-甲基-5-苄氧基甲氧基-4(S)-[N-(4 -氯苯基羰基)胺基]戊醯胺、 (152) N-羥基-2(S)-甲基-5-(2·甲氧基乙氧基)甲氧基· 4(S)-[N-(4-氯苯基羰基)胺基]戊醯胺、 (153) N-羥基-2(S)-甲基-5-乙氧基甲氧基-4(SMN-(2 -硝苯基羰基)胺基]戊醯胺、 (154) N-羥基-2(S)-甲基-5-乙氧基甲氧基 經濟部中央標準局員工福利委員會印製 -硝苯基羰基)胺基]戊醯胺、 (155) Ν-羥基-2(S)-甲基-5-乙氧基甲氧基-4(3卜[〜(2 -甲氧基-4-硝苯基羰基)胺基]戊醯胺、 (156) N-羥基-2(S)-甲基-5-乙氧基甲氧基-4(SMN_(3 -甲氧基-4-硝苯基羰基)胺基]戊醯胺、 (157) N-羥基-2(S)-甲基-5-乙氧基甲氧基 -羥基-4-硝苯基羰基)胺基]戊醯胺、 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 25 310112 7 ^ 9 8 8 6 Ml (158) N-羥基-2(S)-甲基-5·乙氧基甲氧基-4(3)_[^(4 -二羥基冰片基苯基羰基)胺基]戊醯胺' (159) Ν-羥基-2(S)-異丁基-5-甲氧基甲氧基-4(SMN_ (4-苯氧基苯基羰基)胺基]戊醯胺、 (160) N-羥基-2(S)-乙基-5-甲氧基甲氧基-4(3)-[Ν_(4 -苯氧基苯基羰基)胺基]戊醯胺、 (161) Ν-羥基-2(S)-丙基-5-甲氧基甲氧基-4(S)-[…(4 -苯氧基苯基羰基)胺基]戊醯胺、 (162) N-羥基-2(R)-第三丁氧羰基甲基-5-甲氧基甲氧1@ -4(S)-[N-(4·苯氧基苯基羰基)胺基]戊醯肢' (163) N-羥基-2(S)-烯丙基-5·甲氧基甲氧基+ (4-苯氧基苯基羰基)胺基]戊醯胺、 (164) N-羥基- 2(S)-乙基-5-乙氧基甲氧基-4(S)-[N、4 -苯氧基苯基羰基)胺基]戊醯胺、 (165) N-羥基-2(S)-乙基-5-(2-甲氧基乙氧基)甲氧基· 4(S)-[N-(4-苯氧基苯基羰基)胺基]戊醯胺' (166) N-羥基-2(S)-乙基-5-第三丁基羰基氧基 Ν-(4-苯氧基苯基羰基)胺基]戊醯胺、 經濟部中央標準局員工福利委員會印製 (167) Ν-羥基-2(S)·烯丙基-5-乙氧基甲氧基·4θ)-β· (4-甲基苯基羰基)胺基]戊醯胺、 (168) Ν-羥基- 2(S)-烯丙基-5-乙氧基甲氧基-4(SM& (4-硝基苯基羰基)胺基]戊醯胺、 (171) N-羥基- 2(S)·烯丙基-5-(2-甲氧基乙氧基)甲氧基 4(S)-[N-(4-氰苯基羰基)胺基]戊醯胺、 (174) N-羥基-2(S)-烯丙基-5-乙氧基甲氧基-4(S)-[N_ 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 568897 H3___^ (4-溴苯基羰基)胺基]戊醯胺、 (175) N-羥基-2(S)-烯丙基-5-乙氧基甲氧基-4(S)-[N-(4-氯苯基羰基)胺基]戊醯胺、 (176) N-羥基-2(R)-二甲基胺基甲基-5-乙氧基甲氧基-4(S)-[N-(4-硝基苯基羰基)胺基]戊醯胺、 (17 8) N-羥基- 2(R)-苄基-5-甲氧基甲氧基-4(R)-[N-(4 -苯氧基苯基羰基)胺基]戊醯胺、 (179) N-羥基-2(R)-苄基-5-甲氧基甲氧基-4(R)-[N-[4 -(3-苯氧基-1-丙炔基)苯基羰基]胺基]戊醯胺、 (1.80) N-羥基-2(R)-甲基-5-乙氧基甲氧基-4(R)-[N-[4 -(4-氰苯基)苯基羰基]胺基]戊醯胺、 (181) N-羥基-2(R)-烯丙基-5-乙氧基甲氧基-4(R)-[N- (4-苯氧基苯基羰基)胺基]戊醯胺、 (182) N-羥基-2(R)-甲基-5-乙氧基甲氧基-4(R)-[N-(4 -苯氧基苯基羰基)胺基]戊醯胺、 (183) N-羥基-2(S)-苄基-5-甲氧基甲氧基-4(SMN-[4 -[2E-(4_氯苯基)乙烯基]苯基羰基]胺基]戊醯胺 經濟部中央標準局員工福利委員會印製 (184) N-羥基-2(S)-(卩引哚-3-基)-5-甲氧基甲氧基-4(S) -[N-[4-(苯并呋喃-2-基)苯基羰基]胺基]戊醯胺 (185) N-羥基-2(S)-苄基-5-甲氧基甲氧基-4(S)-[N-[4-[3_(4_氯苯氧基-丨-丙炔基)苯基]羰基]胺基]戊醯 胺、 (186) N-羥基-2(S)-T基-5·甲氧基甲氧基-4(SMN-(4 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 27 310112 568897 H3 經濟部中央標準局員工福利委員會印製 -苯氧基苯基羰基)胺基]戊醯胺、 (187) N-羥基-2(S)-苄基-5-甲氧基甲氧基-4(S)-[N-[4 -(4-苯基哌啶-1-基)苯基羰基]胺基]戊醯胺、 (188) N-羥基-2(S)-苄基-5-甲氧基甲氧基-4(S)-[N-[4 -(6-咪唑基-1-己炔基)苯基羰基]胺基]戊醯胺、 (189) N-羥基- 2(S)-(萘-卜基)-5_甲氧基甲氧基-4(S)-[N-(4-苯氧基苯基羰基)胺基]戊醯胺、 (190) N-羥基-2(SM4-(苯并呋喃-2-基)T基]-5-甲氧_ 甲氧基-4(S)-[N-(4-碘苯基羰基)胺基]戊醯胺、 (191) N-羥基- 2(S)-T基-5-乙氧基甲氧基-4(S)-[N-( 反-4-甲基環己基羰基)胺基]戊醯胺、 (192) N-羥基-2(S)-(4-硝基苄基)-5-乙氧基甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (193) N-羥基-2(S)-(D引哚-3-基)-5-乙氧基甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (194) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[( 吡啶-4-基)羰基]胺基]戊醯胺、 (195) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4 -羥基苯基羰基)胺基]戊醯胺、 (196) N·羥基- 2(S)-(2-硝基苄基)-5-乙氧基甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (197) N-羥基-2(S)-(3-硝基〒基)-5-乙氧基甲氧基-4(S)-[N-(反甲基環己基羰基)胺基]戊醯胺、 (198) N·羥基-2(S)-〒基-5-乙氧基甲氧基-4(S)-[N-[( 1-甲基吡咯-2-基)羰基]胺基]戊醯胺、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 28 31〇1!2 568897 H3 (200) N-羥基-2(S)-T 基-5-乙氧基甲氧基-4(3)-[Ν·(4 •乙基苯基羰基)胺基]戊醯胺、 (201) Ν-羥基- 2(S)-T 基-5-乙氧基甲氧基- 4(S)-[N-(4 -甲基苯基羰基)胺基]戊醯胺、 (202) N-羥基-2(S)-T基-5-乙氧基甲氧基-4(3)-[Ν·(4 -硝基苯基羰基)胺基]戊醯胺、 (203) Ν-羥基-2(S)-苄基-5-乙氧基甲氧基-4(3)-[Ν·(2 ,2,3,3-四甲基環丙基羰基)胺基]戊醯胺' (204) Ν-羥基-2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基-4(S)-[N-(4-甲基苯基羰基)胺基]戊醯胺' (205) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[fM 1-環己烯基羰基)胺基]戊醯胺、 (206) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[( 1-環己烯-4-基)羰基]胺基]戊醯胺、 (207) N-羥基-2(S)-T 基-5·乙氧基甲氧基-4(S)-[N_(4 -二甲基胺基苯基羰基)胺基]戊醯胺、 (208) N-羥基-2(S)-T 基-5-乙氧基甲氧基 •胺基甲醯基苯基羰基)胺基]戊醯胺、 經濟部中央標準局員工福利委員會印製 (209) N-羥基-2(S)-苄基-5·乙氧基甲氧基-4(S)-[…(4 -甲氧基羰基苯基羰基)胺基]戊醯胺、 (210) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[…(4 -環戊基羰基)胺基]戊醯胺、 (211) N-羥基-2(S)-(萘-2-基)-5-乙氧基甲氧基 [Ν·(反-4-甲基環己基羰基)胺基]戊醯胺' (213) Ν-羥基-2(S)-T 基-5-乙氧基甲氧基 本紙張尺度適用中國國家標準(CNS) Α4規格(210 x 297公釐) 29 31〇!12 568897 H3 -碘苯基羰基)胺基]戊醯胺、 (214) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[4 -(2-碘乙炔基)苯基羰基]胺基]戊醯胺、 (215) N-羥基-2(S)-T 基-5-乙氧基甲氧基-4(S)-[N-(4 -環庚基羰基)胺基]戊醯胺、 (216) N-羥基-2(S)·苄基-5-乙氧基甲氧基-4(S)-[N-(2 -噻吩基羰基)胺基]戊醯胺、 (217) N-羥基-2(R)-(3,4,4-三甲基_2,5_二氧代咪卩坐啶- 1- 基)甲基-5-乙氧基甲氧基-4(S)-[N-(4-甲基苯 基羰基)胺基]戊醯胺、 (218) N-羥基-2(S)-T 基-5-乙氧基甲氧基-4(S)-[N-[( 2- 溴-5-噻吩基)羰基]胺基]戊醯胺、 (219) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4 -溴苯基羰基)胺基]戊醯胺、 (220) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4 -羥甲基苯基羰基)胺基]戊醯胺、 (221) N-羥基-2(S)-(苯并噻吩-3-基)-5-乙氧基甲氧基· 4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 經濟部中央標準局員工福利委員會印製 (222) N-羥基-2(S)-T基-5-乙氧基甲氧基-4(S)-[N-(4 -氰苯基羰基)胺基]戊醯胺、 (223) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[( 1-乙醯基哌啶-4-基)羰基]胺基]戊醯胺、 (224) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[( 1-甲基哌啶-4-基)羰基]胺基]戊醯胺、 (225) N-羥基-2(S)-T基-5-乙氧基甲氧基-4(S)-[N-(4 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 30 310112 568897 H3 經濟部中央標準局員工福利委員會印製 -甲醯基苯基羰基)胺基]戊醯胺、 (226) N-羥基-2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基-4(S)-[N-(4-硝苯基羰基)胺基]戊醯胺、 (227) N-羥基-2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基-4(SMN-(4-氯苯基羰基)胺基]戊醯胺、 (22 8) N-羥基-2(S)-(4-甲氧基T基)-5-乙氧基甲氧基-4(S)-[N-(4-甲基苯基羰基)胺基]戊醯胺、 (229) N-羥基-2(S)-(2-甲氧基T基)-5·乙氧基甲氧基-4(SMN-(4-甲基苯基羰基)胺基]戊醯胺、 (230) N·羥基-2(S)-(萘-1-基)甲基-5-乙氧基甲氧基 -4(S)-[N-(4-甲基苯基羰基)胺基]戊醯胺、 (231) N-羥基-2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (232) N-羥基- 2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4 -甲氧基環己基羰基)胺基]戊醯胺、 (23 3) N-羥基-2(S)-(苯并噻吩-3-基)甲基-5-乙氧基甲 氧基-4(S)-[N-(4-氯苯基羰基)胺基]戊醯胺、 (234) N-羥基-2(S)-(苯并噻吩-3-基)甲基-5-乙氧基甲 氧基-4(S)-[N-(4-氯苯基羰基)胺基]戊醯胺、 (23 5 ) N·羥基-2(S)-T 基-5-乙氧基甲氧基-4(S)-[N-[( 2-氯吡啶-5·基)羰基]胺基]戊醯胺、 (23 6) N-羥基-2(S)-(3,5-二甲氧基T基)-5-乙氧基甲 氧基-4(S)-[N-(4-甲基苯基羰基)胺基]戊醯胺、 (23 7) N-羥基-2(S)-T 基-5-乙氧基甲氧基-4(S)-[N-(4 -甲基環己基羰基)胺基]戊醯胺、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 31 310112 568897 經濟部中央標準局員工福利委員會印製 ___H3_ (238) N-羥基-2(S)-(3-甲氧基T基)-5-乙氧基甲氧基-4(S)-[N-(4-氰苯基羰基)胺基]戊醯胺、 (23 9) N-羥基-2(RM3,4,4-三甲基-2,5-二氧代咪唑啶-1-基)甲基-5-乙氧基甲氧基-4(S)-[N-(反-4-甲 基環己基羰基)胺基]戊醯胺、 (240) N·羥基-2(R)-(苯并呋喃-2-基)甲基-5-乙氧基甲 氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊 醯胺、 (24 1) N-羥基-2(R)-(苯并噻吩-3-基)甲基-5-乙氧基甲 氧基_4(S)-[N-(4-硝基苯基羰基)胺基]戊醯胺、 (242) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4 -氰基苯基羰基)胺基]戊醯胺、 (24 3) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4 -亞甲基環己基羰基)胺基]戊醯胺、 (244) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[( 1_甲醯基哌啶-4-基)羰基]胺基]戊醯胺、 (245) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[( 1-甲基-1-環己烯-4-基)羰基]胺基]戊醯胺、 (246) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[( 4-甲基-1-環己烯基)羰基]胺基]戊醯肢、 (247) N-羥基-2(S)-T 基·5-乙氧基甲氧基-4(S)-[N-(4 -氟苯基羰基)胺基]戊醯胺、 (248) N-羥基-2(S)-苄基-5·乙氧基甲氧基-4(3)-[Ν·(4 -氯苯基羰基)胺基]戊醯胺、 (249) Ν-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 32 310112 一 * 568897 ________H3_ -羥基環己基羰基)胺基]戊醯胺、 (25 0) N-羥基-2(S)-(苯并呋喃-3-基)甲基-5-乙氧基甲 氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊 醯胺、 (251) N-羥基-2(S)-(3-甲氧基T基)-5-乙氧基甲氧基·4 (S)-[N-(4-三氟甲基苯基羰基)胺基]戊醯胺、 (25 2) N-羥基-2(SM1-甲基吲哚-3-基)甲基-5-(2-甲氧 基乙氧基)甲氧基-4(S)-[N-(反-4-甲基環己基羰 基)胺基]戊醯胺、 (25 3) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[( 1,3-二噻烷-2基)羰基]胺基]戊醯胺、 (254) N-羥基-2(S)-(3-甲氧苄基)-5-乙氧基甲氧基-4(S)-[N-(4-溴苯基羰基)胺基]戊醯胺、 (25 5) N-羥基-2(S)-(3-甲氧基苄基)-5-乙氧基甲氧基-4(S)-[N-[(2-溴噻吩-5-基)羰基]胺基]戊醯胺、 (25 6) N-羥基-2(S)-(2-甲氧基苄基)-5-乙氧基甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (257) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-[( 經濟部中央標準局員工福利委員會印製 2-甲基吡啶-5·基)羰基]胺基]戊醯胺、 (25 8) N-羥基-2(S)-(苯并呋喃-3-基)甲基-5-乙氧基甲 氧基-4(S)-[N-(4-硝基苯基羰基)胺基]戊醯胺、 (25 9) N-羥基-2(S)-T基-5-乙氧基甲氧基-4(S)-[N-( 反-4-羥基環己基羰基)胺基]戊醯胺、 (260) N-羥基_2(S)-(3-氯苄基)-5-乙氧基甲氧基-4(S) -[N-(4-甲基苯基羰基)胺基]戊醯胺、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 33 3i〇ll2 經濟部中央標準局員工福利委員會印製 ____H3_ (261) N-羥基-2(S)-T 基-5-乙氧基甲氧基-4(S)-[N-[( 2-羥基吡啶-5-基)羰基]胺基]戊醯胺、 (262) 1羥基-2(1〇-(3,4,4-三甲基-2,5-二氧代咪唑啶-1-基)甲基-5-乙氧基甲氧基-4(S)-[N-(4-溴苯基 羰基)胺基]戊醯胺、 (264) N-羥基-2 (S M3-三氟甲基氧基T基)-5-乙氧基甲 氧基-4(SMN-(4-氯苯基羰基)胺基]戊醯胺、 (265) N-羥基-2(S)-(3-甲氧基苄基卜5-乙氧基甲氧基-4(S)-[N-[2-硝基噻吩-5-基羰基]胺基]戊醯胺、 (266) N-羥基- 2(R)-(苯并三唑-1-基)甲基-5-乙氧基甲 氧基-4(SMN-(4-硝基苯基羰基)胺基]戊醯胺、 (267) 1羥基-2(!〇-(3,4,4-三甲基-2,5-二氧代咪唑啶-1-基)甲基-5-乙氧基甲氧基-4(S)-[N-(4·硝基苯 基羰基)胺基]戊醯胺、 (26 8)1羥基-2(尺)-(3,4,4-三甲基-2,5-二氧代咪唑啶-1-基)甲基-5-乙氧基甲氧基-4(3)-^-(4-氯苯基 羰基)胺基]戊醯胺、 (269) N-羥基-2(S)-(3-苯基丙基)-5-甲氧基甲氧基-4(S)-[N-(4_,氧基苯基羰基)胺基]戊醯胺、 (270) 屮羥基-2(3)-(3-苯基丙基)-5-甲氧基甲氧基-4(3)-[1^[4-[2£-(4-氯苯基)乙烯基]苯基羰基]胺 基]戊醯胺、 (271) N-羥基-2(S)-(3-苯基丙基)-5-甲氧基甲氧基-4(3)-[1[4-(4-苯基-1,2,5,6-四氫吡啶-1-基)苯 基羰基]胺基]戊醯胺、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 34 310112 568897 經濟部中央標準局員工福利委員會印製 H3_ (272) N-羥基-2(S)-(3-苯基-2-丙烯基)-5-乙氧基甲氧 基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯 胺、 (273) N-羥基-2(S)-(3-苯基丙基)-5-乙氧基甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (274) N-羥基-2(S)-(3-苯基乙基)-5-(2-甲氧基乙氧基 )甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基] 戊醯胺、 (27 5) N-羥基-2(S)-(4·苯基丁基)-5-(2-甲氧基乙氧基) 甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基] 戊醯胺、 (276) N-羥基-2(S)-(3-苯基丙基)-5-乙氧基甲氧基-4(S)-[N-(4-溴苯基羰基)胺基]戊醯胺、 (277) N-羥基-2(S)-(3-苯基丙基)-5-乙氧基甲氧基-4(S)-[N-(4-硝基苯基羰基)胺基]戊醯胺、 (27 8) N-羥基-2(R)-(2-苯氧基乙基)-5-乙氧基甲氧基-4(S)-[N-(4-硝基苯基羰基)胺基]戊醯胺、 (27 9) N-羥基-2(R)-(2-吡啶基)甲基-5-甲氧基甲氧基-4 (S)-[N-(4-苯氧基苯基羰基)胺基]戊醯胺、 (2 80) N-羥基-2(R)-(2-吡啶基)甲基-5-甲氧基甲氧基-4(SMN-[4-(苯并呋喃-2-基)苯基羰基]胺基]戊醯 胺、 (281) N-羥基-2(S)-(3-吡啶基)甲基-5-甲氧基甲氧基-4 (S)-[N-(4-苯氧基苯基羰基)胺基]戊醯胺、 (282) N-羥基-2(S)-(3-吡啶基)甲基-5-甲氧基甲氧基-4 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 35 310112 568897 ______H3_ (S)-[N-[4-[2-(4-甲基苯基)乙炔基]苯基羰基]胺 基]戊醯胺、 (283) N-羥基-2(S)-(3-吡啶基)甲基-5-甲氧基甲氧基-4 (S)-[N-[4-(卜庚炔基)苯基羰基]胺基]戊醯胺、 (284) N-羥基-2(S)-(3-吡啶基)甲基-5-甲氧基甲氧基-4 (S)-[N-[4-[2E-(4-氯苯基)乙烯基]苯基羰基]胺 基]戊醯胺、 (285) N-羥基-2(S)-(3-吡啶基)甲基-5-甲氧基甲氧基-4 (S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (286) N-羥基-2(S)-(4-吡啶基)甲基-5-甲氧基甲氧基-4 (S)-[N-(4-苯氧基苯基羰基)胺基]戊醯胺、 (28 7) N-羥基-2(R)-(2-吡啶基)甲基-5-(2-甲氧基乙氧 基)甲氧基-4(S)-[N-(4-苯氧基苯基羰基)胺基] 戊醯胺、 (288) N -經基- 2(S)-(3 -卩比卩定基)甲基-5-乙氧基甲氧基_ 4(S)-[N-(2-甲基苯基羰基)胺基]戊醯胺、 (2 8 9) N-羥基-2(S)-(3-吡啶基)甲基-5-乙氧基甲氧基-4(S)-[N-(3-甲基苯基羰基)胺基]戊醯胺、 經濟部中央標準局員工福利委員會印製 (290) N-羥基-2(S)-(3-吡啶基)甲基-5-乙氧基甲氧基-4(SMN-(4-甲基苯基羰基)胺基]戊醯胺、 (291) N-羥基-2(S)-(3-吡啶基)甲基-5·乙氧基甲氧基· 4(S)-[N-(4-甲氧基苯基羰基)胺基]戊醯胺、 (292) N-羥基-2(S)-(3-吡啶基)甲基-5-乙氧基甲氧基· 4(S)-(N-環己基羰基胺基)戊醯胺、 (293) N-羥基-2(S)-(3 =吡啶基)甲基-5-乙氧基甲氧基- 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 36 310112 568897 H3__ 4(S)-[N-(4-硝基苯基羰基)胺基]戊醯胺、 (294) N-羥基-2(S)-(3-吡啶基)甲基-5-乙氧基甲氧基_ 4(S)-[N-(4-溴苯基羰基)胺基]戊醯胺、 (295) N-羥基-2(SM3-喹啉基)甲基-5-乙氧基甲氧基· 4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (296) N-羥基-2(S)-苯硫基-5-甲氧基甲氧基-4(S)-[N-(4-苯氧基苯基羰基)胺基]戊醯胺、 (297) N-羥基-2(S)-苯硫基-5-乙氧基甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (29 8) N-羥基-2(S)-甲硫基-5-乙氧基甲氧基-4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (299) N-羥基-2(S)-(4-吡啶基)硫基-5-乙氧基甲氧基_ 4(S)-[N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (300) N-羥基-2(S)-羥基-5-甲氧基甲氧基-4(S)-[N-(4 -苯氧基苯基羰基)胺基]戊醯胺、 (301) N-羥基-2(R)-羥甲基-5-乙氧基甲氧基-4(S)-[N_ (4-氯苯基羰基)胺基]戊醯胺、 經濟部中央標準局員工福利委員會印製 (302) N-羥基-2(R)-甲氧基甲基-5-乙氧基甲氧基-4(S) -[N-(4-硝苯基羰基)胺基]戊醯胺、 (3 03) N-羥基-2(R)-苄氧甲基-5-乙氧基甲氧基-4(S)-[ N-(4-硝基苯基羰基)胺基]戊醯胺、 (304) N-羥基-2(R)-(2-甲氧基乙氧基)甲基-5-乙氧基甲 氧基-4(S)-[N-(4-硝苯基羰基)胺基]戊醯胺、 (305) N-羥基-2(R)-甲氧基甲基-5-(2-甲氧基乙氧基)甲 氧基-4(SMN-(4-氰苯基羰基)胺基]戊醯胺、 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公髮) 37 310112 568897 H3 經濟部中央標準局員工福利委員會印製 (306) N-羥基- 2(R) -甲氧基甲基-5-乙氧基甲氧基- 4(S) -[N-(反-4-甲基環己基基羰基)胺基]戊醯胺、 (307) N-羥基-2(R)-甲氧基甲基-5-乙氧基甲氧基-4(S) -[N-(4-溴苯基羰基)胺基]戊醯胺、 (308) N-羥基-2(R)-甲氧基甲基-5-乙氧基甲氧基-4(S) -[N-(4-氯苯基羰基)胺基]戊醯胺、 (309) N-羥基-2(R)-苄氧基甲基-5-(2-甲氧基乙氧基)甲 氧基_4(SMN-(4-氰苯基羰基)胺基]戊醯胺、 (310) N-羥基-2(R)-T氧基甲基-5-乙氧基甲氧基-4(S) -[N-(4_氯苯基羰基)胺基]戊醯胺、 (311) N-羥基-2(R)-苄氧基甲基-5-乙氧基甲氧基-4(S) -[N-(4-溴苯基羰基)胺基]戊醯胺、 (312) N-羥基-2(R)-[2-(3-甲氧基苯氧基)乙基]-5-乙氧 基甲氧基-4(S)-[N-(4-硝基苯基羰基)胺基]戊醯 胺、 (313) N-羥基-2(R)-甲氧基甲基-5-乙氧基甲氧基-4(S) -[N-[(2-硝基噻吩-5-基)羰基]胺基]戊醯胺、 (314) N-羥基-2(R)-甲氧基甲基-5-乙氧基甲氧基-4(S) -[N-[(2-溴噻吩-5·基)羰基]胺基]戊醯胺、 (315) N-羥基-2(RM2-甲氧基乙氧基)甲基-5-乙氧基甲 氧基-4(S)-[N-(4-溴苯基羰基)胺基]戊醯胺、 (316) N-羥基-2(RM2-甲氧基乙氧基)甲基-5-(2-甲氧 基乙氧基)甲氧基-4(S)-[N-(4-氰基苯基羰基)胺 基]戊醯胺、 (317) N-羥基-2(R)-(2-甲氧基乙氧基)甲基-5-乙氧基甲 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 38 310112 568897 _____H3_ 氧基-4(S)-[N-(4-氯苯基羰基)胺基]戊醯胺、 (318) N-羥基-2(R)-苄氧甲基-5-乙氧基甲氧基-4(S)-[ N-(反-4-甲基環己基羰基)胺基]戊醯胺、 (319) N-羥基-2 (RM3-噻吩基)甲氧基甲基-5-乙氧基 甲氧基-4(S)-[N-(4-硝基苯基羰基)胺基]戊醯 胺、 (3 20) N-羥基-2(R)-(2-吡啶基)甲基·5-羥基-4(S)-[N- (4-苯氧基苯基羰基)胺基]戊醯胺、 (321) N·羥基-2(S)-甲基-5-羥基-4(SMN-(4-苯氧基 苯基羰基)胺基]戊醯胺、 (322) N-羥基-2(S)-甲基-5-羥基-4(S)-[N-(4·溴苯基 羰基)胺基]戊醯胺、 (323) N-羥基-2(S)-(3-甲氧基苄基)-5-羥基-4(S)-[N- (4-溴苯基羰基)胺基]戊醯胺、 (3 24) N-羥基- 2(S)-(3-甲氧基苄基)-5-羥基·4(3)-[Ν- (4-硝基苯基羰基)胺基]戊醯胺、 (3 25) Ν-羥基-2(S)-(3-甲氧基苄基)-5-羥基-4(S)-[N- (4-氯苯基羰基)胺基]戊醯胺、 經濟部中央標準局員工福利委員會印製 (326) N-羥基-2(S)-(3-甲氧基苄基)-5-羥基 [(2-溴噻吩-5-基)羰基]胺基]戊醯胺、 (327) N-羥基-2(S)-(3-甲氧基苄基)-5-羥基 [(2-硝基噻吩-5-基)羰基]胺基]戊醯胺、 (328) N-羥基-2(S)-(3-甲氧基苄基)·5-羥基 (4-氰苯基羰基)胺基]戊醯胺、 (329) Ν-羥基-2(R)-〒氧基甲基-5-羥基-4(S)-[ + (4_ 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 39 310112 568897 H3 經濟部中央標準局員工福利委員會印制衣 硝基苯基羰基)胺基]戊醯胺、 (330) N-羥基-5-甲氧基甲氧基-4(S)-[N-甲基-N-[4-(4 -氯苯基)苯基羰基]胺基]戊醯胺、 (331) N-羥基-2(S)-(3-吡啶基)甲基-5-甲氧基甲氧基-4(S)-[N-甲基-Ν-[4·(4-氯苯基)苯基羰基]胺基] 戊醯胺、 (332) Ν-羥基-2(S)-甲基-5-乙氧基甲氧基-4(SMN-甲基-N-(4-溴苯基羰基)胺基]戊醯胺、 (333) N-羥基-2(S)-3-(甲氧基T基)-5-乙氧基甲氧基-4(S)-[N-甲基-N-(4-溴苯基羰基)胺基]戊醯胺、 (334) N-羥基-2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-甲 基-N-(4-硝基苯基羰基)胺基]戊醯胺、 (335) N-羥基-2(S)-甲基-5-T氧基甲氧基-4(S)-[N-甲 基-N-(4-硝基苯基羰基)胺基]戊醯胺、 (336) N-羥基-2(S)-(3-甲氧基 T基)-5-羥基-4(S)-[N-甲基-N-(4-氯苯基羰基)胺基]戊醯胺、 (3 37) N-羥基-2(S)-(3-甲氧基苄基)-5-羥基-4(S)-[N-甲基-N-(4-硝基苯基羰基)胺基]戊醯胺、 (33 8) N-羥基- 2(S)-(3·甲氧基 T 基)-5-羥基-4(S)-[N-甲基-N-(4-溴苯基羰基)胺基]戊醯胺、 (339) N-羥基-2(S)-甲基-5·羥基-4(S)-[N-甲基-Ν·(4-硝基苯基羰基)胺基]戊醯胺、 (340) Ν-羥基-2(S)-T 基-5-羥基-4(S)-[N-甲基-Ν-(4-硝基苯基羰基)胺基]戊醯胺、 (341) Ν-羥基-2(S)-甲基-5-羥基-4(S)-[N-甲基(心 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 40 310112 568897 Η3 溴苯基羰基)胺基]戊醯胺、 (342) N-羥基-2(S)-〒基-5·羥基- 4(S)-[N-甲基 溴苯基羰基)胺基]戊醯胺、 (343) N-羥基-2(S)-甲基-5-羥基-4(S)-[N-甲基 氯苯基羰基)胺基]戊醯胺、 (344) N-羥基-2(S)-苄氧基-3(S)-羥基-4-(Ν·(4-(>_ 氧基-1-丙炔基)苯基羰基)胺基)丁醯胺、 (345) Ν·羥基-2-Τ氧基-4-(Ν-(4-(3-甲氧基-卜珂炔基) 苯基羰基)胺基)-2-丁烯醯胺、 (346) 順-1·(Ν-羥基胺基羰基甲基)-2-(N-(4-(3-_ -1-丙炔基)苯基羰基)胺基)環戊烷、 (347) 反-1-(N-羥基胺基羰基甲基)-2-(N-(4-(3-_ -1_丙炔基)苯基羰基)胺基)環戊烷、 (348) 反-1-(Ν·羥基胺基羰基)·3-(Ν-(4-(3-甲氧基-卜 丙炔基)苯基羰基)胺基)環戊烷、 (349) 順-1-(Ν-羥基胺基羰基)-3-(Ν-(4-(3-甲氧基-卜 丙炔基)苯基羰基)胺基)環戊烷、 經濟部中央標準局員工福利委員會印製 (350) 反-1-(Ν-羥基胺基羰基)-2-(Ν-(4-(3-甲氧 丙炔基)苯基羰基)胺基甲基)環戊烷、 (351) N-羥基-2(R)-烯丙基-5-乙氧基甲氧基-4(ShfN_( 4-苯氧基苯基羰基)胺基]戊醯胺、 (352) N-羥基-2(R)-T基-5-甲氧基甲氧基+ (苯并咲喃-2-基)苯基幾基]胺基]戊醯胺、 (353) N-羥基-2(R)-甲基-5-乙氧基甲氧基·4(3)-[Ν-(4·* 苯氧基苯基幾基)胺基]戊醯胺、 ^ 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 41 310112 568897 (3 54) N-羥基-2(R)-甲基-5-乙氧基甲氧基-4(S)-[N-[心 (4-氰基苯基)苯基羰基]胺基]戊醯胺、 (3 55) N-羥基-2(S)-T基-5-甲氧基甲氧基-4(R)-[N-(心 苯氧基苯基羰基)胺基]戊醯胺、 (3 56) N-羥基-2(S)-T基-5-甲氧基甲氧基-4(RMN-[心 (3-苯氧基-1-丙炔基)苯基羰基]胺基]戊醯胺、 (357) N-羥基- 2(S)-(3-胺基T基)-5-乙氧基甲氧基-4(S )-[N-(反-4-甲基環己基羰基)胺基]戊醯胺' (35 8) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4-羰基苯基羰基)胺基]戊醯胺、 (359) N-羥基-2(S)-苄基-5-乙氧基甲氧基-4(S)-[N-(4-胺基苯基羰基)胺基]戊醯胺、 (360) N-羥基-2(S)-T 基-5-乙氧基甲氧基-4(S)-[N-(4-哌啶基羰基)胺基]戊醯胺、 (361) N-羥基-2(S)-(3-羥基T基)-5-乙氧基甲氧基-4(S )-[N-(4-甲基苯基羰基)胺基]戊醯胺、 (362) N-羥基-2-T基-4-[N-[4-(苯并呋喃-2-基)苯基羰 基]胺基]丁醯胺、 經濟部中央標準局員工福利委員會印製 (3 63) N-羥基- 2-(3-苯基丙基)-4-[N-[4-(苯并呋喃- 2-基)苯基羰基]胺基]丁醯胺、 (364) N-羥基-2-(2-苯基乙基)-4-[N-[4-(苯并呋喃-2-基)苯基羰基]胺基]丁醯胺、 (3 65) N-羥基-2-〒基·4-[Ν-[4-[2Ε-(4-氯苯基)乙烯基] 苯基羰基]胺基]丁醯胺、 (366) Ν-羥基-2-苄基-4-[Ν-(4-苯氧基苯基羰基)胺基] 本紙張尺度適用中國國家標準(CNS) Α4規袼(210 X 297公釐) 568897 H3 丁醯胺、 (3 67) N-羥基-2-(萘-1-基)甲基-4-[N-(4-苯氧基苯基羰 基)胺基]丁醯胺、 (368) N-羥基-2-異丙基-4-[N-(4-苯氧基苯基羰基)胺基 ]丁醯胺、 (369) N-羥基-2-(嗤啉-4-基)甲基-4-[N-(4-苯氧基苯基 羰基)胺基]丁醯胺、 (370) N-羥基-2-(2-吡啶基)甲基-4-[N-(4-苯氧基苯基 羰基)胺基]丁醯胺、 (371) N-羥基-2-(3-吡啶基)甲基·4·[N-(4-苯氧基苯基 羰基)胺基]丁醯胺、 (372) N-羥基-2-(萘-2-基)甲基-4-[N-(4-苯氧基苯基羰 基)胺基]丁醯胺、 (373) N-羥基-2-(4-吡啶基)甲基-4-[N-(4-苯氧基苯基 羰基)胺基]丁醯胺、 (374) N-羥基-2-(3-甲氧基T基)-4-[N-(4-苯氧基苯基 羰基)胺基]丁醯胺、 經濟部中央標準局員工福利委員會印製 (375) N-羥基-2-異丁基-4-[N-(4-苯氧基苯基羰基)胺基 ]丁醯胺、 (376) N-羥基-5-甲氧基-4(S)-[N-[4-(4-氯苯基)苯基羰 基]胺基]戊醯胺、 (377) N-羥基-2(S)-甲基-5-琥珀醯亞胺-4(S)-[N-(4·氯 苯基羰基)胺基]戊醯胺、 (378) N-羥基-2(S)-甲基-5-琥珀醯亞胺氧基-4(SMN· 甲基-N-(4-硝基苯基羰基)胺基]戊醯胺、 本紙張尺度適用中國國家標準(CNS) A4規格(210x297公釐) 43 310112 568897 H3 (379) N-羥基-2(S)-甲基-5-乙氧基甲氧基-4(S)-[N-(4-苯氧基苯基羰基)胺基]戊醯胺、 (3 80) N-羥基-2(S)-烯丙基-5-乙氧基甲氧基-4(8)-[Ν-( 4-苯氧基苯基羰基)胺基]戊醯胺、 (381) Ν-羥基-2(S)-甲基-5-乙氧基甲氧基-4(S)_[N-[4-(4-氰苯基)苯基羰基]胺基]戊醯胺。 9·如申請專利範圍第2項之化合物,其中之化合物爲下列 化合物或其無毒性之鹽者: (1) 1-乙醯基硫基-5-乙氧基甲氧基-4-[N-(4-苯氧基 苯基羰基)胺基]戊烷、 (2) 5-乙氧基甲氧基-4-[Ν-(4·苯氧基苯基羰基)胺基] 戊烷硫醇。 10·如申請專利範圍第3項之化合物,其中之化合物爲下列 化合物或其無毒性之鹽: (64) 2(SM2-丙炔基)-5-乙氧基甲氧基-4(S)-[N-(4-硝基苯基羰基)胺基]戊酸、 (67) 2(S)-(2-丙炔基)-5-乙氧基甲氧基-4(S)-[N-(4- 溴苯基羰基)胺基]戊酸、 經濟部中央標準局員工福利委員會印製 (68) 2(S)-(2-丙炔基)-5·乙氧基甲氧基·4〇-[Ν-(4- 氯苯基羰基)胺基]戊酸、 (79) 2(S)-(2-丙炔基)-5-(2-甲氧基乙氧基)甲氧基-4(S)-[N-(心氰基苯基羰基)胺基]戊酸。 1 1 ·如申請專利範圍第3項之化合物,其中之化合物爲下列 化合物或其無毒性之鹽: (170) N-羥基-2(S)-(2-丙炔基)-5-乙氧基甲氧基-4(S)- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 44 310112 H3 ___— [N-(4-硝基苯基羰基)胺基]戊醯胺、 (172) N-羥基-2(S)-(2-丙炔基)-5-乙氧基甲氧基-4(S)· [N-(4-溴苯基羰基)胺基]戊醯胺、 (173) N-羥基-2(S)-(2-丙炔基)-5-乙氧基甲氧基-4(S)-[N-(4-氯苯基羰基)胺基]戊醯胺、 (177) N-羥基-2(S)-(2-丙炔基)-5-(2-甲氧基乙氧基)甲 氧基-4(S)-[N-(4-氰苯基羰基)胺基]戊醯胺。 12.如申請專利範圍第1項之化合物,係 N-羥基-5-[N-[4-(苯并呋喃-2-基)苯基羰基]胺基]戊醯 胺、 N-羥基-6-[N-[4-(苯并呋喃-2-基)苯基羰基]胺基]己醯胺 或其非毒性鹽者。 13·—種用於抑制金屬蛋白酶之醫藥組成物,其係含有申請專 利範圍第1項之式(I)所示之化合物或其非毒性鹽作爲有 效成分。 經濟部中央標準局員工福利委員會印製 14.一種用於治療風濕性關節炎、骨關節炎、病態的骨吸收、 骨質疏鬆症、牙周病、間質性腎炎、動脈硬化、肺氣腫、 肝硬化、角膜損傷、癌細胞之轉移浸潤或增殖之疾病、自 體免疫疾病、白血球系細胞之血管滲出或浸潤引起之疾 病、血管新生、多發性硬化症、大動脈瘤、子宮內膜症之 醫藥組成,物,其係含有申請專利範圍第1項之式(I)所示 之化合物或其非毒性鹽作爲有效成分。 本紙張尺度適用中國國家標準(CNS) A4規袼(210 X 297公釐) 45 310112 568897 SL2.2 2 附件四 第87116686專利申請案 補充實施例 (91年2月22日) 青施例72至72 ( 7) 使用適當之化合物進行與實施例1—實施例2—實施例· 實施例4相同之操作,獲得下列化合物。 管施例72 N-羥基-5-乙氧基甲氧基_2 (R)-甲氧基甲基-4 (S) _【N (4-氰基苯基羰基)胺基]戊醯胺TLC ·· Rf 0.38 (氣仿:甲醇=9··1); 經濟部中央標準局員工福利委員會印製 NMRide-DMSO) : δ 10.44(1H, s), 8/75(lH, s), 8.40(1H, d, J^S.7Hz), 7·97(2Η, d, J=8·册zh 7.95(2H, d, J=8·册z), 4·58(2Η, s), 4·16-4·〇3(ΐΗ,n), 3·54-3·28(6Η,里),3·17(3Η, s),2·44· 2.33(1H, m), 1.80-L69(1H, a),L68一 1·55(1Η, ah 1·07(3Η, t, J=7.1Hz)。 實施例72 ( 1 ) N_經基-2 (R)-乙氧基甲基-5 -乙氧基甲氧基-4 (4-硝基笨基羰基)胺基]戊醯胺 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1 310112 568897 H3NO〇 TLC : Rf 0.29 (氣仿:甲醇=19:1); NMRide-DMSO) : δ 10.45(s, 1H), 8.75(s, 1H), 8.49((1, J=8.4Hz, 1H), 8.30(d, J=8.8Hz, 2H), 8.06(d, J=8.8Hz, 2H), 4.59(s, 2H), 4.21-4.00(m, 1H), 3.60-3.28(m, 8H), 2.43-2.26(β, 1H), 1. 86-1.50(m, 2H), 1.08(t, J=7.0HzJ 3H), 1.05(t, J=7.0Hz, 3H)〇 管施例72 ( 2) N-羥基-5-乙氧基甲氧基-2 (S) - (3-噻嗯基甲基)-4 (S) -[N- (4_硝基苯基羰基)胺基]戊醯胺〇 一 OCHsCH;} 〇 〇 經濟部中央標準局員工福利委員會印製 TLC : Rf 0.43 (氣仿:甲醇=9:1); NMR(de-DMSO) : δ 10.42(s, 1H), 8.72(s, 1H), 8.50(d, J=8.4Hz, 1H), 8.30(d, J=8.7Hz, 2H), 8.07(d, J=8.7Hz, 2H), 7.39(dd, J=5.1, 3.9Hz, 1H), 7.07(1, 1H), 6.89(dd, J=5.1, L2Hz, 1H), 4.58(s, 2H), 4.28-4.13(a, 1H), 3.51(d, J=5.7Hz, 2H), 3.45(q, J=7.2Hz, 2H), 2.85-2.68(η, 2H), 2.42-2.28(m, 1H), 1·83-1.60(μ, 2H), 1.08(t, J=7.2Hz, 3H)〇 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公爱) 2 310112 568897 H3 f施例72 ( 3 ) N-羥基-5-乙氧基甲氧基-2 (S) - (3-呋喃基甲基)-4 (S) -[N- (4-硝基苯基羰基)胺基]戊醯胺〇CH2CH3 TLC : Rf 0·43 (氣仿··甲醇二 9:1); NMR(de-DMSO) : δ 10.45(brs, 1H), 8.75(brs, 1H), 8-51(d, J=8.0Hz, 1H), 8.29(d, J=8-8Hz, 2H), 8.07(d, J=8.8Hz, 2H), 7.51(m, 1H), 7.35(ι, 1H), 6.28(m, 1H), 4.59(s, 2H), 4.30-4.04(a, 1H), 3.62-3.38(a, 4H), 2.70-2.45(m, 2H), 2.40-2.20(1, 1H), 1.90-1.58(m, 2H), l-〇7(t, J=7.〇Hz, 3H)〇 實施例72 ( 4) N-羥基-5-乙醯氧基·2 (S)-苯甲基_4 (S) _[N- (4_硝基 笨基羰基)胺基]戊醯胺經濟部中央標準局員工福利委員會印製 NMR(de-DMSO) : δ 10.38(s, 1H), 8.65(brs, 1H), 8.57(d, J=8.4Hz, 1H), 8·32-8·28(·, 2H>, 8,07-8.03(麗,2H), 7·26-7·11(ιβ,5H), 4.35-4.23《屋,1H), 4.11(dd, J=ll.lHz, 4.2Hz, 1H), 4.01(dd, J=1L1, 6.6Hz, 1H), 2.84-2.68(m, 2H), 2.43-2.34(m, 1H), 1.93(s, 3H), L80-1.63(m, 2H)〇 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 3 310112 568897 H3 jr 施例 72 ( 5) N-羥基-5-乙氧基甲氧基-2 (R)-甲氧基甲基-4 ( S) (4- (2-呋喃基)苯基羰基)胺基]戊醯胺經濟部中央標準局員工福利委員會印製 TLC : Rf 0.39 (氣仿:甲醇:乙酸··水=1〇〇:1〇:1:1); NMR(CDC13 + CD30D(微量)7.82((1, J=8』Hz32H),7.n(d,J=8·册z, 2H), 7.51(a, 1H), 7.17(d, J=8.8Hz, 1H), 6.75(ι, 1H), 6.50<m, 1H), 4.71(d, J=6.6Hz, 1H), 4.67(d, J=6.6Hz, 1H), 4.31(ι, 1H), 3.73-3.46(a, 6H), 3.35(s, 3H), 2·64(·, 1H), 2·11(·, 1H), 1.83(a, 1H), 1.20(t, J=7,lHz, 3H)〇 f施例72 ( 6) N-羥基-5-乙氧基甲氧基-2 ( S)-苯甲基-4 ( S) -[N- ( 2-噁雙環[0,1,4]庚烷-5-基羰基)胺基]戊醯胺TLC : Rf 0.27 (氣仿:甲醇=19:1); NMR(de-DMSO) : δ 10.32(s, 1H), 8-67 (s, 1Η), 7.58-7.44 (ι, 1H), 7.28-7.03(1, 5H), 4.58-4.50(·, 2H), 4.00-3.81(m, 1H), 3.55-3.24(m, 4H), 3.18-3.02(1, 2H), 2.78-2.59(ι, 2H), 2.32-2.17(m, 1H), 2.11-1.77(i, 4H), 1.76-L2K·, 5H)a M6-L04(m, 3H)〇 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 4 310112 568897 H3 實施例72 ( 7) N-羥基-5-乙氧基甲氧基-2 (S)_苯甲基-4 (S) -[N- ( 3 ’ 4-二甲氧基苯基羰基)胺基]戊醯胺TLC : Rf 0.36 (氣仿:甲醇二 19:1); NMRide-DMSO) : δ 10^36(s, 1H), 8.67(s, lfl), 7.95((1, J = 8.4Hz, 1H), 7.52-7.40(·, 2H), 7.28-7.04(ι, 5H), 6.99(d, J = 8.4 Hz, 1H), 4.57(s, 2H), 4.30-4-13U, 1H), 3.80(s, 3H), 3.79(s, 3H), 3.58-3.39(m, 4fi), 2.84-2·68(β, 2H), 2.42-2.28(a, 1H), L84-1.58(a, 2H), l.〇8(t, J = 7.0 Hz, 3H)〇 實施例73 ( 1 )至73 ( 2) 經濟部中央標準局員工福利委員會印製 使用反-2·胺基甲基環己酸(J.Chem.Soc.Perkin Trans I, 2563 ( 1982)記載之化合物)或2-胺基環己基乙酸 (J.Chem.S oc· Perkin Trans I,2555 ( 1982)記載之化合物) 與適當之醯基幽,進行與實施例1—實施例2—實施例3—實 施例4相同之操作,獲得下列化合物。 實施例73〔 1、 反-1- (N_羥基胺基羰基)-2-[ (4-硝基苯基羰基)胺基甲 基]環己烷 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇 X 297公釐) 5 310112 568897 H3 ΟTLC : Rf 0·38 (氣仿:曱醇=9:1); NMR(de-DMSO) :δ 10.43(8, 1Η), 8-57(t, J=5.4HZ, 1H), 8.28(d, J=8.9Hz3 2H), 8.05(d, J=8.9Hz, 2H), 3·20-3.02(ι, 2H), 1.95-1.55(a, 6H), 1.55-L30(m, 1H), 1·3(Μ·02(β,2H), 1.00-0.80(a, Iff)。 實施例73 ( 2) 反-1- (N-羥基胺基羰基甲基)-2-[ (4-硝基苯基羰基)胺 基]環己烷 HO^xr 〇 TLC ·· Rf 0·37 (氣仿··甲醇=9:1); NMR(de-DMSO) : δ 10.33(s, 1H), 8.62(d, J=8-7Hz, 1H), 8.29 (d, J=8.7Hz, 2H), 8.05(d, J=8.7Hz, 2H), 3.70-3.50(ι, 1H, overlap with H20 in DMSO), 2.16(dd, J=14.1, 3·3Ηζ, 1H), 2.00-1.60(a, 6H), 1.45-0-85(m, 4H)〇 經濟部中央標準局員工福利委員會印製 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 6 310112 568897 附件六 第8 7 1 1 6 6 8 6號專利申請案& 補充藥理數據 MI0P-5 :藥理數據表(1)實施例編號 R9 !C50(/iM) 明膠酶A 膠原酶 基質溶素 49(133) 〇 0.27 0.81 1.40 49(144) 〇 5.50 17.0 48(128) 0.44 0.38 0.34 49(150) 4.60 4.10 IC50 = 50%抑制濃度 1 310112 568897 MIOP-5 :藥理數據表(2) 表2實施例編號 R9 IC50(/iM) 明膠酶A 基質溶素 49(135) ~〇^Me 0.14 0.66 49(125) 0.31 1.10實施例編號 R9 ICSO (μ Μ) 明膠酶A 基質溶素 49(188) _0^Br 0.0019 0,049 49(189) 0-0041 0.12 2 310112 568897 MIOP-5 :藥理數據表(3) ^_4 hohnoc/^^nhco^r9 實施例編號 R9 IC50("M) 明膠酶A 基質溶素 4(13) |~0_ 0.165 1.68 4(4) 2.75 12.7 表5 HOHNOC"^Nv^^nhco*rS 實施例編號 R9 IC50 (β Μ) 明谬酶A 基質溶素 4(21) 0.038 2.80 4(18) 3.46 9.96 3 310112 568897 MIOP-5 :藥理數據表(4) 表 6 實施例編號 R2, R4, R6 !C50(//M) 明膠酶A 基質溶素 4 R2=R4=R6=H 0.0029 1.80 12 Η2=: OH R4=R6=H 0.0033 1.30 24 R4=OH R2=R6=H 0.0050 1.50 49(1) R6=CH20H R2=R4=H 0.0019 0.54 HOHNOC^__7 HOHNOCxS:;;^NHC 實施例編號 IC50(//M) 明膠酶A 基質溶素 4 0.0029 1.80 24(5) 0.472 16.9 310112 第871 1668 6號專利申請案 實施例之基與實施例編號之對照表 568897 附 件.ΜίΟΡ_5 ··實施例之基之實施例編號表(1) 九[I:實施例編號 R1 -COOH [2], ^COOMe [3], -COOEt [1], -C00t8u (281, .COOCH2*Ph [34], -CONHOH [4], -C0NH0-C(Me)2-0Me [3], -CH2C0NH0H [4(25)], -CH2CH2CONHOH [4(26)] -CH2-SH [68], -CH2-S-C0Me [67], % 有關實施例之基[]内或其右側所示之數字為實施例編號。 第2頁之[]内若無特別言明係有關R2之實施例。 []内若有R4或R6,則係有關R4或R6之實施例。 粗髏且下附二底線者為追加實施例之基β 568897 Mt〇P-5:實施例之基之實施例編號表(2) [1:實施例編號 1 1 f f f 3 Η [1] Me [71], Et (49(98)), Pr (49(95)], iPr (61 (7)], iBu (62), -CH2<CH=CH2 (49(102)1 -0CH20CH2-Ph (R4: 24(6)], -OH (12], -OH (R4: 24], -OCOMe [R4: 21], -0CH20Me [R4: 24(2)], -0CH20CH2-Ph (12(2)], -OCH2COOH [14], -OCH2COOtBu [13], -OCH2CONMe«Ph -OCH2CONMe-CH2-Ph [17], .〇CH2CONMe-(CH2)2-Ph (17(2)], •SMe [49(232)1· -S-Ph [49(230)], [49(233)] -CH20H (2η, -CH20H [Π6: 49(1)], -CH20Me (44(8)], -CH2QEt [72(1)] .ΟΜθ 崩‘ -CH2CH20Ph (49(212)), -(CH2)2-G-〇 49(246) 鬌, —[R6: 66(1)] •CH20CH2-Ph [261· —0H2OCH2-^ 49(253) -CH2-O.COMe fR6: 72⑷ 1· -CH2-0-C0tSu [R6: 49(69)] -CH2-0-(CH2)2-0W1 -CH2-0-CH2-0W2 W1=:Me (49(249)], W2sMe [R6: 41], Et [R6: 44(4)], CH2-Ph [Π6: 49(25)], -CH2CH2-OM9 [R6: 44(13)] -CH2N(Me)2 (49(110)] -CH2COOtBu [49(96)] .(CH2)r-Ph (r«1 (49(3)], 2 [49(208)], 3 [49(6)], 4 [49(209)]), -CH2-8 QQ 49(123) 72(3) 〇 ^2(2) ¢^49(219) 〇ρ^49(174) • QL>49(155) 03^(127) CO 61(8) ^9(200) ^ <H2〈^ ,2 ^Ζ1)Γ (Z1)r=:OMe [49(163)], N02 [49(230)], Cl [49(194)], OH (60(5)], NH2 (60(1)1 Q^-[49(124)Jr OCF3 [49(198)1, diOMe (49(170)] 〇〇 49(136) Mm [49(151)], ^H2*〇 tR6: SS1 •CH2-CH=CH-Ph [49(5}1· =12+34 : -(0^(2)3- [56(4)1.彳CH2座(73(1)] =HCH2)3· [56丨· ^CH2M; [73(2)) R2^R6 ^ ^(CH2)2- [56(2)1 ^2CH^^2-0-Q (Q=£t [49(104)1,CH20Me (49(111)]) 568897 MIQP^ :實施例之基之實施例編號表(3)Ph [27], cydo3 [49(137)1, cycloS [49(144)), cyclo-S [49(130}】,cydo-7 [49(149>1, 一 Ο 49(139) & 49(74) Hy 49(75) CS> 49(150^ d? 49(132) ζ) 49(169) 60(4) <SD 49(137)CX^) 4(22> 49(76) 72(6) -C0NH2 [49(142)] -NHC〇.(4.Me-Ph) (49(66)] ^COOH (60(2)], COOMe [49(143)], -CHO (49(139)], COMe (49(157)], -COPh [49(45)] -CH^CH-GS (G5=:cip (49(63)], ^O"01 [4(1〇)Π-C C-GS G6= H (49(175)], CSH11 (4(35)], I [49(148)], -<ch2)^n^^ 49(122) -(CH2)2-OH[31], -CH2-OR35 (R3S=Me (4(7)], Ph (4(30)] -〇-Ci W29)]) -S02NH.(4-Sr-Ph) [4(14)1 :CH2 [49(177)] (4(13)]. Q1 H [4(9)]f Me [2(1)], Et [49(134)], Pr (4(12)1,Bu (4(8)1 <^>(15) CjO 4_ & 72(5) O 4(5}〇i>4 cc>49^ CXn>49(64) [4(16)1,OMe [4(20)1,〇& (^9(43)1, ^ Cl [4(18)],. CN [49(60)], 〇H (4(17)], 〇P^ (49(49)], .0-CH2-CONH2 [4(27)] -CH2-CN [49(50)], Ph [49(51)] [4(28)1 πν〇*〇·ί^[4(33Η [49(33)1 '^ r/Ln\] OPh f4(24)l, -O-pyridine (49(82)], *0CH2-Ph 0Hf49(129)l, OMe (49(225)], 08u (4(3)1,OPh [4(^ li, (Z4-OH (49(52)1,OMe (4(31)1,[49(57)1, Ρ(49(7η], Br(44(1S)], Ci [12(5)1,1(49(124)], (49(47)]) N〇2 (49(187)1, CN (44(13)]5|8897 十 M[0P-5 :申請專利範圍及實施例 第8711668 6號專利申請案 申請專利範圍與實施例之對照表Ph=苯基, Naph=萘基, cyclo-3=環丙基, cyclo_5=環戊基, cyclo-6環己基, cyclo-7=環庚基, substd?經取代 請求項(符號及定義) 實施例+補充實^Π R1 -COOR10, -(CH2)mCONHOR10 R10=(i) H, (ii) C1-S alkyl, I; (以經Ph或OMe取代之Cl-4烷基 m=0, 1,2 •(CH2)nSR50 RSO=Ht COMe n=s〇-3 <COOHf -COOMe, -COOEt, -COOtBu, — •COOCH2-Ph, ^ ^CONHOH, -C0NH0-C(Me)2-0Me, -CH2C0NH0H, -CH2CH2CONHOH ^CH2-SH, -CH2-S-C0Me, 粗體二底線之基係補充實施例之基。 對應之實施例另示於他表。 省略但書· / 568897 M【〇P_5 :申請專利範圍及實例< 請求項(符號及定義) 實施例+補充實施例_之基 R3. RS. R2. R4, R€ ^ Η -1) Η, Η — Η 2)Cl-6 烷基, Me, Et, Pr, \Pr, iBut 3) C2-6鏈烯基5 -CH2-CH=CH2 4) -0R11, R11 =H, -COMe, -CH20R15 (R15=Me, CH2-Ph) -OH, -OCOMe, -0CH20Me, -OCH2〇CH2-Ph, •CH2COOH,-CH2COOtBu, •0CH2C00H, ·0ΟΗ2Ο30ίΒΐ·ΐ, -CH2CONR20R21 -0CH2C0NMe-Pht -OCH2CONMe-CH2-Ph R20, R21 = Me, Ph,苯基取代之Cl-2烧基 -OCH2CONMe-(CH2)2-Pht 5) -SMe, -SPh, 3-¾咬 -SMe, -S-Ph, 6) 0R111取代之Cl-2烷基 Φ Rlll=(a)H,(b)Cl-4 烷基, -CH2QH. -CH20Me. -CH20Ei OMe (c) 可經OMe取代之苯基, (d) 琥珀醯亞胺 -CH2CH20Phf -<ch2)2.〇-<5 -OM2 -O— (e)CH2-Ph,(f)噻嗯基甲基 (g)-C2-7 醯基 6 -CH20CH2-Ph, —CH2O0H2-^ (h)-Cl-2 烷基-0-W •*CH2-0-00Me . -CH2-0-C0tSu W=可經Ph,OMe取代之C1-4烷基 -CH2-0-(CH2)2-0W11 -CH2-0-CH2-0W2 W1=sMe, 7) -CH2NR12R13 (R12, R13=H,Me) W2=Me, El CH2-Ph, -CH2CH2-OMe 8)-CH2COO-(Cl-4 烷基) -CH2N(Me)2 9)-(CH2)q-Cycl q=l-4 -CH2COOtBu, Cycl=(l)苯基、萘基、呋嘀基、噻嗯 .(CH2)q-Ph (q=1-4), 基、吼咬基、笨并咲蜂基、 -CH2·3 B= GO 0 0 苯并噻嗯基、吲哚基、喹啉 基、苯并三唑基 CO CO CO cx> (2)可經(Zl)r取代之ph Γ=1,2 ^CH2〇 r<2 Zl=OMe,Ν02,鹵素,〇Η νη2, 笨并块锋基,〇CF3 ^(2i)r (Z1)r=OM0, N02f Cl, OH, NH2 、 〇CF3, diOMe (3)可經Me取代之吲哚基 〇 (4) X=NMe, CH2; 22, Z3=H, Me 1〇)可經苯基取代之C2-6鍵烯基 -CH2-CH:CH-Ph· R2+R4 =-(CH2)s- (s=:3f4), f W4.R4 = -(CH213-, -fCH2^4-. R4+R6 =-(CH2)t- (t = 3,4), f = -(CH2、3-. -rCH2、4· R2+R6 = *(CH2)u- (u = 2), or f 心邮= -(CH2)2' 脅麵··,孀•碡·_<···_·_嫌看嫌 R2=2-丙炔基,R4, R6=同上 j ,· · -..................................................- 丙块基,fl4=H. ^6=-CH20CH2-0-Q (Q=a. CH20Me) 568897 M[〇P—5:申請專利範圍及實施例 請求項(符號及定義) 實施例+補充實施例之芊 R8 H, Me HT Me --- R9 -(Ring A)-(R25)p -(Ring A)-(R25)p _ 環A Ph,C3-7環烷基, 環己烯基、金鋼烷基 呋嘀基、噻嗯基、吡咯基、吡啶基、哌啶基、 1,3-二嗥烷基、苯并呋喃基、吲哚基、苯并 噻唑基、2-噁雙環[1,0,4]庚基 Ph, cycio-3, cycio-5t cycio-6, cycio-7 o or h ' ύ O 〇 〇 〇 ⑺ o3 co o: R25 1) G1 2) C0NH2, 3> NHC0-G2 (G2=可經Me取代之苯基) 4) C00-G3 (G3=H, Me) 5) -C0-G4 (G4=sHt Me, Ph) 6) -CH=CH-G5 吡啶基,可經產素取代之苯基 7) -C2C-G6 G6=(a)H,(b)C4·6 烷基,(c)鹵素, (d) 可經Me、味唑基、取代之苯基 (e) 可經味吐基、OR35(R35為氫或Me) 取代之C14烷基、可經鹵素取代之苯基 8) -S〇2NH-G7 (G7=可經鹵素取代之苯基) 9) =CH2 參照G1 __ -C0NH2 -NHC〇.(4-Me-Ph) -C00H, COOMe, -CHO, COMe, -COPh -CH=CH:G5 (G5= ) -C=C-G6 Go= H, C5H11, I, ^ΟΗ2)^ν2> -(CH2)2-〇H, -CH2-OR35 (R35=Me,Ph:^Q^a ) -S02NH-(4-3r-Ph) =CH2 G1 I) H2)Cl-6 院基, 3) 環己基、萘基、呋喃基、吡咯基、苯 并呋喃基、笨并噻嗯基、苯井噁唑基 4) 可經下列(i)至(ix)之基取代之苯基 (i)Cl«4 烷基,(ii)Cl-2 烷氧基, (iii)鹵素,(iv)CN,(vPB (vi)笨氧基 (vii>OCH2CONH2, (viii>CH2CN, (ix)Ph 5) 經苯基或苯氧基取代之派啶基 6) 經苯基取代之1,2,5,6»四氫吡啶 7) -OR355, ^55=(1)¾ (2)C1 «4 炫基,(3)Ph (4)11 比啶基 (5)CH2-Ph, (6)經Z4取代之苯基 Z4=〇H〇Me,Ph,經OMe取代之苯基 8) 鹵素,9)NO2,10)CN, f II) -NR36R37, R36, R37=H, Me . 1 H, Me, Et, Pr, Bu O CO- (f? ώ Q—^ R=Pr, OMe, oet, Cl, CNt OH, OPh, -0-CH2-C0NH2 · OH2-CN, Ph k —N y^Ph ~N )>-〇.Ph 一〇-ph OH. OMe, OBu, OPh, ·0-ϋ比咬, -0CH2-Ph,分 (Z4=0H, OMe, Ph, OMe) F, Br, Cl, lf N02, CN NH2, N(Me)2 P 1-4 1,2: (R2S)2=OMe and N02, diQMe 冬:(R25)4=四個 Me — 單鍵、雙鍵 單鍵、雙鍵 其無毒性鹽
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29183497 | 1997-10-09 | ||
JP2853398 | 1998-02-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW568897B true TW568897B (en) | 2004-01-01 |
Family
ID=26366653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW087116686A TW568897B (en) | 1997-10-09 | 1998-10-09 | Aminobutanoic acid derivatives |
Country Status (15)
Country | Link |
---|---|
US (1) | US6420427B1 (zh) |
EP (1) | EP1024134A4 (zh) |
JP (1) | JP3155536B2 (zh) |
KR (1) | KR20010024456A (zh) |
CN (1) | CN1282319A (zh) |
AU (1) | AU760181B2 (zh) |
BR (1) | BR9812807A (zh) |
CA (1) | CA2305463C (zh) |
HU (1) | HUP0100579A3 (zh) |
NO (1) | NO20001813L (zh) |
NZ (1) | NZ503789A (zh) |
RU (1) | RU2215735C2 (zh) |
TR (3) | TR200101020T2 (zh) |
TW (1) | TW568897B (zh) |
WO (1) | WO1999019296A1 (zh) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020002419A (ko) * | 1999-04-06 | 2002-01-09 | 우에노 도시오 | 4-아미노부탄산 유도체 및 그 유도체를 유효성분으로 하는약제 |
AUPP982399A0 (en) * | 1999-04-19 | 1999-05-13 | Fujisawa Pharmaceutical Co., Ltd. | Mmp inhibitor |
GB9914825D0 (en) * | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
EP1293202A4 (en) * | 2000-02-10 | 2004-12-22 | Ono Pharmaceutical Co | MEDICINE FOR DEGENERATIVE ARTHRITIS |
US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
SK13072002A3 (sk) | 2000-03-17 | 2003-08-05 | Bristol-Myers Squibb Pharma Company | Deriváty cyklických beta-aminokyselín ako inhibítory matrixových metaloproteáz a TNF-alfa |
US20040068015A1 (en) * | 2000-04-06 | 2004-04-08 | Hiroyuki Matsuno | Remedies for diseases due to stenotic lesions of blood vessel |
JP2001335476A (ja) * | 2000-05-29 | 2001-12-04 | Shionogi & Co Ltd | 三環化合物の新規用途 |
US6462076B2 (en) * | 2000-06-14 | 2002-10-08 | Hoffmann-La Roche Inc. | Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
KR20030059125A (ko) * | 2000-09-08 | 2003-07-07 | 오노 야꾸힝 고교 가부시키가이샤 | N-히드록시-2(s)-메틸-5-에톡시메톡시-4(s)-[n-(4-페녹시페닐카르보닐)아미노]펜탄아미드의 신규 결정, 그 제조방법 및 그것을 유효 성분으로서 함유하는 약제 |
GB0023983D0 (en) | 2000-09-29 | 2000-11-15 | Prolifix Ltd | Therapeutic compounds |
US7569724B2 (en) * | 2000-09-29 | 2009-08-04 | Topotarget Uk Limited | Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
US6620829B2 (en) | 2000-10-17 | 2003-09-16 | Warner-Lambert Company | Method of treating noninflammatory cartilage damage |
GB0100761D0 (en) * | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
JP2004359546A (ja) * | 2001-03-15 | 2004-12-24 | Ono Pharmaceut Co Ltd | ヒドロキサム酸誘導体、それらの非毒性塩およびそれらのプロドラッグ体を有効成分として含有する、固形癌の予防および/または治療剤 |
WO2002074298A1 (fr) * | 2001-03-21 | 2002-09-26 | Ono Pharmaceutical Co., Ltd. | Inhibiteurs de production d'il-6 |
WO2003013494A1 (fr) * | 2001-08-06 | 2003-02-20 | Ono Pharmaceutical Co., Ltd. | Agent curatif pour arthrosis deformans |
CA2457033A1 (en) * | 2001-08-20 | 2003-02-27 | Ono Pharmaceutical Co., Ltd. | A medecine for cardiac failure |
EP1426046A4 (en) * | 2001-09-14 | 2005-11-02 | Shionogi & Co | NEW USE OF TRICYCLIC COMPOUNDS |
TW200406197A (en) * | 2002-04-25 | 2004-05-01 | Ono Pharmaceutical Co | Therapelitic agent for inflammatory bowel disease containing hydroxamic acid as effective component |
TW200410923A (en) * | 2002-10-17 | 2004-07-01 | Ono Pharmaceutical Co | Therapeutic agent for chronic obstructive pulmonary disease |
ATE457716T1 (de) | 2002-12-30 | 2010-03-15 | Angiotech Int Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung |
WO2004069158A2 (en) * | 2003-01-27 | 2004-08-19 | Merck & Co., Inc. | Substituted pyrazoles, compositions containing such compounds and methods of use |
JP4790594B2 (ja) * | 2003-02-25 | 2011-10-12 | トポターゲット ユーケー リミテッド | Hdacインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物 |
WO2004089293A2 (en) * | 2003-04-01 | 2004-10-21 | Memorial Sloan-Kettering Cancer Center | Hydroxamic acid compounds and methods of use thereof |
GB0403864D0 (en) * | 2004-02-20 | 2004-03-24 | Ucl Ventures | Modulator |
BRPI0511703B8 (pt) * | 2004-06-04 | 2021-05-25 | Merck Sharp & Dhome Corp | composto, composição farmacêutica, e, métodos de tratar diabete melito tipo 2, de retardar o início do diabete melito tipo 2, de tratar hiperglicemia, diabete ou resistência à insulina, obesidade, síndrome x, um distúrbio lipídico, aterosclerose, e uma condição |
US7709658B2 (en) * | 2005-07-26 | 2010-05-04 | Merck Sharp & Dohme Corp. | Process for synthesizing a substituted pyrazole |
EP2327696A1 (en) | 2006-06-26 | 2011-06-01 | Warner Chilcott Company, LLC | Prolyl hydroxylase inhibitors and methods of use |
US7838542B2 (en) * | 2006-06-29 | 2010-11-23 | Kinex Pharmaceuticals, Llc | Bicyclic compositions and methods for modulating a kinase cascade |
US20080221132A1 (en) * | 2006-09-11 | 2008-09-11 | Xiong Cai | Multi-Functional Small Molecules as Anti-Proliferative Agents |
US7713541B1 (en) * | 2006-11-21 | 2010-05-11 | Abbott Cardiovascular Systems Inc. | Zwitterionic terpolymers, method of making and use on medical devices |
WO2008147480A2 (en) * | 2007-02-01 | 2008-12-04 | Panthera Biopharna, Llc. | Hydroxamic acid derivatives of 3-phenyl propionic acids useful as thrapeutic agents for treating anthrax poisoning |
CA2934114A1 (en) | 2007-06-12 | 2008-12-18 | Achaogen, Inc. | Antibacterial agents |
EP2543368A1 (en) | 2007-12-11 | 2013-01-09 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
JP5713999B2 (ja) * | 2009-05-15 | 2015-05-07 | コリア リサーチ インスティテュート オブ ケミカル テクノロジー | アミド化合物、その製造方法及びそれを含む薬学組成物 |
CN103717214A (zh) | 2011-06-06 | 2014-04-09 | 阿克比治疗有限公司 | 用于稳定低氧诱导因子-2α作为治疗癌症的方法的化合物和组合物 |
NO2686520T3 (zh) | 2011-06-06 | 2018-03-17 | ||
EP2847168A1 (en) | 2012-05-10 | 2015-03-18 | Achaogen, Inc. | Antibacterial agents |
FR3000491B1 (fr) * | 2012-09-27 | 2015-08-28 | Univ Lille Ii Droit & Sante | Composes utilisables dans le traitement des infections mycobacteriennes |
US10550327B2 (en) | 2012-11-21 | 2020-02-04 | Merck Patent Gmbh | Polymerisable compounds and the use thereof in liquid-crystal displays |
RU2019134558A (ru) | 2013-06-13 | 2020-02-20 | Экебиа Терапьютикс, Инк. | Композиции и способы лечения анемии |
AU2014348523B2 (en) | 2013-11-15 | 2019-01-03 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
WO2015107139A1 (en) | 2014-01-17 | 2015-07-23 | Proyecto De Biomedicina Cima, S.L. | Compounds for use as antifibrinolytic agents |
EP3247355A4 (en) | 2015-01-23 | 2018-06-13 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
SG11201707994UA (en) | 2015-04-01 | 2017-10-30 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
KR102386426B1 (ko) * | 2017-10-11 | 2022-04-13 | 정원혁 | 페닐아세틸렌 유도체를 포함하는 pd-1과 pd-l1의 상호작용 억제제 |
CN112088155A (zh) | 2018-05-09 | 2020-12-15 | 阿克比治疗有限公司 | 用于制备2-[[5-(3-氯苯基)-3-羟基吡啶-2-羰基]氨基]乙酸的方法 |
US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2702820A (en) * | 1952-07-12 | 1955-02-22 | Ruhrchemie Ag | Production of acylamino carboxylic acids |
US2745875A (en) | 1953-06-30 | 1956-05-15 | Hoechst Ag | Preparation of nu-acylamino-phenylpropane diols |
DE2234399A1 (de) * | 1972-07-17 | 1974-01-31 | Thomae Gmbh Dr K | Hautschutzmittel |
DE2423390A1 (de) * | 1974-05-14 | 1975-12-04 | Hoechst Ag | Pyroglutamylverbindungen mit antidepressiver wirkung und verfahren zu ihrer herstellung |
US3892801A (en) * | 1974-09-11 | 1975-07-01 | American Cyanamid Co | Method for preparing alkali salts of p-methylaminobenzoylglutamic acid |
JPS545949A (en) * | 1977-06-16 | 1979-01-17 | Hisamitsu Pharmaceut Co Inc | Novel cyclohexanecarboxylic acid and its derivatives |
LU78805A1 (de) * | 1977-12-30 | 1979-07-20 | Byk Gulden Lomberg Chem Fab | Acylhydrocarbylaminoalkansaeuren,ihre herstellung und verwendung sowie sie enthaltende arzneimittel |
JPS57106651A (en) * | 1980-12-23 | 1982-07-02 | Ono Pharmaceut Co Ltd | 1,4-disubstituted benzene compound, its preparation, and inhibitor against leukotriene biosynthesis comprising it as active ingredient |
JPS6210052A (ja) | 1985-07-05 | 1987-01-19 | Kohjin Co Ltd | N−置換グルタミン酸5−フエニルヒドラジド類の製造方法 |
JPS6281385A (ja) * | 1985-10-02 | 1987-04-14 | Shionogi & Co Ltd | 新規メトトレキサ−ト誘導体 |
GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
SE455093B (sv) * | 1986-07-16 | 1988-06-20 | Nii Farmakol Akad Med | N-nikotinoylaminosyror |
IT1196849B (it) * | 1986-12-16 | 1988-11-25 | Rotta Research Lab | Nuovi derivati degli acidi 5 pentilammino 5 oxo pentaoico e 4 pentilammino 4 oxo butanoico ad attivita antagonista della colecistochinina e procedimento per la loro preparazione |
US4971978A (en) * | 1987-09-21 | 1990-11-20 | Nadzan Alex M | Derivatives of D-glutamic acid and D-aspartic acid |
US5326760A (en) * | 1992-06-29 | 1994-07-05 | Glaxo, Inc. | Aminobutanoic acid compounds having metalloprotease inhibiting properties |
US5594006A (en) * | 1993-03-18 | 1997-01-14 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives as matrix metalloproteinases inhibitors |
UA48121C2 (uk) | 1993-11-04 | 2002-08-15 | Сінтекс (С.Ш.А.) Інк. | Інгібітори матричних металопротеаз і фармацетична композиція на їх основі |
KR980009238A (ko) | 1995-07-28 | 1998-04-30 | 우에노 도시오 | 설포닐아미노산 유도체 |
DK0757984T3 (da) | 1995-08-08 | 2003-03-03 | Ono Pharmaceutical Co | Hydroxamsyrederivater, der kan anvendes til inhibering af gelatinase |
US5665777A (en) * | 1995-11-14 | 1997-09-09 | Abbott Laboratories | Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
JP2000502343A (ja) | 1995-12-22 | 2000-02-29 | ワーナー―ランバート・コンパニー | マトリックスメタロプロテイナーゼのインヒビターとしての芳香族ケト酸およびその誘導体 |
TW448172B (en) * | 1996-03-08 | 2001-08-01 | Pharmacia & Upjohn Co Llc | Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation |
GB9707333D0 (en) | 1997-04-11 | 1997-05-28 | British Biotech Pharm | Metalloproteinase inhibitors |
BR9810841A (pt) | 1997-07-31 | 2001-07-10 | Procter & Gamble | Inibidores de metaloprotease alicìclicos |
-
1998
- 1998-09-07 EP EP98947771A patent/EP1024134A4/en not_active Withdrawn
- 1998-09-07 CN CN98811901A patent/CN1282319A/zh active Pending
- 1998-09-07 US US09/529,056 patent/US6420427B1/en not_active Expired - Fee Related
- 1998-10-07 CA CA002305463A patent/CA2305463C/en not_active Expired - Fee Related
- 1998-10-07 HU HU0100579A patent/HUP0100579A3/hu unknown
- 1998-10-07 RU RU2000111472/04A patent/RU2215735C2/ru not_active IP Right Cessation
- 1998-10-07 NZ NZ503789A patent/NZ503789A/xx unknown
- 1998-10-07 TR TR2001/01020T patent/TR200101020T2/xx unknown
- 1998-10-07 BR BR9812807-8A patent/BR9812807A/pt not_active Application Discontinuation
- 1998-10-07 KR KR1020007003763A patent/KR20010024456A/ko not_active Application Discontinuation
- 1998-10-07 WO PCT/JP1998/004529 patent/WO1999019296A1/ja not_active Application Discontinuation
- 1998-10-07 JP JP2000515869A patent/JP3155536B2/ja not_active Expired - Fee Related
- 1998-10-07 AU AU94580/98A patent/AU760181B2/en not_active Ceased
- 1998-10-07 TR TR2000/01732T patent/TR200001732T2/xx unknown
- 1998-10-07 TR TR2001/01019T patent/TR200101019T2/xx unknown
- 1998-10-09 TW TW087116686A patent/TW568897B/zh active
-
2000
- 2000-04-07 NO NO20001813A patent/NO20001813L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO20001813L (no) | 2000-06-09 |
KR20010024456A (ko) | 2001-03-26 |
EP1024134A1 (en) | 2000-08-02 |
CA2305463A1 (en) | 1999-04-22 |
JP3155536B2 (ja) | 2001-04-09 |
US6420427B1 (en) | 2002-07-16 |
HUP0100579A2 (hu) | 2001-05-28 |
RU2215735C2 (ru) | 2003-11-10 |
TR200001732T2 (tr) | 2001-01-22 |
AU760181B2 (en) | 2003-05-08 |
AU9458098A (en) | 1999-05-03 |
EP1024134A4 (en) | 2003-05-14 |
NO20001813D0 (no) | 2000-04-07 |
CA2305463C (en) | 2005-12-27 |
BR9812807A (pt) | 2000-10-17 |
CN1282319A (zh) | 2001-01-31 |
WO1999019296A8 (en) | 2000-11-02 |
WO1999019296A1 (fr) | 1999-04-22 |
TR200101019T2 (tr) | 2002-06-21 |
NZ503789A (en) | 2002-11-26 |
TR200101020T2 (tr) | 2002-06-21 |
HUP0100579A3 (en) | 2001-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW568897B (en) | Aminobutanoic acid derivatives | |
US11639353B2 (en) | Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors | |
US10214540B2 (en) | Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes | |
CN104822680B (zh) | 咪唑并吡啶化合物 | |
ES2383239T3 (es) | Compuestos de ácidos policíclicos útiles como antagonistas de CRTH2 y como agentes antialérgicos | |
US10717736B2 (en) | Pyrrole amides as alpha V integrin inhibitors | |
EP3053916B1 (en) | Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof | |
TW200304808A (en) | N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives | |
CA3007280A1 (en) | Apelin receptor agonists and methods of use | |
CN111683926A (zh) | 化合物 | |
CN106164047B (zh) | 作为阿立新受体拮抗剂的1,2-取代环戊烷 | |
CN114555594A (zh) | 作为trmp8调节剂的取代的氮杂环 | |
RO117791B1 (ro) | Derivati ai acidului 1-(2-oxo-acetil)-piperidin-2-carboxilic, procedeu de obtinere, compozitie farmaceutica care ii contine si metoda de tratament | |
CA2922532A1 (en) | Aminoheteroaryl benzamides as kinase inhibitors | |
CN105228982A (zh) | 用于治疗过度增殖性病症的3-乙酰基氨基-1-(苯基-杂芳基-氨基羰基或苯基-杂芳基-羰基氨基)苯衍生物 | |
BR112020022340A2 (pt) | benzamidas substituídas por 1,3-tiazol-2-il para o tratamento de doenças associadas com sensibilização de fibras nervosas | |
CN109071563A (zh) | 布鲁顿氏酪氨酸激酶的抑制剂及其使用方法 | |
CN110520413B (zh) | 大环广谱抗生素 | |
EP2729149A1 (en) | Voltage-gated sodium channel blockers | |
CN112047944A (zh) | 一种选择性抑制激酶化合物及其用途 | |
WO2018140339A1 (en) | Amide compounds and use thereof | |
TW202333663A (zh) | Rxfp1促效劑 | |
WO2021218992A1 (zh) | 取代的吡咯烷类化合物及其在药物中的应用 | |
JPH10509706A (ja) | エンドセリン拮抗剤 | |
JP2001172245A (ja) | アミノブタン酸誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent |